Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:progestogen
go back to main search page
Accession:CHEBI:50745 term browser browse the term
Definition:A compound that interacts with progesterone receptors in target tissues to bring about effects similar to those of progesterone.
Synonyms:related_synonym: gestagen;   gestagens;   progestagen;   progestagens;   progestogens


show annotations for term's descendants           Sort by:
11-deoxycorticosterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acta2 actin alpha 2, smooth muscle increases expression
multiple interactions 		ISO Desoxycorticosterone results in increased expression of ACTA2 mRNA; Desoxycorticosterone results in increased expression of ACTA2 protein
Rotenone inhibits the reaction [Desoxycorticosterone results in increased expression of ACTA2 protein] 		CTD PMID:17596522 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Agt angiotensinogen increases activity EXP Desoxycorticosterone results in increased activity of AGT protein CTD PMID:9087624 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases metabolic processing ISO AKR1C18 protein results in increased metabolism of Desoxycorticosterone CTD PMID:17122075 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Ar androgen receptor multiple interactions ISO Desoxycorticosterone binds to and results in increased activity of AR protein mutant form CTD PMID:11956172 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein]; atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein] CTD PMID:22431579 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein]; Atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein] CTD PMID:22431579 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Cat catalase multiple interactions EXP CAT protein results in increased susceptibility to [tert-Butylhydroperoxide co-treated with Desoxycorticosterone co-treated with tempol] CTD PMID:12646410 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 mRNA; [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein] CTD PMID:21135038 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Cdh1 cadherin 1 decreases expression
multiple interactions 		ISO Desoxycorticosterone results in decreased expression of CDH1 mRNA; Desoxycorticosterone results in decreased expression of CDH1 protein
Rotenone inhibits the reaction [Desoxycorticosterone results in decreased expression of CDH1 protein] 		CTD PMID:17596522 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression
multiple interactions 		EXP Desoxycorticosterone results in increased expression of CYBA mRNA; Desoxycorticosterone results in increased expression of CYBA protein
[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of CYBA protein 		CTD PMID:16271043 PMID:22431579 NCBI chr19:50,487,598...50,495,669
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 affects metabolic processing
multiple interactions
increases chemical synthesis 		ISO
EXP 		CYP11B1 protein affects the metabolism of Desoxycorticosterone
Plant Extracts inhibits the reaction [Desoxycorticosterone binds to CYP11B1 protein]
CYP11B1 protein results in increased chemical synthesis of Desoxycorticosterone 		CTD PMID:15666820 PMID:16054388 PMID:19900470 NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 affects metabolic processing
multiple interactions
increases hydroxylation 		ISO CYP11B2 protein affects the metabolism of Desoxycorticosterone
[CYP11B2 protein results in increased hydroxylation of Desoxycorticosterone] which results in increased chemical synthesis of Corticosterone 		CTD PMID:15985365 PMID:21384875 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Edn1 endothelin 1 multiple interactions
increases expression 		EXP [Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased expression of EDN1 mRNA; [Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased expression of EDN1 protein; Clofibrate inhibits the reaction [Desoxycorticosterone results in increased expression of EDN1 protein]; Mibefradil inhibits the reaction [[Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased expression of EDN1 mRNA]
Desoxycorticosterone results in increased expression of EDN1; Desoxycorticosterone results in increased expression of EDN1 protein 		CTD PMID:1860718 PMID:8934362 PMID:12600921 PMID:16054168 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Ednra endothelin receptor type A multiple interactions
affects response to substance 		EXP [5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide binds to and results in decreased activity of EDNRA protein] inhibits the reaction [Desoxycorticosterone results in increased chemical synthesis of Reactive Oxygen Species]; [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of EDNRA protein
EDNRA protein affects the susceptibility to Desoxycorticosterone 		CTD PMID:12600921 PMID:16271043 PMID:22431579 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Egf epidermal growth factor multiple interactions
increases response to substance 		EXP 4,5-dianilinophthalimide inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone]; RTKI cpd inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone] CTD PMID:11751714 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP Desoxycorticosterone promotes the reaction [EP300 protein binds to SULT1A1 promoter]; Desoxycorticosterone promotes the reaction [EP300 protein binds to TAT promoter] CTD PMID:22465009 NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574 		JBrowse link
G Fabp3 fatty acid binding protein 3 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of FABP3 protein; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of FABP3 protein] CTD PMID:21135038 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881 		JBrowse link
G Gas6 growth arrest specific 6 multiple interactions EXP GAS6 protein promotes the reaction [Desoxycorticosterone results in increased expression of IL6 protein]; GAS6 protein promotes the reaction [Desoxycorticosterone results in increased expression of TNF protein] CTD PMID:19564549 NCBI chr16:76,045,430...76,075,904
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of GPX1 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of GPX1 protein]; atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of GPX1 protein] CTD PMID:22431579 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of HAVCR1 mRNA CTD PMID:21135038 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of IL1B mRNA CTD PMID:21135038 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions 		EXP Desoxycorticosterone results in increased expression of IL6 protein
GAS6 protein promotes the reaction [Desoxycorticosterone results in increased expression of IL6 protein] 		CTD PMID:19564549 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Lcn2 lipocalin 2 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of LCN2 mRNA; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of LCN2 mRNA] CTD PMID:21135038 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 affects localization EXP Desoxycorticosterone affects the localization of NCF1 protein CTD PMID:16271043 NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079 		JBrowse link
G Nos3 nitric oxide synthase 3 decreases phosphorylation
multiple interactions
increases expression 		EXP Desoxycorticosterone results in decreased phosphorylation of NOS3 protein
NOS3 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein]
Desoxycorticosterone results in increased expression of NOS3 protein 		CTD PMID:11834524 PMID:14993198 PMID:16271043 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of NOX1 protein CTD PMID:22431579 NCBI chr  X:101,572,338...101,625,571
Ensembl chr  X:101,572,340...101,595,520 		JBrowse link
G Nppa natriuretic peptide A increases expression EXP Desoxycorticosterone results in increased expression of NPPA protein CTD PMID:2965178 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 increases phosphorylation
multiple interactions
decreases expression 		ISO
EXP 		Desoxycorticosterone results in increased phosphorylation of NR3C1 protein
Desoxycorticosterone promotes the reaction [NR3C1 protein binds to TAT promoter]
Desoxycorticosterone results in decreased expression of NR3C1 mRNA
Desoxycorticosterone binds to and results in increased activity of NR3C1 protein 		CTD PMID:8969928 PMID:11956172 PMID:18483179 PMID:22465009 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 decreases expression EXP Desoxycorticosterone results in decreased expression of NR3C2 mRNA CTD PMID:8969928 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Pdgfa platelet derived growth factor subunit A multiple interactions EXP [PDGFA protein binds to PDGFB protein] which results in increased susceptibility to Desoxycorticosterone CTD PMID:11751714 NCBI chr12:15,645,549...15,667,056
Ensembl chr12:20,754,208...20,780,322 		JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions EXP [PDGFA protein binds to PDGFB protein] which results in increased susceptibility to Desoxycorticosterone CTD PMID:11751714 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343 		JBrowse link
G Pomc proopiomelanocortin increases abundance ISO POMC protein results in increased abundance of Desoxycorticosterone CTD PMID:3015796 NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO PPARA protein affects the susceptibility to [Sodium Chloride, Dietary co-treated with Desoxycorticosterone] CTD PMID:16054168 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha increases expression ISO Desoxycorticosterone results in increased expression of PPARGC1A mRNA CTD PMID:23056435 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression EXP Desoxycorticosterone results in increased expression of PTGS2 protein CTD PMID:15834289 PMID:16271043 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Rac1 Rac family small GTPase 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of RAC1 protein CTD PMID:22431579 NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109 		JBrowse link
G Ren renin multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of REN protein CTD PMID:11039 NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions EXP Desoxycorticosterone inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions EXP Desoxycorticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353 		JBrowse link
G Slco1a1 solute carrier organic anion transporter family, member 1a1 multiple interactions
decreases activity 		EXP Desoxycorticosterone inhibits the reaction [SLCO1A1 protein results in increased uptake of estradiol-17 beta-glucuronide]
Desoxycorticosterone results in decreased activity of SLCO1A1 protein 		CTD PMID:11883641 NCBI chr 4:176,606,924...176,682,027
Ensembl chr 4:176,607,687...176,681,992 		JBrowse link
G Sod1 superoxide dismutase 1 decreases expression
multiple interactions 		EXP Desoxycorticosterone results in decreased expression of SOD1 protein
[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD1 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD1 protein]; atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD1 protein]; tempol inhibits the reaction [Desoxycorticosterone results in decreased expression of SOD1 protein] 		CTD PMID:12646410 PMID:22431579 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
decreases expression 		EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein]; Atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein]; SOD2 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein]
Desoxycorticosterone results in decreased expression of SOD2 protein 		CTD PMID:11834524 PMID:22431579 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of SPP1 mRNA; [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of SPP1 protein; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of SPP1 mRNA] CTD PMID:21135038 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 multiple interactions EXP Desoxycorticosterone promotes the reaction [EP300 protein binds to SULT1A1 promoter] CTD PMID:22465009 NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131 		JBrowse link
G Tat tyrosine aminotransferase multiple interactions EXP Desoxycorticosterone promotes the reaction [EP300 protein binds to TAT promoter]; Desoxycorticosterone promotes the reaction [NR3C1 protein binds to TAT promoter] CTD PMID:22465009 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482 		JBrowse link
G Tnc tenascin C multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TNC mRNA; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TNC mRNA]; Spironolactone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TNC mRNA] CTD PMID:21135038 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		EXP GAS6 protein promotes the reaction [Desoxycorticosterone results in increased expression of TNF protein] CTD PMID:19564549 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tp53 tumor protein p53 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein]; atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein] CTD PMID:22431579 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions
increases expression 		EXP NOS3 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein]; SOD2 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein] CTD PMID:11834524 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Xdh xanthine dehydrogenase increases activity
multiple interactions 		EXP Desoxycorticosterone results in increased activity of XDH protein
Desoxycorticosterone promotes the reaction [XDH protein results in increased chemical synthesis of Reactive Oxygen Species] 		CTD PMID:16271043 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350 		JBrowse link
17alpha-hydroxyprogesterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO 17-alpha-Hydroxyprogesterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Ar androgen receptor increases activity
multiple interactions 		ISO 17-alpha-Hydroxyprogesterone results in increased activity of AR protein
17-alpha-Hydroxyprogesterone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] 		CTD PMID:21543282 PMID:33049310 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions EXP [Diethylstilbestrol results in decreased expression of CYP11A1 protein] which results in decreased abundance of 17-alpha-Hydroxyprogesterone CTD PMID:23873838 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 affects abundance
increases metabolic processing
multiple interactions
affects metabolic processing
affects chemical synthesis 		ISO CYP17A1 protein affects the abundance of 17-alpha-Hydroxyprogesterone
CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone
[[abiraterone results in decreased activity of CYP17A1 protein] which results in decreased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone; [CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone; [CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone] which results in increased chemical synthesis of Androstenedione; Duloxetine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone]; Duloxetine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone] which results in increased chemical synthesis of Androstenedione]; Duloxetine Hydrochloride inhibits the reaction [CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone]; TNF protein inhibits the reaction [CYP17A1 protein affects the metabolism of 17-alpha-Hydroxyprogesterone]; Venlafaxine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone]; Venlafaxine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone] which results in increased chemical synthesis of Androstenedione]; Venlafaxine Hydrochloride inhibits the reaction [CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone]
CYP17A1 protein affects the chemical synthesis of 17-alpha-Hydroxyprogesterone 		CTD PMID:16030167 PMID:17194026 PMID:21427057 PMID:29100959 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO 17-alpha-Hydroxyprogesterone binds to and results in increased activity of ESR1 protein CTD PMID:33049310 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO 17-alpha-Hydroxyprogesterone binds to and results in increased activity of ESR2 protein CTD PMID:33049310 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO [17-alpha-Hydroxyprogesterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein CTD PMID:29782964 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Ins2 insulin 2 multiple interactions ISO 17-alpha-Hydroxyprogesterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; [17-alpha-Hydroxyprogesterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein CTD PMID:29782964 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO 17-alpha-Hydroxyprogesterone binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO 17-alpha-Hydroxyprogesterone analog binds to and results in increased activity of NR3C1 protein CTD PMID:18060946 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO 17-alpha-Hydroxyprogesterone analog binds to and results in increased activity of PGR protein CTD PMID:18060946 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO 17-alpha-Hydroxyprogesterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO TNF protein inhibits the reaction [CYP17A1 protein affects the metabolism of 17-alpha-Hydroxyprogesterone] CTD PMID:16030167 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
21-dehydrocortisol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1b15 aldo-keto reductase family 1 member B15 multiple interactions EXP [AKR1B8 protein co-treated with NADP] affects the reduction of 21-dehydrocortisol CTD PMID:18845131 NCBI chr 4:63,964,421...63,976,995
Ensembl chr 4:63,960,880...63,978,349 		JBrowse link
5alpha-pregnane-3,20-dione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1c1 aldo-keto reductase family 1, member C1 affects reduction
increases reduction 		ISO AKR1C1 protein affects the reduction of 5-alpha-Dihydroprogesterone
AKR1C1 protein results in increased reduction of 5-alpha-Dihydroprogesterone 		CTD PMID:11995921 PMID:12604236 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 affects reduction
increases reduction 		ISO AKR1C2 protein affects the reduction of 5-alpha-Dihydroprogesterone
AKR1C2 protein results in increased reduction of 5-alpha-Dihydroprogesterone 		CTD PMID:11995921 PMID:12604236 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases chemical synthesis ISO AKR1C3 protein results in increased chemical synthesis of 5-alpha-Dihydroprogesterone CTD PMID:25463305 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 increases chemical synthesis
multiple interactions 		ISO AKR1D1 protein results in increased chemical synthesis of 5-alpha-Dihydroprogesterone
AKR1D1 protein alternative form results in increased chemical synthesis of 5-alpha-Dihydroprogesterone
[AKR1D1 protein alternative form results in increased reduction of Progesterone] which results in increased chemical synthesis of 5-alpha-Dihydroprogesterone 		CTD PMID:18624455 PMID:30928400 NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases expression 		ISO 3-hydroxypregn-4-en-20-one inhibits the reaction [5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA] CTD PMID:19931389 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 increases hydroxylation ISO CYP17A1 protein results in increased hydroxylation of 5-alpha-Dihydroprogesterone CTD PMID:14522586 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Egr2 early growth response 2 increases expression EXP 5-alpha-Dihydroprogesterone results in increased expression of EGR2 mRNA; 5-alpha-Dihydroprogesterone results in increased expression of EGR2 protein CTD PMID:17478888 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Esr1 estrogen receptor 1 increases expression ISO 5-alpha-Dihydroprogesterone results in increased expression of ESR1 mRNA CTD PMID:17683929 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta decreases expression EXP 5-alpha-Dihydroprogesterone results in decreased expression of GSK3B protein CTD PMID:17443805 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Mapt microtubule-associated protein tau decreases expression
increases phosphorylation 		EXP 5-alpha-Dihydroprogesterone results in decreased expression of MAPT protein
5-alpha-Dihydroprogesterone results in increased phosphorylation of MAPT protein 		CTD PMID:17443805 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 affects activity
multiple interactions 		ISO 5-alpha-Dihydroprogesterone affects the activity of NR1I2 protein
5-alpha-Dihydroprogesterone binds to and results in increased activity of NR1I2 protein
NR1I2 protein affects the susceptibility to [5-alpha-Dihydroprogesterone co-treated with Methacholine Chloride]; NR1I2 protein affects the susceptibility to [5-alpha-Dihydroprogesterone co-treated with N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide] 		CTD PMID:15846226 PMID:16054614 PMID:17159084 PMID:21291553 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity ISO 5-alpha-Dihydroprogesterone results in increased activity of NR1I3 protein CTD PMID:28927721 NCBI chr13:83,632,940...83,638,193
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Sox10 SRY-box transcription factor 10 increases expression EXP 5-alpha-Dihydroprogesterone results in increased expression of SOX10 mRNA; 5-alpha-Dihydroprogesterone results in increased expression of SOX10 protein CTD PMID:17478888 NCBI chr 7:112,605,721...112,615,097
Ensembl chr 7:112,605,721...112,615,990 		JBrowse link
G Srd5a1 steroid 5 alpha-reductase 1 multiple interactions
increases chemical synthesis 		ISO [SRD5A1 protein results in increased metabolism of Progesterone] which results in increased chemical synthesis of 5-alpha-Dihydroprogesterone
SRD5A1 protein results in increased chemical synthesis of 5-alpha-Dihydroprogesterone 		CTD PMID:23183084 PMID:25463305 NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:35,514,846...35,548,903 		JBrowse link
6alpha-methylprednisolone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases expression
increases secretion 		ISO ABCB1 gene polymorphism affects the susceptibility to [Methotrexate co-treated with Methylprednisolone]; ABCB1 protein results in increased susceptibility to [Methotrexate co-treated with Methylprednisolone]; Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Methylprednisolone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Methylprednisolone]
Methylprednisolone results in increased expression of ABCB1 mRNA; Methylprednisolone results in increased expression of ABCB1 protein 		CTD PMID:16932953 PMID:22079615 PMID:22464980 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions ISO Methylprednisolone inhibits the reaction [ABCG2 protein affects the transport of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] CTD PMID:15365089 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Ackr3 atypical chemokine receptor 3 decreases expression ISO Methylprednisolone results in decreased expression of ACKR3 mRNA CTD PMID:19192274 NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:98,246,605...98,260,214 		JBrowse link
G Adora2a adenosine A2a receptor decreases expression ISO Methylprednisolone results in decreased expression of ADORA2A mRNA CTD PMID:19192274 NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases phosphorylation
multiple interactions 		EXP Methylprednisolone results in decreased phosphorylation of AKT1 protein
naringin inhibits the reaction [Methylprednisolone results in decreased phosphorylation of AKT1 protein] 		CTD PMID:15187100 PMID:30878453 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
increases secretion 		EXP Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein]; Nebivolol promotes the reaction [Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein]] CTD PMID:30291735 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 decreases expression ISO Methylprednisolone results in decreased expression of AMIGO2 mRNA CTD PMID:19192274 NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 increases expression ISO Methylprednisolone results in increased expression of ANTXR1 mRNA CTD PMID:19192274 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Aox1 aldehyde oxidase 1 increases expression ISO Methylprednisolone results in increased expression of AOX1 mRNA CTD PMID:19192274 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Ar androgen receptor multiple interactions ISO Methylprednisolone binds to and results in decreased activity of AR protein; Methylprednisolone binds to and results in increased activity of AR protein CTD PMID:25752796 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) decreases expression ISO Methylprednisolone results in decreased expression of ASNS mRNA CTD PMID:19192274 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of BAX mRNA]; Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BAX mRNA]; Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BAX protein] CTD PMID:17570061 PMID:26093215 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions EXP Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]; Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] CTD PMID:17570061 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2a1 BCL2-related protein A1 decreases expression ISO Methylprednisolone results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein decreases secretion
decreases expression
multiple interactions 		EXP Methylprednisolone results in decreased secretion of BGLAP protein
Methylprednisolone results in decreased expression of BGLAP mRNA; Methylprednisolone results in decreased expression of BGLAP protein
[Nebivolol co-treated with Alendronate] inhibits the reaction [Methylprednisolone results in decreased secretion of BGLAP protein]; bisphenol A diglycidyl ether inhibits the reaction [Methylprednisolone results in decreased expression of BGLAP mRNA]; bisphenol A diglycidyl ether inhibits the reaction [Methylprednisolone results in decreased expression of BGLAP protein]; Methylprednisolone inhibits the reaction [bisphenol A diglycidyl ether results in increased expression of BGLAP mRNA]; Methylprednisolone inhibits the reaction [bisphenol A diglycidyl ether results in increased expression of BGLAP protein] 		CTD PMID:30291735 PMID:37659742 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression ISO Methylprednisolone results in decreased expression of BST2 mRNA CTD PMID:19192274 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Capn2 calpain 2 multiple interactions EXP Methylprednisolone inhibits the reaction [Hydrogen Peroxide results in increased expression of CAPN2 protein] CTD PMID:17570061 NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP Methylprednisolone inhibits the reaction [Hydrogen Peroxide results in increased cleavage of and results in increased activity of CASP3 protein] CTD PMID:17570061 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Cat catalase multiple interactions
decreases activity
increases activity 		EXP [Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of CAT protein; Alendronate inhibits the reaction [Methylprednisolone results in decreased activity of CAT protein]; Nebivolol promotes the reaction [Alendronate inhibits the reaction [Methylprednisolone results in decreased activity of CAT protein]]
Methylprednisolone results in increased activity of CAT protein 		CTD PMID:1942778 PMID:30291735 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases expression ISO Methylprednisolone results in decreased expression of CCL20 mRNA; Methylprednisolone results in decreased expression of CCL20 protein CTD PMID:19192274 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Methylprednisolone results in increased expression of CCN1 mRNA CTD PMID:19192274 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression ISO Methylprednisolone results in increased expression of CCN2 mRNA CTD PMID:19192274 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn5 cellular communication network factor 5 increases expression ISO Methylprednisolone results in increased expression of CCN5 mRNA CTD PMID:19192274 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Clgn calmegin decreases expression ISO Methylprednisolone results in decreased expression of CLGN mRNA CTD PMID:19192274 NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions
increases expression 		EXP
ISO 		Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]
Methylprednisolone results in increased expression of COL1A1 mRNA 		CTD PMID:19192274 PMID:26093215 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions EXP Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of COL4A1 mRNA] CTD PMID:1762292 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Ctsd cathepsin D multiple interactions EXP Methylprednisolone inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] CTD PMID:894732 NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression ISO Methylprednisolone results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 decreases expression ISO Methylprednisolone results in decreased expression of CXCL2 mRNA CTD PMID:19192274 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO Methylprednisolone results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression ISO Methylprednisolone results in decreased expression of CXCR4 mRNA CTD PMID:19192274 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases expression
increases activity 		ISO Methylprednisolone results in decreased expression of CYP3A4 mRNA
Methylprednisolone results in increased activity of CYP3A4 protein 		CTD PMID:15964336 PMID:16837568 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression
multiple interactions 		EXP Methylprednisolone results in increased expression of DDIT4 protein
Testosterone inhibits the reaction [Methylprednisolone results in increased expression of DDIT4 protein] 		CTD PMID:21931329 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Dio2 iodothyronine deiodinase 2 increases expression ISO Methylprednisolone results in increased expression of DIO2 mRNA CTD PMID:19192274 NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:115,396,308...115,410,594 		JBrowse link
G Dmd dystrophin multiple interactions ISO Methylprednisolone inhibits the reaction [DMD gene mutant form results in increased expression of RELA protein modified form]; Methylprednisolone inhibits the reaction [DMD gene mutant form results in increased expression of SIRT1 mRNA] CTD PMID:26930420 NCBI chr  X:47,272,324...49,504,219
Ensembl chr  X:51,070,273...53,437,835 		JBrowse link
G Edn1 endothelin 1 multiple interactions EXP Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDN1 mRNA] CTD PMID:7756592 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Ednrb endothelin receptor type B multiple interactions EXP Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDNRB mRNA] CTD PMID:7756592 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 increases expression ISO Methylprednisolone results in increased expression of EFEMP1 mRNA CTD PMID:19192274 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO Methylprednisolone binds to and results in increased activity of ESR1 protein CTD PMID:25752796 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G F8 coagulation factor VIII increases expression ISO Methylprednisolone results in increased expression of F8 protein CTD PMID:20405515 NCBI chr18:140,848...172,330
Ensembl chr18:155,309...186,683 		JBrowse link
G Fabp4 fatty acid binding protein 4 increases expression
multiple interactions 		EXP Methylprednisolone results in increased expression of FABP4 mRNA
bisphenol A diglycidyl ether inhibits the reaction [Methylprednisolone results in increased expression of FABP4 mRNA] 		CTD PMID:37659742 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fbln1 fibulin 1 increases expression ISO Methylprednisolone results in increased expression of FBLN1 mRNA CTD PMID:19192274 NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965 		JBrowse link
G Fbxo32 F-box protein 32 increases expression
multiple interactions 		EXP Methylprednisolone results in increased expression of FBXO32 protein
Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FBXO32 protein] 		CTD PMID:21931329 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fcer2 Fc epsilon receptor II multiple interactions ISO Methylprednisolone inhibits the reaction [IL4 protein promotes the reaction [STAT6 protein binds to FCER2 promoter]]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of FCER2 mRNA]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of FCER2 protein] CTD PMID:11997017 NCBI chr12:6,540,697...6,552,364
Ensembl chr12:6,540,703...6,549,374 		JBrowse link
G Foxo1 forkhead box O1 increases expression
multiple interactions 		EXP Methylprednisolone results in increased expression of FOXO1 protein
echinacoside inhibits the reaction [Methylprednisolone results in increased expression of FOXO1 protein]; Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FOXO1 protein] 		CTD PMID:21931329 PMID:38336255 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Gbp1 guanylate binding protein 1 decreases expression ISO Methylprednisolone results in decreased expression of GBP1 mRNA CTD PMID:19192274 NCBI chr 2:234,071,366...234,106,012
Ensembl chr 2:234,190,708...234,206,802
Ensembl chr 2:234,190,708...234,206,802 		JBrowse link
G Gfap glial fibrillary acidic protein decreases expression ISO Methylprednisolone results in decreased expression of GFAP protein CTD PMID:18509235 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685 		JBrowse link
G Gip gastric inhibitory polypeptide increases secretion EXP Methylprednisolone results in increased secretion of GIP protein CTD PMID:6753106 NCBI chr10:81,465,070...81,473,216
Ensembl chr10:81,465,062...81,473,216 		JBrowse link
G Gpm6b glycoprotein m6b increases expression ISO Methylprednisolone results in increased expression of GPM6B mRNA CTD PMID:19192274 NCBI chr  X:31,689,485...31,836,199
Ensembl chr  X:31,690,359...31,733,272 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO [Polymyxin B co-treated with Methylprednisolone] inhibits the reaction [Alpha-Amanitin results in increased expression of GPT protein]; Methylprednisolone inhibits the reaction [Alpha-Amanitin results in increased expression of GPT protein] CTD PMID:30891624 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
increases activity 		EXP [Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of GPX1 protein
Methylprednisolone results in increased activity of GPX1 protein 		CTD PMID:1942778 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gsdme gasdermin E decreases expression ISO Methylprednisolone results in decreased expression of GSDME mRNA CTD PMID:19192274 NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525 		JBrowse link
G Herc6 HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 decreases expression ISO Methylprednisolone results in decreased expression of HERC6 mRNA CTD PMID:19192274 NCBI chr 4:88,854,612...88,897,043
Ensembl chr 4:88,854,640...88,896,993 		JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated decreases expression ISO Methylprednisolone results in decreased expression of HILPDA mRNA CTD PMID:19192274 NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:58,836,463...58,839,423 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of HMOX1 mRNA] CTD PMID:26093215 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 decreases expression ISO Methylprednisolone results in decreased expression of HSD11B1 mRNA CTD PMID:19192274 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Htr3a 5-hydroxytryptamine receptor 3A multiple interactions
decreases activity 		ISO [Methylprednisolone co-treated with Metoclopramide] results in decreased activity of HTR3A protein; [Methylprednisolone co-treated with ramosetron] results in decreased activity of HTR3A protein
Methylprednisolone results in decreased activity of HTR3A protein 		CTD PMID:15329590 NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884 		JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression ISO Methylprednisolone results in increased expression of ID3 mRNA CTD PMID:19192274 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 decreases expression ISO Methylprednisolone results in decreased expression of IFI27 mRNA CTD PMID:19192274 NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:128,355,079...128,361,781 		JBrowse link
G Ifi35 interferon-induced protein 35 decreases expression ISO Methylprednisolone results in decreased expression of IFI35 mRNA CTD PMID:19192274 NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750 		JBrowse link
G Ifi44 interferon-induced protein 44 decreases expression ISO Methylprednisolone results in decreased expression of IFI44 mRNA CTD PMID:19192274 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877 		JBrowse link
G Ifi44l interferon-induced protein 44-like decreases expression ISO Methylprednisolone results in decreased expression of IFI44L mRNA CTD PMID:19192274 NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:243,328,723...243,366,404 		JBrowse link
G Ifih1 interferon induced with helicase C domain 1 decreases expression ISO Methylprednisolone results in decreased expression of IFIH1 mRNA CTD PMID:19192274 NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:67,637,545...67,683,968 		JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 decreases expression ISO Methylprednisolone results in decreased expression of IFIT3 mRNA CTD PMID:19192274 NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521 		JBrowse link
G Il10 interleukin 10 increases expression ISO Methylprednisolone results in increased expression of IL10 protein CTD PMID:28557239 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA] CTD PMID:26093215 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO Methylprednisolone results in decreased expression of IL1RN mRNA CTD PMID:19192274 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il23a interleukin 23 subunit alpha decreases expression ISO Methylprednisolone results in decreased expression of IL23A mRNA CTD PMID:19192274 NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434 		JBrowse link
G Il4 interleukin 4 multiple interactions
decreases expression 		ISO Methylprednisolone inhibits the reaction [IL4 protein promotes the reaction [STAT6 protein binds to FCER2 promoter]]; Methylprednisolone inhibits the reaction [IL4 protein results in increased activity of and results in increased phosphorylation of STAT6 protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of FCER2 mRNA]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of FCER2 protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of IL4R mRNA]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of IL4R protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased phosphorylation of IL4R protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased phosphorylation of JAK1 protein]
Methylprednisolone results in decreased expression of IL4 protein 		CTD PMID:7988651 PMID:11997017 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il4r interleukin 4 receptor multiple interactions ISO Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of IL4R mRNA]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of IL4R protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased phosphorylation of IL4R protein] CTD PMID:11997017 NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636 		JBrowse link
G Il5 interleukin 5 decreases expression ISO Methylprednisolone results in decreased expression of IL5 protein CTD PMID:7988651 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Il6 interleukin 6 multiple interactions
decreases expression 		EXP
ISO 		Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]
Methylprednisolone results in decreased expression of IL6 mRNA; Methylprednisolone results in decreased expression of IL6 protein 		CTD PMID:19192274 PMID:26093215 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ins1 insulin 1 multiple interactions ISO cobaltiprotoporphyrin inhibits the reaction [Methylprednisolone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Methylprednisolone inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:15919478 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Irf7 interferon regulatory factor 7 decreases expression ISO Methylprednisolone results in decreased expression of IRF7 mRNA CTD PMID:19192274 NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023 		JBrowse link
G Isg15 ISG15 ubiquitin-like modifier decreases expression ISO Methylprednisolone results in decreased expression of ISG15 mRNA CTD PMID:19192274 NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656 		JBrowse link
G Isg20 interferon stimulated exonuclease gene 20 decreases expression ISO Methylprednisolone results in decreased expression of ISG20 mRNA CTD PMID:19192274 NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401 		JBrowse link
G Jak1 Janus kinase 1 multiple interactions ISO Methylprednisolone inhibits the reaction [IL4 protein results in increased phosphorylation of JAK1 protein] CTD PMID:11997017 NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:120,896,046...120,996,758 		JBrowse link
G Lamb1 laminin subunit beta 1 multiple interactions EXP Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA] CTD PMID:1762292 NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:53,563,073...53,630,760 		JBrowse link
G Lamb2 laminin subunit beta 2 multiple interactions EXP Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB2 mRNA] CTD PMID:1762292 NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:118,056,935...118,069,090 		JBrowse link
G Lamb3 laminin subunit beta 3 decreases expression ISO Methylprednisolone results in decreased expression of LAMB3 mRNA CTD PMID:19192274 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081 		JBrowse link
G Ly6e lymphocyte antigen 6 family member E decreases expression ISO Methylprednisolone results in decreased expression of LY6E mRNA CTD PMID:19192274 NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
decreases expression
decreases phosphorylation 		EXP cobaltous chloride inhibits the reaction [Methylprednisolone results in decreased expression of MAPK1 protein modified form]; cobaltous chloride inhibits the reaction [Methylprednisolone results in decreased phosphorylation of MAPK1 protein] CTD PMID:12904460 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate decreases expression ISO Methylprednisolone results in decreased expression of MARCKS mRNA CTD PMID:19192274 NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882 		JBrowse link
G Mbp myelin basic protein decreases expression ISO Methylprednisolone results in decreased expression of MBP protein CTD PMID:18509235 NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase decreases expression ISO Methylprednisolone results in decreased expression of MET mRNA CTD PMID:19192274 NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821 		JBrowse link
G Mmp10 matrix metallopeptidase 10 decreases expression ISO Methylprednisolone results in decreased expression of MMP10 mRNA CTD PMID:19192274 NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613 		JBrowse link
G Mmp12 matrix metallopeptidase 12 decreases expression ISO Methylprednisolone results in decreased expression of MMP12 mRNA CTD PMID:19192274 NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mpo myeloperoxidase multiple interactions
decreases expression 		EXP
ISO 		Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of MPO protein]
[Polymyxin B co-treated with Methylprednisolone] inhibits the reaction [Alpha-Amanitin results in increased activity of MPO protein]; Methylprednisolone inhibits the reaction [Alpha-Amanitin results in increased activity of MPO protein]
Methylprednisolone results in decreased expression of MPO protein 		CTD PMID:26093215 PMID:28557239 PMID:30891624 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Muc5ac mucin 5AC, oligomeric mucus/gel-forming multiple interactions EXP Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of MUC5AC mRNA] CTD PMID:26093215 NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:206,293,869...206,326,006 		JBrowse link
G Mx1 MX dynamin like GTPase 1 decreases expression ISO Methylprednisolone results in decreased expression of MX1 mRNA CTD PMID:19192274 NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904 		JBrowse link
G Ndufa4l2 NDUFA4, mitochondrial complex associated like 2 decreases expression ISO Methylprednisolone results in decreased expression of NDUFA4L2 mRNA CTD PMID:19192274 NCBI chr 7:65,242,169...65,244,296
Ensembl chr 7:65,242,135...65,244,277 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions EXP Methylprednisolone inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA] CTD PMID:26093215 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions EXP Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of NFKB1 mRNA] CTD PMID:26093215 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nid2 nidogen 2 increases expression ISO Methylprednisolone results in increased expression of NID2 mRNA CTD PMID:19192274 NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949 		JBrowse link
G Nmb neuromedin B decreases expression ISO Methylprednisolone results in decreased expression of NMB mRNA CTD PMID:19192274 NCBI chr 1:144,278,678...144,290,523
Ensembl chr 1:144,278,453...144,281,422 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions EXP Methylprednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] CTD PMID:22422321 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 decreases expression ISO Methylprednisolone results in decreased expression of NR4A3 mRNA CTD PMID:19192274 NCBI chr 5:67,157,141...67,198,287
Ensembl chr 5:67,157,375...67,198,285 		JBrowse link
G Oas1a 2'-5' oligoadenylate synthetase 1A decreases expression ISO Methylprednisolone results in decreased expression of OAS1 mRNA CTD PMID:19192274 NCBI chr12:41,330,423...41,341,130
Ensembl chr12:41,285,211...41,341,128 		JBrowse link
G Oas3 2'-5'-oligoadenylate synthetase 3 decreases expression ISO Methylprednisolone results in decreased expression of OAS3 mRNA CTD PMID:19192274 NCBI chr12:35,779,028...35,802,781
Ensembl chr12:41,439,643...41,464,420 		JBrowse link
G Oasl 2'-5'-oligoadenylate synthetase-like decreases expression ISO Methylprednisolone results in decreased expression of OASL mRNA CTD PMID:19192274 NCBI chr12:47,343,551...47,356,509
Ensembl chr12:47,343,551...47,356,483 		JBrowse link
G Phgdh phosphoglycerate dehydrogenase decreases expression ISO Methylprednisolone results in decreased expression of PHGDH mRNA CTD PMID:19192274 NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789 		JBrowse link
G Pla1a phospholipase A1 member A multiple interactions ISO Methylprednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 NCBI chr11:62,320,112...62,357,779
Ensembl chr11:75,825,585...75,878,165 		JBrowse link
G Pla2g4a phospholipase A2 group 4A multiple interactions ISO Methylprednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] CTD PMID:20573295 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Plpp3 phospholipid phosphatase 3 decreases expression ISO Methylprednisolone results in decreased expression of PLPP3 mRNA CTD PMID:19192274 NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
increases expression 		EXP bisphenol A diglycidyl ether inhibits the reaction [Methylprednisolone results in increased expression of PPARG mRNA]; bisphenol A diglycidyl ether inhibits the reaction [Methylprednisolone results in increased expression of PPARG protein]; Methylprednisolone inhibits the reaction [bisphenol A diglycidyl ether results in decreased expression of PPARG mRNA]; Methylprednisolone inhibits the reaction [bisphenol A diglycidyl ether results in decreased expression of PPARG protein]
Methylprednisolone results in increased expression of PPARG mRNA; Methylprednisolone results in increased expression of PPARG protein 		CTD PMID:37659742 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Prelp proline and arginine rich end leucine rich repeat protein increases expression ISO Methylprednisolone results in increased expression of PRELP mRNA CTD PMID:19192274 NCBI chr13:45,368,407...45,391,480
Ensembl chr13:47,922,590...47,932,324 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO Methylprednisolone results in decreased expression of PTGS2 mRNA CTD PMID:19192274 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO Methylprednisolone inhibits the reaction [DMD gene mutant form results in increased expression of RELA protein modified form] CTD PMID:26930420 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Ren renin increases activity
multiple interactions 		EXP Methylprednisolone results in increased activity of REN protein
Sodium Chloride inhibits the reaction [Methylprednisolone results in increased activity of REN protein] 		CTD PMID:235222 PMID:6277579 NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543 		JBrowse link
G Rgs4 regulator of G-protein signaling 4 decreases expression ISO Methylprednisolone results in decreased expression of RGS4 mRNA CTD PMID:19192274 NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884 		JBrowse link
G Rig1 RNA sensor RIG-1 decreases expression ISO Methylprednisolone results in decreased expression of RIGI mRNA CTD PMID:19192274 NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:60,117,398...60,165,995 		JBrowse link
G Ripk2 receptor-interacting serine-threonine kinase 2 decreases expression ISO Methylprednisolone results in decreased expression of RIPK2 mRNA CTD PMID:19192274 NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:34,428,573...34,459,663 		JBrowse link
G Rnf19b ring finger protein 19B decreases expression ISO Methylprednisolone results in decreased expression of RNF19B mRNA CTD PMID:19192274 NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:146,690,577...146,714,394 		JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 decreases expression ISO Methylprednisolone results in decreased expression of RSAD2 mRNA CTD PMID:19192274 NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320 		JBrowse link
G Runx2 RUNX family transcription factor 2 multiple interactions
decreases expression 		EXP bisphenol A diglycidyl ether inhibits the reaction [Methylprednisolone results in decreased expression of RUNX2 mRNA]; bisphenol A diglycidyl ether inhibits the reaction [Methylprednisolone results in decreased expression of RUNX2 protein]; Methylprednisolone inhibits the reaction [bisphenol A diglycidyl ether results in increased expression of RUNX2 protein]
Methylprednisolone results in decreased expression of RUNX2 mRNA; Methylprednisolone results in decreased expression of RUNX2 protein 		CTD PMID:37659742 NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO Methylprednisolone inhibits the reaction [DMD gene mutant form results in increased expression of SIRT1 mRNA] CTD PMID:26930420 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000 		JBrowse link
G Slc43a3 solute carrier family 43, member 3 decreases expression ISO Methylprednisolone results in decreased expression of SLC43A3 mRNA CTD PMID:19192274 NCBI chr 3:90,414,822...90,450,654
Ensembl chr 3:90,415,977...90,436,976 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 decreases expression ISO Methylprednisolone results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695 		JBrowse link
G Sms spermine synthase decreases expression ISO Methylprednisolone results in decreased expression of SMS mRNA CTD PMID:19192274 NCBI chr  X:41,331,693...41,387,713
Ensembl chr  X:41,331,799...41,387,712 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
decreases expression
increases activity 		EXP
ISO 		[Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of SOD2 protein
Methylprednisolone results in decreased expression of SOD2 mRNA
Methylprednisolone results in increased activity of SOD2 protein 		CTD PMID:1942778 PMID:19192274 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Stat1 signal transducer and activator of transcription 1 decreases expression ISO Methylprednisolone results in decreased expression of STAT1 mRNA CTD PMID:19192274 NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stat4 signal transducer and activator of transcription 4 decreases expression ISO Methylprednisolone results in decreased expression of STAT4 mRNA CTD PMID:19192274 NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stat6 signal transducer and activator of transcription 6 multiple interactions ISO Methylprednisolone inhibits the reaction [IL4 protein promotes the reaction [STAT6 protein binds to FCER2 promoter]]; Methylprednisolone inhibits the reaction [IL4 protein results in increased activity of and results in increased phosphorylation of STAT6 protein] CTD PMID:11997017 NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795 		JBrowse link
G Sts steroid sulfatase increases expression ISO Methylprednisolone results in increased expression of STS mRNA CTD PMID:19192274 NCBI chr  X:46,102,524...46,110,868
Ensembl chr  X:46,102,548...46,111,104 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA] CTD PMID:26093215 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Thbs1 thrombospondin 1 increases expression ISO Methylprednisolone results in increased expression of THBS1 mRNA CTD PMID:19192274 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Tlr2 toll-like receptor 2 decreases expression ISO Methylprednisolone results in decreased expression of TLR2 mRNA CTD PMID:19192274 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
decreases expression 		EXP
ISO 		Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TNF mRNA]
[Cyclophosphamide co-treated with Methylprednisolone] inhibits the reaction [Paraquat results in increased expression of TNF protein]
Methylprednisolone results in decreased expression of TNF protein 		CTD PMID:8384958 PMID:26093215 PMID:28557239 PMID:33737140 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfaip2 TNF alpha induced protein 2 decreases expression ISO Methylprednisolone results in decreased expression of TNFAIP2 mRNA CTD PMID:19192274 NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:136,298,082...136,311,106 		JBrowse link
G Trim63 tripartite motif containing 63 increases expression
multiple interactions 		EXP Methylprednisolone results in increased expression of TRIM63 protein
Testosterone inhibits the reaction [Methylprednisolone results in increased expression of TRIM63 protein] 		CTD PMID:21931329 NCBI chr 5:151,817,209...151,831,026
Ensembl chr 5:151,817,225...151,831,058 		JBrowse link
G Txnip thioredoxin interacting protein increases expression ISO Methylprednisolone results in increased expression of TXNIP mRNA CTD PMID:19192274 NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731 		JBrowse link
G Vwf von Willebrand factor decreases expression
increases expression 		ISO Methylprednisolone results in decreased expression of VWF protein
Methylprednisolone results in increased expression of VWF protein 		CTD PMID:7491699 PMID:20405515 NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757 		JBrowse link
alclometasone dipropionate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO alclometasone dipropionate results in decreased expression of CCL2 protein CTD PMID:20116850 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO alclometasone dipropionate results in increased expression of CCL3 protein CTD PMID:20116850 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO alclometasone dipropionate results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Csf2 colony stimulating factor 2 decreases expression ISO alclometasone dipropionate results in decreased expression of CSF2 protein CTD PMID:11407316 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Ifng interferon gamma decreases expression ISO alclometasone dipropionate results in decreased expression of IFNG protein CTD PMID:11407316 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Il2 interleukin 2 decreases expression ISO alclometasone dipropionate results in decreased expression of IL2 protein CTD PMID:11407316 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il3 interleukin 3 decreases expression ISO alclometasone dipropionate results in decreased expression of IL3 protein CTD PMID:11407316 NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,906,460...38,908,810 		JBrowse link
G Il4 interleukin 4 decreases expression ISO alclometasone dipropionate results in decreased expression of IL4 protein CTD PMID:11407316 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il5 interleukin 5 decreases expression ISO alclometasone dipropionate results in decreased expression of IL5 protein CTD PMID:11407316 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO alclometasone dipropionate results in decreased expression of VEGFA protein CTD PMID:20116850 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
beclomethasone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases expression
increases secretion 		ISO Beclomethasone inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]; Beclomethasone inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Beclomethasone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Beclomethasone]
Beclomethasone results in increased expression of ABCB1 mRNA; Beclomethasone results in increased expression of ABCB1 protein 		CTD PMID:15370884 PMID:16442095 PMID:22464980 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 increases expression ISO Beclomethasone results in increased expression of ABCB4 mRNA CTD PMID:15370884 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 increases expression ISO Beclomethasone results in increased expression of ABCC1 mRNA CTD PMID:15370884 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions
increases activity 		ISO Beclomethasone inhibits the reaction [ABCG2 protein affects the transport of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]; Beclomethasone inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]
Beclomethasone results in increased activity of ABCG2 protein 		CTD PMID:15365089 PMID:16442095 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant decreases activity ISO Beclomethasone results in decreased activity of ACP5 protein CTD PMID:8429434 NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929 		JBrowse link
G Adrb2 adrenoceptor beta 2 increases expression ISO Beclomethasone results in increased expression of ADRB2 mRNA CTD PMID:9032216 PMID:15679717 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Bdkrb1 bradykinin receptor B1 decreases expression ISO Beclomethasone results in decreased expression of BDKRB1 mRNA CTD PMID:18039523 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein decreases expression ISO Beclomethasone results in decreased expression of BGLAP protein CTD PMID:7746775 PMID:9232087 PMID:9544892 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Casp9 caspase 9 increases activity ISO Beclomethasone results in increased activity of CASP9 protein CTD PMID:11734450 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase increases expression ISO Beclomethasone results in increased expression of CAT protein CTD PMID:10445599 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO Beclomethasone inhibits the reaction [IL13 protein results in increased expression of CCL11 protein] CTD PMID:17988555 NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO Beclomethasone results in decreased expression of CCL2 protein CTD PMID:20116850 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Beclomethasone results in increased expression of CCL3 protein CTD PMID:20116850 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO Beclomethasone results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions
decreases expression 		ISO [Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein; [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CCL5 protein; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CCL5 protein]
Beclomethasone results in decreased expression of CCL5 mRNA; Beclomethasone results in decreased expression of CCL5 protein 		CTD PMID:8534483 PMID:10903220 PMID:14643170 PMID:15679717 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Cd44 CD44 molecule multiple interactions ISO Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]; Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]] CTD PMID:18076728 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
decreases secretion
increases activity 		ISO [Beclomethasone co-treated with Albuterol] results in decreased secretion of CSF2 protein; [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CSF2 protein; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CSF2 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of CSF2 protein]; Beclomethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]
Beclomethasone results in decreased secretion of CSF2 protein
Beclomethasone results in increased activity of CSF2 protein 		CTD PMID:7545059 PMID:10460758 PMID:10868704 PMID:11167953 PMID:11730731 More... NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 decreases secretion ISO Beclomethasone results in decreased secretion of CXCL10 protein CTD PMID:17996064 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 decreases expression ISO Beclomethasone results in decreased expression of CYP2S1 mRNA CTD PMID:22155357 NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions
increases expression 		ISO 1-aminobenzotriazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Ketoconazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Mifepristone inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Paraoxon inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Physostigmine inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] CTD PMID:12538830 PMID:23512537 PMID:24555085 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Epx eosinophil peroxidase multiple interactions EXP Beclomethasone inhibits the reaction [sephadex results in increased expression of EPX protein] CTD PMID:10850854 NCBI chr10:73,164,096...73,175,180
Ensembl chr10:73,164,096...73,175,180 		JBrowse link
G Fcer1g Fc epsilon receptor Ig decreases expression EXP Beclomethasone results in decreased expression of FCER1G protein CTD PMID:1834581 NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859 		JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
decreases activity 		ISO [Beclomethasone co-treated with Albuterol] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; [Beclomethasone co-treated with Formoterol Fumarate] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Albuterol promotes the reaction [Beclomethasone results in decreased activity of FGF2 protein]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone results in decreased activity of FGF2 protein] CTD PMID:18076728 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO [Beclomethasone co-treated with Albuterol] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; [Beclomethasone co-treated with Formoterol Fumarate] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein] CTD PMID:18076728 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Beclomethasone results in decreased expression of FOS protein CTD PMID:9797757 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Ggt5 gamma-glutamyltransferase 5 increases activity
increases expression
multiple interactions 		ISO Beclomethasone results in increased activity of GGT5 protein
Beclomethasone results in increased expression of GGT5 mRNA
[Beclomethasone results in increased activity of GGT5 protein] which results in increased metabolism of Leukotriene C4 		CTD PMID:11447392 NCBI chr20:13,042,694...13,070,960
Ensembl chr20:13,042,696...13,070,892 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 increases metabolic processing ISO HSD11B2 protein results in increased metabolism of Beclomethasone CTD PMID:16549198 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO Beclomethasone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] CTD PMID:9150321 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Il10 interleukin 10 decreases secretion ISO Beclomethasone results in decreased secretion of IL10 protein CTD PMID:9819297 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il13 interleukin 13 multiple interactions
increases activity 		ISO Beclomethasone inhibits the reaction [IL13 protein results in increased expression of CCL11 protein]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 protein]
Beclomethasone results in increased activity of IL13 protein 		CTD PMID:17988555 NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases secretion
decreases expression 		ISO Beclomethasone inhibits the reaction [IL1B protein results in increased expression of SELE mRNA]; Beclomethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
Beclomethasone results in decreased secretion of IL1B protein
Beclomethasone results in decreased expression of IL1B protein 		CTD PMID:7545059 PMID:9176529 PMID:9371735 PMID:10460758 PMID:15337628 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO Beclomethasone results in decreased expression of IL1RN protein CTD PMID:11015126 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il2ra interleukin 2 receptor subunit alpha decreases expression ISO Beclomethasone results in decreased expression of IL2RA protein CTD PMID:8111605 PMID:9314351 NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507 		JBrowse link
G Il3 interleukin 3 multiple interactions ISO Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL3 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of IL3 protein] CTD PMID:11167953 NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,906,460...38,908,810 		JBrowse link
G Il4 interleukin 4 multiple interactions
decreases expression 		ISO Albuterol promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]]; Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]]
Beclomethasone results in decreased expression of IL4 protein 		CTD PMID:7988651 PMID:18076728 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il5 interleukin 5 multiple interactions
decreases expression 		ISO Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL5 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of IL5 protein]
Beclomethasone results in decreased expression of IL5 protein 		CTD PMID:7988651 PMID:10813552 PMID:11167953 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 protein] CTD PMID:17988555 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 increases expression ISO Beclomethasone results in increased expression of KLK3 mRNA CTD PMID:9815800 NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:103,539,527...103,543,586 		JBrowse link
G Ltf lactotransferrin multiple interactions
decreases secretion 		ISO Beclomethasone inhibits the reaction [methylcholine results in increased secretion of LTF protein]
Beclomethasone results in decreased secretion of LTF protein 		CTD PMID:11112886 NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:119,878,344...119,901,189 		JBrowse link
G Mefv MEFV innate immunity regulator, pyrin increases response to substance ISO MEFV mutant form results in increased susceptibility to Beclomethasone CTD PMID:20828792 NCBI chr10:11,786,948...11,796,977
Ensembl chr10:12,293,782...12,303,333 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] CTD PMID:10455257 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
decreases expression 		ISO Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]
Beclomethasone results in decreased expression of MMP9 protein 		CTD PMID:10452757 PMID:10455257 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Nos2 nitric oxide synthase 2 decreases expression ISO Beclomethasone results in decreased expression of NOS2 protein CTD PMID:12668791 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO Beclomethasone results in increased activity of NR1I2 protein CTD PMID:21068194 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects localization
increases expression
affects binding
multiple interactions
increases activity 		ISO
EXP 		Beclomethasone affects the localization of NR3C1 protein
Beclomethasone results in increased expression of NR3C1 mRNA
Beclomethasone binds to NR3C1 protein
[Beclomethasone co-treated with Albuterol] affects the localization of NR3C1 protein; [Beclomethasone co-treated with Formoterol Fumarate] affects the localization of NR3C1 protein; Beclomethasone affects the localization of and results in increased activity of NR3C1 protein; Beclomethasone binds to and results in increased activity of NR3C1 protein
Beclomethasone results in increased activity of NR3C1 protein 		CTD PMID:16814 PMID:2207292 PMID:15362971 PMID:15679717 PMID:15860753 More... NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 increases activity ISO Beclomethasone results in increased activity of NR3C2 protein CTD PMID:15362971 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Pla1a phospholipase A1 member A multiple interactions ISO Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 NCBI chr11:62,320,112...62,357,779
Ensembl chr11:75,825,585...75,878,165 		JBrowse link
G Pla2g4a phospholipase A2 group 4A decreases activity
multiple interactions 		ISO Beclomethasone results in decreased activity of PLA2G4A protein
Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] 		CTD PMID:15337628 PMID:20573295 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Ppp1r14a protein phosphatase 1, regulatory (inhibitor) subunit 14A multiple interactions EXP Beclomethasone inhibits the reaction [Acetylcholine results in increased phosphorylation of PPP1R14A protein] CTD PMID:18577381 NCBI chr 1:93,708,269...93,718,218
Ensembl chr 1:93,708,218...93,719,147 		JBrowse link
G Rhoa ras homolog family member A multiple interactions EXP Beclomethasone inhibits the reaction [[[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein] which results in increased susceptibility to Acetylcholine]; Beclomethasone inhibits the reaction [[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein]; Beclomethasone inhibits the reaction [[Antigens, Bacterial co-treated with Allergens] results in increased expression of RHOA mRNA] CTD PMID:18391481 NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302 		JBrowse link
G Rnase2 ribonuclease A family member 2 decreases expression ISO Beclomethasone results in decreased expression of RNASE2 protein CTD PMID:12166584 NCBI chr15:24,449,618...24,450,427
Ensembl chr15:26,923,134...26,923,955 		JBrowse link
G Rnase3 ribonuclease A family member 3 multiple interactions
decreases expression 		ISO [Salmeterol Xinafoate co-treated with Beclomethasone] affects the reaction [Allergens results in increased expression of RNASE3 protein]; Beclomethasone affects the reaction [Allergens results in increased expression of RNASE3 protein]
Beclomethasone results in decreased expression of RNASE3 protein 		CTD PMID:1443864 PMID:10513351 PMID:10573242 PMID:12166584 PMID:12587966 More... NCBI chr15:24,511,894...24,512,764
Ensembl chr15:26,985,271...26,986,400 		JBrowse link
G Sele selectin E multiple interactions ISO Beclomethasone inhibits the reaction [IL1B protein results in increased expression of SELE mRNA] CTD PMID:9371735 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Beclomethasone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Thy1 Thy-1 cell surface antigen multiple interactions ISO Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]] CTD PMID:18076728 NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression ISO Beclomethasone results in increased expression of TIMP1 protein CTD PMID:10452757 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
decreases secretion 		ISO Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Beclomethasone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CCL5 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]
Beclomethasone results in decreased secretion of TNF protein 		CTD PMID:8937731 PMID:9150321 PMID:9819297 PMID:10100995 PMID:10903220 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO Beclomethasone inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] CTD PMID:10100995 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO Beclomethasone results in decreased expression of VEGFA protein CTD PMID:20116850 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
cyproterone acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO Cyproterone Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Apoa1 apolipoprotein A1 affects expression ISO Cyproterone Acetate affects the expression of APOA1 protein CTD PMID:16323982 NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apoa2 apolipoprotein A2 affects expression ISO Cyproterone Acetate affects the expression of APOA2 protein CTD PMID:16323982 NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410 		JBrowse link
G Ar androgen receptor multiple interactions
increases response to substance
affects localization
decreases activity
affects binding
increases expression
decreases expression 		ISO
EXP 		[AR protein mutant form results in increased susceptibility to Cyproterone Acetate] which results in increased activity of AR protein mutant form; [Cyproterone Acetate binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to NFKBIB protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to NR0B1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to HELZ2 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to MEN1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to NCOR1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to NRIP1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to PELP1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to PGR protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to PPRC1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to TGFB1I1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to TRERF1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to UBE3A protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to AR protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to BLOC1S1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to BRD8 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CHD9 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CNOT1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CREBBP protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to DHX30 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to EP300 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to GNAQ protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to ITGB3BP protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to KIF11 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to MED1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to MTA1 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NCOA2 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NCOA3 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NR0B2 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NRBF2 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to PNRC2 protein modified form]; [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to PRAME protein modified form]; [Cyproterone Acetate binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 enhancer]; [Cyproterone Acetate binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 promoter]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 enhancer]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 promoter]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOR1 protein binds to KLK3 promoter]; Cyproterone Acetate binds to and affects the folding of AR protein; Cyproterone Acetate binds to and results in decreased activity of AR protein; Cyproterone Acetate binds to and results in increased activity of AR protein; Cyproterone Acetate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Cyproterone Acetate inhibits the reaction [[Dihydrotestosterone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; Cyproterone Acetate inhibits the reaction [[Metribolone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; Cyproterone Acetate inhibits the reaction [Cadmium Chloride results in decreased expression of AR protein]; Cyproterone Acetate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; Cyproterone Acetate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; Cyproterone Acetate inhibits the reaction [Metribolone results in increased activity of AR protein]; Cyproterone Acetate promotes the reaction [Metribolone results in increased expression of AR mRNA]; NCOA1 protein results in increased activity of [Cyproterone Acetate binds to AR protein]; PA2G4 protein inhibits the reaction [Cyproterone Acetate promotes the reaction [Metribolone results in increased expression of AR mRNA]]; PA2G4 protein inhibits the reaction [Cyproterone Acetate results in increased expression of AR mRNA]
Cyproterone Acetate affects the localization of AR protein
Cyproterone Acetate results in decreased activity of AR protein
[Cyproterone Acetate binds to AR protein] which binds to KLK3 enhancer; [Cyproterone Acetate binds to AR protein] which binds to KLK3 promoter; Cyproterone Acetate binds to AR protein
Cyproterone Acetate results in decreased expression of AR mRNA 		CTD PMID:10053169 PMID:11751618 PMID:14565775 PMID:14751673 PMID:15084347 More... NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Bloc1s1 biogenesis of lysosomal organelles complex-1, subunit 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to BLOC1S1 protein modified form] CTD PMID:28751236 NCBI chr 7:1,347,495...1,351,103
Ensembl chr 7:1,925,335...1,936,049 		JBrowse link
G Brd8 bromodomain containing 8 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to BRD8 protein modified form] CTD PMID:28751236 NCBI chr18:26,455,824...26,504,106
Ensembl chr18:26,455,512...26,504,006 		JBrowse link
G Ccr1 C-C motif chemokine receptor 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in increased expression of CCR1 protein CTD PMID:10770211 NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374 		JBrowse link
G Ccr5 C-C motif chemokine receptor 5 multiple interactions ISO [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in increased expression of CCR5 protein CTD PMID:10770211 NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594 		JBrowse link
G Chd9 chromodomain helicase DNA binding protein 9 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CHD9 protein modified form] CTD PMID:28751236 NCBI chr19:15,941,535...16,146,220
Ensembl chr19:32,115,920...32,319,042 		JBrowse link
G Cnot1 CCR4-NOT transcription complex, subunit 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CNOT1 protein modified form] CTD PMID:28751236 NCBI chr19:9,261,290...9,352,636
Ensembl chr19:9,261,294...9,352,636 		JBrowse link
G Crebbp CREB binding protein multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CREBBP protein modified form]; [Cyproterone Acetate binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 enhancer]; [Cyproterone Acetate binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 promoter] CTD PMID:15308689 PMID:28751236 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Crp C-reactive protein multiple interactions ISO [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in increased expression of CRP protein CTD PMID:14557435 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Cxcr3 C-X-C motif chemokine receptor 3 multiple interactions ISO [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in increased expression of CXCR3 protein CTD PMID:10770211 NCBI chr  X:70,884,293...70,886,944
Ensembl chr  X:70,883,958...70,886,871 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases activity ISO Cyproterone Acetate results in decreased activity of CYP1A1 protein CTD PMID:34181028 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression ISO Cyproterone Acetate results in increased expression of CYP2B10 mRNA CTD PMID:28541575 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 increases expression ISO Cyproterone Acetate results in increased expression of CYP2C55 mRNA CTD PMID:28541575 NCBI chr 1:246,286,341...246,348,607
Ensembl chr 1:246,286,341...246,348,607 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression ISO Cyproterone Acetate results in increased expression of CYP3A4 mRNA CTD PMID:12505310 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Dhx30 DExH-box helicase 30 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to DHX30 protein modified form] CTD PMID:28751236 NCBI chr 8:110,064,751...110,096,954
Ensembl chr 8:118,943,187...118,975,592 		JBrowse link
G Egf epidermal growth factor multiple interactions EXP [EGF protein co-treated with Cyproterone Acetate] results in increased expression of MYC mRNA CTD PMID:12632255 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to EP300 protein modified form] CTD PMID:28751236 NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO Cyproterone Acetate binds to and results in increased activity of ESR1 protein CTD PMID:33049310 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO Cyproterone Acetate binds to and results in increased activity of ESR2 protein CTD PMID:33049310 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO [Cyproterone Acetate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Cyproterone Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions
decreases expression 		ISO [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in decreased expression of FSHB protein
Cyproterone Acetate results in decreased expression of FSHB protein 		CTD PMID:11994349 PMID:16002536 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Gnaq G protein subunit alpha q multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to GNAQ protein modified form] CTD PMID:28751236 NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions ISO Cyproterone Acetate inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] CTD PMID:16496412 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Helz2 helicase with zinc finger 2 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to HELZ2 protein modified form] CTD PMID:28751236 NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:188,716,370...188,730,716 		JBrowse link
G Hsd3b5 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 increases expression
multiple interactions 		EXP Cyproterone Acetate results in increased expression of HSD3B5 mRNA
[Cyproterone Acetate co-treated with Testosterone] results in increased expression of HSD3B5 mRNA 		CTD PMID:25603467 NCBI chr 2:188,697,669...188,717,141
Ensembl chr 2:188,697,670...188,709,118 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in decreased expression of IGF1 protein CTD PMID:16002536 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Ins2 insulin 2 multiple interactions ISO [Cyproterone Acetate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Cyproterone Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Cyproterone Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Itgb3bp integrin subunit beta 3 binding protein multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to ITGB3BP protein modified form] CTD PMID:28751236 NCBI chr 5:119,575,657...119,640,974
Ensembl chr 5:119,575,248...119,640,997 		JBrowse link
G Kif11 kinesin family member 11 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to KIF11 protein modified form] CTD PMID:28751236 NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250 		JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 affects binding
decreases expression
multiple interactions 		ISO [Cyproterone Acetate binds to AR protein] which binds to KLK3 enhancer; [Cyproterone Acetate binds to AR protein] which binds to KLK3 promoter
Cyproterone Acetate results in decreased expression of KLK3 protein
[Cyproterone Acetate binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 enhancer]; [Cyproterone Acetate binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 promoter]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 enhancer]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 promoter]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOR1 protein binds to KLK3 promoter]; [Cyproterone Acetate co-treated with Estradiol] results in decreased expression of KLK3 protein; [Cyproterone Acetate co-treated with Ethinyl Estradiol] results in decreased expression of KLK3 protein; Cyproterone Acetate inhibits the reaction [[Dihydrotestosterone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; Cyproterone Acetate inhibits the reaction [[Metribolone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein] 		CTD PMID:10687981 PMID:15308689 PMID:15336702 NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:103,539,527...103,543,586 		JBrowse link
G Kpna1 karyopherin subunit alpha 1 increases expression EXP Cyproterone Acetate results in increased expression of KPNA1 mRNA CTD PMID:16906019 NCBI chr11:64,715,844...64,774,647
Ensembl chr11:78,222,884...78,267,067 		JBrowse link
G Kpna2 karyopherin subunit alpha 2 decreases expression
increases expression 		EXP Cyproterone Acetate results in decreased expression of KPNA2 mRNA
Cyproterone Acetate results in increased expression of KPNA2 mRNA 		CTD PMID:16906019 NCBI chr10:92,433,678...92,445,841
Ensembl chr10:92,433,679...92,445,937 		JBrowse link
G Kpna3 karyopherin subunit alpha 3 increases expression EXP Cyproterone Acetate results in increased expression of KPNA3 mRNA CTD PMID:16906019 NCBI chr15:35,536,310...35,610,066
Ensembl chr15:39,712,381...39,786,319 		JBrowse link
G Kpna4 karyopherin subunit alpha 4 decreases expression EXP Cyproterone Acetate results in decreased expression of KPNA4 mRNA CTD PMID:16906019 NCBI chr 2:153,319,380...153,381,085
Ensembl chr 2:155,634,247...155,691,053 		JBrowse link
G Kpna5 karyopherin subunit alpha 5 decreases expression EXP Cyproterone Acetate results in decreased expression of KPNA5 mRNA CTD PMID:16906019 NCBI chr20:31,365,647...31,430,793
Ensembl chr20:31,365,656...31,430,792 		JBrowse link
G Lhb luteinizing hormone subunit beta decreases expression
multiple interactions
increases expression 		ISO
EXP 		Cyproterone Acetate results in decreased expression of LHB protein
Cyproterone Acetate inhibits the reaction [testosterone enanthate results in decreased expression of LHB protein]
Cyproterone Acetate results in increased expression of LHB protein
[Ethinyl Estradiol co-treated with Cyproterone Acetate] results in decreased expression of LHB protein 		CTD PMID:11994349 PMID:16002536 PMID:20463352 PMID:23085480 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445 		JBrowse link
G Med1 mediator complex subunit 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to MED1 protein modified form] CTD PMID:28751236 NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,641,862...83,685,545 		JBrowse link
G Men1 menin 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to MEN1 protein modified form] CTD PMID:28751236 NCBI chr 1:203,638,905...203,644,871
Ensembl chr 1:213,068,166...213,074,120 		JBrowse link
G Mta1 metastasis associated 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to MTA1 protein modified form] CTD PMID:28751236 NCBI chr 6:137,999,845...138,038,696
Ensembl chr 6:137,999,915...138,038,696 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions EXP [EGF protein co-treated with Cyproterone Acetate] results in increased expression of MYC mRNA CTD PMID:12632255 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Ncoa1 nuclear receptor coactivator 1 multiple interactions ISO NCOA1 protein results in increased activity of [Cyproterone Acetate binds to AR protein] CTD PMID:17804755 NCBI chr 6:32,952,090...33,229,829
Ensembl chr 6:32,952,090...33,195,924 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NCOA2 protein modified form]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 enhancer]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 promoter] CTD PMID:15308689 PMID:28751236 NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:10,618,722...10,852,776 		JBrowse link
G Ncoa3 nuclear receptor coactivator 3 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NCOA3 protein modified form] CTD PMID:28751236 NCBI chr 3:175,157,824...175,237,831
Ensembl chr 3:175,157,821...175,240,631 		JBrowse link
G Ncor1 nuclear receptor co-repressor 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to NCOR1 protein modified form]; [Cyproterone Acetate binds to AR protein] promotes the reaction [NCOR1 protein binds to KLK3 promoter] CTD PMID:15308689 PMID:28751236 NCBI chr10:47,498,852...47,641,612
Ensembl chr10:47,498,852...47,640,350 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases activity ISO Cyproterone Acetate results in increased activity of NFE2L2 protein CTD PMID:30203046 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfkbib NFKB inhibitor beta multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to NFKBIB protein modified form] CTD PMID:28751236 NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:93,173,820...93,326,366 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
decreases expression 		EXP Cyproterone Acetate inhibits the reaction [testosterone enanthate results in increased expression of NOS2 mRNA]; Cyproterone Acetate inhibits the reaction [testosterone enanthate results in increased expression of NOS2 protein]
Cyproterone Acetate results in decreased expression of NOS2 mRNA 		CTD PMID:20463352 PMID:23085480 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nr0b1 nuclear receptor subfamily 0, group B, member 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to NR0B1 protein modified form] CTD PMID:28751236 NCBI chr  X:50,756,886...50,761,014
Ensembl chr  X:54,707,639...54,712,083 		JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NR0B2 protein modified form] CTD PMID:28751236 NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO Cyproterone Acetate binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity ISO Cyproterone Acetate results in increased activity of NR1I3 protein CTD PMID:30203046 NCBI chr13:83,632,940...83,638,193
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Nrbf2 nuclear receptor binding factor 2 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NRBF2 protein modified form] CTD PMID:28751236 NCBI chr20:21,308,555...21,326,881
Ensembl chr20:21,290,787...21,325,724 		JBrowse link
G Nrip1 nuclear receptor interacting protein 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to NRIP1 protein modified form] CTD PMID:28751236 NCBI chr11:14,895,843...14,979,490
Ensembl chr11:28,378,878...28,467,353 		JBrowse link
G Pa2g4 proliferation-associated 2G4 multiple interactions ISO PA2G4 protein inhibits the reaction [Cyproterone Acetate promotes the reaction [Metribolone results in increased expression of AR mRNA]]; PA2G4 protein inhibits the reaction [Cyproterone Acetate results in increased expression of AR mRNA] CTD PMID:15994225 NCBI chr 7:984,795...992,264
Ensembl chr 7:1,569,327...1,576,802 		JBrowse link
G Pbsn probasin multiple interactions EXP Cyproterone Acetate inhibits the reaction [Cadmium Chloride results in increased expression of PBSN mRNA] CTD PMID:11751618 NCBI chr  X:41,914,346...41,929,591
Ensembl chr  X:45,792,738...45,807,983 		JBrowse link
G Pde5a phosphodiesterase 5A multiple interactions EXP Cyproterone Acetate inhibits the reaction [testosterone enanthate results in increased expression of PDE5A mRNA] CTD PMID:20463352 NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:213,542,923...213,684,298 		JBrowse link
G Pelp1 proline, glutamate and leucine rich protein 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to PELP1 protein modified form] CTD PMID:28751236 NCBI chr10:55,593,444...55,610,478
Ensembl chr10:55,593,447...55,610,758 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to PGR protein modified form]; Cyproterone Acetate binds to and results in increased activity of PGR protein CTD PMID:20599585 PMID:28751236 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pnrc2 proline-rich nuclear receptor coactivator 2 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to PNRC2 protein modified form] CTD PMID:28751236 NCBI chr 5:148,103,966...148,106,950
Ensembl chr 5:153,378,863...153,390,748 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO Cyproterone Acetate binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Pprc1 PPARG related coactivator 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to PPRC1 protein modified form] CTD PMID:28751236 NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:254,851,164...254,867,570 		JBrowse link
G Pramex1 PRAME like, X-linked 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to PRAME protein modified form] CTD PMID:28751236 NCBI chr  X:102,862,457...102,867,725
Ensembl chr  X:102,861,881...102,870,708 		JBrowse link
G Prl prolactin multiple interactions ISO
EXP 		[Cyproterone Acetate co-treated with Ethinyl Estradiol] results in decreased expression of PRL protein
Cyproterone Acetate inhibits the reaction [Testosterone results in decreased expression of PRL mRNA] 		CTD PMID:3157511 PMID:25603467 NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217 		JBrowse link
G Prlr prolactin receptor multiple interactions
increases expression 		EXP [Cyproterone Acetate co-treated with Testosterone] results in increased expression of PRLR mRNA
Cyproterone Acetate results in increased expression of PRLR mRNA 		CTD PMID:25603467 NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882 		JBrowse link
G Tfrc transferrin receptor multiple interactions ISO [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in decreased expression of TFRC protein CTD PMID:16002536 NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318 		JBrowse link
G Tgfb1i1 transforming growth factor beta 1 induced transcript 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to TGFB1I1 protein modified form] CTD PMID:28751236 NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:192,258,598...192,265,903 		JBrowse link
G Trerf1 transcriptional regulating factor 1 multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to TRERF1 protein modified form] CTD PMID:28751236 NCBI chr 9:13,631,619...13,858,326
Ensembl chr 9:21,131,777...21,176,016 		JBrowse link
G Ube3a ubiquitin protein ligase E3A multiple interactions ISO [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to UBE3A protein modified form] CTD PMID:28751236 NCBI chr 1:119,204,244...119,297,097
Ensembl chr 1:119,206,148...119,297,097 		JBrowse link
desogestrel term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity ISO Desogestrel results in decreased activity of AKR1C3 protein CTD PMID:21182831 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Apoe apolipoprotein E multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of APOE mRNA CTD PMID:18160741 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Cat catalase multiple interactions ISO [Ethinyl Estradiol co-treated with Desogestrel] results in decreased activity of CAT protein CTD PMID:17541152 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccn5 cellular communication network factor 5 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CCN5 mRNA CTD PMID:18160741 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Cpb2 carboxypeptidase B2 increases activity ISO Desogestrel results in increased activity of CPB2 protein CTD PMID:11301170 NCBI chr15:56,967,128...57,015,964
Ensembl chr15:56,966,839...57,015,962 		JBrowse link
G Crp C-reactive protein multiple interactions ISO [Ethinyl Estradiol co-treated with Desogestrel] results in increased expression of CRP protein; Simvastatin inhibits the reaction [[Ethinyl Estradiol co-treated with Desogestrel] results in increased expression of CRP protein] CTD PMID:17105841 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Cst9l cystatin 9-like multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in increased expression of CST9L mRNA CTD PMID:18160741 NCBI chr 3:136,288,093...136,290,906
Ensembl chr 3:156,741,232...156,744,045 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP11A1 mRNA CTD PMID:18160741 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP17A1 mRNA CTD PMID:18160741 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity ISO Desogestrel results in decreased activity of CYP1A2 protein CTD PMID:18816299 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Ddr1 discoidin domain receptor tyrosine kinase 1 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in increased expression of DDR1 mRNA CTD PMID:18160741 NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,050,375...3,069,276 		JBrowse link
G Dhcr24 24-dehydrocholesterol reductase multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DHCR24 mRNA CTD PMID:18160741 NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936 		JBrowse link
G Dpep3 dipeptidase 3 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DPEP3 mRNA CTD PMID:18160741 NCBI chr19:50,778,079...50,786,451
Ensembl chr19:50,777,579...50,783,741 		JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of HMGCS2 mRNA CTD PMID:18160741 NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242 		JBrowse link
G Insl3 insulin-like 3 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of INSL3 mRNA CTD PMID:18160741 NCBI chr16:18,432,668...18,434,539 JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
increases expression 		ISO [Desogestrel co-treated with Ethinyl Estradiol] results in increased expression of LDLR protein
Desogestrel results in increased expression of LDLR protein 		CTD PMID:17900441 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675 		JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions ISO [Ethinyl Estradiol co-treated with Desogestrel] results in decreased expression of LHB protein; Simvastatin promotes the reaction [[Ethinyl Estradiol co-treated with Desogestrel] results in decreased expression of LHB protein] CTD PMID:17105841 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445 		JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of PAPSS2 mRNA CTD PMID:18160741 NCBI chr 1:239,867,597...239,952,614
Ensembl chr 1:239,867,574...239,952,616 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO Desogestrel binds to and affects the activity of PGR protein CTD PMID:15697108 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pgrmc1 progesterone receptor membrane component 1 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of PGRMC1 mRNA CTD PMID:18160741 NCBI chr  X:120,698,610...120,706,805
Ensembl chr  X:120,698,610...120,706,805 		JBrowse link
G Pon1 paraoxonase 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Desogestrel] affects the activity of PON1 protein CTD PMID:17541152 NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:34,261,289...34,287,924 		JBrowse link
G Proc protein C, inactivator of coagulation factors Va and VIIIa decreases activity ISO Desogestrel results in decreased activity of PROC protein CTD PMID:11301170 NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964 		JBrowse link
G Prok1 prokineticin 1 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of PROK1 mRNA CTD PMID:18160741 NCBI chr 2:197,538,747...197,547,550
Ensembl chr 2:197,537,068...197,547,550 		JBrowse link
G Pros1 protein S affects expression ISO Desogestrel affects the expression of PROS1 protein CTD PMID:11442481 NCBI chr11:230,597...311,288
Ensembl chr11:13,676,769...13,757,852 		JBrowse link
G Rhob ras homolog family member B multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of RHOB mRNA CTD PMID:18160741 NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772 		JBrowse link
G Sycp1 synaptonemal complex protein 1 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of SYCP1 mRNA CTD PMID:18160741 NCBI chr 2:192,985,164...193,145,234
Ensembl chr 2:192,984,621...193,145,421 		JBrowse link
G Taf4b TATA-box binding protein associated factor 4b multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of TAF4B mRNA CTD PMID:18160741 NCBI chr18:6,227,299...6,360,970
Ensembl chr18:6,227,345...6,356,275 		JBrowse link
G Tex19.2 testis expressed gene 19.2 multiple interactions ISO [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of TEX19 mRNA CTD PMID:18160741 NCBI chr10:106,878,083...106,880,671
Ensembl chr10:106,878,085...106,880,671 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Desogestrel] results in decreased expression of VCAM1 protein; Simvastatin promotes the reaction [[Ethinyl Estradiol co-treated with Desogestrel] results in decreased expression of VCAM1 protein] CTD PMID:17105841 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
dienogest term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1c1 aldo-keto reductase family 1, member C1 decreases expression ISO dienogest results in decreased expression of AKR1C1 mRNA CTD PMID:23183084 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 decreases expression ISO dienogest results in decreased expression of AKR1C2 mRNA CTD PMID:23183084 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein] CTD PMID:22014880 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Cd4 Cd4 molecule multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in decreased expression of CD4 protein CTD PMID:10813102 NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461 		JBrowse link
G Crp C-reactive protein multiple interactions ISO [Estradiol co-treated with dienogest] results in increased expression of CRP protein CTD PMID:15970291 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 decreases expression ISO dienogest results in decreased expression of CYP19A1 mRNA; dienogest results in decreased expression of CYP19A1 protein CTD PMID:22130322 NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G F2 coagulation factor II, thrombin multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in increased expression of F2 protein CTD PMID:15288212 NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246 		JBrowse link
G F7 coagulation factor VII multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in increased expression of F7 protein CTD PMID:15288212 NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738 		JBrowse link
G Fga fibrinogen alpha chain multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:15288212 NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:170,672,012...170,679,577 		JBrowse link
G Fgb fibrinogen beta chain multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:15288212 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434 		JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:15288212 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170 		JBrowse link
G Fshb follicle stimulating hormone subunit beta decreases expression ISO dienogest results in decreased expression of FSHB protein CTD PMID:11994349 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein]; dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CXCL8 protein]; dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of IL6 protein]; dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of TLR4 mRNA] CTD PMID:22014880 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression ISO dienogest results in decreased expression of HSD17B2 mRNA CTD PMID:23183084 NCBI chr19:45,753,576...45,825,203
Ensembl chr19:62,662,098...62,733,943 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in decreased expression of IGF1 protein CTD PMID:11172797 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of IL6 protein] CTD PMID:22014880 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Lhb luteinizing hormone subunit beta decreases expression ISO dienogest results in decreased expression of LHB protein CTD PMID:11994349 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions
affects localization 		ISO dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]
dienogest affects the localization of NFKB1 protein 		CTD PMID:15866594 PMID:22130322 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Plat plasminogen activator, tissue type multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in decreased expression of PLAT protein CTD PMID:15288212 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Proc protein C, inactivator of coagulation factors Va and VIIIa multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in increased activity of PROC protein CTD PMID:15288212 NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964 		JBrowse link
G Pros1 protein S multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in decreased expression of PROS1 protein CTD PMID:15288212 NCBI chr11:230,597...311,288
Ensembl chr11:13,676,769...13,757,852 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO dienogest results in decreased expression of PTGS2 mRNA; dienogest results in decreased expression of PTGS2 protein CTD PMID:22130322 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Serpinc1 serpin family C member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in decreased activity of SERPINC1 protein CTD PMID:15288212 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with dienogest] results in decreased expression of SERPINE1 protein CTD PMID:15288212 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of TLR4 mRNA] CTD PMID:22014880 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]; dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased expression of CXCL8 mRNA]; dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased expression of CXCL8 protein] CTD PMID:15866594 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
drospirenone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO drospirenone results in decreased activity of ABCB11 protein CTD PMID:23956101 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581 		JBrowse link
G Ar androgen receptor multiple interactions
affects localization 		ISO drospirenone binds to and results in increased activity of AR protein
drospirenone affects the localization of AR protein 		CTD PMID:28478275 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO [Ethinyl Estradiol co-treated with drospirenone] results in decreased activity of CYP17A1 protein CTD PMID:17418832 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions ISO drospirenone inhibits the reaction [HSD11B1 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:28257955 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with drospirenone] results in increased expression of HSPD1 mRNA CTD PMID:19631796 NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO [Ethinyl Estradiol co-treated with drospirenone] results in decreased expression of NOS2 mRNA CTD PMID:19631796 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 affects binding EXP drospirenone binds to NR3C2 protein CTD PMID:1493716 PMID:14667981 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Pgr progesterone receptor affects binding ISO drospirenone binds to PGR protein CTD PMID:14667981 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Serpina6 serpin family A member 6 multiple interactions ISO [Ethinyl Estradiol co-treated with drospirenone] results in increased expression of SERPINA6 protein CTD PMID:11245553 NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:128,544,831...128,555,139 		JBrowse link
G Shbg sex hormone binding globulin multiple interactions ISO [Ethinyl Estradiol co-treated with drospirenone] results in increased expression of SHBG protein CTD PMID:11245553 NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760 		JBrowse link
dydrogesterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1c1 aldo-keto reductase family 1, member C1 increases expression
decreases expression
decreases activity
increases metabolic processing 		ISO Dydrogesterone results in increased expression of AKR1C1 mRNA
Dydrogesterone results in decreased expression of AKR1C1 mRNA
Dydrogesterone results in decreased activity of AKR1C1 protein
AKR1C1 protein results in increased metabolism of Dydrogesterone 		CTD PMID:21182831 PMID:23183084 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 decreases activity
decreases expression 		ISO Dydrogesterone results in decreased activity of AKR1C2 protein
Dydrogesterone results in decreased expression of AKR1C2 mRNA 		CTD PMID:22245609 PMID:23183084 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity
decreases expression 		ISO Dydrogesterone results in decreased activity of AKR1C3 protein
Dydrogesterone results in decreased expression of AKR1C3 mRNA 		CTD PMID:21182831 PMID:23183084 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Edn1 endothelin 1 multiple interactions ISO Dydrogesterone affects the reaction [Estradiol results in decreased expression of EDN1 protein] CTD PMID:12385860 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression
increases expression 		ISO Dydrogesterone results in decreased expression of HSD17B2 mRNA
Dydrogesterone results in increased expression of HSD17B2 protein 		CTD PMID:23183084 NCBI chr19:45,753,576...45,825,203
Ensembl chr19:62,662,098...62,733,943 		JBrowse link
G Ifng interferon gamma decreases expression
multiple interactions 		ISO Dydrogesterone results in decreased expression of IFNG protein
Mifepristone inhibits the reaction [Dydrogesterone results in decreased expression of IFNG protein] 		CTD PMID:16045524 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Il10 interleukin 10 increases expression ISO Dydrogesterone results in increased expression of IL10 protein CTD PMID:16389545 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il4 interleukin 4 increases expression
multiple interactions 		ISO Dydrogesterone results in increased expression of IL4 protein
Mifepristone inhibits the reaction [Dydrogesterone results in increased expression of IL4 protein] 		CTD PMID:16045524 PMID:16389545 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions 		ISO Dydrogesterone results in increased expression of IL6 protein
Mifepristone inhibits the reaction [Dydrogesterone results in increased expression of IL6 protein] 		CTD PMID:16045524 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Pgr progesterone receptor affects activity
decreases expression 		ISO Dydrogesterone affects the activity of PGR protein
Dydrogesterone results in decreased expression of PGR mRNA 		CTD PMID:16045524 PMID:23183084 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pibf1 progesterone immunomodulatory binding factor 1 affects expression
increases expression 		ISO Dydrogesterone affects the expression of PIBF1 protein
Dydrogesterone results in increased expression of PIBF1 protein 		CTD PMID:15760377 PMID:16045524 NCBI chr15:82,258,243...82,427,546
Ensembl chr15:82,258,468...82,427,548 		JBrowse link
G Srd5a1 steroid 5 alpha-reductase 1 decreases expression ISO Dydrogesterone results in decreased expression of SRD5A1 mRNA CTD PMID:23183084 NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:35,514,846...35,548,903 		JBrowse link
G Tacr1 tachykinin receptor 1 decreases expression ISO Dydrogesterone results in decreased expression of TACR1 protein CTD PMID:16389545 NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:116,478,617...116,647,492 		JBrowse link
G Tnf tumor necrosis factor decreases expression
multiple interactions 		ISO Dydrogesterone results in decreased expression of TNF protein
Mifepristone inhibits the reaction [Dydrogesterone results in decreased expression of TNF protein] 		CTD PMID:16045524 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
ethisterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Esr1 estrogen receptor 1 multiple interactions ISO ESR1 protein affects the reaction [Ethisterone results in increased expression of GREB1 mRNA]; ESR1 protein affects the reaction [Ethisterone results in increased expression of SGK1 mRNA] CTD PMID:33405908 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions
increases expression 		ISO ESR1 protein affects the reaction [Ethisterone results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [Ethisterone results in increased expression of GREB1 mRNA] CTD PMID:33405908 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Mybl1 MYB proto-oncogene like 1 multiple interactions
increases expression 		ISO Fulvestrant inhibits the reaction [Ethisterone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 multiple interactions
increases expression 		ISO ESR1 protein affects the reaction [Ethisterone results in increased expression of SGK1 mRNA]; Fulvestrant inhibits the reaction [Ethisterone results in increased expression of SGK1 mRNA] CTD PMID:33405908 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
ethynodiol diacetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor affects localization
multiple interactions 		ISO Ethynodiol Diacetate affects the localization of AR protein
Ethynodiol Diacetate binds to and results in increased activity of AR protein 		CTD PMID:28478275 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
etonogestrel term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 affects metabolic processing ISO CYP3A4 protein affects the metabolism of etonogestrel CTD PMID:15963096 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G F2 coagulation factor II, thrombin multiple interactions EXP etonogestrel promotes the reaction [F2 protein results in increased expression of F3 mRNA] CTD PMID:11733402 NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246 		JBrowse link
G F2r coagulation factor II (thrombin) receptor multiple interactions
increases expression 		EXP Mifepristone inhibits the reaction [etonogestrel results in increased expression of F2R mRNA] CTD PMID:11733402 NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:28,604,066...28,620,579 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions EXP etonogestrel promotes the reaction [F2 protein results in increased expression of F3 mRNA] CTD PMID:11733402 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Pgr progesterone receptor increases expression ISO etonogestrel results in increased expression of PGR protein CTD PMID:11041225 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
fluorometholone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein] CTD PMID:35264022 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in increased activity of CASP3 protein] CTD PMID:35264022 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of CDKN1A protein] CTD PMID:35264022 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 protein] CTD PMID:35264022 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Glb1 galactosidase, beta 1 multiple interactions ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]]; Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein] CTD PMID:35264022 NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased secretion of IL6 protein] CTD PMID:35264022 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Rb1 RB transcriptional corepressor 1 multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of RB1 protein] CTD PMID:35264022 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Fluorometholone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Tert telomerase reverse transcriptase multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in decreased activity of TERT protein] CTD PMID:35264022 NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:31,466,056...31,488,111 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased secretion of TNF protein] CTD PMID:35264022 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein]]; Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein] CTD PMID:35264022 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of VEGFA mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased expression of VEGFA protein] CTD PMID:35264022 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
levonorgestrel term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO Levonorgestrel results in increased expression of ABCB1 mRNA CTD PMID:15290871 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA CTD PMID:19074003 NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947 		JBrowse link
G Ace2 angiotensin converting enzyme 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ACE2 mRNA CTD PMID:19074003 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:33,925,458...33,971,596 		JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ADGRF5 mRNA CTD PMID:19074003 NCBI chr 9:25,014,861...25,128,045
Ensembl chr 9:25,018,277...25,121,237 		JBrowse link
G Afg1l AFG1 like ATPase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AFG1L mRNA CTD PMID:19074003 NCBI chr20:45,798,344...45,967,997
Ensembl chr20:47,380,583...47,550,126 		JBrowse link
G Agt angiotensinogen multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of AGT protein CTD PMID:17519148 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Ahctf1 AT hook containing transcription factor 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AHCTF1 mRNA CTD PMID:19074003 NCBI chr13:91,481,936...91,536,391
Ensembl chr13:94,014,469...94,068,058 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity ISO Levonorgestrel results in decreased activity of AKR1C3 protein CTD PMID:21182831 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Alms1 ALMS1, centrosome and basal body associated protein multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ALMS1 mRNA CTD PMID:19074003 NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:119,683,076...119,783,471 		JBrowse link
G Alpk2 alpha-kinase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ALPK2 mRNA CTD PMID:19074003 NCBI chr18:61,045,717...61,161,703
Ensembl chr18:61,045,380...61,175,985 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] CTD PMID:12521655 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Ammecr1 AMMECR nuclear protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of AMMECR1 mRNA CTD PMID:19074003 NCBI chr  X:111,262,792...111,368,099
Ensembl chr  X:111,262,792...111,368,099 		JBrowse link
G Ankdd1a ankyrin repeat and death domain containing 1A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ANKDD1A mRNA CTD PMID:19074003 NCBI chr 8:74,912,707...74,938,870
Ensembl chr 8:74,916,011...74,937,863 		JBrowse link
G Api5 apoptosis inhibitor 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of API5 mRNA CTD PMID:19074003 NCBI chr 3:100,833,417...100,858,580
Ensembl chr 3:100,833,417...100,858,580 		JBrowse link
G Apob apolipoprotein B multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of APOB protein CTD PMID:15769986 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814 		JBrowse link
G Ar androgen receptor affects binding
multiple interactions 		EXP
ISO 		Levonorgestrel binds to AR protein
Levonorgestrel binds to and results in increased activity of AR protein 		CTD PMID:14565775 PMID:19833195 PMID:20438827 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arhgap23 Rho GTPase activating protein 23 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARHGAP23 mRNA CTD PMID:19074003 NCBI chr10:82,437,578...82,496,846
Ensembl chr10:82,890,853...82,993,228 		JBrowse link
G Arl9 ARF like GTPase 9 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARL9 mRNA CTD PMID:19074003 NCBI chr14:31,511,845...31,521,038
Ensembl chr14:31,511,330...31,520,988 		JBrowse link
G Asap1 ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ASAP1 mRNA CTD PMID:19074003 NCBI chr 7:95,786,130...96,093,111
Ensembl chr 7:97,675,354...97,982,024 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of AZGP1 mRNA CTD PMID:19074003 NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020 		JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of B4GALT5 mRNA CTD PMID:19074003 NCBI chr 3:176,437,073...176,453,001
Ensembl chr 3:176,437,073...176,488,978 		JBrowse link
G Bbx BBX high mobility group box domain containing multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of BBX mRNA CTD PMID:19074003 NCBI chr11:63,850,034...64,097,700
Ensembl chr11:63,850,018...64,093,265 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Levonorgestrel results in decreased expression of BCL2 protein CTD PMID:16019350 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l14 Bcl2-like 14 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of BCL2L14 mRNA CTD PMID:19074003 NCBI chr 4:168,948,919...168,989,450
Ensembl chr 4:168,948,946...168,990,079 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Btbd3 BTB domain containing 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of BTBD3 mRNA CTD PMID:19074003 NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:146,044,096...146,074,635 		JBrowse link
G C3 complement C3 multiple interactions EXP Levonorgestrel inhibits the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA] CTD PMID:11566438 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C4bpb complement component 4 binding protein, beta multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein; F5 gene polymorphism inhibits the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein] CTD PMID:14551147 NCBI chr13:44,673,064...44,683,781
Ensembl chr13:44,673,065...44,683,793 		JBrowse link
G Cat catalase multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of CAT protein CTD PMID:17541152 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccn3 cellular communication network factor 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CCN3 mRNA CTD PMID:19074003 NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581 		JBrowse link
G Cd86 CD86 molecule multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CD86 mRNA CTD PMID:19074003 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDC25C mRNA CTD PMID:19074003 NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,609,959...26,630,292 		JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CDC42BPB mRNA CTD PMID:19074003 NCBI chr 6:130,333,712...130,416,631
Ensembl chr 6:136,154,905...136,237,570 		JBrowse link
G Cdkn2d cyclin dependent kinase inhibitor 2D multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDKN2D mRNA CTD PMID:19074003 NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809 		JBrowse link
G Cep170b centrosomal protein 170B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CEP170B mRNA CTD PMID:19074003 NCBI chr 6:131,780,935...131,806,658
Ensembl chr 6:137,602,707...137,627,750 		JBrowse link
G Cfap65 cilia and flagella associated protein 65 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CFAP65 mRNA CTD PMID:19074003 NCBI chr 9:76,459,211...76,494,199
Ensembl chr 9:83,907,276...83,942,714 		JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CHEK2 mRNA CTD PMID:19074003 NCBI chr12:45,788,823...45,821,382
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Cimap1a ciliary microtubule associated protein 1A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CIMAP1A mRNA CTD PMID:19074003 NCBI chr 1:205,355,601...205,358,882
Ensembl chr 1:205,355,675...205,358,882 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of COL1A1 mRNA CTD PMID:19074003 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col22a1 collagen type XXII alpha 1 chain multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of COL22A1 mRNA CTD PMID:19074003 NCBI chr 7:105,619,776...105,857,246
Ensembl chr 7:105,619,757...105,856,960 		JBrowse link
G Cpeb3 cytoplasmic polyadenylation element binding protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CPEB3 mRNA CTD PMID:19074003 NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:244,161,690...244,343,561 		JBrowse link
G Cpxcr1 CPX chromosome region, candidate 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CPXCR1 mRNA CTD PMID:19074003 NCBI chr  X:81,756,909...81,794,661 JBrowse link
G Crlf3 cytokine receptor-like factor 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CRLF3 mRNA CTD PMID:19074003 NCBI chr10:65,024,228...65,060,746
Ensembl chr10:65,521,492...65,558,804 		JBrowse link
G Crp C-reactive protein multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of CRP protein CTD PMID:15769986 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CSMD1 mRNA CTD PMID:19074003 NCBI chr16:78,920,549...80,520,710
Ensembl chr16:78,921,002...80,519,944 		JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CSNK1A1 mRNA CTD PMID:19074003 NCBI chr18:57,285,156...57,320,540
Ensembl chr18:57,287,412...57,320,538 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CXCL10 mRNA CTD PMID:19074003 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CYP17A1 mRNA CTD PMID:19074003 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Dap3 death associated protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DAP3 mRNA CTD PMID:19074003 NCBI chr 2:174,319,341...174,347,489
Ensembl chr 2:176,617,155...176,644,270 		JBrowse link
G Dcn decorin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DCN mRNA CTD PMID:19074003 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Ddhd1 DDHD domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DDHD1 mRNA CTD PMID:19074003 NCBI chr15:18,824,389...18,891,036
Ensembl chr15:21,303,826...21,370,608 		JBrowse link
G Dlgap2 DLG associated protein 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DLGAP2 mRNA CTD PMID:19074003 NCBI chr16:81,489,059...82,198,693
Ensembl chr16:81,494,649...82,198,684 		JBrowse link
G Dnase1l3 deoxyribonuclease 1L3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DNASE1L3 mRNA CTD PMID:19074003 NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531 		JBrowse link
G Dock8 dedicator of cytokinesis 8 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DOCK8 mRNA CTD PMID:19074003 NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833 		JBrowse link
G Dok5 docking protein 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DOK5 mRNA CTD PMID:19074003 NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333 		JBrowse link
G Dsg1 desmoglein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DSG1 mRNA CTD PMID:19074003 NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451 		JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ELOVL5 mRNA CTD PMID:19074003 NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616 		JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of EPRS1 mRNA CTD PMID:19074003 NCBI chr13:99,431,955...99,503,510
Ensembl chr13:99,433,130...99,503,509 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO Levonorgestrel binds to and results in increased activity of ESR1 protein CTD PMID:33049310 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Etnk1 ethanolamine kinase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ETNK1 mRNA CTD PMID:19074003 NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:177,856,960...177,924,721 		JBrowse link
G Evi2b ecotropic viral integration site 2B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of EVI2B mRNA CTD PMID:19074003 NCBI chr10:64,970,659...64,972,277
Ensembl chr10:64,964,719...64,979,417 		JBrowse link
G F5 coagulation factor V multiple interactions ISO F5 gene polymorphism inhibits the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein] CTD PMID:14551147 NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247 		JBrowse link
G F7 coagulation factor VII multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of F7 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F7 protein CTD PMID:12618251 PMID:15157790 NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738 		JBrowse link
G F8 coagulation factor VIII multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F8 protein CTD PMID:12618251 NCBI chr18:140,848...172,330
Ensembl chr18:155,309...186,683 		JBrowse link
G Fam20a FAM20A, golgi associated secretory pathway pseudokinase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAM20A mRNA CTD PMID:19074003 NCBI chr10:95,136,799...95,197,176
Ensembl chr10:95,142,458...95,197,053 		JBrowse link
G Far2 fatty acyl CoA reductase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAR2 mRNA CTD PMID:19074003 NCBI chr 4:180,973,968...181,087,862
Ensembl chr 4:182,705,381...182,825,279 		JBrowse link
G Fcrl5 Fc receptor-like 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FCRL5 mRNA CTD PMID:19074003 NCBI chr 2:172,881,763...172,912,912
Ensembl chr 2:175,179,690...175,211,039 		JBrowse link
G Fermt2 FERM domain containing kindlin 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FERMT2 mRNA CTD PMID:19074003 NCBI chr15:18,682,927...18,751,959
Ensembl chr15:21,162,605...21,258,115 		JBrowse link
G Fga fibrinogen alpha chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:170,672,012...170,679,577 		JBrowse link
G Fgb fibrinogen beta chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434 		JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170 		JBrowse link
G Fkbp6 FKBP prolyl isomerase family member 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FKBP6 mRNA CTD PMID:19074003 NCBI chr12:21,318,251...21,390,350
Ensembl chr12:26,947,384...27,026,913 		JBrowse link
G Fmnl3 formin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of FMNL3 mRNA CTD PMID:19074003 NCBI chr 7:130,454,270...130,505,626
Ensembl chr 7:132,333,130...132,384,483 		JBrowse link
G Fnbp1 formin binding protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of FNBP1 mRNA CTD PMID:19074003 NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:34,706,814...34,822,117 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of FSHB protein; Avosentan affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of FSHB protein] CTD PMID:16291413 PMID:17190377 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 increases expression EXP Levonorgestrel results in increased expression of GABRG2 protein CTD PMID:22634062 NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523 		JBrowse link
G Gas6 growth arrest specific 6 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of GAS6 protein CTD PMID:17717130 NCBI chr16:76,045,430...76,075,904
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gdf10 growth differentiation factor 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of GDF10 mRNA CTD PMID:19074003 NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,243,317...9,256,794 		JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of GH1 protein CTD PMID:11172797 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Glyr1 glyoxylate reductase 1 homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of GLYR1 mRNA CTD PMID:19074003 NCBI chr10:10,532,036...10,567,639
Ensembl chr10:11,038,568...11,074,090 		JBrowse link
G Gpr135 G protein-coupled receptor 135 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of GPR135 mRNA CTD PMID:19074003 NCBI chr 6:96,363,466...96,366,594
Ensembl chr 6:96,362,867...96,382,988 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of GREB1 mRNA CTD PMID:19074003 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HMMR mRNA CTD PMID:19074003 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390 		JBrowse link
G Hoxc6 homeo box C6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HOXC6 mRNA CTD PMID:19074003 NCBI chr 7:134,138,017...134,148,899
Ensembl chr 7:136,024,961...136,027,365 		JBrowse link
G Htr7 5-hydroxytryptamine receptor 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HTR7 mRNA CTD PMID:19074003 NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:243,049,081...243,173,230 		JBrowse link
G Ice2 interactor of little elongation complex ELL subunit 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ICE2 mRNA CTD PMID:19074003 NCBI chr 8:70,043,419...70,085,217
Ensembl chr 8:78,924,421...78,966,200 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of IGF1 protein CTD PMID:11172797 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of IGFBP3 mRNA CTD PMID:19074003 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Igsf1 immunoglobulin superfamily, member 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of IGSF1 mRNA CTD PMID:19074003 NCBI chr  X:129,069,891...129,085,331
Ensembl chr  X:133,947,429...133,962,962 		JBrowse link
G Inha inhibin subunit alpha multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of INHA mRNA CTD PMID:19074003 NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:84,443,109...84,446,009 		JBrowse link
G Insl3 insulin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of INSL3 mRNA CTD PMID:19074003 NCBI chr16:18,432,668...18,434,539 JBrowse link
G Insl6 insulin-like 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of INSL6 mRNA CTD PMID:19074003 NCBI chr 1:236,483,530...236,487,065
Ensembl chr 1:236,483,530...236,487,065 		JBrowse link
G Kbtbd7 kelch repeat and BTB domain containing 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KBTBD7 mRNA CTD PMID:19074003 NCBI chr15:61,215,957...61,220,536
Ensembl chr15:61,215,396...61,223,671 		JBrowse link
G Kcnh7 potassium voltage-gated channel subfamily H member 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of KCNH7 mRNA CTD PMID:19074003 NCBI chr 3:47,329,338...47,822,122
Ensembl chr 3:67,747,063...68,230,741 		JBrowse link
G Kdsr 3-ketodihydrosphingosine reductase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KDSR mRNA CTD PMID:19074003 NCBI chr13:23,374,101...23,408,779
Ensembl chr13:23,376,779...23,408,897 		JBrowse link
G Klhl28 kelch-like family member 28 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KLHL28 mRNA CTD PMID:19074003 NCBI chr 6:88,723,624...88,755,072
Ensembl chr 6:88,727,205...88,752,457 		JBrowse link
G Klhl4 kelch-like family member 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KLHL4 mRNA CTD PMID:19074003 NCBI chr  X:83,626,047...83,916,328
Ensembl chr  X:83,819,076...83,916,328 		JBrowse link
G Ldlr low density lipoprotein receptor affects expression
multiple interactions 		ISO Levonorgestrel affects the expression of LDLR protein
[Levonorgestrel co-treated with Ethinyl Estradiol] results in decreased expression of LDLR protein 		CTD PMID:17900441 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675 		JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions
decreases secretion 		ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of LHB protein; Avosentan affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of LHB protein]
Levonorgestrel results in decreased secretion of LHB protein 		CTD PMID:16291413 PMID:17190377 PMID:20599585 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445 		JBrowse link
G Limd1 LIM domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of LIMD1 mRNA CTD PMID:19074003 NCBI chr 8:123,121,363...123,168,476
Ensembl chr 8:131,999,770...132,045,922 		JBrowse link
G Lmntd1 lamin tail domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of LMNTD1 mRNA CTD PMID:19074003 NCBI chr 4:180,085,128...180,319,362
Ensembl chr 4:180,085,134...180,329,707 		JBrowse link
G Lrig2 leucine-rich repeats and immunoglobulin-like domains 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of LRIG2 mRNA CTD PMID:19074003 NCBI chr 2:191,947,322...192,012,996
Ensembl chr 2:194,638,182...194,700,940 		JBrowse link
G Man2a1 mannosidase, alpha, class 2A, member 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MAN2A1 mRNA CTD PMID:19074003 NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:111,698,913...111,867,850 		JBrowse link
G Mbnl1 muscleblind-like splicing regulator 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MBNL1 mRNA CTD PMID:19074003 NCBI chr 2:144,639,819...144,814,395
Ensembl chr 2:146,789,596...146,964,134 		JBrowse link
G Mep1b meprin A subunit beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of MEP1B mRNA CTD PMID:19074003 NCBI chr18:12,641,041...12,667,759
Ensembl chr18:12,641,041...12,667,755 		JBrowse link
G Midn midnolin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MIDN mRNA CTD PMID:19074003 NCBI chr 7:10,198,761...10,210,563
Ensembl chr 7:10,200,306...10,207,203 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO Levonorgestrel results in decreased expression of MKI67 protein CTD PMID:16019350 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mro maestro multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRO mRNA CTD PMID:19074003 NCBI chr18:67,450,186...67,467,593
Ensembl chr18:69,725,798...69,743,031 		JBrowse link
G Mrps6 mitochondrial ribosomal protein S6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRPS6 mRNA CTD PMID:19074003 NCBI chr11:44,778,667...44,834,420
Ensembl chr11:44,781,554...44,834,962 		JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of MTSS1 mRNA CTD PMID:19074003 NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303 		JBrowse link
G Mysm1 myb-like, SWIRM and MPN domains 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MYSM1 mRNA CTD PMID:19074003 NCBI chr 5:109,761,345...109,826,652
Ensembl chr 5:114,889,269...114,942,385 		JBrowse link
G Nacc2 NACC family member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NACC2 mRNA CTD PMID:19074003 NCBI chr 3:8,879,952...8,946,660
Ensembl chr 3:29,281,190...29,344,840 		JBrowse link
G Ndfip1 Nedd4 family interacting protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NDFIP1 mRNA CTD PMID:19074003 NCBI chr18:30,516,931...30,567,199
Ensembl chr18:30,516,981...30,568,471 		JBrowse link
G Nexn nexilin (F actin binding protein) multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NEXN mRNA CTD PMID:19074003 NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:243,846,433...243,887,114 		JBrowse link
G Nid1 nidogen 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NID1 mRNA CTD PMID:19074003 NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO Levonorgestrel binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nsg1 neuronal vesicle trafficking associated 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NSG1 mRNA CTD PMID:19074003 NCBI chr14:76,861,079...76,882,822
Ensembl chr14:76,860,746...76,883,390 		JBrowse link
G Olfml3 olfactomedin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of OLFML3 mRNA CTD PMID:19074003 NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:193,932,665...193,935,494 		JBrowse link
G Opn5 opsin 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OPN5 mRNA CTD PMID:19074003 NCBI chr 9:18,368,393...18,416,098
Ensembl chr 9:25,865,610...25,913,315 		JBrowse link
G Or10j2 olfactory receptor family 10 subfamily J member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OR10J1 mRNA CTD PMID:19074003 NCBI chr13:85,723,300...85,724,290
Ensembl chr13:88,255,644...88,256,634 		JBrowse link
G Osbpl10 oxysterol binding protein-like 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OSBPL10 mRNA CTD PMID:19074003 NCBI chr 8:114,661,050...114,918,664
Ensembl chr 8:123,539,235...123,796,822 		JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAK3 mRNA CTD PMID:19074003 NCBI chr  X:111,912,967...112,171,037
Ensembl chr  X:111,913,059...112,165,035 		JBrowse link
G Pappa pappalysin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAPPA mRNA CTD PMID:19074003 NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361 		JBrowse link
G Pard6b par-6 family cell polarity regulator beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PARD6B mRNA CTD PMID:19074003 NCBI chr 3:156,790,540...156,811,620
Ensembl chr 3:177,209,258...177,230,510 		JBrowse link
G Pcdh7 protocadherin 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PCDH7 mRNA CTD PMID:19074003 NCBI chr14:56,684,817...57,114,976
Ensembl chr14:56,687,725...57,112,665 		JBrowse link
G Pde1c phosphodiesterase 1C multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PDE1C mRNA CTD PMID:19074003 NCBI chr 4:85,300,858...85,777,948
Ensembl chr 4:86,626,282...87,193,259 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO Levonorgestrel binds to and results in increased activity of PGR protein CTD PMID:20599585 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pkp4 plakophilin 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PKP4 mRNA CTD PMID:19074003 NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:64,141,771...64,244,586 		JBrowse link
G Plagl1 PLAG1 like zinc finger 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PLAGL1 mRNA CTD PMID:19074003 NCBI chr 1:9,297,066...9,337,394
Ensembl chr 1:9,330,204...9,337,394 		JBrowse link
G Plat plasminogen activator, tissue type multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PLAT protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased activity of PLAT protein CTD PMID:12618251 PMID:15157790 PMID:15288212 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plg plasminogen multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PLG protein CTD PMID:12618251 PMID:15157790 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320 		JBrowse link
G Poglut1 protein O-glucosyltransferase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of POGLUT1 mRNA CTD PMID:19074003 NCBI chr11:62,198,600...62,226,446
Ensembl chr11:75,703,833...75,733,519 		JBrowse link
G Pon1 paraoxonase 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] affects the activity of PON1 protein CTD PMID:17541152 NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:34,261,289...34,287,924 		JBrowse link
G Ppp2r2c protein phosphatase 2, regulatory subunit B, gamma multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PPP2R2C mRNA CTD PMID:19074003 NCBI chr14:73,846,547...73,931,489
Ensembl chr14:78,071,274...78,156,212 		JBrowse link
G Prkab1 protein kinase AMP-activated non-catalytic subunit beta 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PRKAB1 mRNA CTD PMID:19074003 NCBI chr12:46,248,971...46,259,487
Ensembl chr12:46,249,010...46,259,482 		JBrowse link
G Proc protein C, inactivator of coagulation factors Va and VIIIa multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased activity of PROC protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PROC protein CTD PMID:12618251 PMID:14551147 PMID:15288212 NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964 		JBrowse link
G Pros1 protein S multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of PROS1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PROS1 protein CTD PMID:12618251 PMID:14551147 NCBI chr11:230,597...311,288
Ensembl chr11:13,676,769...13,757,852 		JBrowse link
G Ptbp2 polypyrimidine tract binding protein 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTBP2 mRNA CTD PMID:19074003 NCBI chr 2:210,497,610...210,558,497
Ensembl chr 2:210,497,706...210,558,291 		JBrowse link
G Ptger2 prostaglandin E receptor 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTGER2 mRNA CTD PMID:19074003 NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950 		JBrowse link
G Ptges prostaglandin E synthase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTGES mRNA CTD PMID:19074003 NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995 		JBrowse link
G Rab11fip3 RAB11 family interacting protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAB11FIP3 mRNA CTD PMID:19074003 NCBI chr10:15,507,151...15,591,173
Ensembl chr10:15,507,151...15,591,173 		JBrowse link
G Rab1a RAB1A, member RAS oncogene family multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RAB1A mRNA CTD PMID:19074003 NCBI chr14:94,422,219...94,448,799
Ensembl chr14:98,623,635...98,661,582 		JBrowse link
G Rapgef6 Rap guanine nucleotide exchange factor 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAPGEF6 mRNA CTD PMID:19074003 NCBI chr10:38,655,854...38,824,227
Ensembl chr10:39,156,620...39,324,946 		JBrowse link
G Recql RecQ like helicase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RECQL mRNA CTD PMID:19074003 NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:177,035,128...177,063,838 		JBrowse link
G Rftn2 raftlin family member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RFTN2 mRNA CTD PMID:19074003 NCBI chr 9:64,146,062...64,202,342
Ensembl chr 9:64,124,865...64,215,186 		JBrowse link
G Rln1 relaxin 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RLN1 mRNA CTD PMID:19074003 NCBI chr 1:227,079,960...227,082,960
Ensembl chr 1:236,493,536...236,496,440 		JBrowse link
G Rnf216 ring finger protein 216 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNF216 mRNA CTD PMID:19074003 NCBI chr12:16,568,327...16,689,868
Ensembl chr12:16,568,347...16,690,989 		JBrowse link
G Rnft1 ring finger protein, transmembrane 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNFT1 mRNA CTD PMID:19074003 NCBI chr10:71,807,403...71,821,132
Ensembl chr10:71,807,456...71,821,141 		JBrowse link
G RT1-Bb RT1 class II, locus Bb multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HLA-DQB1 mRNA CTD PMID:19074003 NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118 		JBrowse link
G Saraf store-operated calcium entry-associated regulatory factor multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SARAF mRNA CTD PMID:19074003 NCBI chr16:64,720,404...64,738,653
Ensembl chr16:64,720,418...64,738,653 		JBrowse link
G Scaf4 SR-related CTD-associated factor 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SCAF4 mRNA CTD PMID:19074003 NCBI chr11:29,460,479...29,521,153
Ensembl chr11:42,951,254...43,007,293 		JBrowse link
G Senp1 SUMO specific peptidase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SENP1 mRNA CTD PMID:19074003 NCBI chr 7:131,042,237...131,105,826
Ensembl chr 7:131,044,818...131,100,851 		JBrowse link
G Serpina5 serpin family A member 5 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of SERPINA5 protein CTD PMID:14551147 NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:128,784,991...128,793,186 		JBrowse link
G Serpinb3 serpin family B member 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SERPINB3 mRNA CTD PMID:19074003 NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,788,758...23,795,298 		JBrowse link
G Serpinc1 serpin family C member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of SERPINC1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of SERPINC1 protein CTD PMID:12618251 PMID:14981370 PMID:15288212 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of SERPINE1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of SERPINE1 protein CTD PMID:14981370 PMID:15157790 PMID:15288212 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Sfrp5 secreted frizzled-related protein 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SFRP5 mRNA CTD PMID:19074003 NCBI chr 1:241,006,762...241,011,224
Ensembl chr 1:250,956,050...250,960,512 		JBrowse link
G Shbg sex hormone binding globulin affects binding
multiple interactions 		ISO Levonorgestrel binds to SHBG protein
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of SHBG protein 		CTD PMID:12586319 PMID:14981370 PMID:17519148 NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760 		JBrowse link
G Skic3 SKI3 subunit of superkiller complex multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SKIC3 mRNA CTD PMID:19074003 NCBI chr 2:5,631,544...5,783,643
Ensembl chr 2:7,363,535...7,483,496 		JBrowse link
G Slc16a9 solute carrier family 16, member 9 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SLC16A9 mRNA CTD PMID:19074003 NCBI chr20:18,334,946...18,376,195
Ensembl chr20:18,334,946...18,376,195 		JBrowse link
G Slc25a2 solute carrier family 25 member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC25A2 mRNA CTD PMID:19074003 NCBI chr18:29,704,182...29,707,563
Ensembl chr18:29,703,871...29,708,827 		JBrowse link
G Slc2a5 solute carrier family 2 member 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC2A5 mRNA CTD PMID:19074003 NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:165,866,172...165,894,038 		JBrowse link
G Smyd2 SET and MYND domain containing 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SMYD2 mRNA CTD PMID:19074003 NCBI chr13:101,425,270...101,466,576
Ensembl chr13:103,956,473...103,997,774 		JBrowse link
G Snrpn small nuclear ribonucleoprotein polypeptide N multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SNRPN mRNA CTD PMID:19074003 NCBI chr 1:111,101,327...111,123,400
Ensembl chr 1:120,315,556...120,323,924 		JBrowse link
G Sobp sine oculis binding protein homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SOBP mRNA CTD PMID:19074003 NCBI chr20:48,064,445...48,243,607
Ensembl chr20:48,064,445...48,243,607 		JBrowse link
G Spin4 spindlin family, member 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SPIN4 mRNA CTD PMID:19074003 NCBI chr  X:59,888,728...59,892,817
Ensembl chr  X:63,900,148...63,903,811 		JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SPTBN1 mRNA CTD PMID:19074003 NCBI chr14:108,042,629...108,217,884
Ensembl chr14:108,042,629...108,217,836 		JBrowse link
G Srgn serglycin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SRGN mRNA CTD PMID:19074003 NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,985,508...31,000,327 		JBrowse link
G Stxbp5l syntaxin binding protein 5L multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of STXBP5L mRNA CTD PMID:19074003 NCBI chr11:63,334,667...63,654,270
Ensembl chr11:76,838,900...77,161,306 		JBrowse link
G Syt11 synaptotagmin 11 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SYT11 mRNA CTD PMID:19074003 NCBI chr 2:176,503,845...176,530,354
Ensembl chr 2:176,503,845...176,529,775 		JBrowse link
G Thrb thyroid hormone receptor beta multiple interactions ISO Levonorgestrel binds to and results in increased activity of THRB protein CTD PMID:33049310 NCBI chr15:7,685,180...8,031,920
Ensembl chr15:10,115,954...10,313,680 		JBrowse link
G Tmem217 transmembrane protein 217 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of TMEM217 mRNA CTD PMID:19074003 NCBI chr20:7,594,223...7,620,628
Ensembl chr20:7,594,405...7,620,558 		JBrowse link
G Tmem225 transmembrane protein 225 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of TMEM225 mRNA CTD PMID:19074003 NCBI chr 8:40,497,483...40,500,041
Ensembl chr 8:49,394,504...49,397,485 		JBrowse link
G Tmem35a transmembrane protein 35A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMEM35A mRNA CTD PMID:19074003 NCBI chr  X:97,503,350...97,514,198
Ensembl chr  X:101,796,623...101,807,470 		JBrowse link
G Tmod2 tropomodulin 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMOD2 mRNA CTD PMID:19074003 NCBI chr 8:85,197,222...85,250,627
Ensembl chr 8:85,196,226...85,246,371 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of TNF protein CTD PMID:15769986 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B increases expression ISO Levonorgestrel results in increased expression of TNFRSF11B mRNA CTD PMID:16114553 NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075 		JBrowse link
G Tnfsf11 TNF superfamily member 11 decreases expression ISO Levonorgestrel results in decreased expression of TNFSF11 mRNA CTD PMID:16114553 NCBI chr15:53,673,850...53,705,325
Ensembl chr15:60,083,008...60,114,479 		JBrowse link
G Tnrc6b trinucleotide repeat containing adaptor 6B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TNRC6B mRNA CTD PMID:19074003 NCBI chr 7:114,132,574...114,350,010
Ensembl chr 7:114,132,573...114,342,973 		JBrowse link
G Tra2a transformer 2 alpha multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TRA2A mRNA CTD PMID:19074003 NCBI chr 4:79,551,699...79,570,621
Ensembl chr 4:79,551,542...79,570,619 		JBrowse link
G Trmt13 tRNA methyltransferase 13 homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TRMT13 mRNA CTD PMID:19074003 NCBI chr 2:204,533,630...204,547,711
Ensembl chr 2:207,218,552...207,231,701 		JBrowse link
G Ubap1 ubiquitin-associated protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBAP1 mRNA CTD PMID:19074003 NCBI chr 5:56,520,722...56,561,153
Ensembl chr 5:61,316,643...61,357,076 		JBrowse link
G Ube2d3 ubiquitin-conjugating enzyme E2D 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBE2D3 mRNA CTD PMID:19074003 NCBI chr 2:226,543,194...226,571,001
Ensembl chr 2:226,540,531...226,573,144 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of VCAM1 protein CTD PMID:15769986 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vdr vitamin D receptor multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein]; VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:130,866,745...130,916,757 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO Levonorgestrel results in increased expression of VEGFA mRNA; Levonorgestrel results in increased expression of VEGFA mRNA alternative form CTD PMID:17010073 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Xylt1 xylosyltransferase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of XYLT1 mRNA CTD PMID:19074003 NCBI chr 1:171,643,925...171,929,774
Ensembl chr 1:181,078,222...181,361,047 		JBrowse link
G Yeats2 YEATS domain containing 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of YEATS2 mRNA CTD PMID:19074003 NCBI chr11:94,247,538...94,333,652
Ensembl chr11:94,247,538...94,333,292 		JBrowse link
G Zcchc7 zinc finger CCHC-type containing 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZCCHC7 mRNA CTD PMID:19074003 NCBI chr 5:58,992,558...59,173,308
Ensembl chr 5:63,788,217...63,968,549 		JBrowse link
G Zeb2 zinc finger E-box binding homeobox 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZEB2 mRNA CTD PMID:19074003 NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323 		JBrowse link
G Zfand6 zinc finger AN1-type containing 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZFAND6 mRNA CTD PMID:19074003 NCBI chr 1:147,990,099...148,061,221
Ensembl chr 1:147,990,108...148,061,134 		JBrowse link
G Zfp518a zinc finger protein 518A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF518A mRNA CTD PMID:19074003 NCBI chr 1:249,668,815...249,694,401
Ensembl chr 1:249,657,809...249,695,569 		JBrowse link
G Zfp638 zinc finger protein 638 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF638 mRNA CTD PMID:19074003 NCBI chr 4:117,913,528...118,032,644
Ensembl chr 4:117,913,545...118,032,643 		JBrowse link
G Zfr zinc finger RNA binding protein multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZFR mRNA CTD PMID:19074003 NCBI chr 2:61,137,611...61,200,322
Ensembl chr 2:62,864,338...62,929,133 		JBrowse link
G Zkscan7 zinc finger with KRAB and SCAN domains 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ZKSCAN7 mRNA CTD PMID:19074003 NCBI chr 8:122,501,938...122,519,600
Ensembl chr 8:131,378,013...131,397,065 		JBrowse link
medroxyprogesterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor affects binding
multiple interactions 		EXP
ISO 		Medroxyprogesterone binds to AR protein
Medroxyprogesterone binds to and results in decreased activity of AR protein; Medroxyprogesterone binds to and results in increased activity of AR protein 		CTD PMID:14565775 PMID:25752796 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Cat catalase multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone] affects the activity of CAT protein CTD PMID:16584521 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 decreases activity ISO Medroxyprogesterone results in decreased activity of CYP2C8 protein CTD PMID:15601807
G Fshb follicle stimulating hormone subunit beta multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone] affects the expression of FSHB protein CTD PMID:16584521 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Lpo lactoperoxidase multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone] affects the expression of LPO protein CTD PMID:16584521 NCBI chr10:72,606,950...72,626,220
Ensembl chr10:73,104,188...73,123,456 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO Medroxyprogesterone binds to and results in increased activity of PGR protein CTD PMID:25752796 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Medroxyprogesterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
medroxyprogesterone acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO Medroxyprogesterone Acetate results in decreased activity of ABCB11 protein CTD PMID:23956101 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581 		JBrowse link
G Ackr1 atypical chemokine receptor 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ACKR1 mRNA CTD PMID:20843944 NCBI chr13:85,782,396...85,784,015
Ensembl chr13:88,293,188...88,317,807 		JBrowse link
G Acp3 acid phosphatase 3 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of ACP3 mRNA CTD PMID:20843944 NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:113,785,032...113,833,033 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ACSL1 mRNA CTD PMID:18497975 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ADAMTS1 mRNA CTD PMID:20823114 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adora3 adenosine A3 receptor increases expression ISO Medroxyprogesterone Acetate results in increased expression of ADORA3 mRNA CTD PMID:20843944 NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:196,077,042...196,080,686 		JBrowse link
G Agt angiotensinogen multiple interactions ISO AGT protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of and results in increased localization of FOXO1 protein]; AGT protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased secretion of PRL protein]; Losartan inhibits the reaction [AGT protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased secretion of PRL protein]] CTD PMID:36682589 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of AHR mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Kynurenine co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of AHR mRNA]; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of AHR mRNA; [Kynurenine co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of AHR mRNA CTD PMID:32781018 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Aif1 allograft inflammatory factor 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of AIF1 mRNA CTD PMID:20843944 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Ak5 adenylate kinase 5 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of AK5 mRNA CTD PMID:20823114 NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:244,057,240...244,241,366 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases expression
increases expression
decreases activity 		ISO Medroxyprogesterone Acetate results in decreased expression of AKR1C1 mRNA
Medroxyprogesterone Acetate results in increased expression of AKR1C1 mRNA
Medroxyprogesterone Acetate results in decreased activity of AKR1C1 protein 		CTD PMID:12604236 PMID:18497975 PMID:21182831 PMID:23183084 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 decreases activity ISO Medroxyprogesterone Acetate results in decreased activity of AKR1C2 protein CTD PMID:12604236 PMID:22245609 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions
decreases activity 		ISO [Medroxyprogesterone Acetate inhibits the reaction [[AKR1C3 protein results in increased metabolism of Prostaglandin D2] which results in increased abundance of Dinoprost]] which results in increased abundance of 15-deoxy-delta(12,14)-prostaglandin J2; Medroxyprogesterone Acetate inhibits the reaction [[AKR1C3 protein co-treated with NADP] results in increased reduction of cyclopentanone]; Medroxyprogesterone Acetate inhibits the reaction [[AKR1C3 protein results in increased metabolism of Prostaglandin D2] which results in increased abundance of Dinoprost]
Medroxyprogesterone Acetate results in decreased activity of AKR1C3 protein 		CTD PMID:12604236 PMID:19997560 PMID:21182831 PMID:23261716 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule increases expression ISO Medroxyprogesterone Acetate results in increased expression of ALCAM mRNA CTD PMID:18497975 PMID:20843944 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein increases expression ISO Medroxyprogesterone Acetate results in increased expression of ALOX5AP mRNA CTD PMID:20843944 NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ANTXR1 mRNA CTD PMID:20823114 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Anxa2 annexin A2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ANXA2 mRNA CTD PMID:20823114 NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631 		JBrowse link
G Apod apolipoprotein D increases expression ISO Medroxyprogesterone Acetate results in increased expression of APOD mRNA CTD PMID:20843944 NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) increases expression ISO Medroxyprogesterone Acetate results in increased expression of AQP3 mRNA CTD PMID:18497975 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Ar androgen receptor affects binding
increases activity 		ISO
EXP 		Medroxyprogesterone Acetate binds to AR protein
Medroxyprogesterone Acetate results in increased activity of AR protein 		CTD PMID:11861974 PMID:14565775 PMID:14751673 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arhgef19 Rho guanine nucleotide exchange factor 19 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ARHGEF19 mRNA CTD PMID:20843944 NCBI chr 5:153,536,038...153,554,203
Ensembl chr 5:158,818,932...158,837,196 		JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ARHGEF2 mRNA CTD PMID:20823114 NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646 		JBrowse link
G Atp11a ATPase phospholipid transporting 11A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ATP11A mRNA CTD PMID:20823114 NCBI chr16:76,657,752...76,767,640
Ensembl chr16:83,359,884...83,469,767 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ATP1A1 mRNA CTD PMID:15866426 NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425 		JBrowse link
G Atp2b1 ATPase plasma membrane Ca2+ transporting 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ATP2B1 mRNA CTD PMID:20823114 NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904 		JBrowse link
G Atp2b4 ATPase plasma membrane Ca2+ transporting 4 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of ATP2B4 mRNA CTD PMID:20843944 NCBI chr13:45,156,137...45,255,292
Ensembl chr13:47,711,121...47,758,876 		JBrowse link
G Atp6v0c ATPase H+ transporting V0 subunit C multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ATP6V0C mRNA CTD PMID:20823114 NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,700,764...13,706,245 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding increases expression ISO Medroxyprogesterone Acetate results in increased expression of AZGP1 mRNA CTD PMID:15866426 NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BAX protein CTD PMID:16709600 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcat1 branched chain amino acid transaminase 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of BCAT1 mRNA CTD PMID:20823114 NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288 		JBrowse link
G Bckdk branched chain ketoacid dehydrogenase kinase multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of BCKDK mRNA CTD PMID:20823114 NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453 		JBrowse link
G Bcl2l11 Bcl2-like 11 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein CTD PMID:16709600 NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bcl2l13 Bcl2-like 13 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of BCL2L13 mRNA CTD PMID:20823114 NCBI chr 4:154,056,116...154,112,890
Ensembl chr 4:155,728,284...155,781,158 		JBrowse link
G Bdkrb1 bradykinin receptor B1 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of BDKRB1 mRNA CTD PMID:20843944 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973 		JBrowse link
G Bet1l Bet1 golgi vesicular membrane trafficking protein-like multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of BET1L mRNA CTD PMID:20823114 NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:205,361,041...205,364,706 		JBrowse link
G Bicd1 BICD cargo adaptor 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of BICD1 mRNA CTD PMID:20823114 NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:184,210,363...184,357,391 		JBrowse link
G Bsnd barttin CLCNK type accessory subunit beta multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of BSND mRNA CTD PMID:20823114 NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:126,480,592...126,489,389 		JBrowse link
G C1qa complement C1q A chain increases expression ISO Medroxyprogesterone Acetate results in increased expression of C1QA mRNA CTD PMID:20843944 NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:154,417,087...154,427,732 		JBrowse link
G C1qb complement C1q B chain increases expression ISO Medroxyprogesterone Acetate results in increased expression of C1QB mRNA CTD PMID:20843944 NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840 		JBrowse link
G C1qc complement C1q C chain increases expression ISO Medroxyprogesterone Acetate results in increased expression of C1QC mRNA CTD PMID:20843944 NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468 		JBrowse link
G C1r complement C1r multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of C1R mRNA CTD PMID:20823114 NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:159,098,918...159,109,714 		JBrowse link
G C2cd4b C2 calcium-dependent domain containing 4B decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of NLF2 mRNA CTD PMID:20843944 NCBI chr 8:77,254,327...77,277,620
Ensembl chr 8:77,238,551...77,279,879 		JBrowse link
G C2h1orf162 similar to human chromosome 1 open reading frame 162 increases expression ISO Medroxyprogesterone Acetate results in increased expression of C1ORF162 mRNA CTD PMID:20843944 NCBI chr 2:193,410,730...193,420,824
Ensembl chr 2:196,100,702...196,106,832 		JBrowse link
G C3 complement C3 multiple interactions EXP Medroxyprogesterone Acetate inhibits the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA]; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA]] CTD PMID:11566438 PMID:16806946 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C3h15orf48 similar to human chromosome 15 open reading frame 48 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of C15ORF48 mRNA CTD PMID:20843944 NCBI chr 3:109,719,952...109,723,505
Ensembl chr 3:130,173,416...130,177,089 		JBrowse link
G Ca8 carbonic anhydrase 8 increases expression ISO Medroxyprogesterone Acetate results in increased expression of CA8 mRNA CTD PMID:20843944 NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:26,102,813...26,199,796 		JBrowse link
G Calm1 calmodulin 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CALM1 mRNA CTD PMID:20823114 NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381 		JBrowse link
G Capn2 calpain 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CAPN2 mRNA CTD PMID:20823114 NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625 		JBrowse link
G Car2 carbonic anhydrase 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of CA2 mRNA CTD PMID:18497975 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064 		JBrowse link
G Cast calpastatin multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of CAST mRNA CTD PMID:20823114 NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:5,707,640...5,817,180 		JBrowse link
G Cat catalase multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CAT mRNA CTD PMID:16709600 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cav2 caveolin 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CAV2 mRNA CTD PMID:20823114 NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:46,582,096...46,591,425 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression
decreases secretion 		EXP Medroxyprogesterone Acetate results in decreased expression of CCL2 mRNA; Medroxyprogesterone Acetate results in decreased expression of CCL2 protein
Medroxyprogesterone Acetate results in decreased secretion of CCL2 protein 		CTD PMID:18606702 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of CCN2 mRNA CTD PMID:20823114 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of CCNB1 mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of CCNB1 protein CTD PMID:22534328 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] affects the expression of CCND1 protein; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in decreased expression of CCND1 mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in decreased expression of CCND1 mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in decreased expression of CCND1 protein CTD PMID:22534328 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Cd163 CD163 molecule increases expression ISO Medroxyprogesterone Acetate results in increased expression of CD163 mRNA CTD PMID:20843944 NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:158,770,749...158,804,146 		JBrowse link
G Cd40lg CD40 ligand multiple interactions
decreases activity 		ISO [Bezafibrate co-treated with Medroxyprogesterone Acetate] results in decreased activity of CD40LG protein
Medroxyprogesterone Acetate results in decreased activity of CD40LG protein 		CTD PMID:18923439 NCBI chr  X:140,164,341...140,176,057
Ensembl chr  X:140,164,302...140,176,475 		JBrowse link
G Cdc42bpa CDC42 binding protein kinase alpha multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CDC42BPA mRNA CTD PMID:20823114 NCBI chr13:94,215,359...94,435,681
Ensembl chr13:94,215,959...94,435,681 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of CDKN1A mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of CDKN1A mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of CDKN1A protein CTD PMID:20823114 PMID:22534328 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions
increases expression 		ISO Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased expression of CDKN1B protein]; Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] CTD PMID:17283133 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cebpz CCAAT/enhancer binding protein zeta multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA CTD PMID:20823114 NCBI chr 6:16,119,871...16,137,600
Ensembl chr 6:21,872,025...21,889,749 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form CTD PMID:16709600 NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434 		JBrowse link
G Cilp cartilage intermediate layer protein decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of CILP mRNA CTD PMID:20843944 NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409 		JBrowse link
G Cldn5 claudin 5 increases expression ISO Medroxyprogesterone Acetate results in increased expression of CLDN5 mRNA CTD PMID:20843944 NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322 		JBrowse link
G Cngb1 cyclic nucleotide gated channel subunit beta 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of CNGB1 mRNA CTD PMID:20823114 NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,732,646...9,797,224 		JBrowse link
G Cnr1 cannabinoid receptor 1 increases expression
multiple interactions 		ISO Medroxyprogesterone Acetate results in increased expression of CNR1 mRNA
[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of CNR1 mRNA 		CTD PMID:20843944 PMID:31154070 NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252 		JBrowse link
G Cnr2 cannabinoid receptor 2 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of CNR2 mRNA CTD PMID:31154070 NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:153,409,147...153,435,961 		JBrowse link
G Col6a2 collagen type VI alpha 2 chain multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A2 mRNA CTD PMID:20823114 NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,265...12,057,042 		JBrowse link
G Col6a3 collagen type VI alpha 3 chain multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A3 mRNA CTD PMID:20823114 NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:98,809,171...98,886,990 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of COX6A2 mRNA CTD PMID:20823114 NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716 		JBrowse link
G Cplx1 complexin 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of CPLX1 mRNA CTD PMID:20823114 NCBI chr14:1,184,677...1,216,392
Ensembl chr14:1,329,032...1,360,769 		JBrowse link
G Crebbp CREB binding protein multiple interactions ISO Medroxyprogesterone Acetate promotes the reaction [CREBBP protein binds to SOD2 promoter] CTD PMID:20685861 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Crem cAMP responsive element modulator multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CREM mRNA CTD PMID:20823114 NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160 		JBrowse link
G Crp C-reactive protein multiple interactions ISO [Estrogens, Conjugated (USP) co-treated with Medroxyprogesterone Acetate] results in increased expression of CRP protein CTD PMID:15990257 PMID:17882670 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Ctps2 CTP synthase 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CTPS2 mRNA CTD PMID:20823114 NCBI chr  X:35,277,658...35,418,505
Ensembl chr  X:35,277,658...35,418,505 		JBrowse link
G Ctsd cathepsin D increases expression ISO Medroxyprogesterone Acetate results in increased expression of CTSD mRNA CTD PMID:18497975 NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Cyb5d1 cytochrome b5 domain containing 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of CYB5D1 mRNA CTD PMID:20823114 NCBI chr10:54,612,230...54,616,375
Ensembl chr10:54,612,230...54,616,713 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions EXP [Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CYBB protein CTD PMID:21670166 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of CYP19A1 mRNA; Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of CYP19A1 mRNA]; Dronabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of CYP19A1 mRNA] CTD PMID:31953017 NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Kynurenine co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA]; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA; [Kynurenine co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA; [Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA; Medroxyprogesterone Acetate inhibits the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased expression of CYP1A1 mRNA]
Medroxyprogesterone Acetate results in increased expression of CYP1A1 mRNA 		CTD PMID:10706104 PMID:20843944 PMID:32781018 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Kynurenine co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA]; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA; [Kynurenine co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA; [Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA; CYP1B1 gene polymorphism affects the susceptibility to [Estrogens co-treated with Medroxyprogesterone Acetate] CTD PMID:15987428 PMID:32781018 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of CYP27B1 mRNA CTD PMID:20843944 NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of CYP3A4 mRNA; Medroxyprogesterone Acetate results in increased expression of CYP3A4 protein CTD PMID:15650019 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Dcn decorin multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DCN protein; Azacitidine promotes the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DCN protein] CTD PMID:20823114 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Ddx27 DEAD-box helicase 27 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DDX27 mRNA CTD PMID:20823114 NCBI chr 3:155,744,182...155,763,380
Ensembl chr 3:176,163,203...176,182,410 		JBrowse link
G Depp1 DEPP autophagy regulator 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of DEPP1 mRNA CTD PMID:20843944 NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:151,581,502...151,586,233 		JBrowse link
G Des desmin multiple interactions EXP
ISO 		[Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of DES mRNA
[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate co-treated with Azacitidine] results in increased expression of DES mRNA 		CTD PMID:19089455 PMID:20823114 NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:84,298,447...84,307,347 		JBrowse link
G Dhx9 DExH-box helicase 9 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DHX9 mRNA CTD PMID:20823114 NCBI chr13:68,152,813...68,189,580
Ensembl chr13:68,152,813...68,189,546 		JBrowse link
G Dio2 iodothyronine deiodinase 2 decreases expression
multiple interactions 		ISO Medroxyprogesterone Acetate results in decreased expression of DIO2 mRNA
[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DIO2 mRNA 		CTD PMID:20823114 PMID:20843944 NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:115,396,308...115,410,594 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of DKK1 mRNA CTD PMID:20843944 NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dlg5 discs large MAGUK scaffold protein 5 increases expression ISO Medroxyprogesterone Acetate results in increased expression of DLG5 mRNA CTD PMID:18497975 PMID:19146866 NCBI chr15:75,786...209,735
Ensembl chr15:125,290...237,332 		JBrowse link
G Dner delta/notch-like EGF repeat containing increases expression ISO Medroxyprogesterone Acetate results in increased expression of DNER mRNA CTD PMID:20843944 NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:93,035,108...93,350,568 		JBrowse link
G Dtymk deoxythymidylate kinase multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DTYMK mRNA CTD PMID:20823114 NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504 		JBrowse link
G Dusp23 dual specificity phosphatase 23 increases expression ISO Medroxyprogesterone Acetate results in increased expression of DUSP23 mRNA CTD PMID:20843944 NCBI chr13:87,630,245...87,632,400
Ensembl chr13:87,630,245...87,632,400 		JBrowse link
G Eda ectodysplasin-A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EDA mRNA CTD PMID:20823114 NCBI chr  X:65,078,454...65,480,172
Ensembl chr  X:69,118,796...69,520,274 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of EEF1A1 mRNA CTD PMID:20823114 NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EFEMP1 mRNA CTD PMID:20823114 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Efhd1 EF-hand domain family, member D1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of EFHD1 mRNA CTD PMID:20843944 NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798 		JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EGR2 mRNA CTD PMID:20823114 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Elf3 E74 like ETS transcription factor 3 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ELF3 mRNA CTD PMID:18497975 NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ENPP2 mRNA CTD PMID:20843944 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957 		JBrowse link
G Epb41l4a erythrocyte membrane protein band 4.1 like 4A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EPB41L4A mRNA CTD PMID:20823114 NCBI chr18:25,680,169...25,890,998
Ensembl chr18:25,680,171...25,888,498 		JBrowse link
G Epha3 Eph receptor A3 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EPHA3 mRNA CTD PMID:20823114 NCBI chr11:14,585,041...14,920,721
Ensembl chr11:14,586,727...14,920,425 		JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions
increases expression 		ISO ESR1 protein promotes the reaction [Medroxyprogesterone Acetate results in increased expression of EPHX1 protein]
Medroxyprogesterone Acetate results in increased expression of EPHX1 mRNA; Medroxyprogesterone Acetate results in increased expression of EPHX1 protein 		CTD PMID:20383792 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
decreases expression 		ISO [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of ESR1 mRNA; Cadmium inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of ESR1 mRNA]; ESR1 protein promotes the reaction [Medroxyprogesterone Acetate results in increased expression of EPHX1 protein]
Medroxyprogesterone Acetate results in decreased expression of ESR1 mRNA 		CTD PMID:20383792 PMID:20843944 PMID:39892737 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Eya1 EYA transcriptional coactivator and phosphatase 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of EYA1 mRNA CTD PMID:20823114 NCBI chr 5:4,863,501...5,101,483
Ensembl chr 5:9,646,591...9,884,614 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions
decreases expression 		ISO [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 mRNA; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 protein; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]
Medroxyprogesterone Acetate results in decreased expression of EZH2 mRNA; Medroxyprogesterone Acetate results in decreased expression of EZH2 protein 		CTD PMID:21903722 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G F13a1 coagulation factor XIII A1 chain increases expression ISO Medroxyprogesterone Acetate results in increased expression of F13A1 mRNA CTD PMID:20843944 NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948 		JBrowse link
G F2 coagulation factor II, thrombin multiple interactions
increases expression 		ISO
EXP 		Medroxyprogesterone Acetate promotes the reaction [F2 protein results in increased expression of F3 mRNA]
Medroxyprogesterone Acetate results in increased expression of F2 		CTD PMID:1828463 PMID:11733402 NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246 		JBrowse link
G F2r coagulation factor II (thrombin) receptor increases expression
multiple interactions 		ISO
EXP 		Medroxyprogesterone Acetate results in increased expression of F2R protein
Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of F2R mRNA]
Medroxyprogesterone Acetate results in increased expression of F2R mRNA; Medroxyprogesterone Acetate results in increased expression of F2R protein 		CTD PMID:11733402 NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:28,604,066...28,620,579 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions
increases expression 		ISO
EXP 		Medroxyprogesterone Acetate promotes the reaction [F2 protein results in increased expression of F3 mRNA]
Medroxyprogesterone Acetate results in increased expression of F3 protein 		CTD PMID:11733402 PMID:16011840 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G F7 coagulation factor VII decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of F7 CTD PMID:1828463 NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738 		JBrowse link
G F9 coagulation factor IX increases expression ISO Medroxyprogesterone Acetate results in increased expression of F9 CTD PMID:1828463 NCBI chr  X:143,388,642...143,433,143
Ensembl chr  X:143,388,621...143,433,146 		JBrowse link
G Fads2 fatty acid desaturase 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of FADS2 mRNA CTD PMID:20823114 NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066 		JBrowse link
G Fam107a family with sequence similarity 107, member A increases expression ISO Medroxyprogesterone Acetate results in increased expression of FAM107A mRNA CTD PMID:20843944 NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219 		JBrowse link
G Fas Fas cell surface death receptor increases expression ISO Medroxyprogesterone Acetate results in increased expression of FAS mRNA CTD PMID:18497975 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Faslg Fas ligand multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FASLG protein CTD PMID:16709600 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503 		JBrowse link
G Fbln1 fibulin 1 increases expression
multiple interactions 		ISO Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA; Medroxyprogesterone Acetate results in increased expression of FBLN1 protein
Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA] 		CTD PMID:15774544 NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965 		JBrowse link
G Fbxo11 F-box protein 11 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FBXO11 mRNA CTD PMID:20823114 NCBI chr 6:12,240,348...12,316,223
Ensembl chr 6:12,239,801...12,316,221 		JBrowse link
G Fbxw5 F-box and WD repeat domain containing 5 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FBXW5 mRNA CTD PMID:20823114 NCBI chr 3:28,720,670...28,725,237
Ensembl chr 3:28,720,778...28,725,235 		JBrowse link
G Fcgbp Fc gamma binding protein increases expression ISO Medroxyprogesterone Acetate results in increased expression of FCGBP mRNA CTD PMID:20843944 NCBI chr 1:92,502,461...92,540,658
Ensembl chr 1:92,499,498...92,540,658 		JBrowse link
G Fgd1 FYVE, RhoGEF and PH domain containing 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of FGD1 mRNA CTD PMID:20823114 NCBI chr  X:20,023,746...20,066,734
Ensembl chr  X:23,467,530...23,509,979 		JBrowse link
G Fgf7 fibroblast growth factor 7 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of FGF7 mRNA CTD PMID:20843944 NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328 		JBrowse link
G Fibin fin bud initiation factor homolog increases expression ISO Medroxyprogesterone Acetate results in increased expression of FIBIN mRNA CTD PMID:20843944 NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479 		JBrowse link
G Filip1l filamin A interacting protein 1-like multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of FILIP1L mRNA CTD PMID:20823114 NCBI chr11:56,403,467...56,646,422
Ensembl chr11:56,410,582...56,646,402 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 increases expression ISO Medroxyprogesterone Acetate results in increased expression of FKBP5 mRNA CTD PMID:19146866 PMID:20843944 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of FN1 mRNA; [Medroxyprogesterone Acetate co-treated with Carbon Tetrachloride] results in increased expression of FN1 protein CTD PMID:1465320 PMID:20823114 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Folr2 folate receptor beta increases expression ISO Medroxyprogesterone Acetate results in increased expression of FOLR2 mRNA CTD PMID:20843944 NCBI chr 1:156,200,044...156,218,380
Ensembl chr 1:165,612,063...165,617,731 		JBrowse link
G Foxo1 forkhead box O1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate co-treated with Azacitidine] results in increased expression of FOXO1 mRNA; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FOXO1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 protein; [Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of and results in increased localization of FOXO1 protein; [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of FOXO1 mRNA; AGT protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of and results in increased localization of FOXO1 protein]; Cadmium inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of FOXO1 mRNA]; Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of FOXO1 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein]; Hydrogen Peroxide inhibits the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 mRNA]; Hydrogen Peroxide inhibits the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 protein] CTD PMID:16709600 PMID:20823114 PMID:31953017 PMID:36682589 PMID:39892737 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Foxo3 forkhead box O3 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] inhibits the reaction [Hydrogen Peroxide results in increased expression of FOXO3 mRNA]; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] inhibits the reaction [Hydrogen Peroxide results in increased expression of FOXO3 protein]; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA] CTD PMID:16709600 NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845 		JBrowse link
G Fpr1 formyl peptide receptor 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of FPR1 mRNA CTD PMID:20843944 NCBI chr 1:67,417,991...67,429,813
Ensembl chr 1:67,421,313...67,422,520 		JBrowse link
G Fscn2 fascin actin-bundling protein 2, retinal multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FSCN2 mRNA CTD PMID:20823114 NCBI chr10:106,121,038...106,139,683
Ensembl chr10:106,133,144...106,139,683 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions ISO [Estrogens, Conjugated (USP) co-treated with Medroxyprogesterone Acetate] results in decreased expression of FSHB protein CTD PMID:16236362 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Fxyd3 FXYD domain-containing ion transport regulator 3 increases expression ISO Medroxyprogesterone Acetate results in increased expression of FXYD3 mRNA CTD PMID:18497975 NCBI chr 1:86,305,531...86,312,455
Ensembl chr 1:95,432,919...95,439,702 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of GADD45A mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of GADD45A protein CTD PMID:16709600 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Galnt15 polypeptide N-acetylgalactosaminyltransferase 15 increases expression ISO Medroxyprogesterone Acetate results in increased expression of GALNT15 mRNA CTD PMID:20843944 NCBI chr16:7,233,524...7,273,290
Ensembl chr16:7,233,606...7,273,285 		JBrowse link
G Gars1 glycyl-tRNA synthetase 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GARS1 mRNA CTD PMID:20823114 NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876 		JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of GBE1 mRNA CTD PMID:20823114 NCBI chr11:22,181,194...22,446,640
Ensembl chr11:22,181,103...22,446,638 		JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GBP2 mRNA CTD PMID:20823114 NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810 		JBrowse link
G Gcnt2 glucosaminyl (N-acetyl) transferase 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA CTD PMID:20823114 NCBI chr17:23,796,859...23,901,625
Ensembl chr17:24,002,597...24,106,989 		JBrowse link
G Gdf10 growth differentiation factor 10 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of GDF10 mRNA CTD PMID:20843944 NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,243,317...9,256,794 		JBrowse link
G Gipc1 GIPC PDZ domain containing family, member 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of GIPC1 mRNA CTD PMID:20823114 NCBI chr19:41,380,125...41,392,078
Ensembl chr19:41,380,125...41,391,725 		JBrowse link
G Gja1 gap junction protein, alpha 1 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of GJA1 mRNA CTD PMID:20843944 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Glrx glutaredoxin increases expression ISO Medroxyprogesterone Acetate results in increased expression of GLRX mRNA CTD PMID:20843944 NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543 		JBrowse link
G Gpkow G patch domain and KOW motifs multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of GPKOW mRNA CTD PMID:20823114 NCBI chr  X:14,791,601...14,806,384
Ensembl chr  X:17,463,525...17,478,298 		JBrowse link
G Gpnmb glycoprotein nmb multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GPNMB mRNA CTD PMID:20823114 NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240 		JBrowse link
G Gpr34 G protein-coupled receptor 34 increases expression ISO Medroxyprogesterone Acetate results in increased expression of GPR34 mRNA CTD PMID:20843944 NCBI chr  X:11,777,667...11,786,640
Ensembl chr  X:11,776,371...11,843,240 		JBrowse link
G Gpr83 G protein-coupled receptor 83 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of GPR83 mRNA CTD PMID:20843944 NCBI chr 8:11,693,540...11,704,028
Ensembl chr 8:19,974,993...19,985,490 		JBrowse link
G Gpx3 glutathione peroxidase 3 increases expression ISO Medroxyprogesterone Acetate results in increased expression of GPX3 mRNA CTD PMID:20843944 NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,529,448...39,537,405 		JBrowse link
G Gsn gelsolin increases expression ISO Medroxyprogesterone Acetate results in increased expression of GSN mRNA CTD PMID:18497975 NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:38,982,671...39,035,850 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression EXP Medroxyprogesterone Acetate results in increased expression of GSTA2 mRNA CTD PMID:11502894 NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092 		JBrowse link
G Gstm5 glutathione S-transferase, mu 5 increases expression ISO Medroxyprogesterone Acetate results in increased expression of GSTM3 mRNA CTD PMID:18497975 NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731 		JBrowse link
G Havcr2 hepatitis A virus cellular receptor 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of HAVCR2 mRNA CTD PMID:20843944 NCBI chr10:30,882,484...30,914,018
Ensembl chr10:31,383,925...31,413,872 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of HBEGF mRNA CTD PMID:20843944 NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220 		JBrowse link
G Hoxa1 homeobox A1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA] CTD PMID:20823114 NCBI chr 4:82,586,505...82,589,209
Ensembl chr 4:82,586,505...82,589,209 		JBrowse link
G Hoxa10 homeobox A10 multiple interactions
increases expression 		ISO [Medroxyprogesterone Acetate co-treated with Estrogens] results in increased expression of HOXA10 mRNA; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of HOXA10 mRNA] CTD PMID:16632680 PMID:21670700 NCBI chr 4:81,331,591...81,340,878
Ensembl chr 4:82,662,204...82,665,922 		JBrowse link
G Hoxa11 homeobox A11 increases expression ISO Medroxyprogesterone Acetate results in increased expression of HOXA11 mRNA CTD PMID:16632680 NCBI chr 4:81,342,527...81,346,189
Ensembl chr 4:82,673,140...82,676,844 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of and results in increased activity of HSD11B1 protein; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA CTD PMID:23275455 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B2 protein CTD PMID:23275455 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of HSD17B2 mRNA CTD PMID:23183084 NCBI chr19:45,753,576...45,825,203
Ensembl chr19:62,662,098...62,733,943 		JBrowse link
G Htr1a 5-hydroxytryptamine receptor 1A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of HTR1A mRNA CTD PMID:20823114 NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:38,427,083...38,540,760 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO Medroxyprogesterone Acetate inhibits the reaction [Hydrocortisone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]]; Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]] CTD PMID:15358673 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Idh1 isocitrate dehydrogenase (NADP(+)) 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of IDH1 mRNA CTD PMID:20843944 NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555 		JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 multiple interactions ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 protein]; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 mRNA; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 protein CTD PMID:32781018 NCBI chr16:67,430,654...67,442,726
Ensembl chr16:74,133,259...74,145,328 		JBrowse link
G Ifng interferon gamma multiple interactions ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased abundance of Kynurenine]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of AHR mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of TDO2 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [IFNG protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [IFNG protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; [Estrogens, Conjugated (USP) co-treated with Medroxyprogesterone Acetate] results in decreased secretion of IFNG protein; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased abundance of Kynurenine; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of AHR mRNA; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 mRNA; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of IDO1 protein; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of TDO2 mRNA; IFNG protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; IFNG protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]] CTD PMID:16236362 PMID:32781018 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Ifrd2 interferon-related developmental regulator 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IFRD2 mRNA CTD PMID:20823114 NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions
increases expression 		ISO 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [IFNG protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; 4-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA; [Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 protein; [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1; [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA; [Estradiol deficiency co-treated with Medroxyprogesterone Acetate deficiency] results in decreased expression of IGFBP1 mRNA; [Estradiol deficiency co-treated with Medroxyprogesterone Acetate deficiency] results in increased expression of IGFBP1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein; [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA; [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 protein; [Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of IGFBP1 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; Azacitidine promotes the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 protein]; Cadmium inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; Cadmium inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 protein]; Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased expression of IGFBP1 mRNA]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein]; IFNG protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; NAD inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]; Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:11756571 PMID:12093828 PMID:16709600 PMID:20685861 PMID:20823114 More... NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP3 mRNA CTD PMID:20823114 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP4 mRNA CTD PMID:20823114 NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of IGFBP5 mRNA CTD PMID:20843944 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Il11 interleukin 11 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of IL11 mRNA CTD PMID:20843944 NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IL12B mRNA CTD PMID:20823114 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases expression 		ISO [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased secretion of IL1B protein
Medroxyprogesterone Acetate results in decreased expression of IL1B mRNA 		CTD PMID:16537180 PMID:20843944 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il2 interleukin 2 multiple interactions ISO [Estrogens, Conjugated (USP) co-treated with Medroxyprogesterone Acetate] results in decreased secretion of IL2 protein CTD PMID:16236362 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il23a interleukin 23 subunit alpha multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of IL23A mRNA CTD PMID:20823114 NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434 		JBrowse link
G Il24 interleukin 24 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of IL24 mRNA CTD PMID:20843944 NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760 		JBrowse link
G Il6 interleukin 6 multiple interactions
decreases expression
decreases secretion 		ISO [Polyphenols co-treated with Antioxidants co-treated with Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Medroxyprogesterone Acetate co-treated with Celecoxib] results in decreased expression of IL6
Medroxyprogesterone Acetate results in decreased expression of IL6 mRNA
Medroxyprogesterone Acetate results in decreased secretion of IL6 protein
[Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased secretion of IL6 protein 		CTD PMID:16537180 PMID:16702388 PMID:20843944 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ints7 integrator complex subunit 7 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of INTS7 mRNA CTD PMID:20823114 NCBI chr13:103,155,123...103,207,953
Ensembl chr13:105,686,128...105,739,608 		JBrowse link
G Irf9 interferon regulatory factor 9 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IRF9 mRNA CTD PMID:20823114 NCBI chr15:29,095,474...29,101,924
Ensembl chr15:33,065,659...33,071,879 		JBrowse link
G Irs2 insulin receptor substrate 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of IRS2 mRNA CTD PMID:20843944 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543 		JBrowse link
G Isg20l2 interferon stimulated exonuclease gene 20-like 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ISG20L2 mRNA CTD PMID:20823114 NCBI chr 2:173,396,780...173,407,102
Ensembl chr 2:175,695,615...175,705,095 		JBrowse link
G Itga1 integrin subunit alpha 1 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of ITGA1 mRNA CTD PMID:20843944 NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:48,386,249...48,545,284 		JBrowse link
G Itga11 integrin subunit alpha 11 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of ITGA11 mRNA CTD PMID:20843944 NCBI chr 8:63,145,998...63,254,714
Ensembl chr 8:72,016,652...72,150,137 		JBrowse link
G Itga2 integrin subunit alpha 2 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of ITGA2 mRNA CTD PMID:18497975 NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509 		JBrowse link
G Itgb1 integrin subunit beta 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ITGB1 mRNA CTD PMID:20823114 NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269 		JBrowse link
G Itgb5 integrin subunit beta 5 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of ITGB5 mRNA CTD PMID:18497975 NCBI chr11:66,828,428...66,944,231
Ensembl chr11:80,333,590...80,449,373 		JBrowse link
G Itih5 inter-alpha-trypsin inhibitor heavy chain 5 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ITIH5 mRNA CTD PMID:20823114 NCBI chr17:73,161,886...73,261,930
Ensembl chr17:73,161,611...73,262,496 		JBrowse link
G Kcnb1 potassium voltage-gated channel subfamily B member 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of KCNB1 mRNA CTD PMID:20843944 NCBI chr 3:155,820,255...155,913,383
Ensembl chr 3:176,242,589...176,332,408 		JBrowse link
G Kcnc4 potassium voltage-gated channel subfamily C member 4 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of KCNC4 mRNA CTD PMID:20823114 NCBI chr 2:195,063,967...195,100,244
Ensembl chr 2:197,759,010...197,788,433 		JBrowse link
G Kdr kinase insert domain receptor decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of KDR mRNA CTD PMID:18497975 NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192 		JBrowse link
G Klf4 KLF transcription factor 4 increases expression ISO Medroxyprogesterone Acetate results in increased expression of KLF4 mRNA CTD PMID:18497975 NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592 		JBrowse link
G Krt8 keratin 8 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of KRT8 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of KRT8 mRNA] CTD PMID:20823114 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Lama4 laminin subunit alpha 4 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of LAMA4 mRNA CTD PMID:20843944 NCBI chr20:42,392,268...42,533,347
Ensembl chr20:43,946,898...44,087,972 		JBrowse link
G Lamb2 laminin subunit beta 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of LAMB2 mRNA CTD PMID:20823114 NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:118,056,935...118,069,090 		JBrowse link
G Lcn2 lipocalin 2 multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone Acetate] results in decreased expression of LCN2 mRNA CTD PMID:15866426 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Ldha lactate dehydrogenase A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of LDHA mRNA CTD PMID:20823114 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521 		JBrowse link
G Lgals3 galectin 3 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G LOC120095955 mucin-12-like multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MUC12 mRNA CTD PMID:20823114 NCBI chr12:19,486,041...19,493,995 JBrowse link
G Loxl4 lysyl oxidase-like 4 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of LOXL4 mRNA CTD PMID:20843944 NCBI chr 1:251,345,445...251,365,640
Ensembl chr 1:251,347,238...251,365,577 		JBrowse link
G Lpar3 lysophosphatidic acid receptor 3 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of LPAR3 mRNA CTD PMID:20823114 NCBI chr 2:237,785,371...237,854,199
Ensembl chr 2:237,787,766...237,854,197 		JBrowse link
G Lratd2 LRAT domain containing 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of LRATD2 mRNA CTD PMID:20843944 NCBI chr 7:92,376,713...92,387,045
Ensembl chr 7:94,073,513...94,277,046 		JBrowse link
G Ltbp1 latent transforming growth factor beta binding protein 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of LTBP1 mRNA CTD PMID:20823114 NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:25,781,638...26,454,036 		JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of XLKD1 mRNA CTD PMID:20843944 NCBI chr 1:174,393,387...174,410,977 JBrowse link
G Map1a microtubule-associated protein 1A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MAP1A mRNA CTD PMID:20823114 NCBI chr 3:128,716,907...128,736,638
Ensembl chr 3:128,716,940...128,740,159 		JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA CTD PMID:20823114 NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353 		JBrowse link
G Map7 microtubule-associated protein 7 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of MAP7 mRNA CTD PMID:20843944 NCBI chr 1:14,910,433...15,037,574
Ensembl chr 1:16,730,075...16,857,170 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO Medroxyprogesterone Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein CTD PMID:20535544 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO Medroxyprogesterone Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein CTD PMID:20535544 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Marco macrophage receptor with collagenous structure increases expression ISO Medroxyprogesterone Acetate results in increased expression of MARCO mRNA CTD PMID:20843944 NCBI chr13:31,616,278...31,648,521
Ensembl chr13:34,169,011...34,201,255 		JBrowse link
G Mgat4b alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MGAT4B mRNA CTD PMID:20823114 NCBI chr10:34,548,918...34,559,229
Ensembl chr10:35,050,512...35,060,309 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of MGST1 mRNA CTD PMID:20843944 NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875 		JBrowse link
G Mir142 microRNA 142 increases expression ISO Medroxyprogesterone Acetate results in increased expression of MIR142 mRNA CTD PMID:22543862 NCBI chr10:72,557,864...72,557,950
Ensembl chr10:73,055,097...73,055,207 		JBrowse link
G Mir146b microRNA 146b increases expression ISO Medroxyprogesterone Acetate results in increased expression of MIR146B mRNA CTD PMID:22543862 NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:255,144,860...255,144,947 		JBrowse link
G Mir193b microRNA 193b decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of MIR193B mRNA CTD PMID:22543862 NCBI chr10:1,317,742...1,317,824
Ensembl chr10:1,824,944...1,825,026 		JBrowse link
G Mir21 microRNA 21 increases expression ISO Medroxyprogesterone Acetate results in increased expression of MIR21 mRNA CTD PMID:22543862 NCBI chr10:71,902,600...71,902,691 JBrowse link
G Mir27b microRNA 27b multiple interactions ISO [Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MIR27B mRNA CTD PMID:30328349 NCBI chr17:1,819,147...1,819,243 JBrowse link
G Mmp1 matrix metallopeptidase 1 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of MMP1 mRNA CTD PMID:20843944 NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:12,943,453...12,963,964 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions
decreases activity 		ISO [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP2 protein
[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MMP2 mRNA
Medroxyprogesterone Acetate results in decreased activity of MMP2 protein 		CTD PMID:16537180 PMID:20823114 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
decreases expression
decreases activity 		ISO [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein
Medroxyprogesterone Acetate results in decreased expression of MMP9 mRNA
Medroxyprogesterone Acetate results in decreased activity of MMP9 protein 		CTD PMID:16537180 PMID:20843944 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mmrn1 multimerin 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of MMRN1 mRNA CTD PMID:20843944 NCBI chr 4:89,875,408...89,950,814
Ensembl chr 4:91,233,240...91,280,861 		JBrowse link
G Ms4a6a membrane spanning 4-domains A6A increases expression ISO Medroxyprogesterone Acetate results in increased expression of MS4A6A mRNA CTD PMID:20843944 NCBI chr 1:217,826,261...217,839,606
Ensembl chr 1:217,826,261...217,850,013 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MTHFD2 mRNA CTD PMID:20823114 NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350 		JBrowse link
G Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MTR mRNA CTD PMID:20823114 NCBI chr17:62,911,705...62,996,544
Ensembl chr17:62,911,771...62,996,541 		JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of MTSS1 mRNA CTD PMID:20843944 NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303 		JBrowse link
G Muc1 mucin 1, cell surface associated increases expression ISO Medroxyprogesterone Acetate results in increased expression of MUC1 mRNA CTD PMID:18497975 NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:176,933,047...176,938,491 		JBrowse link
G Myb MYB proto-oncogene, transcription factor decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of MYB mRNA CTD PMID:18497975 NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:17,759,309...17,792,547 		JBrowse link
G Myh9 myosin, heavy chain 9 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYH9 mRNA CTD PMID:20823114 NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963 		JBrowse link
G Myl12a myosin light chain 12A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYL12A mRNA CTD PMID:20823114 NCBI chr 9:110,891,970...110,899,655
Ensembl chr 9:118,338,604...118,342,634 		JBrowse link
G Myl12b myosin light chain 12B multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYL12B mRNA CTD PMID:20823114 NCBI chr 9:118,320,479...118,334,810
Ensembl chr 9:118,320,489...118,324,418 		JBrowse link
G Mylk myosin light chain kinase multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYLK mRNA CTD PMID:20823114 NCBI chr11:65,783,008...66,030,239
Ensembl chr11:79,288,243...79,535,659 		JBrowse link
G Myof myoferlin multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYOF mRNA CTD PMID:20823114 NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:245,086,109...245,234,768 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NCF1 mRNA CTD PMID:20823114 NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079 		JBrowse link
G Ncf2 neutrophil cytosolic factor 2 multiple interactions EXP [Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of NCF2 protein CTD PMID:21670166 NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149 		JBrowse link
G Ncoa1 nuclear receptor coactivator 1 multiple interactions ISO Medroxyprogesterone Acetate promotes the reaction [PGR protein binds to NCOA1 protein] CTD PMID:15937332 NCBI chr 6:32,952,090...33,229,829
Ensembl chr 6:32,952,090...33,195,924 		JBrowse link
G Ndst1 N-deacetylase and N-sulfotransferase 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of NDST1 mRNA CTD PMID:20823114 NCBI chr18:56,407,308...56,470,007
Ensembl chr18:56,411,200...56,448,612 		JBrowse link
G Nefm neurofilament medium chain decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of NEFM mRNA CTD PMID:20843944 NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163 		JBrowse link
G Nexn nexilin (F actin binding protein) multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NEXN mRNA CTD PMID:20823114 NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:243,846,433...243,887,114 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of NFE2L2 mRNA CTD PMID:18497975 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nom1 nucleolar protein with MIF4G domain 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NOM1 mRNA CTD PMID:20823114 NCBI chr 4:6,562,931...6,586,093
Ensembl chr 4:6,567,836...6,585,036 		JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions ISO
EXP 		Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased activity of NOS3 protein]; Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of NOS3 protein] CTD PMID:15358673 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Nphp1 nephrocystin 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of NPHP1 mRNA CTD PMID:20823114 NCBI chr 3:114,960,650...115,016,234
Ensembl chr 3:135,413,927...135,469,505 		JBrowse link
G Nptx2 neuronal pentraxin 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of NPTX2 mRNA CTD PMID:20843944 NCBI chr12:10,037,435...10,048,345
Ensembl chr12:15,151,136...15,162,045 		JBrowse link
G Nptxr neuronal pentraxin receptor multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NPTXR mRNA CTD PMID:20823114 NCBI chr 7:113,217,046...113,235,122
Ensembl chr 7:113,217,050...113,235,156 		JBrowse link
G Npy1r neuropeptide Y receptor Y1 multiple interactions
decreases expression 		ISO Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of NPY1R mRNA]
Medroxyprogesterone Acetate results in decreased expression of NPY1R mRNA 		CTD PMID:18497975 PMID:19146866 NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO Medroxyprogesterone Acetate results in increased activity of NR1I2 protein CTD PMID:15650019 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NR2F1 mRNA CTD PMID:20823114 NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:9,776,179...9,785,924 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects response to substance
multiple interactions 		ISO NR3C1 protein affects the susceptibility to Medroxyprogesterone Acetate
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 protein 		CTD PMID:23275455 PMID:23658782 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 protein CTD PMID:23275455 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of NR4A2 mRNA CTD PMID:20843944 NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769 		JBrowse link
G Nrip1 nuclear receptor interacting protein 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NRIP1 mRNA CTD PMID:20823114 NCBI chr11:14,895,843...14,979,490
Ensembl chr11:28,378,878...28,467,353 		JBrowse link
G Nt5e 5' nucleotidase, ecto decreases expression
multiple interactions 		ISO Medroxyprogesterone Acetate results in decreased expression of NT5E mRNA
[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of NT5E mRNA 		CTD PMID:20823114 PMID:20843944 NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:98,150,900...98,195,645 		JBrowse link
G Nts neurotensin multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NTS mRNA CTD PMID:20823114 NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961 		JBrowse link
G Nup155 nucleoporin 155 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NUP155 mRNA CTD PMID:20823114 NCBI chr 2:57,201,310...57,252,918
Ensembl chr 2:58,928,537...58,981,242 		JBrowse link
G Ogfrl1 opioid growth factor receptor-like 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of OGFRL1 mRNA CTD PMID:20823114 NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:33,324,392...33,339,237 		JBrowse link
G Or8b8 olfactory receptor family 8 subfamily B member 8 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of OR8B8 mRNA CTD PMID:20823114 NCBI chr 8:37,693,578...37,694,510
Ensembl chr 8:45,882,321...45,883,253 		JBrowse link
G P4hb prolyl 4-hydroxylase subunit beta multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of P4HB mRNA CTD PMID:20823114 NCBI chr10:105,836,972...105,848,583
Ensembl chr10:106,335,300...106,346,911 		JBrowse link
G Paep progestagen associated endometrial protein multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PAEP mRNA CTD PMID:20823114 NCBI chr 3:8,531,136...8,534,430 JBrowse link
G Pakap paralemmin A kinase anchor protein multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PALM2AKAP2 mRNA CTD PMID:20823114 NCBI chr 5:76,976,906...77,443,656
Ensembl chr 5:76,977,112...77,443,656 		JBrowse link
G Pcdh17 protocadherin 17 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of PCDH17 mRNA CTD PMID:20843944 NCBI chr15:66,631,549...66,725,007
Ensembl chr15:66,633,142...66,722,105 		JBrowse link
G Pcdh18 protocadherin 18 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDH18 mRNA CTD PMID:20823114 NCBI chr 2:135,982,929...135,996,917
Ensembl chr 2:135,983,144...135,996,826 		JBrowse link
G Pcdh20 protocadherin 20 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of PCDH20 mRNA CTD PMID:20843944 NCBI chr15:64,425,534...64,431,790
Ensembl chr15:70,834,042...70,840,298 		JBrowse link
G Pcdhb5 protocadherin beta 5 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDHB4 mRNA CTD PMID:20823114 NCBI chr18:29,302,466...29,305,048 JBrowse link
G Pdgfa platelet derived growth factor subunit A multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone Acetate] results in decreased secretion of [PDGFA protein binds to PDGFB protein] CTD PMID:15866426 NCBI chr12:15,645,549...15,667,056
Ensembl chr12:20,754,208...20,780,322 		JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone Acetate] results in decreased secretion of [PDGFA protein binds to PDGFB protein] CTD PMID:15866426 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PDK1 mRNA CTD PMID:20823114 NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145 		JBrowse link
G Penk proenkephalin decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of PENK mRNA CTD PMID:20843944 NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705 		JBrowse link
G Pgr progesterone receptor decreases expression
multiple interactions 		ISO Medroxyprogesterone Acetate results in decreased expression of PGR protein
Medroxyprogesterone Acetate results in decreased expression of PGR mRNA; Medroxyprogesterone Acetate results in decreased expression of PGR protein
[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PGR mRNA; Cadmium inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PGR mRNA]; Medroxyprogesterone Acetate promotes the reaction [PGR protein binds to NCOA1 protein] 		CTD PMID:2151368 PMID:15937332 PMID:20843944 PMID:23183084 PMID:39892737 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pgrmc2 progesterone receptor membrane component 2 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PGRMC2 mRNA CTD PMID:20823114 NCBI chr 2:125,996,190...126,012,090
Ensembl chr 2:125,996,193...126,012,090 		JBrowse link
G Pitpnc1 phosphatidylinositol transfer protein, cytoplasmic 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PITPNC1 mRNA CTD PMID:20823114 NCBI chr10:92,663,260...92,928,616
Ensembl chr10:92,663,260...92,928,344 		JBrowse link
G Pkd2l1 polycystin 2 like 1, transient receptor potential cation channel multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PKD2L1 mRNA CTD PMID:20823114 NCBI chr 1:252,982,096...253,019,235
Ensembl chr 1:252,982,096...253,023,359 		JBrowse link
G Plat plasminogen activator, tissue type multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PLAT mRNA CTD PMID:20823114 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plau plasminogen activator, urokinase decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of PLAU mRNA CTD PMID:20843944 NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030 		JBrowse link
G Plcxd3 phosphatidylinositol-specific phospholipase C, X domain containing 3 increases expression ISO Medroxyprogesterone Acetate results in increased expression of PLCXD3 mRNA CTD PMID:20843944 NCBI chr 2:53,567,022...53,746,384
Ensembl chr 2:55,294,613...55,474,220 		JBrowse link
G Plekhg3 pleckstrin homology and RhoGEF domain containing G3 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PLEKHG3 mRNA CTD PMID:20823114 NCBI chr 6:100,998,965...101,042,120
Ensembl chr 6:100,994,417...101,042,118 		JBrowse link
G Plg plasminogen increases expression ISO Medroxyprogesterone Acetate results in increased expression of PLG CTD PMID:1828463 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320 		JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of PLOD2 mRNA CTD PMID:20843944 NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022 		JBrowse link
G Pls3 plastin 3 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PLS3 mRNA CTD PMID:20823114 NCBI chr  X:116,401,247...116,495,898
Ensembl chr  X:116,401,293...116,495,893 		JBrowse link
G Ppbp pro-platelet basic protein decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of PPBP mRNA CTD PMID:20843944 NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299 		JBrowse link
G Ppia peptidylprolyl isomerase A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PPIA mRNA CTD PMID:20823114 NCBI chr14:81,279,292...81,282,960
Ensembl chr14:85,492,484...85,497,115 		JBrowse link
G Prdx5 peroxiredoxin 5 affects expression
multiple interactions 		EXP Medroxyprogesterone Acetate affects the expression of PRDX5
[Medroxyprogesterone Acetate co-treated with Estradiol] affects the expression of PRDX5 		CTD PMID:21159850 NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020 		JBrowse link
G Prl prolactin multiple interactions
increases expression 		ISO 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [IFNG protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; 4-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA; [Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate co-treated with Azacitidine] results in increased expression of PRL mRNA; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate co-treated with Azacitidine] results in increased expression of PRL protein; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL protein; [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein; [Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased secretion of PRL protein; [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA; [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL protein; [Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of PRL mRNA; [Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased secretion of PRL protein; AGT protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased secretion of PRL protein]; Cadmium inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]; Cadmium inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL protein]; Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]; Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of PRL mRNA]; Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased secretion of PRL protein]; Cannabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of PRL mRNA]; Cannabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased secretion of PRL protein]; Dinoprostone promotes the reaction [[Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]; Dronabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of PRL mRNA]; Dronabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased secretion of PRL protein]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein]; IFNG protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]; Losartan inhibits the reaction [AGT protein promotes the reaction [[Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased secretion of PRL protein]]; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of PRL mRNA]; Rimonabant inhibits the reaction [Dronabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of PRL mRNA]]; Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA] CTD PMID:7506205 PMID:15774544 PMID:16709600 PMID:20823114 PMID:21903722 More... NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217 		JBrowse link
G Prl8a2 prolactin family 8, subfamily A, member 2 multiple interactions EXP [Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of PRL8A2 mRNA CTD PMID:19089455 NCBI chr17:37,613,263...37,622,288
Ensembl chr17:37,821,651...37,830,676 		JBrowse link
G Prrx1 paired related homeobox 1 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of PRRX1 mRNA CTD PMID:20843944 NCBI chr13:78,136,783...78,205,379
Ensembl chr13:78,136,783...78,204,058 		JBrowse link
G Prss12 serine protease 12 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PRSS12 mRNA CTD PMID:20823114 NCBI chr 2:214,308,695...214,368,679
Ensembl chr 2:214,308,774...214,369,941 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of PTGS2 mRNA CTD PMID:20843944 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Ptk7 protein tyrosine kinase 7 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PTK7 mRNA CTD PMID:20823114 NCBI chr 9:14,352,155...14,418,473
Ensembl chr 9:21,849,801...21,916,078 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 multiple interactions ISO Cycloheximide inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of PTP4A1 mRNA]]; Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of PTP4A1 mRNA] CTD PMID:19146866 NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176 		JBrowse link
G Ptpa protein phosphatase 2 phosphatase activator multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PTPA mRNA CTD PMID:20823114 NCBI chr 3:13,689,742...13,720,287
Ensembl chr 3:34,087,575...34,162,772 		JBrowse link
G Rab1b RAB1B, member RAS oncogene family multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of RAB1B mRNA CTD PMID:20823114 NCBI chr 1:211,835,133...211,843,408
Ensembl chr 1:211,835,073...211,843,337
Ensembl chr  X:211,835,073...211,843,337 		JBrowse link
G Rab31 RAB31, member RAS oncogene family multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of RAB31 mRNA CTD PMID:20823114 NCBI chr 9:112,693,596...112,828,104
Ensembl chr 9:112,693,597...112,828,092 		JBrowse link
G Ran RAN, member RAS oncogene family multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RAN mRNA CTD PMID:20823114 NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO Medroxyprogesterone Acetate inhibits the reaction [Hydrocortisone inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]]; Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]] CTD PMID:15358673 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Ret ret proto-oncogene multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RET mRNA CTD PMID:20823114 NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:152,998,812...153,040,556 		JBrowse link
G Rgs10 regulator of G-protein signaling 10 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RGS10 mRNA CTD PMID:20823114 NCBI chr 1:192,376,772...192,422,640
Ensembl chr 1:192,376,774...192,418,904 		JBrowse link
G Rhobtb3 Rho-related BTB domain containing 3 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RHOBTB3 mRNA CTD PMID:20823114 NCBI chr 2:7,094,972...7,201,507
Ensembl chr 2:7,095,253...7,150,906 		JBrowse link
G Rin1 Ras and Rab interactor 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of RIN1 mRNA CTD PMID:20823114 NCBI chr 1:202,355,729...202,362,731
Ensembl chr 1:211,784,943...211,791,368 		JBrowse link
G Rnase1 ribonuclease A family member 1, pancreatic increases expression ISO Medroxyprogesterone Acetate results in increased expression of RNASE1 mRNA CTD PMID:20843944 NCBI chr15:24,361,924...24,363,633
Ensembl chr15:26,835,463...26,837,248 		JBrowse link
G Rpgr retinitis pigmentosa GTPase regulator increases expression ISO Medroxyprogesterone Acetate results in increased expression of RPGR mRNA CTD PMID:20843944 NCBI chr  X:15,238,961...15,299,004
Ensembl chr  X:15,239,159...15,298,999 		JBrowse link
G Rpn1 ribophorin I multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of RPN1 mRNA CTD PMID:20823114 NCBI chr 4:120,543,667...120,565,069
Ensembl chr 4:122,100,813...122,122,382 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of RPS6KB1 mRNA CTD PMID:20823114 NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238 		JBrowse link
G Rpsa ribosomal protein SA multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RPSA mRNA CTD PMID:20823114 NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:128,728,862...128,732,737 		JBrowse link
G Runx1 RUNX family transcription factor 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of RUNX1 mRNA CTD PMID:18497975 NCBI chr11:45,325,778...45,560,300
Ensembl chr11:45,329,044...45,564,925 		JBrowse link
G S100a14 S100 calcium binding protein A14 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of S100A14 mRNA CTD PMID:20823114 NCBI chr 2:176,008,395...176,010,423
Ensembl chr 2:178,306,025...178,307,999 		JBrowse link
G Saraf store-operated calcium entry-associated regulatory factor multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of SARAF mRNA CTD PMID:20823114 NCBI chr16:64,720,404...64,738,653
Ensembl chr16:64,720,418...64,738,653 		JBrowse link
G Scamp4 secretory carrier membrane protein 4 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of SCAMP4 mRNA CTD PMID:20823114 NCBI chr 7:9,752,193...9,764,614
Ensembl chr 7:9,752,193...9,778,736 		JBrowse link
G Sdcbp syndecan binding protein multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of SDCBP mRNA CTD PMID:20823114 NCBI chr 5:19,473,499...19,517,188
Ensembl chr 5:24,245,033...24,326,197 		JBrowse link
G Selenop selenoprotein P increases expression ISO Medroxyprogesterone Acetate results in increased expression of SELENOP mRNA CTD PMID:18497975 NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019 		JBrowse link
G Sema3a semaphorin 3A multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of SEMA3A mRNA CTD PMID:20823114 NCBI chr 4:21,282,398...21,754,834
Ensembl chr 4:22,245,322...22,535,774 		JBrowse link
G Septin11 septin 11 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of SEPTIN11 mRNA CTD PMID:20823114 NCBI chr14:15,119,760...15,275,222
Ensembl chr14:15,128,951...15,275,200 		JBrowse link
G Serpinc1 serpin family C member 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SERPINC1 CTD PMID:1828463 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643 		JBrowse link
G Serpine1 serpin family E member 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SERPINE1 mRNA; Medroxyprogesterone Acetate results in increased expression of SERPINE1 protein CTD PMID:16011840 PMID:20843944 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Sfn stratifin multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein CTD PMID:22534328 NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SGK1 mRNA CTD PMID:18497975 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SIRT1 protein CTD PMID:16709600 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000 		JBrowse link
G Slc1a3 solute carrier family 1 member 3 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SLC1A3 mRNA CTD PMID:20843944 NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:59,482,709...59,557,808 		JBrowse link
G Slc46a2 solute carrier family 46, member 2 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of SLC46A2 mRNA CTD PMID:20843944 NCBI chr 5:74,800,226...74,808,128
Ensembl chr 5:79,595,150...79,603,114 		JBrowse link
G Slc47a1 solute carrier family 47 member 1 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of SLC47A1 mRNA CTD PMID:20843944 NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,533,583...46,587,096 		JBrowse link
G Slc5a3 solute carrier family 5 member 3 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of SLC5A3 mRNA CTD PMID:20843944 NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157 		JBrowse link
G Slc7a2 solute carrier family 7 member 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SLC7A2 mRNA CTD PMID:20843944 NCBI chr16:58,115,991...58,174,256
Ensembl chr16:58,120,968...58,174,256 		JBrowse link
G Slc7a8 solute carrier family 7 member 8 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SLC7A8 mRNA CTD PMID:20843944 NCBI chr15:32,153,016...32,212,715
Ensembl chr15:32,153,018...32,212,715 		JBrowse link
G Slc9a9 solute carrier family 9 member A9 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SLC9A9 mRNA CTD PMID:20843944 NCBI chr 8:104,112,279...104,675,944
Ensembl chr 8:104,112,559...104,676,891 		JBrowse link
G Sln sarcolipin increases expression ISO Medroxyprogesterone Acetate results in increased expression of SLN mRNA CTD PMID:20843944 NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:63,139,722...63,143,971 		JBrowse link
G Smox spermine oxidase decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of SMOX mRNA CTD PMID:20843944 NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:139,184,798...139,220,170
Ensembl chr  X:139,184,798...139,220,170 		JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
increases expression
increases activity 		ISO [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased activity of SOD1 protein; [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of SOD1 mRNA; [Estradiol deficiency co-treated with Medroxyprogesterone Acetate deficiency] results in decreased activity of SOD1 protein; [Estradiol deficiency co-treated with Medroxyprogesterone Acetate deficiency] results in decreased expression of SOD1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD1 mRNA; Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased activity of SOD1 protein]
Medroxyprogesterone Acetate results in increased expression of SOD1 mRNA 		CTD PMID:11756571 PMID:12093828 PMID:16709600 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
affects expression
increases expression
increases activity 		ISO
EXP 		[Estradiol co-treated with Medroxyprogesterone Acetate] results in increased activity of SOD2 protein; [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of SOD2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 protein; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA]; Medroxyprogesterone Acetate promotes the reaction [CREBBP protein binds to SOD2 promoter]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of SOD2 mRNA]; protein kinase inhibitor peptide inhibits the reaction [[Estradiol co-treated with Medroxyprogesterone Acetate] results in increased activity of SOD2 protein]; WNT5A protein affects the reaction [[Medroxyprogesterone Acetate results in increased abundance of Cyclic AMP] which results in increased expression of SOD2 mRNA]
[Medroxyprogesterone Acetate co-treated with Estradiol] affects the expression of SOD2
Medroxyprogesterone Acetate affects the expression of SOD2
Medroxyprogesterone Acetate results in increased activity of SOD2 protein 		CTD PMID:11756571 PMID:12093828 PMID:16709600 PMID:20685861 PMID:21159850 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SPP1 mRNA CTD PMID:20843944 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Spry1 sprouty RTK signaling antagonist 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of SPRY1 mRNA CTD PMID:20843944 NCBI chr 2:122,484,995...122,490,008
Ensembl chr 2:122,484,355...122,492,956 		JBrowse link
G Srpx sushi-repeat-containing protein, X-linked increases expression ISO Medroxyprogesterone Acetate results in increased expression of SRPX mRNA CTD PMID:20843944 NCBI chr  X:12,676,984...12,751,296
Ensembl chr  X:15,349,440...15,420,392 		JBrowse link
G Srsf7 serine and arginine rich splicing factor 7 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of SRSF7 mRNA CTD PMID:20823114 NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:20,564,044...20,571,212 		JBrowse link
G Stk38 serine/threonine kinase 38 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of STK38 mRNA CTD PMID:20823114 NCBI chr20:7,034,245...7,067,803
Ensembl chr20:7,035,933...7,069,711 		JBrowse link
G Stom stomatin increases expression ISO Medroxyprogesterone Acetate results in increased expression of STOM mRNA CTD PMID:18497975 NCBI chr 3:39,042,503...39,064,818
Ensembl chr 3:39,042,503...39,064,818 		JBrowse link
G Sulf1 sulfatase 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of SULF1 mRNA CTD PMID:20823114 NCBI chr 5:11,145,950...11,308,622
Ensembl chr 5:11,145,950...11,308,643 		JBrowse link
G Tagln transgelin multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of TAGLN mRNA CTD PMID:20823114 NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563 		JBrowse link
G Tbxas1 thromboxane A synthase 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of TBXAS1 mRNA CTD PMID:20843944 NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969 		JBrowse link
G Tcea1 transcription elongation factor A1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of TCEA1 mRNA CTD PMID:20823114 NCBI chr 5:14,631,454...14,668,769
Ensembl chr15:12,831,339...12,834,156
Ensembl chr 5:12,831,339...12,834,156 		JBrowse link
G Tdo2 tryptophan 2,3-dioxygenase multiple interactions ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of TDO2 mRNA]; [IFNG protein co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of TDO2 mRNA CTD PMID:32781018 NCBI chr 2:169,567,656...169,585,586
Ensembl chr 2:169,567,654...169,585,586 		JBrowse link
G Tert telomerase reverse transcriptase multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of TERT mRNA CTD PMID:20823114 NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:31,466,056...31,488,111 		JBrowse link
G Tfpi tissue factor pathway inhibitor increases expression ISO Medroxyprogesterone Acetate results in increased expression of TFPI mRNA CTD PMID:20843944 NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:89,939,868...89,980,742 		JBrowse link
G Tfpi2 tissue factor pathway inhibitor 2 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of TFPI2 mRNA CTD PMID:20843944 NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:32,936,854...32,941,426 		JBrowse link
G Tgfb3 transforming growth factor, beta 3 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of TGFB3 mRNA CTD PMID:20843944 NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946 		JBrowse link
G Tgfbr2 transforming growth factor, beta receptor 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of TGFBR2 mRNA CTD PMID:20843944 NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469 		JBrowse link
G Thbs1 thrombospondin 1 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of THBS1 mRNA CTD PMID:18497975 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Timp3 TIMP metallopeptidase inhibitor 3 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of TIMP3 mRNA CTD PMID:20843944 NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:19,409,631...19,459,547 		JBrowse link
G Tmem158 transmembrane protein 158 decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of TMEM158 mRNA CTD PMID:20843944 NCBI chr 8:131,791,137...131,792,135
Ensembl chr 8:131,787,277...131,796,882 		JBrowse link
G Tnc tenascin C multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of TNC mRNA CTD PMID:20823114 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone Acetate] results in decreased secretion of TNF protein; [Polyphenols co-treated with Antioxidants co-treated with Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Medroxyprogesterone Acetate co-treated with Celecoxib] results in decreased expression of TNF CTD PMID:15866426 PMID:16702388 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tox2 TOX high mobility group box family member 2 increases expression ISO Medroxyprogesterone Acetate results in increased expression of TOX2 mRNA CTD PMID:20843944 NCBI chr 3:172,272,718...172,400,235
Ensembl chr 3:172,272,736...172,400,233 		JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of TP53 protein; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of TP53 protein CTD PMID:22534328 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tpd52 tumor protein D52 increases expression ISO Medroxyprogesterone Acetate results in increased expression of TPD52 mRNA CTD PMID:18497975 NCBI chr 2:94,642,514...94,723,442
Ensembl chr 2:94,642,585...94,724,241 		JBrowse link
G Tpi1 triosephosphate isomerase 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of TPI1 mRNA CTD PMID:20823114 NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413 		JBrowse link
G Tpsg1 tryptase gamma 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of TPSG1 mRNA CTD PMID:20823114 NCBI chr10:14,889,838...14,895,605
Ensembl chr10:14,890,734...14,894,786 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 increases expression ISO Medroxyprogesterone Acetate results in increased expression of TSC22D3 mRNA CTD PMID:20843944 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:109,006,420...109,015,519 		JBrowse link
G Tsku tsukushi, small leucine rich proteoglycan decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of TSKU mRNA CTD PMID:20843944 NCBI chr 1:162,071,459...162,082,972
Ensembl chr 1:162,064,126...162,089,272 		JBrowse link
G Txn1 thioredoxin 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of TXN mRNA CTD PMID:20823114 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307 		JBrowse link
G Ube2d2b ubiquitin-conjugating enzyme E2D 2B multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of UBE2D4 mRNA CTD PMID:20823114 NCBI chr14:2,060,926...2,062,400
Ensembl chr14:2,048,235...2,063,764 		JBrowse link
G Ugcg UDP-glucose ceramide glucosyltransferase multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of UGCG mRNA CTD PMID:20823114 NCBI chr 5:78,828,006...78,860,725
Ensembl chr 5:78,828,006...78,860,417 		JBrowse link
G Usp12 ubiquitin specific peptidase 12 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of USP12 mRNA CTD PMID:20823114 NCBI chr12:13,423,625...13,477,547
Ensembl chr12:13,422,427...13,477,547 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO Medroxyprogesterone Acetate inhibits the reaction [Hydrocortisone inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]]; Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]] CTD PMID:15358673 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vdr vitamin D receptor multiple interactions ISO VDR gene polymorphism affects the susceptibility to [Alendronate co-treated with Estrogens, Conjugated (USP) co-treated with Medroxyprogesterone Acetate]; VDR gene polymorphism affects the susceptibility to [Estrogens, Conjugated (USP) co-treated with Medroxyprogesterone Acetate] CTD PMID:15739035 NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:130,866,745...130,916,757 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression
multiple interactions 		ISO Medroxyprogesterone Acetate results in increased expression of VEGFA mRNA; Medroxyprogesterone Acetate results in increased expression of VEGFA mRNA alternative form
Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of VEGFA mRNA] 		CTD PMID:15860260 PMID:17010073 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vim vimentin multiple interactions ISO [Azacitidine co-treated with Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VIM protein CTD PMID:20823114 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746 		JBrowse link
G Vmo1 vitelline membrane outer layer 1 homolog decreases expression ISO Medroxyprogesterone Acetate results in decreased expression of VMO1 mRNA CTD PMID:20843944 NCBI chr10:55,726,572...55,733,432
Ensembl chr10:55,726,572...55,727,856 		JBrowse link
G Vps39 VPS39 subunit of HOPS complex multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VPS39 mRNA CTD PMID:20823114 NCBI chr 3:107,266,846...107,304,884
Ensembl chr 3:127,721,076...127,758,768 		JBrowse link
G Vsig4 V-set and immunoglobulin domain containing 4 increases expression ISO Medroxyprogesterone Acetate results in increased expression of VSIG4 mRNA CTD PMID:20843944 NCBI chr  X:61,144,926...61,170,212
Ensembl chr  X:65,154,424...65,179,708 		JBrowse link
G Wnt5a Wnt family member 5A multiple interactions
increases expression 		ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of WNT5A mRNA; WNT5A protein affects the reaction [[Medroxyprogesterone Acetate results in increased abundance of Cyclic AMP] which results in increased expression of SOD2 mRNA]; WNT5A protein affects the reaction [Medroxyprogesterone Acetate results in increased abundance of Cyclic AMP]
Medroxyprogesterone Acetate results in increased expression of WNT5A mRNA 		CTD PMID:20685861 PMID:20823114 NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860 		JBrowse link
G Wwtr1 WW domain containing transcription regulator 1 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of WWTR1 mRNA CTD PMID:20823114 NCBI chr 2:143,801,181...143,916,941
Ensembl chr 2:143,801,181...143,991,950 		JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ZBTB16 mRNA CTD PMID:20843944 NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507 		JBrowse link
G Zbtb45 zinc finger and BTB domain containing 45 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZBTB45 mRNA CTD PMID:20823114 NCBI chr 1:73,634,895...73,639,802
Ensembl chr 1:82,707,634...82,710,277 		JBrowse link
G Zfp36 zinc finger protein 36 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ZFP36 mRNA CTD PMID:15866426 NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108 		JBrowse link
G Zfp36l1 zinc finger protein 36, C3H type-like 1 multiple interactions ISO [Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of ZFP36L1 mRNA CTD PMID:19146866 NCBI chr 6:98,930,705...98,935,748
Ensembl chr 6:104,663,399...104,687,979 		JBrowse link
G Zpld1 zona pellucida-like domain containing 1 increases expression ISO Medroxyprogesterone Acetate results in increased expression of ZPLD1 mRNA CTD PMID:20843944 NCBI chr11:58,933,803...58,993,503
Ensembl chr11:58,951,901...58,991,704 		JBrowse link
G Zscan10 zinc finger and SCAN domain containing 10 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZSCAN10 mRNA CTD PMID:20823114 NCBI chr10:12,636,302...12,646,275
Ensembl chr10:13,140,929...13,150,897 		JBrowse link
G Zscan20 zinc finger and SCAN domain containing 20 multiple interactions ISO [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZSCAN20 mRNA CTD PMID:20823114 NCBI chr 5:140,926,596...140,956,285
Ensembl chr 5:146,215,082...146,240,777 		JBrowse link
megestrol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Clu clusterin affects expression ISO Megestrol affects the expression of CLU protein CTD PMID:12388792 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Gal galanin and GMAP prepropeptide affects expression ISO Megestrol affects the expression of GAL protein CTD PMID:12388792 NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:210,079,702...210,084,229 		JBrowse link
G Gap43 growth associated protein 43 affects expression ISO Megestrol affects the expression of GAP43 protein CTD PMID:12388792 NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO Megestrol results in increased activity of NR1I2 protein CTD PMID:21068194 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Ret ret proto-oncogene affects expression ISO Megestrol affects the expression of RET protein CTD PMID:12388792 NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:152,998,812...153,040,556 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 affects expression ISO Megestrol affects the expression of TIMP1 protein CTD PMID:12388792 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
megestrol acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO Megestrol Acetate results in decreased activity of ABCB11 protein CTD PMID:23956101 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581 		JBrowse link
G Ahsa1 activator of Hsp90 ATPase activity 1 increases expression ISO Megestrol Acetate results in increased expression of AHSA1 protein CTD PMID:16939895 NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:112,644,479...112,655,595 		JBrowse link
G Ar androgen receptor multiple interactions ISO Megestrol Acetate binds to and results in decreased activity of AR protein CTD PMID:25752796 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Bcl11b BCL11 transcription factor B multiple interactions EXP [Ethinyl Estradiol co-treated with Megestrol Acetate] results in decreased expression of BCL11B mRNA CTD PMID:22085904 NCBI chr 6:132,598,968...132,692,123
Ensembl chr 6:132,598,968...132,691,301 		JBrowse link
G Cct6a chaperonin containing TCP1 subunit 6A increases expression ISO Megestrol Acetate results in increased expression of CCT6A protein CTD PMID:16939895 NCBI chr12:32,508,842...32,519,072
Ensembl chr12:32,508,675...32,519,119 		JBrowse link
G Cldn1 claudin 1 multiple interactions
decreases expression 		ISO Megestrol Acetate results in decreased expression of and affects the localization of CLDN1 protein
Megestrol Acetate results in decreased expression of CLDN1 mRNA 		CTD PMID:22883527 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529 		JBrowse link
G Cldn4 claudin 4 multiple interactions
decreases expression 		ISO Megestrol Acetate results in decreased expression of and results in increased localization of CLDN4 protein
Megestrol Acetate results in decreased expression of CLDN4 mRNA 		CTD PMID:23095775 NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958 		JBrowse link
G Comt catechol-O-methyltransferase increases expression ISO Megestrol Acetate results in increased expression of COMT protein CTD PMID:16939895 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO ESR1 protein affects the reaction [Megestrol Acetate results in increased expression of GREB1 mRNA] CTD PMID:33405908 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 increases expression
multiple interactions 		ISO Megestrol Acetate results in increased expression of GREB1 mRNA
ESR1 protein affects the reaction [Megestrol Acetate results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [Megestrol Acetate results in increased expression of GREB1 mRNA] 		CTD PMID:33405908 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Krt8 keratin 8 increases expression ISO Megestrol Acetate results in increased expression of KRT8 protein CTD PMID:16939895 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Mmp12 matrix metallopeptidase 12 multiple interactions EXP [Ethinyl Estradiol co-treated with Megestrol Acetate] results in increased expression of MMP12 protein CTD PMID:22085904 NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions EXP [Ethinyl Estradiol co-treated with Megestrol Acetate] results in increased expression of MMP3 protein CTD PMID:22085904 NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826 		JBrowse link
G Mmp8 matrix metallopeptidase 8 multiple interactions EXP [Ethinyl Estradiol co-treated with Megestrol Acetate] results in increased expression of MMP8 protein CTD PMID:22085904 NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:13,008,890...13,018,729 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO Megestrol Acetate binds to and results in increased activity of PGR protein CTD PMID:25752796 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Ppia peptidylprolyl isomerase A decreases expression ISO Megestrol Acetate results in decreased expression of PPIA protein CTD PMID:16939895 NCBI chr14:81,279,292...81,282,960
Ensembl chr14:85,492,484...85,497,115 		JBrowse link
G Rab6a RAB6A, member RAS oncogene family increases expression ISO Megestrol Acetate results in increased expression of RAB6A protein CTD PMID:16939895 NCBI chr 1:154,957,870...155,008,922
Ensembl chr 1:164,369,861...164,417,763 		JBrowse link
G Sf3a3 splicing factor 3a, subunit 3 increases expression ISO Megestrol Acetate results in increased expression of SF3A3 protein CTD PMID:16939895 NCBI chr 5:136,967,713...136,987,345
Ensembl chr 5:142,246,568...142,272,052 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression
multiple interactions 		ISO Megestrol Acetate results in increased expression of SGK1 mRNA
Fulvestrant inhibits the reaction [Megestrol Acetate results in increased expression of SGK1 mRNA] 		CTD PMID:33405908 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Megestrol Acetate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Tnc tenascin C multiple interactions EXP [Ethinyl Estradiol co-treated with Megestrol Acetate] results in decreased expression of TNC mRNA CTD PMID:22085904 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
mometasone furoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO Mometasone Furoate inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]; Mometasone Furoate inhibits the reaction [ABCB1 protein results in increased export of fluorexon] CTD PMID:16442095 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions
increases activity 		ISO Mometasone Furoate inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]
Mometasone Furoate results in increased activity of ABCG2 protein 		CTD PMID:16442095 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions ISO Mometasone Furoate inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] CTD PMID:10460758 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 decreases activity ISO Mometasone Furoate results in decreased activity of CYP2C8 protein CTD PMID:15601807
G F3 coagulation factor III, tissue factor increases expression ISO Mometasone Furoate results in increased expression of F3 protein CTD PMID:25569083 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Hsf1 heat shock transcription factor 1 increases activity ISO Mometasone Furoate results in increased activity of HSF1 protein CTD PMID:34170685 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Il10 interleukin 10 decreases secretion ISO Mometasone Furoate results in decreased secretion of IL10 protein CTD PMID:9819297 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO Mometasone Furoate inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of IL12B protein] CTD PMID:19422381 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO Mometasone Furoate inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] CTD PMID:10460758 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects binding EXP
ISO 		Mometasone Furoate binds to NR3C1 protein CTD PMID:16507850 PMID:19422381 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 affects binding ISO Mometasone Furoate binds to NR3C2 protein CTD PMID:19422381 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Pgr progesterone receptor multiple interactions
affects binding 		ISO Mometasone Furoate binds to and results in increased activity of PGR protein
Mometasone Furoate binds to PGR protein 		CTD PMID:15189034 PMID:19422381 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression ISO Mometasone Furoate results in increased expression of SPP1 protein CTD PMID:21885873 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Tat tyrosine aminotransferase increases activity ISO Mometasone Furoate results in increased activity of TAT protein CTD PMID:19422381 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482 		JBrowse link
G Tgm2 transglutaminase 2 increases expression ISO Mometasone Furoate results in increased expression of TGM2 protein CTD PMID:21885873 NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
decreases secretion 		ISO Mometasone Furoate inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
Mometasone Furoate results in decreased secretion of TNF protein 		CTD PMID:9819297 PMID:10100995 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO Mometasone Furoate inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] CTD PMID:10100995 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
norethisterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO Norethindrone results in decreased activity of ABCB11 protein CTD PMID:20829430 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO Norethindrone results in increased expression of ABCB1 mRNA CTD PMID:15290871 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO Norethindrone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases activity ISO Norethindrone results in decreased activity of AKR1C1 protein CTD PMID:21182831 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity ISO Norethindrone results in decreased activity of AKR1C3 protein CTD PMID:21182831 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Ar androgen receptor affects binding
multiple interactions 		EXP
ISO 		Norethindrone binds to AR protein
Norethindrone binds to and results in decreased activity of AR protein; Norethindrone binds to and results in increased activity of AR protein 		CTD PMID:14565775 PMID:25752796 PMID:33049310 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein increases secretion ISO Norethindrone results in increased secretion of BGLAP protein CTD PMID:8053399 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Esr1 estrogen receptor 1 increases activity
multiple interactions 		EXP
ISO 		Norethindrone results in increased activity of ESR1 protein
ESR1 protein affects the reaction [Norethindrone results in increased expression of GREB1 mRNA]; ESR1 protein affects the reaction [Norethindrone results in increased expression of SGK1 mRNA]; Norethindrone binds to and results in increased activity of ESR1 protein 		CTD PMID:11750080 PMID:12504345 PMID:25012808 PMID:25752796 PMID:33049310 More... NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO Norethindrone binds to and results in increased activity of ESR2 protein CTD PMID:25752796 PMID:33049310 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G F10 coagulation factor X multiple interactions ISO [Ethinyl Estradiol binds to Norethindrone] which results in increased expression of F10 protein CTD PMID:14561536 NCBI chr16:83,170,973...83,190,280
Ensembl chr16:83,170,977...83,190,280 		JBrowse link
G F7 coagulation factor VII multiple interactions ISO [Ethinyl Estradiol binds to Norethindrone] which results in increased expression of F7 protein CTD PMID:14561536 NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO Norethindrone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fasn fatty acid synthase increases activity ISO Norethindrone results in increased activity of FASN protein CTD PMID:15870863 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fga fibrinogen alpha chain multiple interactions ISO [Ethinyl Estradiol co-treated with Norethindrone] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:14561536 NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:170,672,012...170,679,577 		JBrowse link
G Fgb fibrinogen beta chain multiple interactions ISO [Ethinyl Estradiol co-treated with Norethindrone] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:14561536 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434 		JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [Ethinyl Estradiol co-treated with Norethindrone] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:14561536 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions
increases expression 		ISO ESR1 protein affects the reaction [Norethindrone results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [Norethindrone results in increased expression of GREB1 mRNA] CTD PMID:33405908 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G H2ax H2A.X variant histone increases phosphorylation ISO Norethindrone results in increased phosphorylation of H2AX protein CTD PMID:15905198 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Ins2 insulin 2 multiple interactions ISO Norethindrone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Norethindrone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Mapt microtubule-associated protein tau decreases expression ISO Norethindrone results in decreased expression of MAPT protein CTD PMID:16930453 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108 		JBrowse link
G Mybl1 MYB proto-oncogene like 1 multiple interactions
increases expression 		ISO Fulvestrant inhibits the reaction [Norethindrone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO Norethindrone binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO Norethindrone binds to and results in increased activity of PGR protein CTD PMID:15189034 PMID:25752796 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Plg plasminogen multiple interactions ISO [Ethinyl Estradiol binds to Norethindrone] which results in increased expression of PLG protein CTD PMID:14561536 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO Norethindrone binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Proc protein C, inactivator of coagulation factors Va and VIIIa multiple interactions ISO [Ethinyl Estradiol binds to Norethindrone] which results in increased expression of PROC protein CTD PMID:14561536 NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964 		JBrowse link
G Serpinc1 serpin family C member 1 multiple interactions ISO [Ethinyl Estradiol binds to Norethindrone] which results in decreased expression of SERPINC1 protein CTD PMID:14561536 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [Ethinyl Estradiol binds to Norethindrone] which results in decreased expression of SERPINE1 protein CTD PMID:14561536 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression
multiple interactions 		ISO Norethindrone results in increased expression of SGK1 mRNA
ESR1 protein affects the reaction [Norethindrone results in increased expression of SGK1 mRNA]; Fulvestrant inhibits the reaction [Norethindrone results in increased expression of SGK1 mRNA] 		CTD PMID:33405908 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Norethindrone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Thra thyroid hormone receptor alpha multiple interactions ISO Norethindrone binds to and results in decreased activity of THRA protein CTD PMID:33049310 NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657 		JBrowse link
G Thrb thyroid hormone receptor beta multiple interactions ISO Norethindrone binds to and results in increased activity of THRB protein CTD PMID:33049310 NCBI chr15:7,685,180...8,031,920
Ensembl chr15:10,115,954...10,313,680 		JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO Norethindrone results in increased expression of and results in increased activity of TP53 protein CTD PMID:15905198 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO Norethindrone results in increased expression of VEGFA mRNA; Norethindrone results in increased expression of VEGFA mRNA alternative form CTD PMID:17010073 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
norgestimate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc2 ATP binding cassette subfamily C member 2 decreases activity ISO norgestimate results in decreased activity of ABCC2 protein CTD PMID:16049127 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Ar androgen receptor multiple interactions
affects localization
decreases expression 		ISO norgestimate binds to and results in decreased activity of AR protein; norgestimate binds to and results in increased activity of AR protein
norgestimate affects the localization of AR protein
norgestimate results in decreased expression of AR mRNA 		CTD PMID:17505938 PMID:28478275 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Crp C-reactive protein multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of CRP protein CTD PMID:16982228 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein CTD PMID:16291717 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP2C19 protein CTD PMID:16291717 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G F7 coagulation factor VII multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F7 protein CTD PMID:12618251 NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738 		JBrowse link
G F8 coagulation factor VIII multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F8 protein CTD PMID:12618251 NCBI chr18:140,848...172,330
Ensembl chr18:155,309...186,683 		JBrowse link
G Fga fibrinogen alpha chain multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:170,672,012...170,679,577 		JBrowse link
G Fgb fibrinogen beta chain multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434 		JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO norgestimate binds to and affects the activity of PGR protein CTD PMID:1324557 PMID:15697108 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Plat plasminogen activator, tissue type multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PLAT protein; [Ethinyl Estradiol co-treated with norgestimate] results in increased activity of PLAT protein CTD PMID:12618251 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plg plasminogen multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PLG protein CTD PMID:12618251 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320 		JBrowse link
G Proc protein C, inactivator of coagulation factors Va and VIIIa multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PROC protein CTD PMID:12618251 NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964 		JBrowse link
G Pros1 protein S multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PROS1 protein CTD PMID:12618251 NCBI chr11:230,597...311,288
Ensembl chr11:13,676,769...13,757,852 		JBrowse link
G Serpina6 serpin family A member 6 multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SERPINA6 protein CTD PMID:16982228 NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:128,544,831...128,555,139 		JBrowse link
G Serpina7 serpin family A member 7 multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SERPINA7 protein CTD PMID:16982228 NCBI chr  X:107,452,044...107,510,958
Ensembl chr  X:107,452,044...107,457,681 		JBrowse link
G Serpinc1 serpin family C member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of SERPINC1 protein CTD PMID:12618251 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643 		JBrowse link
G Shbg sex hormone binding globulin multiple interactions ISO [Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SHBG protein CTD PMID:12586319 PMID:16982228 NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760 		JBrowse link
norgestrel term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Ar androgen receptor multiple interactions ISO 1-hydroxypyrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 17-alpha-Hydroxyprogesterone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2'-bisphenol F inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2'-dihydroxy-6,6'-dinaphthyldisulfide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,4,6-triiodophenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,5-di-tert-butylhydroquinone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-chloro-4-phenylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-tert-butylhydroquinone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-tolidine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 3-iodo-2-propynylbutylcarbamate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 3-phenoxybenzylalcohol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4,4'-dichlorodiphenyl sulfone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-cumylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-phenylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-tert-octylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 7-dimethylamino-4-methylcoumarin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 9-phenanthrol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; [6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein; acetochlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; acetyl methyl tetramethyl tetralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; afimoxifene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; alpha-isomethylionone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Apigenin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; atraric acid inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Azinphosmethyl inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bicalutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bisphenol A inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bisphenol AF inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bromadiolone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bromuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; butylbenzyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; butylphen inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Chlordecone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; chlorobenzilate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; chloroxylenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Clomiphene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; clorophene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Coumaphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Cyproterone Acetate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; d,d-T80-prallethrin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; DDT inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dehydroepiandrosterone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; devrinol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; di-n-pentyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; diallyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dibutyl Phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dichlorodiphenyldichloroethane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dicloran inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dimethomorph inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; diniconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Disulfiram inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dithiopyr inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Diuron inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Endosulfan inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; enilconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Equilin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Estrone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; ethafluralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Ethinyl Estradiol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fenamiphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fenarimol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Fenitrothion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Fenthion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Finasteride inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fludioxonil inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; flumetralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fluoranthene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Flutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Genistein inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Hexestrol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; hydroxyflutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; iprodione inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Linuron inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Melengestrol Acetate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Mestranol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; metconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Methoxychlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Methyl Parathion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; metolachlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Mitotane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; N-(2-ethylhexyl)-5-norbornene-2,3-dicarboxamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nilutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nitrofen inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nonylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Norgestrel binds to and results in increased activity of AR protein; o,p'-DDT inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; oryzalin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; oxybenzone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; p-tert-amylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pendimethalin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phenanthrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phenothiazine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phosalone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phoxim inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; prochloraz inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; procymidone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pronamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Propanil inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; propiconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; propylparaben inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pyrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; S-methyl benzo(1,2,3)thiadiazole-7-carbothioate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Spironolactone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tebuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Testosterone Propionate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tetrabromobisphenol A inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tetrachlorodian inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Tetrachlorvinphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tri-(2-ethylhexyl)trimellitate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tributyltin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Triclosan inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triflumizol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Trifluralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Triiodothyronine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triphenyl phosphate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triphenyltin chloride inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tris(1,3-dichloro-2-propyl)phosphate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triticonazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Troglitazone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; vinclozolin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] CTD PMID:33049310 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Esr1 estrogen receptor 1 increases activity
multiple interactions 		EXP
ISO 		Norgestrel results in increased activity of ESR1 protein
Norgestrel binds to and results in increased activity of ESR1 protein 		CTD PMID:11750080 PMID:12504345 PMID:33049310 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO [Norgestrel co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Ins2 insulin 2 multiple interactions ISO [Norgestrel co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 increases expression ISO Norgestrel results in increased expression of KLK3 protein CTD PMID:11580929 NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:103,539,527...103,543,586 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO Norgestrel binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
prednisolone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ackr3 atypical chemokine receptor 3 decreases expression ISO Prednisolone results in decreased expression of ACKR3 mRNA CTD PMID:19192274 NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:98,246,605...98,260,214 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 increases expression ISO Prednisolone results in increased expression of ACSL1 mRNA CTD PMID:17379860 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Adora2a adenosine A2a receptor decreases expression ISO Prednisolone results in decreased expression of ADORA2A mRNA CTD PMID:19192274 NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802 		JBrowse link
G Ahr aryl hydrocarbon receptor increases activity ISO Prednisolone results in increased activity of AHR protein CTD PMID:30203046 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Akr1b7 aldo-keto reductase family 1, member B7 multiple interactions EXP Prednisolone inhibits the reaction [Freund's Adjuvant results in increased expression of AKR1B7 mRNA] CTD PMID:21149847 NCBI chr 4:64,043,901...64,083,751
Ensembl chr 4:64,020,686...64,064,909 		JBrowse link
G Alb albumin increases expression
decreases secretion
multiple interactions 		ISO
EXP 		Prednisolone results in increased expression of ALB protein
Prednisolone results in decreased secretion of ALB protein
montelukast inhibits the reaction [Prednisolone results in decreased secretion of ALB protein] 		CTD PMID:3404815 PMID:30276927 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 decreases expression ISO Prednisolone results in decreased expression of AMIGO2 mRNA CTD PMID:19192274 NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 increases expression ISO Prednisolone results in increased expression of ANTXR1 mRNA CTD PMID:19192274 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Aox1 aldehyde oxidase 1 increases expression ISO Prednisolone results in increased expression of AOX1 mRNA CTD PMID:19192274 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Ar androgen receptor multiple interactions
increases expression 		ISO Prednisolone binds to and results in decreased activity of AR protein; Prednisolone binds to and results in increased activity of AR protein; Prednisolone binds to and results in increased activity of AR protein mutant form
[Phenytoin co-treated with Prednisolone] results in increased expression of AR protein
Prednisolone results in increased expression of AR mRNA; Prednisolone results in increased expression of AR protein 		CTD PMID:11956172 PMID:19490052 PMID:25752796 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arhgap45 Rho GTPase activating protein 45 decreases expression ISO Prednisolone results in decreased expression of ARHGAP45 mRNA CTD PMID:21621594 NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:10,325,539...10,341,890 		JBrowse link
G Arrdc3 arrestin domain containing 3 increases expression ISO Prednisolone results in increased expression of ARRDC3 mRNA CTD PMID:24356939 NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) decreases expression ISO Prednisolone results in decreased expression of ASNS mRNA CTD PMID:19192274 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Bcl2a1 BCL2-related protein A1 decreases expression ISO Prednisolone results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 increases expression ISO Prednisolone results in increased expression of BMAL1 mRNA CTD PMID:16269518 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression ISO Prednisolone results in decreased expression of BST2 mRNA CTD PMID:19192274 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Casp3 caspase 3 increases expression
multiple interactions 		EXP Prednisolone results in increased expression of CASP3 protein
montelukast inhibits the reaction [Prednisolone results in increased expression of CASP3 protein] 		CTD PMID:30276927 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Cat catalase decreases activity
multiple interactions 		EXP Prednisolone results in decreased activity of CAT protein
[Prednisolone co-treated with pirfenidone] inhibits the reaction [Paraquat results in decreased activity of CAT protein]; montelukast inhibits the reaction [Prednisolone results in decreased activity of CAT protein] 		CTD PMID:28921394 PMID:30276927 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cbll1 Cbl proto-oncogene like 1 decreases expression ISO Prednisolone results in decreased expression of CBLL1 mRNA CTD PMID:21621594 NCBI chr 6:48,071,190...48,086,174
Ensembl chr 6:53,798,712...53,813,880 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL11 mRNA] CTD PMID:23133493 NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression
multiple interactions 		ISO Prednisolone results in decreased expression of CCL2 protein
Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL2 mRNA]
Prednisolone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein] 		CTD PMID:20116850 PMID:23133493 PMID:36416909 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases expression ISO Prednisolone results in decreased expression of CCL20 mRNA; Prednisolone results in decreased expression of CCL20 protein CTD PMID:19192274 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression
multiple interactions 		ISO Prednisolone results in increased expression of CCL3 protein
Prednisolone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein] 		CTD PMID:20116850 PMID:36416909 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO Prednisolone results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Prednisolone results in increased expression of CCN1 mRNA CTD PMID:19192274 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression ISO Prednisolone results in increased expression of CCN2 mRNA CTD PMID:19192274 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn5 cellular communication network factor 5 increases expression ISO Prednisolone results in increased expression of CCN5 mRNA CTD PMID:19192274 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Ccng2 cyclin G2 increases expression ISO Prednisolone results in increased expression of CCNG2 mRNA CTD PMID:24356939 NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206 		JBrowse link
G Ccr3 C-C motif chemokine receptor 3 multiple interactions ISO Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCR3 mRNA] CTD PMID:23133493 NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:132,463,788...132,511,593 		JBrowse link
G Cd34 CD34 molecule multiple interactions ISO [Melphalan co-treated with Prednisolone] results in decreased expression of CD34 protein CTD PMID:10618687 NCBI chr13:106,480,313...106,500,844
Ensembl chr13:109,008,623...109,029,315 		JBrowse link
G Cd84 CD84 molecule increases expression ISO Prednisolone results in increased expression of CD84 mRNA CTD PMID:24356939 NCBI chr13:86,859,979...86,899,984
Ensembl chr13:86,859,990...86,894,318 		JBrowse link
G Clgn calmegin decreases expression ISO Prednisolone results in decreased expression of CLGN mRNA CTD PMID:19192274 NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO Prednisolone results in increased expression of COL1A1 mRNA CTD PMID:19192274 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Crh corticotropin releasing hormone decreases expression
multiple interactions 		EXP Prednisolone results in decreased expression of CRH protein
sairei-to inhibits the reaction [Prednisolone results in decreased expression of CRH protein] 		CTD PMID:9625448 NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386 		JBrowse link
G Crim1 cysteine rich transmembrane BMP regulator 1 increases expression ISO Prednisolone results in increased expression of CRIM1 mRNA CTD PMID:24356939 NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:22,449,948...22,622,416 		JBrowse link
G Cry1 cryptochrome circadian regulator 1 decreases expression ISO Prednisolone results in decreased expression of CRY1 mRNA CTD PMID:16269518 NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression ISO Prednisolone results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 decreases expression ISO Prednisolone results in decreased expression of CXCL2 mRNA CTD PMID:19192274 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO Prednisolone results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcr2 C-X-C motif chemokine receptor 2 decreases expression ISO Prednisolone results in decreased expression of CXCR2 protein CTD PMID:15804745 NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:83,183,808...83,188,602 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression ISO Prednisolone results in decreased expression of CXCR4 mRNA CTD PMID:19192274 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions EXP Prednisolone inhibits the reaction [Freund's Adjuvant results in decreased expression of CYP2C19 mRNA] CTD PMID:21149847 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 decreases expression ISO Prednisolone results in decreased expression of CYP2S1 mRNA CTD PMID:22155357 NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression ISO Prednisolone results in increased expression of CYP3A4 mRNA CTD PMID:12673034 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor decreases expression ISO Prednisolone results in decreased expression of DBP mRNA CTD PMID:16269518 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dio2 iodothyronine deiodinase 2 increases expression ISO Prednisolone results in increased expression of DIO2 mRNA CTD PMID:19192274 NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:115,396,308...115,410,594 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 increases expression ISO Prednisolone results in increased expression of EFEMP1 mRNA CTD PMID:19192274 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Fbln1 fibulin 1 increases expression ISO Prednisolone results in increased expression of FBLN1 mRNA CTD PMID:19192274 NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965 		JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 increases expression ISO Prednisolone results in increased expression of FMO2 mRNA CTD PMID:21621594 NCBI chr13:77,755,131...77,777,597
Ensembl chr13:77,757,629...77,777,534 		JBrowse link
G Gbp1 guanylate binding protein 1 decreases expression ISO Prednisolone results in decreased expression of GBP1 mRNA CTD PMID:19192274 PMID:21621594 NCBI chr 2:234,071,366...234,106,012
Ensembl chr 2:234,190,708...234,206,802
Ensembl chr 2:234,190,708...234,206,802 		JBrowse link
G Gdf5 growth differentiation factor 5 decreases expression ISO Prednisolone results in decreased expression of GDF5 mRNA CTD PMID:18830904 NCBI chr 3:164,914,401...164,918,593
Ensembl chr 3:164,914,401...164,918,593 		JBrowse link
G Gjb1 gap junction protein, beta 1 increases expression ISO Prednisolone results in increased expression of GJB1 mRNA CTD PMID:21621594 NCBI chr  X:66,501,848...66,509,783
Ensembl chr  X:70,541,862...70,549,843 		JBrowse link
G Gm2a ganglioside GM2 activator increases expression ISO Prednisolone results in increased expression of GM2A mRNA CTD PMID:17379860 NCBI chr10:39,719,919...39,732,452
Ensembl chr10:39,719,938...39,732,451 		JBrowse link
G Gpm6b glycoprotein m6b increases expression ISO Prednisolone results in increased expression of GPM6B mRNA CTD PMID:19192274 NCBI chr  X:31,689,485...31,836,199
Ensembl chr  X:31,690,359...31,733,272 		JBrowse link
G Gsdme gasdermin E decreases expression ISO Prednisolone results in decreased expression of GSDME mRNA CTD PMID:19192274 NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525 		JBrowse link
G Herc6 HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 decreases expression ISO Prednisolone results in decreased expression of HERC6 mRNA CTD PMID:19192274 NCBI chr 4:88,854,612...88,897,043
Ensembl chr 4:88,854,640...88,896,993 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression ISO Prednisolone results in increased expression of HMGCS1 mRNA CTD PMID:24356939 NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase multiple interactions ISO Prednisolone results in increased expression of and results in increased activity of HPGD protein CTD PMID:15680906 NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 decreases expression ISO Prednisolone results in decreased expression of HSD11B1 mRNA CTD PMID:19192274 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 increases metabolic processing ISO HSD11B2 protein results in increased metabolism of Prednisolone CTD PMID:16549198 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression ISO Prednisolone results in increased expression of ID3 mRNA CTD PMID:19192274 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 decreases expression ISO Prednisolone results in decreased expression of IFI27 mRNA CTD PMID:19192274 NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:128,355,079...128,361,781 		JBrowse link
G Ifi44 interferon-induced protein 44 decreases expression ISO Prednisolone results in decreased expression of IFI44 mRNA CTD PMID:19192274 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877 		JBrowse link
G Ifi44l interferon-induced protein 44-like decreases expression ISO Prednisolone results in decreased expression of IFI44L mRNA CTD PMID:19192274 NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:243,328,723...243,366,404 		JBrowse link
G Ifih1 interferon induced with helicase C domain 1 decreases expression ISO Prednisolone results in decreased expression of IFIH1 mRNA CTD PMID:19192274 NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:67,637,545...67,683,968 		JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 decreases expression ISO Prednisolone results in decreased expression of IFIT3 mRNA CTD PMID:19192274 NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521 		JBrowse link
G Ifng interferon gamma decreases expression
multiple interactions 		ISO
EXP 		Prednisolone results in decreased expression of IFNG protein
Prednisolone results in decreased expression of IFNG mRNA
Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of IFNG mRNA]; Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of IFNG protein]
Prednisolone inhibits the reaction [Amiodarone results in decreased expression of IFNG protein] 		CTD PMID:11043609 PMID:15821026 PMID:23133493 PMID:34590760 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases response to substance
increases expression 		ISO Prednisolone results in decreased susceptibility to IGF1 protein
Prednisolone results in increased expression of IGF1 protein 		CTD PMID:16079165 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Ighe immunoglobulin heavy constant epsilon decreases expression ISO Prednisolone results in decreased expression of IGHE protein CTD PMID:15821026
G Il10 interleukin 10 decreases expression
decreases secretion
decreases expression 		ISO Prednisolone results in decreased expression of IL10 protein
Prednisolone results in decreased secretion of IL10 protein
prednisolone decreases expression of IL10 protein in LPS-stimulated human PBMC 		CTD
RGD		 PMID:15821026 PMID:28003376 PMID:10493164 RGD:40903016 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il12b interleukin 12B decreases secretion
multiple interactions 		ISO Prednisolone results in decreased secretion of IL12B protein
Prednisolone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein] 		CTD PMID:28003376 PMID:36416909 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il13 interleukin 13 multiple interactions ISO Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of IL13 protein] CTD PMID:23133493 NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483 		JBrowse link
G Il17a interleukin 17A multiple interactions ISO Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of IL17A mRNA] CTD PMID:23133493 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il18 interleukin 18 multiple interactions ISO Prednisolone inhibits the reaction [Picryl Chloride results in increased expression of IL18 protein] CTD PMID:16442096 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases expression
decreases secretion
decreases expression 		ISO
EXP 		Prednisolone inhibits the reaction [Picryl Chloride results in increased expression of IL1B protein]
Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]
Prednisolone results in decreased expression of IL1B mRNA
Prednisolone results in decreased secretion of IL1B protein
Prednisolone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
prednisolone decreases expression of IL1b mRNA and protein in LPS-stimulated human PBMC 		CTD
RGD		 PMID:9259316 PMID:16442096 PMID:17379860 PMID:22119283 PMID:10493164 RGD:40903016 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO Prednisolone results in decreased expression of IL1RN mRNA CTD PMID:19192274 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il2 interleukin 2 decreases expression ISO Prednisolone results in decreased expression of IL2 protein CTD PMID:15821026 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il23a interleukin 23 subunit alpha decreases expression ISO Prednisolone results in decreased expression of IL23A mRNA CTD PMID:19192274 NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434 		JBrowse link
G Il4 interleukin 4 multiple interactions
decreases expression 		ISO
EXP 		Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of IL4 mRNA]; Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of IL4 protein]; Prednisolone inhibits the reaction [Picryl Chloride results in increased expression of IL4 protein]
Prednisolone results in decreased expression of IL4 protein
Prednisolone inhibits the reaction [Amiodarone results in increased expression of IL4 protein] 		CTD PMID:15821026 PMID:16442096 PMID:23133493 PMID:34590760 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il5 interleukin 5 decreases expression
multiple interactions 		ISO Prednisolone results in decreased expression of IL5 protein
Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of IL5 mRNA] 		CTD PMID:15821026 PMID:23133493 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Il6 interleukin 6 multiple interactions
decreases expression
decreases expression 		ISO
EXP 		Prednisolone inhibits the reaction [Amiodarone results in increased secretion of IL6 protein]
Prednisolone inhibits the reaction [Picryl Chloride results in increased expression of IL6 protein]
Prednisolone results in decreased expression of IL6 mRNA
Prednisolone results in decreased expression of IL6 mRNA; Prednisolone results in decreased expression of IL6 protein
prednisolone decreases expression of IL6 mRNA and protein in LPS-stimulated human PBMC
Prednisolone inhibits the reaction [Amiodarone results in increased expression of IL6 protein] 		CTD
RGD		 PMID:11043609 PMID:11288978 PMID:16442096 PMID:19192274 PMID:34590760 More... RGD:40903016 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Irf7 interferon regulatory factor 7 decreases expression ISO Prednisolone results in decreased expression of IRF7 mRNA CTD PMID:19192274 NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023 		JBrowse link
G Isg15 ISG15 ubiquitin-like modifier decreases expression ISO Prednisolone results in decreased expression of ISG15 mRNA CTD PMID:19192274 NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656 		JBrowse link
G Isg20 interferon stimulated exonuclease gene 20 decreases expression ISO Prednisolone results in decreased expression of ISG20 mRNA CTD PMID:19192274 NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP Prednisolone inhibits the reaction [Amiodarone results in increased phosphorylation of JUN protein] CTD PMID:34590760 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Klhl24 kelch-like family member 24 increases expression ISO Prednisolone results in increased expression of KLHL24 mRNA CTD PMID:24356939 NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050 		JBrowse link
G Kmt2a lysine methyltransferase 2A decreases response to substance ISO KMT2A gene mutant form results in decreased susceptibility to Prednisolone CTD PMID:14712291 NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:54,013,547...54,089,317 		JBrowse link
G Krt8 keratin 8 increases expression ISO Prednisolone results in increased expression of KRT8 mRNA CTD PMID:21621594 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Lamb3 laminin subunit beta 3 decreases expression ISO Prednisolone results in decreased expression of LAMB3 mRNA CTD PMID:19192274 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081 		JBrowse link
G Lcn2 lipocalin 2 decreases secretion ISO Prednisolone results in decreased secretion of LCN2 protein CTD PMID:28003376 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Ltf lactotransferrin decreases expression ISO Prednisolone results in decreased expression of LTF mRNA CTD PMID:21621594 NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:119,878,344...119,901,189 		JBrowse link
G Ly6e lymphocyte antigen 6 family member E decreases expression ISO Prednisolone results in decreased expression of LY6E mRNA CTD PMID:19192274 NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443 		JBrowse link
G Ly96 lymphocyte antigen 96 decreases expression ISO Prednisolone results in decreased expression of LY96 mRNA CTD PMID:17379860 NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:7,365,557...7,395,816 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions EXP Prednisolone inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK1 protein] CTD PMID:34590760 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions EXP Prednisolone inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK14 protein] CTD PMID:34590760 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions EXP Prednisolone inhibits the reaction [Amiodarone results in increased phosphorylation of MAPK3 protein] CTD PMID:34590760 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate decreases expression ISO Prednisolone results in decreased expression of MARCKS mRNA CTD PMID:19192274 NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase decreases expression ISO Prednisolone results in decreased expression of MET mRNA CTD PMID:19192274 NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821 		JBrowse link
G Mmp10 matrix metallopeptidase 10 decreases expression ISO Prednisolone results in decreased expression of MMP10 mRNA CTD PMID:19192274 NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613 		JBrowse link
G Mmp12 matrix metallopeptidase 12 decreases expression ISO Prednisolone results in decreased expression of MMP12 mRNA CTD PMID:19192274 NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions EXP pirfenidone promotes the reaction [Prednisolone inhibits the reaction [Paraquat results in increased expression of MMP2 mRNA]]; Prednisolone inhibits the reaction [Paraquat results in increased expression of MMP2 mRNA] CTD PMID:28921394 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein] CTD PMID:22119283 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mpo myeloperoxidase multiple interactions ISO
EXP 		Prednisolone inhibits the reaction [Picryl Chloride results in increased activity of MPO protein]
Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] 		CTD PMID:16442096 PMID:22119283 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Muc16 mucin 16, cell surface associated decreases expression ISO Prednisolone results in decreased expression of MUC16 protein CTD PMID:12169874 NCBI chr 8:16,164,531...16,323,126 JBrowse link
G Mx1 MX dynamin like GTPase 1 decreases expression ISO Prednisolone results in decreased expression of MX1 mRNA CTD PMID:19192274 NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904 		JBrowse link
G Ndufa4l2 NDUFA4, mitochondrial complex associated like 2 decreases expression ISO Prednisolone results in decreased expression of NDUFA4L2 mRNA CTD PMID:19192274 NCBI chr 7:65,242,169...65,244,296
Ensembl chr 7:65,242,135...65,244,277 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases activity ISO Prednisolone results in increased activity of NFE2L2 protein CTD PMID:30203046 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nid2 nidogen 2 increases expression ISO Prednisolone results in increased expression of NID2 mRNA CTD PMID:19192274 NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949 		JBrowse link
G Nmb neuromedin B decreases expression ISO Prednisolone results in decreased expression of NMB mRNA CTD PMID:19192274 NCBI chr 1:144,278,678...144,290,523
Ensembl chr 1:144,278,453...144,281,422 		JBrowse link
G Nos2 nitric oxide synthase 2 increases expression
multiple interactions 		EXP Prednisolone results in increased expression of NOS2 protein
montelukast inhibits the reaction [Prednisolone results in increased expression of NOS2 protein] 		CTD PMID:30276927 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 decreases expression ISO Prednisolone results in decreased expression of NR1D1 mRNA CTD PMID:16269518 NCBI chr10:84,224,599...84,231,812
Ensembl chr10:84,224,540...84,231,812 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects response to substance
multiple interactions
affects binding
increases activity 		ISO NR3C1 protein alternative form affects the susceptibility to Prednisolone
NR3C1 protein alternative form inhibits the reaction [Prednisolone results in increased activity of NR3C1 protein alternative form]; Prednisolone binds to and results in increased activity of NR3C1 protein
Prednisolone binds to NR3C1 protein 		CTD PMID:11956172 PMID:14694204 PMID:15362971 PMID:15704223 PMID:15705660 More... NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 increases activity ISO Prednisolone results in increased activity of NR3C2 protein CTD PMID:15362971 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 decreases expression ISO Prednisolone results in decreased expression of NR4A3 mRNA CTD PMID:19192274 NCBI chr 5:67,157,141...67,198,287
Ensembl chr 5:67,157,375...67,198,285 		JBrowse link
G Oas1a 2'-5' oligoadenylate synthetase 1A decreases expression ISO Prednisolone results in decreased expression of OAS1 mRNA CTD PMID:19192274 NCBI chr12:41,330,423...41,341,130
Ensembl chr12:41,285,211...41,341,128 		JBrowse link
G Oasl 2'-5'-oligoadenylate synthetase-like decreases expression ISO Prednisolone results in decreased expression of OASL mRNA CTD PMID:19192274 NCBI chr12:47,343,551...47,356,509
Ensembl chr12:47,343,551...47,356,483 		JBrowse link
G Olfml2b olfactomedin-like 2B increases expression ISO Prednisolone results in increased expression of OLFML2B mRNA CTD PMID:19192274 NCBI chr13:85,402,151...85,439,342
Ensembl chr13:85,402,169...85,439,342 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 increases expression ISO Prednisolone results in increased expression of PCK1 mRNA CTD PMID:20065017 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561 		JBrowse link
G Pdcd4 programmed cell death 4 increases expression ISO Prednisolone results in increased expression of PDCD4 mRNA CTD PMID:24356939 NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189 		JBrowse link
G Pdlim1 PDZ and LIM domain 1 increases expression ISO Prednisolone results in increased expression of PDLIM1 mRNA CTD PMID:17379860 NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379 		JBrowse link
G Per1 period circadian regulator 1 increases expression ISO Prednisolone results in increased expression of PER1 mRNA; Prednisolone results in increased expression of PER1 protein CTD PMID:16269518 NCBI chr10:54,299,002...54,313,804
Ensembl chr10:54,302,641...54,314,211 		JBrowse link
G Per2 period circadian regulator 2 decreases expression ISO Prednisolone results in decreased expression of PER2 mRNA CTD PMID:16269518 NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993 		JBrowse link
G Phgdh phosphoglycerate dehydrogenase decreases expression ISO Prednisolone results in decreased expression of PHGDH mRNA CTD PMID:19192274 NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789 		JBrowse link
G Pilra paired immunoglobin-like type 2 receptor alpha decreases expression ISO Prednisolone results in decreased expression of PILRA mRNA CTD PMID:19192274 NCBI chr12:23,452,626...23,464,772 JBrowse link
G Pla1a phospholipase A1 member A multiple interactions ISO Prednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 NCBI chr11:62,320,112...62,357,779
Ensembl chr11:75,825,585...75,878,165 		JBrowse link
G Pla2g4a phospholipase A2 group 4A multiple interactions ISO Prednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] CTD PMID:20573295 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Plcl1 phospholipase C-like 1 increases expression ISO Prednisolone results in increased expression of PLCL1 mRNA CTD PMID:24356939 NCBI chr 9:64,395,976...64,733,171
Ensembl chr 9:64,361,520...64,733,171 		JBrowse link
G Plpp3 phospholipid phosphatase 3 decreases expression ISO Prednisolone results in decreased expression of PLPP3 mRNA CTD PMID:19192274 NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667 		JBrowse link
G Pomc proopiomelanocortin decreases expression
multiple interactions 		EXP Prednisolone results in decreased expression of POMC protein; Prednisolone results in decreased expression of POMC protein modified form
sairei-to inhibits the reaction [Prednisolone results in decreased expression of POMC protein modified form] 		CTD PMID:9625448 PMID:14694204 NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
G Ppp1r14a protein phosphatase 1, regulatory (inhibitor) subunit 14A multiple interactions EXP Prednisolone inhibits the reaction [Acetylcholine results in increased phosphorylation of PPP1R14A protein] CTD PMID:18577381 NCBI chr 1:93,708,269...93,718,218
Ensembl chr 1:93,708,218...93,719,147 		JBrowse link
G Prelp proline and arginine rich end leucine rich repeat protein increases expression ISO Prednisolone results in increased expression of PRELP mRNA CTD PMID:19192274 NCBI chr13:45,368,407...45,391,480
Ensembl chr13:47,922,590...47,932,324 		JBrowse link
G Prlr prolactin receptor multiple interactions EXP Prednisolone inhibits the reaction [Freund's Adjuvant results in increased expression of PRLR mRNA] CTD PMID:21149847 NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO Prednisolone results in decreased expression of PTGS2 mRNA CTD PMID:19192274 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Rdh16 retinol dehydrogenase 16 multiple interactions EXP Prednisolone inhibits the reaction [Freund's Adjuvant results in decreased expression of RDH2 mRNA] CTD PMID:21149847 NCBI chr 7:65,499,763...65,510,304 JBrowse link
G Rgs4 regulator of G-protein signaling 4 multiple interactions
decreases expression 		EXP
ISO 		Prednisolone inhibits the reaction [Freund's Adjuvant results in increased expression of RGS4 mRNA]
Prednisolone results in decreased expression of RGS4 mRNA 		CTD PMID:19192274 PMID:21149847 NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884 		JBrowse link
G Rhoa ras homolog family member A multiple interactions EXP Prednisolone inhibits the reaction [[[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein] which results in increased susceptibility to Acetylcholine]; Prednisolone inhibits the reaction [[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein]; Prednisolone inhibits the reaction [[Antigens, Bacterial co-treated with Allergens] results in increased expression of RHOA mRNA] CTD PMID:18391481 NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302 		JBrowse link
G Rig1 RNA sensor RIG-1 decreases expression ISO Prednisolone results in decreased expression of RIGI mRNA CTD PMID:19192274 NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:60,117,398...60,165,995 		JBrowse link
G Ripk2 receptor-interacting serine-threonine kinase 2 decreases expression ISO Prednisolone results in decreased expression of RIPK2 mRNA CTD PMID:19192274 NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:34,428,573...34,459,663 		JBrowse link
G Rnf19b ring finger protein 19B decreases expression ISO Prednisolone results in decreased expression of RNF19B mRNA CTD PMID:19192274 NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:146,690,577...146,714,394 		JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 decreases expression ISO Prednisolone results in decreased expression of RSAD2 mRNA CTD PMID:19192274 NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320 		JBrowse link
G Scg2 secretogranin II multiple interactions EXP Prednisolone inhibits the reaction [Freund's Adjuvant results in increased expression of SCG2 mRNA] CTD PMID:21149847 NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:88,251,354...88,269,598 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions EXP Prednisolone inhibits the reaction [Freund's Adjuvant results in decreased expression of SLC22A8 mRNA] CTD PMID:21149847 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588 		JBrowse link
G Slc43a3 solute carrier family 43, member 3 decreases expression ISO Prednisolone results in decreased expression of SLC43A3 mRNA CTD PMID:19192274 NCBI chr 3:90,414,822...90,450,654
Ensembl chr 3:90,415,977...90,436,976 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression
decreases expression 		ISO Prednisolone results in increased expression of SLC7A11 mRNA
Prednisolone results in decreased expression of SLC7A11 mRNA 		CTD PMID:19192274 PMID:24356939 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695 		JBrowse link
G Slc7a8 solute carrier family 7 member 8 increases expression ISO Prednisolone results in increased expression of SLC7A8 mRNA CTD PMID:19192274 NCBI chr15:32,153,016...32,212,715
Ensembl chr15:32,153,018...32,212,715 		JBrowse link
G Sms spermine synthase decreases expression ISO Prednisolone results in decreased expression of SMS mRNA CTD PMID:19192274 NCBI chr  X:41,331,693...41,387,713
Ensembl chr  X:41,331,799...41,387,712 		JBrowse link
G Sod2 superoxide dismutase 2 decreases expression ISO Prednisolone results in decreased expression of SOD2 mRNA CTD PMID:19192274 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sox9 SRY-box transcription factor 9 decreases expression ISO Prednisolone results in decreased expression of SOX9 mRNA CTD PMID:17379860 NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250 		JBrowse link
G Srsf7 serine and arginine rich splicing factor 7 decreases expression ISO Prednisolone results in decreased expression of SRSF7 mRNA CTD PMID:21621594 NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:20,564,044...20,571,212 		JBrowse link
G Srxn1 sulfiredoxin 1 increases expression ISO Prednisolone results in increased expression of SRXN1 mRNA CTD PMID:24356939 NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765 		JBrowse link
G Stat4 signal transducer and activator of transcription 4 decreases expression ISO Prednisolone results in decreased expression of STAT4 mRNA CTD PMID:19192274 NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Sts steroid sulfatase increases expression ISO Prednisolone results in increased expression of STS mRNA CTD PMID:19192274 NCBI chr  X:46,102,524...46,110,868
Ensembl chr  X:46,102,548...46,111,104 		JBrowse link
G Sult2a2 sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 multiple interactions EXP Prednisolone inhibits the reaction [Freund's Adjuvant results in increased expression of SULT2A2 mRNA] CTD PMID:21149847 NCBI chr 1:75,909,585...75,976,600
Ensembl chr 1:84,962,100...85,104,511 		JBrowse link
G Tafa5 TAFA chemokine like family member 5 increases expression ISO Prednisolone results in increased expression of TAFA5 mRNA CTD PMID:21621594 NCBI chr 7:120,493,447...120,714,720
Ensembl chr 7:120,493,060...120,714,718 		JBrowse link
G Tat tyrosine aminotransferase multiple interactions
increases activity
increases expression 		EXP
ISO 		(3b,5b,7a,12a)-7,12-dihydroxy-3-(2-((4-((11b,17b)-17-hydroxy-3-oxo-17-prop-1-ynylestra-4,9-dien-11-yl) phenyl)(methyl)amino)ethoxy)cholan-24-oic acid inhibits the reaction [Prednisolone results in increased activity of TAT protein]; (3b,5b,7a,12a)-7,12-dihydroxy-3-(2-((4-((11b,17b)-17-hydroxy-3-oxo-17-prop-1-ynylestra-4,9-dien-11-yl) phenyl)(methyl)amino)ethoxy)cholan-24-oic acid inhibits the reaction [Prednisolone results in increased expression of TAT mRNA] CTD PMID:9259316 PMID:14694204 PMID:15784656 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482 		JBrowse link
G Tex261 testis expressed 261 decreases expression ISO Prednisolone results in decreased expression of TEX261 mRNA CTD PMID:21621594 NCBI chr 4:116,253,547...116,260,730
Ensembl chr 4:117,811,176...117,819,180 		JBrowse link
G Tf transferrin increases expression ISO Prednisolone results in increased expression of TF protein CTD PMID:3404815 NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400 		JBrowse link
G Tfpi2 tissue factor pathway inhibitor 2 decreases expression ISO Prednisolone results in decreased expression of TFPI2 mRNA CTD PMID:17379860 NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:32,936,854...32,941,426 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 decreases expression
multiple interactions 		ISO
EXP 		Prednisolone results in decreased expression of TGFB1 protein
pirfenidone promotes the reaction [Prednisolone inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]]; Prednisolone inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA] 		CTD PMID:11728950 PMID:28921394 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Thbs1 thrombospondin 1 increases expression ISO Prednisolone results in increased expression of THBS1 mRNA CTD PMID:19192274 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions EXP pirfenidone promotes the reaction [Prednisolone inhibits the reaction [Paraquat results in increased expression of TIMP1 mRNA]]; Prednisolone inhibits the reaction [Paraquat results in increased expression of TIMP1 mRNA] CTD PMID:28921394 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tlr2 toll-like receptor 2 decreases expression ISO Prednisolone results in decreased expression of TLR2 mRNA CTD PMID:19192274 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194 		JBrowse link
G Tnf tumor necrosis factor increases expression
decreases expression
multiple interactions
decreases expression 		ISO
EXP 		Prednisolone results in increased expression of TNF mRNA
Prednisolone results in decreased expression of TNF mRNA
[pirfenidone co-treated with Prednisolone] inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; Prednisolone inhibits the reaction [Amiodarone results in increased expression of TNF protein]; Prednisolone inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]
Prednisolone inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of TNF protein]
prednisolone decreases expression of TNFa mRNA and protein in LPS-stimulated human PBMC
Prednisolone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein] 		CTD
RGD		 PMID:11043609 PMID:19233868 PMID:20054000 PMID:22119283 PMID:28921394 More... RGD:40903016 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfaip2 TNF alpha induced protein 2 decreases expression ISO Prednisolone results in decreased expression of TNFAIP2 mRNA CTD PMID:19192274 NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:136,298,082...136,311,106 		JBrowse link
G Trim63 tripartite motif containing 63 increases expression ISO Prednisolone results in increased expression of TRIM63 mRNA CTD PMID:20065017 NCBI chr 5:151,817,209...151,831,026
Ensembl chr 5:151,817,225...151,831,058 		JBrowse link
G Txnip thioredoxin interacting protein increases expression ISO Prednisolone results in increased expression of TXNIP mRNA CTD PMID:19192274 NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO Prednisolone results in decreased expression of VEGFA protein CTD PMID:20116850 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vldlr very low density lipoprotein receptor increases expression ISO Prednisolone results in increased expression of VLDLR mRNA CTD PMID:24356939 NCBI chr 1:234,239,769...234,272,150
Ensembl chr 1:234,240,121...234,272,154 		JBrowse link
G Xist X inactive specific transcript decreases expression ISO Prednisolone results in decreased expression of XIST mRNA CTD PMID:17379860 NCBI chr  X:68,474,987...68,492,500 JBrowse link
progesterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin affects expression
decreases expression 		ISO Progesterone affects the expression of A2M mRNA
Progesterone results in decreased expression of A2M mRNA 		CTD PMID:17251523 PMID:22238285 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Aamp angio-associated, migratory cell protein increases expression ISO Progesterone results in increased expression of AAMP mRNA CTD PMID:18497975 NCBI chr 9:75,863,382...75,869,188
Ensembl chr 9:83,312,519...83,318,325 		JBrowse link
G Aard alanine and arginine rich domain containing protein increases expression ISO Progesterone results in increased expression of AARD mRNA CTD PMID:22238285 NCBI chr 7:83,364,478...83,369,319
Ensembl chr 7:85,253,992...85,259,163 		JBrowse link
G Abat 4-aminobutyrate aminotransferase multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of ABAT mRNA CTD PMID:17404688 NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474 		JBrowse link
G Abca6 ATP binding cassette subfamily A member 6 increases expression ISO Progesterone results in increased expression of ABCA6 mRNA CTD PMID:21795739 NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,641,900...95,710,899 		JBrowse link
G Abca8 ATP binding cassette subfamily A member 8 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of ABCA8 mRNA CTD PMID:17404688 NCBI chr10:95,416,984...95,490,647
Ensembl chr10:95,416,205...95,490,452 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases activity 		ISO Progesterone inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Progesterone results in decreased activity of ABCB11 protein 		CTD PMID:24014644 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases expression 		ISO Dactinomycin inhibits the reaction [Progesterone results in increased expression of ABCB1 mRNA]; Dactinomycin inhibits the reaction [Progesterone results in increased expression of ABCB1 protein]
Progesterone results in increased expression of ABCB1 mRNA; Progesterone results in increased expression of ABCB1 protein 		CTD PMID:15290871 PMID:19813763 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression EXP Progesterone results in increased expression of ABCB1B mRNA CTD PMID:20726854 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567 		JBrowse link
G Abcb9 ATP binding cassette subfamily B member 9 decreases expression ISO Progesterone results in decreased expression of ABCB9 mRNA CTD PMID:21540246 NCBI chr12:38,146,659...38,192,862
Ensembl chr12:38,159,904...38,192,860 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 decreases activity ISO Progesterone results in decreased activity of ABCC2 protein CTD PMID:16049127 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions
decreases expression
increases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of ABCC3 mRNA
Progesterone results in decreased expression of ABCC3 mRNA
Progesterone results in increased expression of ABCC3 mRNA 		CTD PMID:17404688 PMID:21795739 PMID:22238285 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ABCC4 mRNA CTD PMID:20660070 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375 		JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 decreases expression ISO Progesterone results in decreased expression of ABCC6 mRNA CTD PMID:18070364 NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895 		JBrowse link
G Abcc9 ATP binding cassette subfamily C member 9 increases expression ISO
EXP 		Progesterone results in increased expression of ABCC9 mRNA CTD PMID:20726854 PMID:20864642 NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348 		JBrowse link
G Abcd1 ATP binding cassette subfamily D member 1 affects expression ISO Progesterone affects the expression of ABCD1 mRNA CTD PMID:17251523 NCBI chr  X:156,579,669...156,601,448
Ensembl chr  X:156,579,785...156,601,446 		JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ABCD3 mRNA CTD PMID:20660070 NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Progesterone results in increased expression of ABCG1 mRNA
Progesterone results in decreased expression of ABCG1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of ABCG1 mRNA 		CTD PMID:18070364 PMID:20660070 PMID:20726854 PMID:21540246 NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,127,803...9,186,563 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 affects expression
decreases activity
multiple interactions 		ISO Progesterone affects the expression of ABCG2
Progesterone results in decreased activity of ABCG2 protein
Progesterone inhibits the reaction [ABCG2 protein results in increased uptake of estrone sulfate]; Progesterone inhibits the reaction [Estradiol results in increased expression of ABCG2] 		CTD PMID:16849015 PMID:18086804 PMID:22581381 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 multiple interactions ISO Progesterone results in decreased activity of [ABCG5 protein binds to ABCG8 protein] CTD PMID:17055487 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376 		JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 multiple interactions ISO Progesterone results in decreased activity of [ABCG5 protein binds to ABCG8 protein] CTD PMID:17055487 NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:15,698,448...15,717,730 		JBrowse link
G Abhd11 abhydrolase domain containing 11 decreases expression ISO Progesterone results in decreased expression of ABHD11 mRNA CTD PMID:18037150 NCBI chr12:21,682,206...21,685,331
Ensembl chr12:27,318,749...27,321,970 		JBrowse link
G Abhd12 abhydrolase domain containing 12, lysophospholipase multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ABHD12 mRNA CTD PMID:20660070 NCBI chr 3:139,659,315...139,719,529
Ensembl chr 3:160,119,724...160,179,969 		JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase increases expression ISO Progesterone results in increased expression of ABHD5 mRNA CTD PMID:20864642 NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947 		JBrowse link
G Abi3bp ABI family member 3 binding protein increases expression ISO Progesterone results in increased expression of ABI3BP mRNA CTD PMID:20864642 NCBI chr11:43,912,187...44,128,888
Ensembl chr11:57,381,422...57,598,120 		JBrowse link
G Ablim1 actin-binding LIM protein 1 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ABLIM1 mRNA
Progesterone results in increased expression of ABLIM1 mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:266,088,870...266,377,098 		JBrowse link
G Ablim2 actin binding LIM protein family, member 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ABLIM2 mRNA CTD PMID:20660070 NCBI chr14:79,090,046...79,214,986
Ensembl chr14:79,090,923...79,214,972 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain increases expression EXP Progesterone results in increased expression of ACADL mRNA CTD PMID:20726854 NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164 		JBrowse link
G Acan aggrecan increases expression ISO Progesterone results in increased expression of ACAN protein CTD PMID:20673848 NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:142,390,951...142,453,779 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 increases expression ISO Progesterone results in increased expression of ACAT2 mRNA CTD PMID:18070364 NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095 		JBrowse link
G Acbd7 acyl-CoA binding domain containing 7 increases expression ISO Progesterone results in increased expression of ACBD7 mRNA CTD PMID:22238285 NCBI chr17:79,813,106...79,821,254
Ensembl chr17:79,813,106...79,818,448 		JBrowse link
G Ackr4 atypical chemokine receptor 4 increases expression
decreases expression 		ISO Progesterone results in increased expression of ACKR4 mRNA
Progesterone results in decreased expression of ACKR4 mRNA 		CTD PMID:18070364 PMID:20864642 NCBI chr 8:113,595,325...113,599,762
Ensembl chr 8:113,595,293...113,602,372 		JBrowse link
G Acod1 aconitate decarboxylase 1 affects expression
increases expression 		ISO Progesterone affects the expression of ACOD1; Progesterone affects the expression of ACOD1 mRNA
Progesterone results in increased expression of ACOD1 mRNA 		CTD PMID:15178747 PMID:17251523 PMID:22238285 NCBI chr15:86,286,531...86,295,803
Ensembl chr15:86,286,579...86,295,687 		JBrowse link
G Acot7 acyl-CoA thioesterase 7 affects expression ISO Progesterone affects the expression of ACOT7 mRNA CTD PMID:17251523 NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033 		JBrowse link
G Acot9 acyl-CoA thioesterase 9 affects expression ISO Progesterone affects the expression of ACOT9 mRNA CTD PMID:17251523 NCBI chr  X:43,922,943...43,973,311
Ensembl chr  X:43,914,923...43,973,205 		JBrowse link
G Acp3 acid phosphatase 3 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of ACP3 mRNA; Progesterone inhibits the reaction [Estradiol results in increased expression of ACP3 mRNA]
Progesterone results in decreased expression of ACP3 mRNA 		CTD PMID:17404688 PMID:21795739 NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:113,785,032...113,833,033 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of ACSL1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ACSL1 mRNA
Progesterone results in increased expression of ACSL1 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:20726854 PMID:20864642 PMID:21795739 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ACSM3 mRNA CTD PMID:20660070 NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle increases expression EXP
ISO 		Progesterone results in increased expression of ACTA1 mRNA CTD PMID:20726854 PMID:22238285 NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178 		JBrowse link
G Acta2 actin alpha 2, smooth muscle increases expression
multiple interactions
decreases expression 		ISO
EXP 		Progesterone results in increased expression of ACTA2 mRNA
Progesterone promotes the reaction [Hydrogen Peroxide results in increased expression of ACTA2 protein]
Progesterone results in decreased expression of ACTA2 mRNA 		CTD PMID:16284289 PMID:18037150 PMID:20864642 PMID:21540246 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actb actin, beta affects expression ISO Progesterone affects the expression of ACTB mRNA CTD PMID:17251523 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actc1 actin, alpha, cardiac muscle 1 decreases expression ISO Progesterone results in decreased expression of ACTC1 mRNA CTD PMID:21795739 NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:121,266,291...121,271,827 		JBrowse link
G Actg2 actin gamma 2, smooth muscle affects expression
increases expression 		ISO Progesterone affects the expression of ACTG2 mRNA
Progesterone results in increased expression of ACTG2 mRNA 		CTD PMID:17251523 PMID:20864642 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Actn1 actinin, alpha 1 decreases expression ISO Progesterone results in decreased expression of ACTN1 mRNA CTD PMID:18037150 NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:104,731,485...104,826,172 		JBrowse link
G Acvr1 activin A receptor type 1 decreases expression ISO Progesterone results in decreased expression of ACVR1 mRNA CTD PMID:21795739 NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:63,387,381...63,477,884 		JBrowse link
G Acvr2b activin A receptor type 2B affects expression ISO Progesterone affects the expression of ACVR2B mRNA CTD PMID:17251523 NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:128,016,526...128,048,171 		JBrowse link
G Acy1 aminoacylase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ACY1 mRNA CTD PMID:19693291 NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405 		JBrowse link
G Ada adenosine deaminase multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ADA mRNA CTD PMID:20660070 NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293 		JBrowse link
G Adam12 ADAM metallopeptidase domain 12 multiple interactions
decreases expression
affects expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ADAM12 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ADAM12 mRNA
Progesterone results in decreased expression of ADAM12 mRNA
Progesterone affects the expression of ADAM12 mRNA 		CTD PMID:17251523 PMID:17404688 PMID:19406945 PMID:21795739 NCBI chr 1:188,686,984...189,014,206
Ensembl chr 1:198,116,975...198,447,552 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of ADAM17 mRNA
[Progesterone co-treated with Estradiol] results in decreased expression of ADAM17 mRNA 		CTD PMID:18692832 NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344 		JBrowse link
G Adam28 ADAM metallopeptidase domain 28 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ADAM28 mRNA CTD PMID:20660070 NCBI chr15:43,774,463...43,840,726
Ensembl chr15:50,127,516...50,250,526 		JBrowse link
G Adam8 ADAM metallopeptidase domain 8 decreases expression ISO Progesterone results in decreased expression of ADAM8 mRNA CTD PMID:22238285 NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485 		JBrowse link
G Adam9 ADAM metallopeptidase domain 9 increases expression ISO Progesterone results in increased expression of ADAM9 mRNA CTD PMID:21795739 NCBI chr16:67,022,538...67,101,647
Ensembl chr16:73,725,114...73,804,646 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with Dihydrotestosterone] results in increased expression of ADAMTS1 mRNA; [Progesterone co-treated with Dihydrotestosterone] results in increased expression of ADAMTS1 protein; [Progesterone co-treated with Estradiol] results in increased expression of ADAMTS1 mRNA; Estradiol inhibits the reaction [Progesterone results in increased expression of ADAMTS1 mRNA]; Estradiol inhibits the reaction [Progesterone results in increased expression of ADAMTS1 protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of ADAMTS1 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of ADAMTS1 protein]
Progesterone results in increased expression of ADAMTS1 mRNA; Progesterone results in increased expression of ADAMTS1 protein 		CTD PMID:17018655 PMID:20226447 PMID:20864642 PMID:21795739 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 increases expression ISO Progesterone results in increased expression of ADAMTS2 mRNA CTD PMID:20864642 NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483 		JBrowse link
G Adamts20 ADAM metallopeptidase with thrombospondin type 1 motif, 20 increases expression ISO Progesterone results in increased expression of ADAMTS20 mRNA CTD PMID:18070364 NCBI chr 7:125,396,227...125,528,020
Ensembl chr 7:127,275,538...127,407,296 		JBrowse link
G Adamts8 ADAM metallopeptidase with thrombospondin type 1 motif, 8 increases expression
multiple interactions 		ISO Progesterone results in increased expression of ADAMTS8 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of ADAMTS8 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ADAMTS8 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ADAMTS8 mRNA 		CTD PMID:17404688 PMID:20226447 PMID:20660070 NCBI chr 8:37,607,001...37,626,597
Ensembl chr 8:37,607,001...37,626,597 		JBrowse link
G Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ADAMTS9 mRNA
Progesterone results in increased expression of ADAMTS9 mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:126,847,729...127,019,876 		JBrowse link
G Adamtsl1 ADAMTS-like 1 increases expression ISO Progesterone results in increased expression of ADAMTSL1 mRNA CTD PMID:22238285 NCBI chr 5:99,964,406...100,919,786
Ensembl chr 5:105,010,464...105,964,394 		JBrowse link
G Adap2 ArfGAP with dual PH domains 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ADAP2 mRNA CTD PMID:20660070 NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,622,434...65,664,022 		JBrowse link
G Adcy1 adenylate cyclase 1 increases expression ISO Progesterone results in increased expression of ADCY1 mRNA CTD PMID:20864642 NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075 		JBrowse link
G Adcy2 adenylate cyclase 2 multiple interactions EXP [Genistein co-treated with estradiol-17-benzoate co-treated with Progesterone] results in increased expression of ADCY2 protein CTD PMID:26529183 NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645 		JBrowse link
G Adcy5 adenylate cyclase 5 increases expression EXP Progesterone results in increased expression of ADCY5 mRNA CTD PMID:20726854 NCBI chr11:78,976,861...79,123,343
Ensembl chr11:78,976,861...79,123,343 		JBrowse link
G Adcyap1 adenylate cyclase activating polypeptide 1 increases abundance ISO ADCYAP1 protein results in increased abundance of Progesterone CTD PMID:19926922 NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:120,550,328...120,556,383 		JBrowse link
G Adcyap1r1 ADCYAP receptor type I multiple interactions ISO ADCYAP1R1 protein promotes the reaction [LHB protein results in increased abundance of Progesterone] CTD PMID:19926922 NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:85,924,100...85,972,973 		JBrowse link
G Adgrd1 adhesion G protein-coupled receptor D1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ADGRD1 mRNA CTD PMID:20660070 NCBI chr12:33,124,981...33,239,778
Ensembl chr12:33,125,915...33,272,509 		JBrowse link
G Adgrg6 adhesion G protein-coupled receptor G6 increases expression ISO Progesterone results in increased expression of ADGRG6 mRNA CTD PMID:18070364 NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023 		JBrowse link
G Adgrl2 adhesion G protein-coupled receptor L2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ADGRL2 mRNA CTD PMID:20660070 NCBI chr 2:237,696,055...238,327,141
Ensembl chr 2:240,356,177...240,855,933 		JBrowse link
G Adh1c alcohol dehydrogenase 1C (class I), gamma polypeptide increases expression ISO Progesterone results in increased expression of ADH1C mRNA CTD PMID:20864642 NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291 		JBrowse link
G Adh5 alcohol dehydrogenase 5 (class III), chi polypeptide multiple interactions ISO [Progesterone results in increased activity of PGR protein] which results in increased expression of ADH5 mRNA CTD PMID:15845616 NCBI chr 2:229,648,557...229,660,964
Ensembl chr 2:229,648,501...229,665,232 		JBrowse link
G Adi1 acireductone dioxygenase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ADI1 mRNA CTD PMID:20660070 NCBI chr 6:45,306,885...45,313,847
Ensembl chr 6:51,034,931...51,042,855 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing affects expression
increases abundance
multiple interactions 		ISO Progesterone affects the expression of ADIPOQ mRNA
ADIPOQ protein results in increased abundance of Progesterone
ADIPOQ protein promotes the reaction [IGF1 protein results in increased abundance of Progesterone] 		CTD PMID:17251523 PMID:19081562 PMID:27181934 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Adipor1 adiponectin receptor 1 increases expression ISO Progesterone results in increased expression of ADIPOR1 mRNA CTD PMID:29603059 NCBI chr13:48,411,438...48,431,251
Ensembl chr13:48,411,826...48,431,255 		JBrowse link
G Adipor2 adiponectin receptor 2 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of ADIPOR2 mRNA
Progesterone results in increased expression of ADIPOR2 mRNA 		CTD PMID:17404688 PMID:29603059 NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:154,172,567...154,231,666 		JBrowse link
G Adm adrenomedullin multiple interactions
affects abundance 		ISO
EXP 		ADM protein modified form inhibits the reaction [ADM protein inhibits the reaction [CGA protein results in increased secretion of Progesterone]]
ADM protein affects the abundance of Progesterone 		CTD PMID:18401014 PMID:21824440 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adora2b adenosine A2B receptor multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of ADORA2B mRNA
Progesterone results in increased expression of ADORA2B mRNA 		CTD PMID:19693291 NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091 		JBrowse link
G Adra2a adrenoceptor alpha 2A increases expression ISO Progesterone results in increased expression of ADRA2A mRNA CTD PMID:15713686 NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871 		JBrowse link
G Adra2c adrenoceptor alpha 2C increases expression ISO Progesterone results in increased expression of ADRA2C mRNA CTD PMID:20864642 NCBI chr14:79,695,514...79,697,476
Ensembl chr14:79,694,995...79,706,656 		JBrowse link
G Adrb2 adrenoceptor beta 2 increases expression EXP Progesterone results in increased expression of ADRB2 mRNA CTD PMID:15985637 PMID:20726854 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Adrb3 adrenoceptor beta 3 increases expression ISO Progesterone results in increased expression of ADRB3 mRNA CTD PMID:15713686 NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420 		JBrowse link
G Afap1l2 actin filament associated protein 1-like 2 decreases expression ISO Progesterone results in decreased expression of AFAP1L2 mRNA CTD PMID:20864642 PMID:21795739 NCBI chr 1:265,969,368...266,065,951
Ensembl chr 1:265,969,368...266,065,943 		JBrowse link
G Afp alpha-fetoprotein multiple interactions
increases response to substance 		ISO [Estradiol co-treated with Progesterone] results in increased expression of AFP protein
AFP protein results in increased susceptibility to Progesterone 		CTD PMID:18497072 PMID:22720075 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Agap3 ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 decreases expression ISO Progesterone results in decreased expression of AGAP3 mRNA CTD PMID:18037150 NCBI chr 4:11,567,191...11,617,610
Ensembl chr 4:11,567,191...11,617,285 		JBrowse link
G Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of AGPAT4 mRNA CTD PMID:17404688 NCBI chr 1:48,525,131...48,633,798
Ensembl chr 1:51,075,081...51,180,976 		JBrowse link
G Agrn agrin increases expression EXP Progesterone results in increased expression of AGRN protein CTD PMID:16777347 NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539 		JBrowse link
G Agt angiotensinogen multiple interactions
decreases secretion
decreases expression 		ISO Progesterone inhibits the reaction [AGT protein results in increased abundance of Inositol Phosphates]
AGT protein results in decreased secretion of Progesterone
Progesterone results in decreased expression of AGT mRNA 		CTD PMID:1337236 PMID:22095930 PMID:28235592 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Ahr aryl hydrocarbon receptor affects binding
decreases expression
multiple interactions
affects expression 		ISO
EXP 		Progesterone binds to AHR protein
Progesterone results in decreased expression of AHR mRNA
[Progesterone co-treated with Estradiol] affects the expression of AHR mRNA; [Progesterone co-treated with Estradiol] affects the expression of AHR protein
Progesterone affects the expression of AHR mRNA; Progesterone affects the expression of AHR protein 		CTD PMID:10478797 PMID:24777823 PMID:32668270 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor affects expression
multiple interactions 		EXP Progesterone affects the expression of AHRR mRNA
[Progesterone co-treated with Estradiol] affects the expression of AHRR mRNA 		CTD PMID:24777823 NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:30,810,866...30,952,866 		JBrowse link
G Aicda activation-induced cytidine deaminase decreases expression ISO Progesterone results in decreased expression of AICDA mRNA; Progesterone results in decreased expression of AICDA protein CTD PMID:19139166 PMID:19553525 NCBI chr 4:157,446,120...157,455,958
Ensembl chr 4:157,444,697...157,456,356 		JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions EXP [Estradiol co-treated with Progesterone] results in decreased expression of AIF1 protein CTD PMID:21277368 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Ajap1 adherens junctions associated protein 1 increases expression ISO Progesterone results in increased expression of AJAP1 mRNA CTD PMID:22238285 NCBI chr 5:163,907,846...164,021,004
Ensembl chr 5:169,190,477...169,304,515 		JBrowse link
G Ak1 adenylate kinase 1 increases expression EXP Progesterone results in increased expression of AK1 mRNA CTD PMID:20726854 NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757 		JBrowse link
G Akap1 A-kinase anchoring protein 1 increases expression EXP Progesterone results in increased expression of AKAP1 mRNA CTD PMID:20726854 NCBI chr10:73,621,021...73,654,123
Ensembl chr10:74,119,124...74,138,190 		JBrowse link
G Akap12 A-kinase anchoring protein 12 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of AKAP12 mRNA
Progesterone results in increased expression of AKAP12 mRNA; Progesterone results in increased expression of AKAP12 protein 		CTD PMID:20660070 PMID:21795739 NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557 		JBrowse link
G Akap13 A-kinase anchoring protein 13 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of AKAP13 mRNA
Progesterone results in increased expression of AKAP13 mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:138,724,150...139,029,401 		JBrowse link
G Akap5 A-kinase anchoring protein 5 increases expression EXP Progesterone results in increased expression of AKAP5 mRNA CTD PMID:20726854 NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:100,790,148...100,796,620 		JBrowse link
G Akap8 A-kinase anchoring protein 8 decreases expression ISO Progesterone results in decreased expression of AKAP8 mRNA CTD PMID:18037150 NCBI chr 7:11,966,769...11,983,056
Ensembl chr 7:11,966,772...11,982,900 		JBrowse link
G Akap9 A-kinase anchoring protein 9 decreases expression ISO Progesterone results in decreased expression of AKAP9 mRNA CTD PMID:18070364 NCBI chr 4:31,011,475...31,147,338
Ensembl chr 4:31,011,475...31,147,338 		JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of AKR1B10 mRNA
Progesterone results in decreased expression of AKR1B10 mRNA 		CTD PMID:17404688 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 affects reduction
decreases expression
multiple interactions
increases reduction 		ISO AKR1C1 protein affects the reduction of Progesterone
Progesterone results in decreased expression of AKR1C1 mRNA
AKR1C1 protein affects the metabolism of and results in decreased activity of Progesterone
AKR1C1 protein results in increased reduction of Progesterone 		CTD PMID:11995921 PMID:12604236 PMID:16338060 PMID:16962702 PMID:22245609 More... NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 increases reduction ISO AKR1C2 protein results in increased reduction of Progesterone CTD PMID:11158055 PMID:22245609 PMID:25463305 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions
increases metabolic processing
affects metabolic processing
affects abundance
increases reduction
increases expression
decreases expression 		ISO
EXP 		[AKR1C3 protein results in increased metabolism of Progesterone] which results in increased chemical synthesis of 20-alpha-Dihydroprogesterone; [AKR1C3 protein results in increased reduction of Progesterone] which results in increased chemical synthesis of 20-alpha-Dihydroprogesterone
AKR1C18 protein results in increased metabolism of Progesterone
AKR1C18 protein affects the metabolism of Progesterone
AKR1C18 protein affects the abundance of Progesterone
Progesterone results in increased expression of AKR1C3 mRNA
Progesterone results in decreased expression of AKR1C3 mRNA 		CTD PMID:8172618 PMID:15261307 PMID:15471942 PMID:17122075 PMID:19010312 More... NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 increases reduction
multiple interactions 		ISO AKR1D1 protein results in increased reduction of Progesterone
AKR1D1 protein alternative form results in increased reduction of Progesterone; AKR1D1 protein results in increased reduction of Progesterone
[AKR1D1 protein alternative form results in increased reduction of Progesterone] which results in increased chemical synthesis of 5-alpha-Dihydroprogesterone 		CTD PMID:18624455 PMID:30928400 NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
increases phosphorylation 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Progesterone results in increased phosphorylation of AKT1 protein]
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of AKT1 protein; Mifepristone inhibits the reaction [Progesterone results in increased phosphorylation of AKT1 protein]; Pertussis Toxin inhibits the reaction [Progesterone results in increased phosphorylation of AKT1 protein]
Progesterone inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] 		CTD PMID:15358673 PMID:15845746 PMID:22465879 PMID:28324061 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Alad aminolevulinate dehydratase multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ALAD mRNA CTD PMID:20660070 NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041 		JBrowse link
G Alas1 5'-aminolevulinate synthase 1 increases expression EXP Progesterone results in increased expression of ALAS1 mRNA CTD PMID:20726854 NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642 		JBrowse link
G Alas2 5'-aminolevulinate synthase 2 affects expression ISO Progesterone affects the expression of ALAS2 mRNA CTD PMID:17251523 NCBI chr  X:22,890,650...22,914,046
Ensembl chr  X:22,890,689...22,914,043 		JBrowse link
G Alb albumin multiple interactions ISO [[IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]] which affects the expression of ALB protein; [[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the expression of ALB protein CTD PMID:20621171 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule increases expression ISO Progesterone results in increased expression of ALCAM mRNA CTD PMID:18497975 PMID:21795739 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 affects expression
decreases expression
multiple interactions 		ISO Progesterone affects the expression of ALDH1A1 mRNA
Progesterone results in decreased expression of ALDH1A1 mRNA
[Progesterone results in increased activity of PGR protein] which results in increased expression of ALDH1A1 mRNA 		CTD PMID:15845616 PMID:17251523 PMID:22238285 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh1a2 aldehyde dehydrogenase 1 family, member A2 affects expression ISO Progesterone affects the expression of ALDH1A2 mRNA CTD PMID:17251523 NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of ALDH1A3 mRNA
Progesterone results in decreased expression of ALDH1A3 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Aldh1l1 aldehyde dehydrogenase 1 family, member L1 increases expression EXP Progesterone results in increased expression of ALDH1L1 mRNA CTD PMID:20726854 NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 decreases expression ISO Progesterone results in decreased expression of ALDH3A1 mRNA CTD PMID:18037150 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldh3b2 aldehyde dehydrogenase 3 family, member B2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ALDH3B2 mRNA CTD PMID:20660070 NCBI chr 1:201,250,260...201,264,699
Ensembl chr 1:210,675,302...210,694,155 		JBrowse link
G Aldh3b3 aldehyde dehydrogenase 3 family, member B3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ALDH3B2 mRNA CTD PMID:20660070 NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:210,622,639...210,629,879 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 increases expression EXP Progesterone results in increased expression of ALDH6A1 mRNA CTD PMID:20726854 NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743 		JBrowse link
G Aldoc aldolase, fructose-bisphosphate C decreases expression ISO Progesterone results in decreased expression of ALDOC mRNA CTD PMID:22238285 NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,715,489...63,719,133 		JBrowse link
G Alg2 ALG2, alpha-1,3/1,6-mannosyltransferase multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ALG2 mRNA CTD PMID:21453500 NCBI chr 5:66,564,328...66,568,887
Ensembl chr 5:66,564,330...66,568,887 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase affects expression
increases expression 		ISO
EXP 		Progesterone affects the expression of ALOX15 mRNA
Progesterone results in increased expression of ALOX15 mRNA 		CTD PMID:17251523 PMID:21770760 NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723 		JBrowse link
G Alox15b arachidonate 15-lipoxygenase, type B multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of ALOX15B mRNA
Progesterone results in increased expression of ALOX15B mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr10:54,391,331...54,400,648
Ensembl chr10:54,391,302...54,400,648 		JBrowse link
G Alpg alkaline phosphatase, germ cell multiple interactions
affects expression 		ISO perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of ALPPL2 mRNA]; Progesterone inhibits the reaction [perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of ALPPL2 mRNA]] CTD PMID:31896193 NCBI chr 9:87,748,721...87,761,500
Ensembl chr 9:95,198,334...95,205,742 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
decreases expression
increases expression
increases activity 		ISO [Estradiol co-treated with Progesterone] results in increased expression of ALPL mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ALPL mRNA; fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein]; Permethrin inhibits the reaction [Progesterone results in increased activity of ALPL protein]
Progesterone results in decreased expression of ALPL mRNA
Progesterone results in increased expression of ALPL mRNA 		CTD PMID:16326432 PMID:17404688 PMID:20660070 PMID:21540246 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Alpp alkaline phosphatase, placental multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of ALPP mRNA
Progesterone results in increased expression of ALPP mRNA 		CTD PMID:17404688 NCBI chr 9:87,765,846...87,768,606
Ensembl chr 9:95,213,374...95,219,451 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of AMIGO2 mRNA CTD PMID:20660070 NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218 		JBrowse link
G Amigo3 adhesion molecule with Ig like domain 3 decreases expression EXP Progesterone results in decreased expression of AMIGO3 mRNA CTD PMID:20726854 NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:117,616,629...117,626,577 		JBrowse link
G Ammecr1 AMMECR nuclear protein 1 increases expression ISO Progesterone results in increased expression of AMMECR1 mRNA CTD PMID:21795739 NCBI chr  X:111,262,792...111,368,099
Ensembl chr  X:111,262,792...111,368,099 		JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 affects expression ISO Progesterone affects the expression of AMPD3 mRNA CTD PMID:17251523 NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608 		JBrowse link
G Amph amphiphysin increases expression ISO Progesterone results in increased expression of AMPH mRNA CTD PMID:22238285 NCBI chr17:45,739,385...45,982,905
Ensembl chr17:50,435,018...50,678,501 		JBrowse link
G Amy2a5 amylase 2a5 decreases expression ISO Progesterone results in decreased expression of AMY2A5 mRNA CTD PMID:22238285 NCBI chr 2:201,261,621...201,270,188 JBrowse link
G Andpro androgen regulated protein multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CST4 mRNA CTD PMID:20660070 NCBI chr 3:157,171,739...157,178,262
Ensembl chr 3:157,171,740...157,178,104 		JBrowse link
G Ang angiogenin increases expression
affects expression 		ISO Progesterone results in increased expression of ANG mRNA
Progesterone affects the expression of ANG mRNA 		CTD PMID:17251523 PMID:21795739 NCBI chr15:24,312,711...24,323,361
Ensembl chr15:26,786,065...26,801,106 		JBrowse link
G Angpt1 angiopoietin 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ANGPT1 mRNA CTD PMID:20660070 NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696 		JBrowse link
G Angpt2 angiopoietin 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ANGPT2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ANGPT2 mRNA CTD PMID:17404688 PMID:20660070 NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239 		JBrowse link
G Angpt4 angiopoietin 4 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estrogens] results in increased expression of ANGPT4 mRNA
Progesterone results in increased expression of ANGPT4 mRNA 		CTD PMID:22821867 NCBI chr 3:160,880,539...160,913,923
Ensembl chr 3:160,880,728...160,913,921 		JBrowse link
G Angptl1 angiopoietin-like 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estrogens] results in increased expression of ANGPTL1 mRNA
Progesterone results in increased expression of ANGPTL1 mRNA 		CTD PMID:22350948 NCBI chr13:71,463,913...71,531,810
Ensembl chr13:71,511,727...71,531,818 		JBrowse link
G Angptl2 angiopoietin-like 2 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of ANGPTL2 mRNA CTD PMID:17404688 NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876 		JBrowse link
G Angptl3 angiopoietin-like 3 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of ANGPTL3 mRNA
[Progesterone co-treated with Estrogens] results in decreased expression of ANGPTL3 mRNA 		CTD PMID:22350948 NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:118,818,499...118,826,444 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression
multiple interactions 		ISO Progesterone results in increased expression of ANGPTL4 mRNA
Progesterone inhibits the reaction [Estrogens results in decreased expression of ANGPTL4 mRNA] 		CTD PMID:21795739 PMID:22350948 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Angptl6 angiopoietin-like 6 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estrogens] results in increased expression of ANGPTL6 mRNA
Progesterone results in increased expression of ANGPTL6 mRNA 		CTD PMID:22350948 NCBI chr 8:27,689,804...27,696,172
Ensembl chr 8:27,689,806...27,696,111 		JBrowse link
G Angptl7 angiopoietin like 7 increases expression ISO Progesterone results in increased expression of ANGPTL7 mRNA CTD PMID:22238285 NCBI chr 5:164,215,223...164,220,408
Ensembl chr 5:164,215,223...164,220,584 		JBrowse link
G Ank3 ankyrin 3 decreases expression ISO Progesterone results in decreased expression of ANK3 mRNA CTD PMID:21540246 NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879 		JBrowse link
G Ankh ANKH inorganic pyrophosphate transport regulator affects expression ISO Progesterone affects the expression of ANK mRNA CTD PMID:17251523 NCBI chr 2:79,883,350...80,011,222
Ensembl chr 2:79,883,544...80,011,699 		JBrowse link
G Ankrd22 ankyrin repeat domain 22 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ANKRD22 mRNA CTD PMID:20660070 NCBI chr 1:231,639,035...231,670,537
Ensembl chr 1:241,052,237...241,105,559 		JBrowse link
G Ankrd35 ankyrin repeat domain 35 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of ANKRD35 mRNA
Progesterone results in decreased expression of ANKRD35 mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr 2:184,207,076...184,227,063
Ensembl chr 2:186,895,945...186,915,902 		JBrowse link
G Ankrd50 ankyrin repeat domain containing 50 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ANKRD50 mRNA CTD PMID:20660070 NCBI chr 2:121,466,275...121,500,758
Ensembl chr 2:123,396,606...123,427,340 		JBrowse link
G Ankrd55 ankyrin repeat domain 55 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of ANKRD55 mRNA CTD PMID:17404688 NCBI chr 2:45,617,011...45,717,086
Ensembl chr 2:45,617,177...45,717,057 		JBrowse link
G Anln anillin, actin binding protein decreases expression ISO Progesterone results in decreased expression of ANLN mRNA CTD PMID:21795739 NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513 		JBrowse link
G Ano9 anoctamin 9 decreases expression ISO Progesterone results in decreased expression of ANO9 mRNA CTD PMID:22238285 NCBI chr 1:196,208,863...196,230,381
Ensembl chr 1:205,638,572...205,659,489 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ANTXR1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ANTXR1 mRNA CTD PMID:17404688 PMID:20660070 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Antxr2 ANTXR cell adhesion molecule 2 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ANTXR2 mRNA
Progesterone results in increased expression of ANTXR2 mRNA 		CTD PMID:20660070 PMID:20864642 PMID:22238285 NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,845,700...11,986,168 		JBrowse link
G Anxa3 annexin A3 decreases expression ISO Progesterone results in decreased expression of ANXA3 mRNA CTD PMID:21540246 NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849 		JBrowse link
G Aoc3 amine oxidase, copper containing 3 decreases expression ISO Progesterone results in decreased expression of AOC3 mRNA CTD PMID:19693291 NCBI chr10:86,773,018...86,780,961 JBrowse link
G Aox1 aldehyde oxidase 1 increases expression ISO
EXP 		Progesterone results in increased expression of AOX1 mRNA CTD PMID:20726854 PMID:21540246 PMID:21795739 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Ap3m2 adaptor related protein complex 3 subunit mu 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of AP3M2 mRNA CTD PMID:20660070 NCBI chr16:69,217,526...69,237,372
Ensembl chr16:75,920,084...75,937,923 		JBrowse link
G Ap5m1 adaptor related protein complex 5 subunit mu 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of AP5M1 mRNA CTD PMID:21453500 NCBI chr15:22,355,478...22,385,222
Ensembl chr15:24,835,100...24,862,606 		JBrowse link
G Apcdd1 APC down-regulated 1 increases expression ISO Progesterone results in increased expression of APCDD1 mRNA CTD PMID:20864642 NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 decreases expression ISO Progesterone results in decreased expression of APEX1 mRNA CTD PMID:18037150 NCBI chr15:24,144,595...24,146,785
Ensembl chr15:26,618,224...26,620,329 		JBrowse link
G Apoc4 apolipoprotein C4 decreases expression ISO Progesterone results in decreased expression of APOC4 mRNA CTD PMID:18037150 NCBI chr 1:88,463,713...88,467,909
Ensembl chr 1:88,463,713...88,468,044 		JBrowse link
G Apod apolipoprotein D multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of APOD mRNA
Progesterone results in increased expression of APOD mRNA 		CTD PMID:17404688 PMID:20864642 PMID:21795739 NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263 		JBrowse link
G Apom apolipoprotein M multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of APOM mRNA CTD PMID:17404688 NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,692,737...3,698,218 		JBrowse link
G App amyloid beta precursor protein decreases metabolic processing
multiple interactions 		ISO APP gene mutant form results in decreased metabolism of Progesterone metabolite
Progesterone inhibits the reaction [APP gene mutant form results in decreased metabolism of Progesterone metabolite] 		CTD PMID:17988898 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Aqp1 aquaporin 1 affects localization
increases expression
multiple interactions 		EXP Progesterone affects the localization of AQP1 protein
Progesterone results in increased expression of AQP1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of AQP1 mRNA; [Estradiol co-treated with Progesterone] results in increased expression of AQP1 protein; [Progesterone co-treated with Estrogens] affects the localization of AQP1 protein; Quercetin inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of AQP1 mRNA]; Quercetin promotes the reaction [[Estradiol co-treated with Progesterone] results in increased expression of AQP1 protein] 		CTD PMID:16452730 PMID:20726854 PMID:28341573 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp2 aquaporin 2 increases expression
multiple interactions 		ISO
EXP 		Progesterone results in increased expression of AQP2 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of AQP2 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of AQP2 protein; Quercetin inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of AQP2 mRNA]; Quercetin inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of AQP2 protein] 		CTD PMID:18692832 PMID:28341573 NCBI chr 7:132,590,286...132,595,321
Ensembl chr 7:132,590,225...132,595,319 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of AQP3 mRNA
Progesterone results in decreased expression of AQP3 mRNA 		CTD PMID:17404688 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp5 aquaporin 5 affects localization
decreases expression
multiple interactions 		EXP
ISO 		Progesterone affects the localization of AQP5 protein
Progesterone results in decreased expression of AQP5 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of AQP5 mRNA; [Estradiol co-treated with Progesterone] results in increased expression of AQP5 protein; [Progesterone co-treated with Estrogens] affects the localization of AQP5 protein; Progesterone inhibits the reaction [Estradiol results in decreased expression of AQP5 mRNA]; Progesterone promotes the reaction [Estradiol results in decreased expression of AQP5 protein]; Quercetin affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of AQP5 mRNA] 		CTD PMID:16452730 PMID:22238285 PMID:28341573 NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:132,601,059...132,605,062 		JBrowse link
G Aqp7 aquaporin 7 multiple interactions EXP [Estradiol co-treated with Progesterone] results in increased expression of AQP7 mRNA; [Estradiol co-treated with Progesterone] results in increased expression of AQP7 protein; Quercetin inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of AQP7 mRNA]; Quercetin inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of AQP7 protein] CTD PMID:28341573 NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Ar androgen receptor multiple interactions
decreases expression
affects activity
increases activity
affects binding 		EXP
ISO 		Progesterone analog binds to and results in decreased activity of AR protein
Progesterone results in decreased expression of AR mRNA
Progesterone affects the activity of AR protein
Progesterone results in increased activity of AR protein
Progesterone binds to and results in decreased activity of AR protein; Progesterone binds to and results in increased activity of AR protein; Progesterone inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; Progesterone inhibits the reaction [Metribolone results in increased activity of AR protein]
Progesterone binds to AR protein 		CTD PMID:9073609 PMID:12676605 PMID:14565775 PMID:15084347 PMID:17804755 More... NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Araf A-Raf proto-oncogene, serine/threonine kinase affects expression ISO Progesterone affects the expression of ARAF mRNA CTD PMID:17251523 NCBI chr  X:3,780,932...3,845,919
Ensembl chr  X:3,780,932...3,792,611 		JBrowse link
G Arap3 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of ARAP3 mRNA CTD PMID:17404688 NCBI chr18:29,806,214...29,834,217
Ensembl chr18:30,058,275...30,084,865 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein decreases expression EXP Progesterone results in decreased expression of ARC mRNA CTD PMID:16376865 NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220 		JBrowse link
G Areg amphiregulin multiple interactions
increases expression
affects expression
increases abundance 		ISO
EXP 		[Progesterone affects the activity of PGR protein alternative form] which affects the expression of AREG mRNA
Progesterone results in increased expression of AREG mRNA
[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of AREG mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of AREG mRNA; [Progesterone co-treated with Estrogens] results in increased expression of AREG protein; Estrogens promotes the reaction [Progesterone results in increased expression of AREG mRNA]
Progesterone affects the expression of AREG
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of AREG mRNA; [Estradiol co-treated with Progesterone] results in increased expression of AREG mRNA; Estradiol promotes the reaction [Progesterone inhibits the reaction [perfluorooctanoic acid results in decreased expression of AREG protein]]; NRG1 protein promotes the reaction [AREG protein results in increased abundance of Progesterone]; Progesterone inhibits the reaction [perfluorooctanoic acid results in decreased expression of AREG protein]; Progesterone promotes the reaction [Estradiol inhibits the reaction [perfluorooctanoic acid results in decreased expression of AREG protein]] 		CTD PMID:15178747 PMID:15866122 PMID:16794005 PMID:18070364 PMID:18556351 More... NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Arfgap2 ARF GTPase activating protein 2 affects expression ISO Progesterone affects the expression of ARFGAP2 mRNA CTD PMID:17251523 NCBI chr 3:97,692,105...97,704,246
Ensembl chr 3:97,692,110...97,704,247 		JBrowse link
G Arg1 arginase 1 affects expression
multiple interactions 		ISO Progesterone affects the expression of ARG1 mRNA
Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with IL4 protein] results in increased expression of ARG1 mRNA]; Progesterone inhibits the reaction [IL4 protein results in increased expression of ARG1 mRNA]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of ARG1 mRNA] 		CTD PMID:17251523 PMID:21977998 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713 		JBrowse link
G Arg2 arginase 2 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ARG2 mRNA
Progesterone results in decreased expression of ARG2 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arhgap18 Rho GTPase activating protein 18 decreases expression ISO Progesterone results in decreased expression of ARHGAP18 mRNA CTD PMID:20864642 NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670 		JBrowse link
G Arhgap28 Rho GTPase activating protein 28 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ARHGAP28 mRNA CTD PMID:20660070 NCBI chr 9:115,277,849...115,444,789
Ensembl chr 9:115,279,734...115,445,008 		JBrowse link
G Arhgdia Rho GDP dissociation inhibitor alpha decreases expression ISO Progesterone results in decreased expression of ARHGDIA mRNA CTD PMID:18070364 NCBI chr10:105,854,526...105,858,020
Ensembl chr10:106,353,491...106,356,347 		JBrowse link
G Arhgef17 Rho guanine nucleotide exchange factor 17 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of ARHGEF17 mRNA CTD PMID:17404688 NCBI chr 1:164,642,690...164,702,241
Ensembl chr 1:164,642,690...164,702,241 		JBrowse link
G Arhgef3 Rho guanine nucleotide exchange factor 3 increases expression ISO Progesterone results in increased expression of ARHGEF3 mRNA CTD PMID:18070364 NCBI chr16:2,308,311...2,588,634
Ensembl chr16:2,308,400...2,588,819 		JBrowse link
G Arl4a ARF like GTPase 4A increases expression ISO Progesterone results in increased expression of ARL4A mRNA CTD PMID:18037150 NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760 		JBrowse link
G Arl4c ARF like GTPase 4C affects expression
multiple interactions
decreases expression 		ISO Progesterone affects the expression of ARL4C mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of ARL4C mRNA
Progesterone results in decreased expression of ARL4C mRNA 		CTD PMID:17251523 PMID:20660070 PMID:20864642 NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772 		JBrowse link
G Armc9 armadillo repeat containing 9 decreases expression ISO Progesterone results in decreased expression of ARMC9 mRNA CTD PMID:21795739 NCBI chr 9:86,802,791...86,928,611
Ensembl chr 9:94,250,859...94,376,589 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator affects expression
multiple interactions 		EXP Progesterone affects the expression of ARNT mRNA
[Progesterone co-treated with Estradiol] affects the expression of ARNT mRNA 		CTD PMID:24777823 NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Arnt2 aryl hydrocarbon receptor nuclear translocator 2 affects expression EXP Progesterone affects the expression of ARNT2 mRNA CTD PMID:24777823 NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:147,599,058...147,801,997 		JBrowse link
G Arpc4 actin related protein 2/3 complex, subunit 4 affects expression ISO Progesterone affects the expression of ARPC4 mRNA CTD PMID:17251523 NCBI chr 4:146,522,255...146,532,784
Ensembl chr 4:148,077,240...148,088,428 		JBrowse link
G Arpin actin-related protein 2/3 complex inhibitor multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ARPIN mRNA CTD PMID:21453500 NCBI chr 1:133,864,288...133,873,124
Ensembl chr 1:143,273,590...143,282,532 		JBrowse link
G Art3 ADP-ribosyltransferase 3 multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of ART3 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ART3 mRNA
Progesterone results in increased expression of ART3 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:20726854 NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806 		JBrowse link
G Asap2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ASAP2 mRNA
Progesterone results in increased expression of ASAP2 mRNA 		CTD PMID:18037150 PMID:20660070 NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:46,386,605...46,549,669 		JBrowse link
G Asb2 ankyrin repeat and SOCS box-containing 2 multiple interactions
increases expression 		ISO [Progesterone co-treated with TGFB1 protein] results in increased expression of ASB2 mRNA
Progesterone results in increased expression of ASB2 mRNA 		CTD PMID:21768398 NCBI chr 6:128,239,550...128,275,833
Ensembl chr 6:128,239,552...128,266,321 		JBrowse link
G Asgr1 asialoglycoprotein receptor 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ASGR1 mRNA CTD PMID:19693291 NCBI chr10:55,274,299...55,278,323
Ensembl chr10:55,274,706...55,278,322 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression ISO Progesterone results in increased expression of ASNS mRNA CTD PMID:18037150 PMID:21795739 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Asph aspartate-beta-hydroxylase multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ASPH mRNA CTD PMID:20660070 NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:27,398,949...27,611,215 		JBrowse link
G Asphd2 aspartate beta-hydroxylase domain containing 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ASPHD2 mRNA CTD PMID:20660070 NCBI chr12:49,908,539...49,919,060
Ensembl chr12:49,908,241...49,925,254 		JBrowse link
G Aspm assembly factor for spindle microtubules increases expression ISO Progesterone results in increased expression of ASPM mRNA CTD PMID:18070364 NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489 		JBrowse link
G Aspn asporin multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ASPN mRNA
Progesterone results in increased expression of ASPN mRNA 		CTD PMID:20660070 PMID:21795739 NCBI chr17:15,286,338...15,310,567
Ensembl chr17:15,287,065...15,310,632 		JBrowse link
G Asrgl1 asparaginase and isoaspartyl peptidase 1 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of ASRGL1 mRNA
Progesterone results in decreased expression of ASRGL1 mRNA 		CTD PMID:17404688 PMID:21540246 NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:215,435,218...215,456,198 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA
Progesterone results in increased expression of ATAD2 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Progesterone results in increased expression of ATF3 mRNA] CTD PMID:15674352 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 increases expression ISO Progesterone results in increased expression of ATF4 mRNA CTD PMID:18037150 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atg13 autophagy related 13 affects expression ISO Progesterone affects the expression of ATG13 mRNA CTD PMID:17251523 NCBI chr 3:98,102,831...98,136,741
Ensembl chr 3:98,101,552...98,136,743 		JBrowse link
G Atg2b autophagy related 2B increases expression ISO Progesterone results in increased expression of ATG2B mRNA CTD PMID:18070364 NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:130,286,986...130,357,109 		JBrowse link
G Atp10a ATPase phospholipid transporting 10A (putative) multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ATP10A mRNA CTD PMID:20660070 NCBI chr 1:109,556,760...109,730,440
Ensembl chr 1:118,692,478...118,866,114 		JBrowse link
G Atp10b ATPase phospholipid transporting 10B decreases expression ISO Progesterone results in decreased expression of ATP10B mRNA CTD PMID:22238285 NCBI chr10:27,996,729...28,252,801
Ensembl chr10:27,910,295...28,251,450 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 increases expression
increases activity 		ISO
EXP 		Progesterone results in increased expression of ATP1A1 mRNA
Progesterone results in increased activity of ATP1A1 protein 		CTD PMID:18037150 PMID:20726854 PMID:22759964 NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 decreases expression ISO Progesterone results in decreased expression of ATP1B1 mRNA CTD PMID:21540246 NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 multiple interactions
decreases expression 		ISO Mifepristone inhibits the reaction [Progesterone results in decreased expression of ATP2A1 mRNA] CTD PMID:27264040 NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 increases expression EXP Progesterone results in increased expression of ATP2A2 mRNA CTD PMID:20726854 NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934 		JBrowse link
G Atp2b4 ATPase plasma membrane Ca2+ transporting 4 decreases expression ISO Progesterone results in decreased expression of ATP2B4 mRNA CTD PMID:18070364 NCBI chr13:45,156,137...45,255,292
Ensembl chr13:47,711,121...47,758,876 		JBrowse link
G Atp2c2 ATPase secretory pathway Ca2+ transporting 2 multiple interactions
increases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in increased expression of ATP2C2 mRNA] CTD PMID:17556502 NCBI chr19:64,662,729...64,719,998
Ensembl chr19:64,662,715...64,719,996 		JBrowse link
G Atp5f1b ATP synthase F1 subunit beta increases phosphorylation EXP Progesterone results in increased phosphorylation of ATP5F1B protein CTD PMID:17303654 NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462 		JBrowse link
G Atp6v1a ATPase H+ transporting V1 subunit A multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of ATP6V1A mRNA CTD PMID:17404688 NCBI chr11:70,066,800...70,120,603
Ensembl chr11:70,035,134...70,120,603 		JBrowse link
G Atp7b ATPase copper transporting beta multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ATP7B mRNA CTD PMID:20660070 NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801 		JBrowse link
G Atp8a1 ATPase phospholipid transporting 8A1 affects expression ISO Progesterone affects the expression of ATP8A1 mRNA CTD PMID:17251523 NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463 		JBrowse link
G Atp8a2 ATPase phospholipid transporting 8A2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ATP8A2 mRNA CTD PMID:20660070 NCBI chr15:37,993,507...38,526,408
Ensembl chr15:38,002,305...38,526,212 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ATP8B1 mRNA
Progesterone results in decreased expression of ATP8B1 mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027 		JBrowse link
G Aurka aurora kinase A increases expression
decreases expression
multiple interactions 		ISO
EXP 		Progesterone results in increased expression of AURKA mRNA
Progesterone results in decreased expression of AURKA mRNA
[Estrogens co-treated with Progesterone] inhibits the reaction [Methylnitrosourea results in increased expression of AURKA mRNA] 		CTD PMID:12124350 PMID:16888808 PMID:21795739 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Aurkb aurora kinase B decreases expression EXP Progesterone results in decreased expression of AURKB mRNA CTD PMID:20726854 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285 		JBrowse link
G Avp arginine vasopressin decreases expression EXP Progesterone results in decreased expression of AVP protein CTD PMID:16454802 NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522 		JBrowse link
G Avpi1 arginine vasopressin-induced 1 multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of AVPI1 mRNA
Progesterone results in increased expression of AVPI1 mRNA 		CTD PMID:20660070 PMID:20726854 NCBI chr 1:250,879,530...250,885,448
Ensembl chr 1:250,879,530...250,885,704 		JBrowse link
G Avpr1a arginine vasopressin receptor 1A increases expression ISO Progesterone results in increased expression of AVPR1A mRNA CTD PMID:20864642 PMID:22238285 NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837 		JBrowse link
G Axin1 axin 1 affects expression
increases expression 		ISO
EXP 		Progesterone affects the expression of AXIN1 mRNA
Progesterone results in increased expression of AXIN1 mRNA 		CTD PMID:17170212 PMID:17251523 NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,667,958...15,720,092 		JBrowse link
G Axin2 axin 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of AXIN2 mRNA CTD PMID:20660070 NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575 		JBrowse link
G B3gnt5 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 increases expression ISO Progesterone results in increased expression of B3GNT5 mRNA CTD PMID:21795739 NCBI chr11:94,645,480...94,657,584
Ensembl chr11:94,645,480...94,660,514 		JBrowse link
G B4galt2 beta-1,4-galactosyltransferase 2 decreases expression
affects expression 		ISO Progesterone results in decreased expression of B4GALT2 mRNA
Progesterone affects the expression of B4GALT2 mRNA 		CTD PMID:17251523 PMID:18037150 NCBI chr 5:131,412,541...131,422,573
Ensembl chr 5:136,697,981...136,710,422 		JBrowse link
G B4galt6 beta-1,4-galactosyltransferase 6 decreases expression ISO Progesterone results in decreased expression of B4GALT6 mRNA CTD PMID:19693291 NCBI chr18:12,233,350...12,290,204
Ensembl chr18:12,233,351...12,290,204 		JBrowse link
G Baalc BAALC binder of MAP3K1 and KLF4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of BAALC mRNA CTD PMID:20660070 NCBI chr 7:69,918,998...69,992,289
Ensembl chr 7:71,774,898...71,879,261 		JBrowse link
G Bach1 BTB domain and CNC homolog 1 affects expression ISO Progesterone affects the expression of BACH1 mRNA CTD PMID:17251523 NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277 		JBrowse link
G Bad BCL2-associated agonist of cell death decreases expression
multiple interactions 		EXP Progesterone results in decreased expression of BAD mRNA
[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of BAD mRNA 		CTD PMID:15941375 PMID:20732338 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bag1 BAG cochaperone 1 decreases expression ISO Progesterone results in decreased expression of BAG1 mRNA CTD PMID:18037150 NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161 		JBrowse link
G Bag3 BAG cochaperone 3 increases expression ISO Progesterone results in increased expression of BAG3 mRNA CTD PMID:18037150 NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:192,475,828...192,557,280 		JBrowse link
G Bag4 BAG cochaperone 4 decreases expression EXP Progesterone results in decreased expression of BAG4 mRNA CTD PMID:21770760 NCBI chr16:66,288,678...66,305,893
Ensembl chr16:72,991,362...73,013,273 		JBrowse link
G Bag5 BAG cochaperone 5 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of BAG5 mRNA CTD PMID:20660070 NCBI chr 6:136,589,623...136,593,278
Ensembl chr 6:136,584,741...136,598,492 		JBrowse link
G Baiap2 BAR/IMD domain containing adaptor protein 2 multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of BAIAP2 mRNA
Progesterone results in increased expression of BAIAP2 mRNA 		CTD PMID:20660070 PMID:20726854 NCBI chr10:105,721,371...105,788,549
Ensembl chr10:105,721,417...105,788,549 		JBrowse link
G Batf3 basic leucine zipper ATF-like transcription factor 3 increases expression ISO Progesterone results in increased expression of BATF3 mRNA CTD PMID:22238285 NCBI chr13:105,220,782...105,232,365
Ensembl chr13:105,220,390...105,232,369 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator decreases expression
increases expression
multiple interactions 		EXP
ISO 		Progesterone results in decreased expression of BAX mRNA
Progesterone results in increased expression of BAX protein
CALB1 protein inhibits the reaction [Progesterone results in increased expression of BAX protein]; S100G protein inhibits the reaction [Progesterone results in increased expression of BAX protein]
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased expression of BAX protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of BAX mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of BAX mRNA 		CTD PMID:15941375 PMID:20732338 PMID:21882229 PMID:22465879 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Baz1a bromodomain adjacent to zinc finger domain, 1A decreases expression ISO Progesterone results in decreased expression of BAZ1A mRNA CTD PMID:22238285 NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:78,124,872...78,247,648 		JBrowse link
G Bbs10 Bardet-Biedl syndrome 10 increases expression ISO Progesterone results in increased expression of BBS10 mRNA CTD PMID:18070364 NCBI chr 7:48,637,324...48,640,395
Ensembl chr 7:48,637,356...48,640,391 		JBrowse link
G Bbs7 Bardet-Biedl syndrome 7 increases expression ISO Progesterone results in increased expression of BBS7 mRNA CTD PMID:18070364 NCBI chr 2:121,362,884...121,402,473
Ensembl chr 2:121,362,885...121,402,473 		JBrowse link
G Bcar3 BCAR3 adaptor protein, NSP family member multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of BCAR3 mRNA CTD PMID:20660070 NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:213,209,893...213,323,302 		JBrowse link
G Bcat1 branched chain amino acid transaminase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of BCAT1 mRNA CTD PMID:20660070 NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288 		JBrowse link
G Bcat2 branched chain amino acid transaminase 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of BCAT2 mRNA CTD PMID:20660070 NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463 		JBrowse link
G Bcl11a BCL11 transcription factor A multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of BCL11A mRNA CTD PMID:20660070 NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623 		JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression
multiple interactions 		EXP
ISO 		Progesterone results in increased expression of BCL2 mRNA; Progesterone results in increased expression of BCL2 protein
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of BCL2 mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of BCL2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of BCL2 mRNA
[Progesterone co-treated with Estrogens, Conjugated (USP)] results in increased expression of BCL2 protein 		CTD PMID:15779298 PMID:15941375 PMID:18829022 PMID:20732338 PMID:22465879 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions
increases expression
affects response to substance 		EXP BCL2L1 mRNA affects the reaction [Progesterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; Mifepristone inhibits the reaction [Progesterone results in increased expression of BCL2L1 protein]
Progesterone results in increased expression of BCL2L1 mRNA; Progesterone results in increased expression of BCL2L1 protein
BCL2L1 mRNA affects the susceptibility to Progesterone 		CTD PMID:15941375 PMID:20726854 PMID:26915917 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl3 BCL3, transcription coactivator affects expression ISO Progesterone affects the expression of BCL3 mRNA CTD PMID:17251523 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bcl6 BCL6, transcription repressor increases expression ISO Progesterone results in increased expression of BCL6 mRNA CTD PMID:33728745 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bdh1 3-hydroxybutyrate dehydrogenase 1 increases expression ISO Progesterone results in increased expression of BDH1 mRNA CTD PMID:22238285 NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636 		JBrowse link
G Bdh2 3-hydroxybutyrate dehydrogenase 2 increases expression ISO Progesterone results in increased expression of BDH2 mRNA CTD PMID:22238285 NCBI chr 2:226,376,346...226,397,010
Ensembl chr 2:226,376,356...226,397,006 		JBrowse link
G Bdkrb1 bradykinin receptor B1 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of BDKRB1 mRNA
Progesterone results in decreased expression of BDKRB1 mRNA 		CTD PMID:17404688 PMID:20864642 PMID:21795739 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973 		JBrowse link
G Bdnf brain-derived neurotrophic factor decreases expression
increases expression
multiple interactions
affects localization 		ISO
EXP 		Progesterone results in decreased expression of BDNF mRNA
Progesterone results in increased expression of BDNF mRNA; Progesterone results in increased expression of BDNF protein
Progesterone inhibits the reaction [Estradiol results in increased expression of BDNF protein]
Progesterone inhibits the reaction [VPS54 gene mutant form results in decreased expression of BDNF mRNA]
Progesterone affects the localization of BDNF protein 		CTD PMID:15570173 PMID:17052708 PMID:17549730 PMID:18070364 PMID:23157231 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Bend6 BEN domain containing 6 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of BEND6 mRNA CTD PMID:20660070 NCBI chr 9:36,081,033...36,135,309
Ensembl chr 9:43,576,982...43,631,194 		JBrowse link
G Bet1 Bet1 golgi vesicular membrane trafficking protein increases expression ISO Progesterone results in increased expression of BET1 mRNA CTD PMID:18037150 NCBI chr 4:33,070,892...33,081,162
Ensembl chr 4:33,070,891...33,081,164 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 increases expression ISO Progesterone results in increased expression of BHLHE40 mRNA CTD PMID:18037150 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Bhlhe41 basic helix-loop-helix family, member e41 multiple interactions
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of BHLHE41 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of BHLHE41 mRNA
Progesterone results in decreased expression of BHLHE41 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:20726854 NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355 		JBrowse link
G Bicd1 BICD cargo adaptor 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of BICD1 mRNA CTD PMID:20660070 NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:184,210,363...184,357,391 		JBrowse link
G Bid BH3 interacting domain death agonist decreases expression ISO Progesterone results in decreased expression of BID mRNA CTD PMID:18037150 NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275 		JBrowse link
G Bin1 bridging integrator 1 increases expression ISO Progesterone results in increased expression of BIN1 mRNA CTD PMID:18037150 NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,283,801...24,341,458 		JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 increases expression EXP Progesterone results in increased expression of BIRC2 mRNA CTD PMID:20726854 NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of BIRC3 mRNA CTD PMID:20660070 NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression
increases expression 		ISO Progesterone results in decreased expression of BIRC5 mRNA
Progesterone results in increased expression of BIRC5 mRNA 		CTD PMID:21549006 PMID:21795739 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Blm BLM RecQ like helicase multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of BLM mRNA CTD PMID:21453500 NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:143,819,090...143,905,210 		JBrowse link
G Blnk B-cell linker decreases expression ISO Progesterone results in decreased expression of BLNK mRNA CTD PMID:22238285 NCBI chr 1:249,703,064...249,770,533
Ensembl chr 1:249,703,072...249,770,533 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 increases expression ISO Progesterone results in increased expression of BMAL1 mRNA CTD PMID:20096720 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bmerb1 bMERB domain containing 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of BMERB1 mRNA CTD PMID:17404688 NCBI chr10:1,779,834...1,946,586
Ensembl chr10:2,287,000...2,453,728 		JBrowse link
G Bmf Bcl2 modifying factor multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of BMF mRNA CTD PMID:18556351 NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258 		JBrowse link
G Bmp15 bone morphogenetic protein 15 multiple interactions EXP [BMP15 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; IGF1 protein inhibits the reaction [BMP15 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]] CTD PMID:22067323 NCBI chr  X:16,169,123...16,174,187
Ensembl chr  X:18,840,829...18,847,438 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions
decreases expression
decreases abundance 		ISO
EXP 		[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of BMP2 mRNA; NCOA2 protein affects the reaction [Progesterone results in decreased expression of BMP2 mRNA]; PGR protein affects the reaction [Progesterone results in decreased expression of BMP2 mRNA]
[BMP2 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; IGF1 protein inhibits the reaction [BMP2 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]
BMP2 protein results in decreased abundance of Progesterone
4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of BMP2 mRNA]; [Estradiol co-treated with Progesterone] results in decreased expression of BMP2 mRNA; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of BMP2 mRNA]; NOG protein inhibits the reaction [BMP2 protein results in decreased abundance of Progesterone] 		CTD PMID:17556502 PMID:20639315 PMID:20660070 PMID:22067323 PMID:23313114 More... NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmp4 bone morphogenetic protein 4 multiple interactions EXP [BMP4 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; GH1 protein inhibits the reaction [BMP4 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP4 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]] CTD PMID:22067323 NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172 		JBrowse link
G Bmp5 bone morphogenetic protein 5 multiple interactions
decreases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA]; PGR protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA] CTD PMID:17556502 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Bmp6 bone morphogenetic protein 6 multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of BMP6 mRNA; BMP6 protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]; FST protein inhibits the reaction [BMP6 protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]]
[BMP6 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; GH1 protein inhibits the reaction [BMP6 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP6 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]
Progesterone results in increased expression of BMP6 mRNA 		CTD PMID:18936084 PMID:20660070 PMID:20726854 PMID:22067323 NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261 		JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions
decreases expression
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of BMP7 mRNA; BMP7 protein inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of IGFBP1 mRNA]; BMP7 protein inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of IGFBP1 protein]
[BMP7 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; GH1 protein inhibits the reaction [BMP7 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP7 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]
Progesterone results in decreased expression of BMP7 mRNA
Progesterone results in increased expression of BMP7 mRNA 		CTD PMID:20085912 PMID:20726854 PMID:22067323 NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:182,052,337...182,135,137 		JBrowse link
G Bnipl BCL2 interacting protein like decreases expression ISO Progesterone results in decreased expression of BNIPL mRNA CTD PMID:22238285 NCBI chr 2:185,507,591...185,519,415
Ensembl chr 2:185,507,593...185,517,582 		JBrowse link
G Bpgm bisphosphoglycerate mutase affects expression
multiple interactions 		ISO Progesterone affects the expression of BPGM mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of BPGM mRNA 		CTD PMID:17251523 PMID:20660070 NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:64,106,804...64,135,627 		JBrowse link
G Brd7 bromodomain containing 7 affects expression ISO Progesterone affects the expression of BRD7 mRNA CTD PMID:17251523 NCBI chr19:18,708,792...18,737,497
Ensembl chr19:34,882,304...34,910,944 		JBrowse link
G Brix1 biogenesis of ribosomes BRX1 decreases expression ISO Progesterone results in decreased expression of BRIX1 mRNA CTD PMID:18037150 NCBI chr 2:61,177,769...61,188,647
Ensembl chr 2:61,177,771...61,188,647 		JBrowse link
G Btbd3 BTB domain containing 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of BTBD3 mRNA CTD PMID:20660070 NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:146,044,096...146,074,635 		JBrowse link
G Btd biotinidase decreases expression ISO Progesterone results in decreased expression of BTD mRNA CTD PMID:19693291 NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,869,291...6,901,410 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression EXP Progesterone results in increased expression of BTG2 mRNA CTD PMID:20726854 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Btnl9 butyrophilin-like 9 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of BTNL9 mRNA CTD PMID:20660070 NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,970,675...33,990,354 		JBrowse link
G Btrc beta-transducin repeat containing E3 ubiquitin protein ligase increases expression EXP Progesterone results in increased expression of BTRC mRNA CTD PMID:17170212 NCBI chr 1:254,159,085...254,324,819
Ensembl chr 1:254,159,124...254,328,357 		JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B decreases expression ISO Progesterone results in decreased expression of BUB1B mRNA CTD PMID:21795739 NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796 		JBrowse link
G Bzw2 basic leucine zipper and W2 domains 2 affects expression ISO Progesterone affects the expression of BZW2 mRNA CTD PMID:17251523 NCBI chr 6:58,555,362...58,615,921
Ensembl chr 6:58,554,961...58,615,912 		JBrowse link
G C1qbp complement C1q binding protein decreases expression ISO Progesterone results in decreased expression of C1QBP mRNA CTD PMID:18037150 NCBI chr10:56,198,534...56,203,185
Ensembl chr10:56,198,540...56,203,235 		JBrowse link
G C1qtnf7 C1q and TNF related 7 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of C1QTNF7 mRNA CTD PMID:20660070 NCBI chr14:67,467,888...67,580,477
Ensembl chr14:71,680,479...71,792,865 		JBrowse link
G C2 complement C2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of C2 mRNA CTD PMID:20660070 NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G C2cd4a C2 calcium-dependent domain containing 4A multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of C2CD4A mRNA CTD PMID:20660070 NCBI chr 8:68,467,017...68,469,781
Ensembl chr 8:77,348,310...77,359,958 		JBrowse link
G C2cd4b C2 calcium-dependent domain containing 4B decreases expression ISO Progesterone results in decreased expression of C2CD4B mRNA CTD PMID:22238285 NCBI chr 8:77,254,327...77,277,620
Ensembl chr 8:77,238,551...77,279,879 		JBrowse link
G C3 complement C3 multiple interactions
decreases activity 		EXP
ISO 		Progesterone inhibits the reaction [Estradiol affects the expression of C3 mRNA]; Progesterone inhibits the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA]
Progesterone results in decreased activity of C3 protein
Progesterone inhibits the reaction [C3 protein results in increased phosphorylation of PRKCA protein]; Progesterone inhibits the reaction [C3 protein results in increased phosphorylation of PRKCZ protein] 		CTD PMID:11566438 PMID:18615583 PMID:24777823 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C5ar2 complement C5a receptor 2 decreases expression ISO Progesterone results in decreased expression of C5AR2 mRNA; Progesterone results in decreased expression of C5AR2 protein CTD PMID:18615583 NCBI chr 1:86,058,557...86,073,583
Ensembl chr 1:86,057,256...86,061,372 		JBrowse link
G Ca12 carbonic anhydrase 12 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CA12 mRNA CTD PMID:20660070 NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:76,169,815...76,225,465 		JBrowse link
G Ca3 carbonic anhydrase 3 affects expression ISO Progesterone affects the expression of CAR3 mRNA CTD PMID:17251523 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C increases expression EXP Progesterone results in increased expression of CACNA1C mRNA CTD PMID:20726854 NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762 		JBrowse link
G Cacna1d calcium voltage-gated channel subunit alpha1 D increases expression ISO Progesterone results in increased expression of CACNA1D mRNA CTD PMID:22238285 NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692 		JBrowse link
G Cacna1g calcium voltage-gated channel subunit alpha1 G multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of CACNA1G mRNA
Progesterone results in increased expression of CACNA1G mRNA 		CTD PMID:17404688 PMID:20726854 NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,851,896...79,919,634 		JBrowse link
G Cacna2d1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 increases expression ISO Progesterone results in increased expression of CACNA2D1 mRNA CTD PMID:22238285 NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:19,905,764...20,330,147 		JBrowse link
G Cadm1 cell adhesion molecule 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CADM1 mRNA CTD PMID:20660070 NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192 		JBrowse link
G Cadps2 calcium dependent secretion activator 2 increases expression ISO Progesterone results in increased expression of CADPS2 mRNA CTD PMID:21540246 NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:52,746,065...53,275,004 		JBrowse link
G Calb1 calbindin 1 multiple interactions
increases expression
decreases expression 		ISO CALB1 protein inhibits the reaction [Progesterone results in increased expression of BAX protein]; CALB1 protein inhibits the reaction [Progesterone results in increased expression of CASP3 protein]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of CALB1 mRNA]
Progesterone results in increased expression of CALB1 mRNA 		CTD PMID:17556502 PMID:21882229 PMID:22238285 NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases activity
multiple interactions
increases expression 		EXP
ISO 		Progesterone results in increased activity of CALCA protein
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of CALCA mRNA
Progesterone results in increased expression of CALCA mRNA 		CTD PMID:9887042 PMID:21770760 PMID:32186404 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529 		JBrowse link
G Calcrl calcitonin receptor like receptor increases expression EXP Progesterone results in increased expression of CALCRL mRNA CTD PMID:15469997 NCBI chr 3:89,835,071...89,932,616
Ensembl chr 3:89,835,077...89,887,350 		JBrowse link
G Calhm6 calcium homeostasis modulator family member 6 increases expression ISO Progesterone results in increased expression of CALHM6 mRNA CTD PMID:21540246 NCBI chr20:26,638,721...26,640,466
Ensembl chr20:26,638,722...26,640,408 		JBrowse link
G Calm1 calmodulin 1 increases expression EXP Progesterone results in increased expression of CALM1 mRNA CTD PMID:16376865 NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381 		JBrowse link
G Calm2 calmodulin 2 multiple interactions
decreases expression 		ISO Mifepristone inhibits the reaction [Progesterone results in decreased expression of CALM2 mRNA] CTD PMID:27264040 PMID:31566189 NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657 		JBrowse link
G Caln1 calneuron 1 decreases expression ISO Progesterone results in decreased expression of CALN1 mRNA CTD PMID:22238285 NCBI chr12:31,447,964...31,939,847 JBrowse link
G Calr calreticulin increases expression
decreases expression 		EXP
ISO 		Progesterone results in increased expression of CALR mRNA
Progesterone results in decreased expression of CALR protein 		CTD PMID:16376865 PMID:19460863 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236 		JBrowse link
G Caly calcyon neuron-specific vesicular protein decreases expression ISO Progesterone results in decreased expression of CALY mRNA CTD PMID:22238285 NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:204,292,318...204,303,196 		JBrowse link
G Camk1d calcium/calmodulin-dependent protein kinase ID increases expression ISO Progesterone results in increased expression of CAMK1D mRNA CTD PMID:22238285 NCBI chr17:77,491,191...77,892,018
Ensembl chr17:77,491,220...77,892,012 		JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta decreases expression ISO Progesterone results in decreased expression of CAMK2B mRNA CTD PMID:21540246 NCBI chr14:80,845,206...80,934,172
Ensembl chr14:85,059,191...85,148,485 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CAMK2D mRNA CTD PMID:20660070 NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276 		JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CAMK2N1 mRNA CTD PMID:20660070 NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:155,957,878...155,961,058 		JBrowse link
G Camp cathelicidin antimicrobial peptide increases expression ISO Progesterone results in increased expression of CAMP mRNA; Progesterone results in increased expression of CAMP protein CTD PMID:17701593 NCBI chr 8:109,841,729...109,843,543
Ensembl chr 8:118,720,184...118,721,998 		JBrowse link
G Cap2 cyclase associated actin cytoskeleton regulatory protein 2 increases expression EXP Progesterone results in increased expression of CAP2 mRNA CTD PMID:20726854 NCBI chr17:18,054,234...18,203,453
Ensembl chr17:18,261,646...18,409,563 		JBrowse link
G Capn6 calpain 6 increases expression
multiple interactions 		ISO Progesterone results in increased expression of CAPN6 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of CAPN6 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of CAPN6 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr  X:112,177,467...112,202,178
Ensembl chr  X:112,177,467...112,202,178 		JBrowse link
G Capn9 calpain 9 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of CAPN9 mRNA
Progesterone results in decreased expression of CAPN9 mRNA 		CTD PMID:19693291 NCBI chr19:69,446,847...69,483,810
Ensembl chr19:69,446,847...69,483,810 		JBrowse link
G Car2 carbonic anhydrase 2 multiple interactions
decreases expression
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of CA2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of CA2 mRNA
Progesterone results in decreased expression of CAR2 mRNA
Progesterone results in increased expression of CA2 mRNA
Progesterone results in decreased expression of CA2 mRNA 		CTD PMID:17404688 PMID:18037150 PMID:18497975 PMID:20660070 PMID:22238285 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases expression
increases activity 		ISO
EXP 		[CCN2 gene mutant form results in increased abundance of Progesterone] which results in increased expression of CASP3 mRNA; CALB1 protein inhibits the reaction [Progesterone results in increased expression of CASP3 protein]; S100G protein inhibits the reaction [Progesterone results in increased expression of CASP3 protein]
Progesterone results in increased activity of CASP3 protein
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP3 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP3 mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of CASP3 mRNA; BCL2L1 mRNA affects the reaction [Progesterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; Progesterone inhibits the reaction [Dicumarol promotes the reaction [Doxorubicin results in increased activity of CASP3 protein]]; Progesterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Progesterone inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]; Progesterone inhibits the reaction [Palmitates results in increased activity of CASP3 protein] 		CTD PMID:20726854 PMID:20732338 PMID:21868453 PMID:21882229 PMID:21933904 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp4 caspase 4 increases expression EXP Progesterone results in increased expression of CASP4 mRNA CTD PMID:21770760 NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727 		JBrowse link
G Casp8 caspase 8 increases expression
multiple interactions 		ISO
EXP 		Progesterone results in increased expression of CASP8 mRNA
Progesterone inhibits the reaction [Cisplatin results in increased activity of CASP8 protein]
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP8 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP8 mRNA 		CTD PMID:20732338 PMID:21549006 PMID:21770760 PMID:22465879 PMID:23482746 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 multiple interactions EXP
ISO 		[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA
Progesterone inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] 		CTD PMID:20732338 PMID:23482746 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Catsperb cation channel sperm associated auxiliary subunit beta decreases expression ISO Progesterone results in decreased expression of CATSPERB mRNA CTD PMID:18070364 NCBI chr 6:120,418,606...120,713,160
Ensembl chr 6:126,147,645...126,472,079 		JBrowse link
G Cav1 caveolin 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of CAV1 mRNA
Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] 		CTD PMID:15674352 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cav3 caveolin 3 multiple interactions ISO CAV3 mutant form inhibits the reaction [Progesterone results in decreased expression of GNAI3 protein]; CAV3 mutant form inhibits the reaction [Progesterone results in increased expression of GNAS protein] CTD PMID:19221014 NCBI chr 4:145,582,168...145,598,142
Ensembl chr 4:147,137,797...147,153,967 		JBrowse link
G Cbfa2t3 CBFA2/RUNX1 partner transcriptional co-repressor 3 affects expression ISO Progesterone affects the expression of CBFA2T3 mRNA CTD PMID:17251523 NCBI chr19:67,584,319...67,658,533
Ensembl chr19:67,589,258...67,658,136 		JBrowse link
G Cblc Cbl proto-oncogene C decreases expression ISO Progesterone results in decreased expression of CBLC mRNA CTD PMID:21540246 NCBI chr 1:88,567,930...88,584,709
Ensembl chr 1:88,567,932...88,584,709 		JBrowse link
G Cblif cobalamin binding intrinsic factor decreases expression ISO Progesterone results in decreased expression of CBLIF mRNA CTD PMID:19693291 NCBI chr 1:218,030,756...218,045,004
Ensembl chr 1:218,030,731...218,045,117 		JBrowse link
G Cbr3 carbonyl reductase 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CBR3 mRNA CTD PMID:20660070 NCBI chr11:46,478,295...46,486,555
Ensembl chr11:46,478,274...46,486,558 		JBrowse link
G Cbs cystathionine beta synthase increases expression ISO Progesterone results in increased expression of CBS mRNA CTD PMID:21795739 PMID:22238285 NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066 		JBrowse link
G Ccdc3 coiled-coil domain containing 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CCDC3 mRNA CTD PMID:20660070 NCBI chr17:73,031,891...73,135,173
Ensembl chr17:77,944,977...78,044,470 		JBrowse link
G Ccdc68 coiled-coil domain containing 68 increases expression ISO Progesterone results in increased expression of CCDC68 mRNA CTD PMID:21795739 NCBI chr18:65,817,232...65,859,529
Ensembl chr18:65,786,926...65,859,526 		JBrowse link
G Ccdc71l coiled-coil domain containing 71-like decreases expression ISO Progesterone results in decreased expression of CCDC71L mRNA CTD PMID:20864642 NCBI chr 6:54,687,474...54,691,566
Ensembl chr 6:54,617,540...55,014,344 		JBrowse link
G Cck cholecystokinin multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of CCK mRNA
Progesterone results in decreased expression of CCK mRNA 		CTD PMID:19693291 PMID:22238285 NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:130,031,013...130,037,686 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
decreases expression
affects expression 		ISO
EXP 		Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein]
Progesterone results in decreased expression of CCL2 mRNA; Progesterone results in decreased expression of CCL2 protein
Progesterone affects the expression of CCL2 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of CCL2 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of CCL2 protein 		CTD PMID:17251523 PMID:20726854 PMID:21277368 PMID:21549006 PMID:22014880 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions EXP [Estradiol co-treated with Progesterone] results in increased expression of CCL3 mRNA CTD PMID:21277368 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA; TGFB1 protein promotes the reaction [Progesterone results in increased expression of CCL5 mRNA]
[Estradiol co-treated with Progesterone] results in decreased expression of CCL5 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of CCL5 protein 		CTD PMID:17404688 PMID:21277368 PMID:21768398 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccn2 cellular communication network factor 2 affects expression
increases expression
increases abundance
multiple interactions 		ISO Progesterone affects the expression of CCN2 mRNA
Progesterone results in increased expression of CCN2 mRNA
CCN2 gene mutant form results in increased abundance of Progesterone
[CCN2 gene mutant form results in increased abundance of Progesterone] which results in increased expression of CASP3 mRNA 		CTD PMID:17251523 PMID:21868453 PMID:22238285 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn3 cellular communication network factor 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CCN3 mRNA CTD PMID:20660070 NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581 		JBrowse link
G Ccn5 cellular communication network factor 5 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of CCN5 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of CCN5 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of CCN5 mRNA 		CTD PMID:17404688 PMID:18692832 PMID:20660070 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Ccna1 cyclin A1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CCNA1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of CCNA1 mRNA CTD PMID:17404688 PMID:20660070 NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300 		JBrowse link
G Ccna2 cyclin A2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CCNA2 mRNA; Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of CCNA2 protein]]; Progesterone inhibits the reaction [Estradiol results in increased expression of CCNA2 protein] CTD PMID:15845746 PMID:19693291 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of CCNB1 mRNA
Progesterone results in increased expression of CCNB1 mRNA 		CTD PMID:18037150 PMID:18070364 PMID:19000923 PMID:20726854 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnb2 cyclin B2 increases expression
multiple interactions
decreases expression 		ISO Progesterone results in increased expression of CCNB2 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of CCNB2 mRNA
Progesterone results in decreased expression of CCNB2 mRNA 		CTD PMID:18070364 PMID:19693291 PMID:21795739 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Progesterone results in increased expression of CCND1 mRNA
[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Progesterone] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of CCND1 protein
Progesterone results in decreased expression of CCND1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of CCND1 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of CCND1 mRNA; Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol affects the localization of CCND1 protein]]; Progesterone inhibits the reaction [Estradiol affects the localization of CCND1 protein] 		CTD PMID:15845746 PMID:16888808 PMID:16966611 PMID:17170212 PMID:18070364 More... NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd3 cyclin D3 increases expression EXP Progesterone results in increased expression of CCND3 mRNA CTD PMID:17170212 NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033 		JBrowse link
G Ccne1 cyclin E1 decreases expression
increases expression 		ISO Progesterone results in decreased expression of CCNE1 mRNA
Progesterone results in increased expression of CCNE1 mRNA 		CTD PMID:16966611 PMID:19847363 NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccng1 cyclin G1 multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in increased expression of CCNG1 mRNA; PGR gene mutant form inhibits the reaction [Progesterone results in increased expression of CCNG1 mRNA] CTD PMID:15661853 PMID:20726854 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccni cyclin I affects expression ISO Progesterone affects the expression of CCNI mRNA CTD PMID:17251523 NCBI chr14:15,164,047...15,186,885
Ensembl chr14:15,164,095...15,186,885 		JBrowse link
G Ccr1 C-C motif chemokine receptor 1 increases expression EXP Progesterone results in increased expression of CCR1 mRNA CTD PMID:21770760 NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374 		JBrowse link
G Cd14 CD14 molecule decreases expression ISO Progesterone results in decreased expression of CD14 mRNA CTD PMID:21549006 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd164 CD164 molecule multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CD164 mRNA CTD PMID:18556351 NCBI chr20:45,024,051...45,035,628
Ensembl chr20:46,606,107...46,638,649 		JBrowse link
G Cd180 CD180 molecule multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CD180 mRNA CTD PMID:19693291 NCBI chr 2:33,855,940...33,870,046
Ensembl chr 2:35,589,451...35,603,982 		JBrowse link
G Cd200 Cd200 molecule increases expression
decreases expression 		ISO
EXP 		Progesterone results in increased expression of CD200 mRNA
Progesterone results in decreased expression of CD200 mRNA 		CTD PMID:20726854 PMID:22238285 NCBI chr11:68,916,200...68,943,570
Ensembl chr11:68,916,224...68,943,569 		JBrowse link
G Cd226 CD226 molecule increases expression ISO Progesterone results in increased expression of CD226 mRNA CTD PMID:20864642 NCBI chr18:84,723,330...84,819,836
Ensembl chr18:84,725,242...84,819,835 		JBrowse link
G Cd24 CD24 molecule multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of CD24 mRNA
Progesterone results in decreased expression of CD24 mRNA 		CTD PMID:20660070 PMID:21795739 NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785 		JBrowse link
G Cd247 Cd247 molecule decreases expression ISO Progesterone results in decreased expression of CD247 mRNA CTD PMID:19693291 NCBI chr13:80,576,264...80,651,422
Ensembl chr13:80,576,202...80,655,248 		JBrowse link
G Cd302 CD302 molecule increases expression ISO Progesterone results in increased expression of CD302 mRNA CTD PMID:20864642 NCBI chr 3:65,131,017...65,164,737
Ensembl chr 3:65,113,102...65,164,737 		JBrowse link
G Cd36 CD36 molecule increases expression EXP Progesterone results in increased expression of CD36 mRNA CTD PMID:20726854 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd38 CD38 molecule multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with TGFB1 protein] results in increased expression of CD38 mRNA
Progesterone results in increased expression of CD38 mRNA 		CTD PMID:21768398 PMID:21770760 NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505 		JBrowse link
G Cd3e CD3 epsilon subunit of T-cell receptor complex multiple interactions EXP [Estradiol co-treated with Progesterone] results in decreased expression of CD3E mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of CD3E protein CTD PMID:21277368 NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876 		JBrowse link
G Cd44 CD44 molecule multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in increased expression of CD44 mRNA
Progesterone results in increased expression of CD44 mRNA
Progesterone results in decreased expression of CD44 mRNA 		CTD PMID:18692832 PMID:20226447 PMID:20726854 PMID:21770760 PMID:22238285 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd52 CD52 molecule multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CD52 mRNA CTD PMID:19693291 NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086 		JBrowse link
G Cd68 Cd68 molecule multiple interactions EXP [Estradiol co-treated with Progesterone] results in decreased expression of CD68 mRNA CTD PMID:21277368 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540 		JBrowse link
G Cd7 Cd7 molecule affects expression ISO Progesterone affects the expression of CD7 mRNA CTD PMID:17251523 NCBI chr10:106,802,373...106,805,269
Ensembl chr10:106,802,383...106,805,294 		JBrowse link
G Cd80 Cd80 molecule decreases expression ISO Progesterone results in decreased expression of CD80 protein CTD PMID:21856019 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cd83 CD83 molecule decreases expression
increases expression 		ISO Progesterone results in decreased expression of CD83 mRNA
Progesterone results in increased expression of CD83 mRNA 		CTD PMID:18037150 PMID:22238285 NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047 		JBrowse link
G Cd86 CD86 molecule decreases expression ISO Progesterone results in decreased expression of CD86 protein CTD PMID:21856019 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cd8b CD8 subunit beta affects expression ISO Progesterone affects the expression of CD8B1 mRNA CTD PMID:17251523 NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:104,870,893...104,886,868 		JBrowse link
G Cd96 CD96 molecule multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CD96 mRNA CTD PMID:17404688 NCBI chr11:54,702,290...54,776,618
Ensembl chr11:68,164,872...68,241,937 		JBrowse link
G Cda cytidine deaminase multiple interactions ISO [Progesterone co-treated with Estradiol] affects the expression of CDA mRNA CTD PMID:17404688 NCBI chr 5:155,839,929...155,866,541
Ensembl chr 5:155,839,929...155,866,541 		JBrowse link
G Cdc14b cell division cycle 14B multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of CDC14B mRNA; [Progesterone co-treated with Estradiol] results in increased expression of CDC14B mRNA
Progesterone results in increased expression of CDC14B mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164 		JBrowse link
G Cdc20 cell division cycle 20 increases expression
decreases expression 		ISO
EXP 		Progesterone results in increased expression of CDC20 mRNA
Progesterone results in decreased expression of CDC20 mRNA 		CTD PMID:18070364 PMID:19693291 PMID:20726854 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdc25b cell division cycle 25B increases expression ISO Progesterone results in increased expression of CDC25B mRNA CTD PMID:18497975 NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492 		JBrowse link
G Cdc42ep3 CDC42 effector protein 3 increases expression ISO Progesterone results in increased expression of CDC42EP3 mRNA CTD PMID:17404688 PMID:21795739 PMID:22238285 NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540 		JBrowse link
G Cdc6 cell division cycle 6 increases expression ISO Progesterone results in increased expression of CDC6 mRNA CTD PMID:18070364 NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241 		JBrowse link
G Cdca3 cell division cycle associated 3 decreases expression ISO Progesterone results in decreased expression of CDCA3 mRNA CTD PMID:21795739 NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068 		JBrowse link
G Cdca7 cell division cycle associated 7 decreases expression ISO Progesterone results in decreased expression of CDCA7 mRNA CTD PMID:21795739 NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947 		JBrowse link
G Cdh16 cadherin 16 decreases expression ISO Progesterone results in decreased expression of CDH16 mRNA CTD PMID:22238285 NCBI chr19:367,202...377,710
Ensembl chr19:367,274...388,934 		JBrowse link
G Cdh2 cadherin 2 decreases expression ISO Progesterone results in decreased expression of CDH2 mRNA CTD PMID:17556502 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdh4 cadherin 4 decreases expression ISO Progesterone results in decreased expression of CDH4 mRNA CTD PMID:22238285 NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:186,902,751...187,381,020 		JBrowse link
G Cdh5 cadherin 5 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CDH5 mRNA CTD PMID:17404688 NCBI chr19:815,415...854,478
Ensembl chr19:822,464...860,822 		JBrowse link
G Cdh6 cadherin 6 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CDH6 mRNA CTD PMID:17404688 NCBI chr 2:63,801,630...63,952,309
Ensembl chr 2:63,806,135...63,952,287 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression
decreases expression 		ISO
EXP 		Progesterone results in increased expression of CDK1 mRNA
Progesterone results in decreased expression of CDK1 mRNA 		CTD PMID:18070364 PMID:20726854 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk19 cyclin-dependent kinase 19 increases expression ISO Progesterone results in increased expression of CDK19 mRNA CTD PMID:18037150 NCBI chr20:43,770,409...43,910,629
Ensembl chr20:45,324,862...45,465,121 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
increases expression
decreases activity 		ISO Progesterone promotes the reaction [CDK2 protein binds to CDKN1A protein]; Progesterone promotes the reaction [CDK2 protein binds to CDKN1B protein]
Progesterone results in increased expression of CDK2 mRNA
Progesterone results in decreased activity of CDK2 protein 		CTD PMID:18850315 PMID:19847363 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 increases expression ISO Progesterone results in increased expression of CDK4 mRNA CTD PMID:19847363 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdk5rap2 CDK5 regulatory subunit associated protein 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CDK5RAP2 mRNA CTD PMID:20660070 NCBI chr 5:83,792,282...83,961,129
Ensembl chr 5:88,807,402...88,976,069 		JBrowse link
G Cdk8 cyclin-dependent kinase 8 increases expression ISO Progesterone results in increased expression of CDK8 mRNA CTD PMID:16888808 NCBI chr12:8,737,198...8,805,026
Ensembl chr12:13,851,024...13,917,992 		JBrowse link
G Cdk9 cyclin-dependent kinase 9 increases expression ISO Progesterone results in increased expression of CDK9 mRNA CTD PMID:16888808 NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:36,394,169...36,399,528 		JBrowse link
G Cdkl1 cyclin dependent kinase like 1 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of CDKL1 mRNA
NCOA2 protein affects the reaction [Progesterone results in decreased expression of CDKL1 mRNA] 		CTD PMID:17556502 NCBI chr 6:93,960,157...94,005,207
Ensembl chr 6:93,959,911...94,006,115 		JBrowse link
G Cdkl2 cyclin dependent kinase like 2 decreases expression ISO Progesterone results in decreased expression of CDKL2 mRNA CTD PMID:16966611 NCBI chr14:16,027,381...16,063,257
Ensembl chr14:16,312,932...16,347,523 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
increases expression 		ISO Progesterone promotes the reaction [CDK2 protein binds to CDKN1A protein]; TP53 mutant form inhibits the reaction [Progesterone results in increased expression of CDKN1A mRNA]; TP53 mutant form inhibits the reaction [Progesterone results in increased expression of CDKN1A protein]
Progesterone results in increased expression of CDKN1A mRNA; Progesterone results in increased expression of CDKN1A protein 		CTD PMID:18045962 PMID:18850315 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions
increases expression
affects localization 		ISO [Estradiol co-treated with Progesterone] results in increased expression of CDKN1B mRNA; [Progesterone co-treated with Estradiol] results in increased expression of and results in increased stability of CDKN1B protein; FZR1 mutant form inhibits the reaction [Progesterone affects the localization of CDKN1B protein]; Progesterone promotes the reaction [CDK2 protein binds to CDKN1B protein]; TP53 mutant form inhibits the reaction [Progesterone results in increased expression of CDKN1B mRNA]; TP53 mutant form inhibits the reaction [Progesterone results in increased expression of CDKN1B protein]
Progesterone results in increased expression of CDKN1B mRNA; Progesterone results in increased expression of CDKN1B protein 		CTD PMID:18850315 PMID:22064387 PMID:23029392 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of CDKN1C mRNA
Progesterone results in increased expression of CDKN1C mRNA 		CTD PMID:20726854 PMID:22064387 NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498 		JBrowse link
G Cdkn2aip CDKN2A interacting protein increases expression ISO Progesterone results in increased expression of CDKN2AIP mRNA CTD PMID:18070364 NCBI chr16:44,536,147...44,546,216
Ensembl chr16:51,268,896...51,274,049 		JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CDKN2B mRNA CTD PMID:20660070 NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C increases expression ISO Progesterone results in increased expression of CDKN2C mRNA CTD PMID:18070364 NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 decreases expression ISO Progesterone results in decreased expression of CDKN3 mRNA CTD PMID:21795739 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cdo1 cysteine dioxygenase type 1 affects expression
increases expression 		ISO
EXP 		Progesterone affects the expression of CDO1 mRNA
Progesterone results in increased expression of CDO1 mRNA 		CTD PMID:17251523 PMID:20726854 NCBI chr18:41,619,076...41,633,719
Ensembl chr18:41,619,070...41,633,891 		JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 multiple interactions ISO Progesterone inhibits the reaction [Estradiol results in increased expression of CDT1 protein] CTD PMID:16966611 NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 increases expression ISO Progesterone results in increased expression of CEACAM1 mRNA CTD PMID:18692832 NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798 		JBrowse link
G Ceacam6 CEA cell adhesion molecule 6 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CEACAM6 mRNA CTD PMID:17404688 NCBI chr 1:80,416,531...80,434,668
Ensembl chr 1:89,544,400...89,562,552 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta increases response to substance
decreases expression
increases expression 		ISO
EXP 		CEBPB protein results in increased susceptibility to Progesterone
Progesterone results in decreased expression of CEBPB mRNA
Progesterone results in increased expression of CEBPB mRNA 		CTD PMID:20726854 PMID:21549006 PMID:23097472 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta affects expression
increases expression
multiple interactions 		ISO
EXP 		Progesterone affects the expression of CEBPD mRNA
Progesterone results in increased expression of CEBPD mRNA
[Estradiol co-treated with Progesterone] results in increased expression of CEBPD mRNA 		CTD PMID:17251523 PMID:18037150 PMID:20660070 PMID:20726854 PMID:21795739 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Cebpg CCAAT/enhancer binding protein gamma increases expression ISO Progesterone results in increased expression of CEBPG mRNA CTD PMID:18037150 NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:96,810,214...96,830,283 		JBrowse link
G Cemip cell migration inducing hyaluronidase 1 multiple interactions ISO Progesterone inhibits the reaction [Estradiol results in increased expression of CEMIP mRNA] CTD PMID:21795739 NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:147,316,052...147,471,768 		JBrowse link
G Cenpa centromere protein A decreases expression ISO Progesterone results in decreased expression of CENPA mRNA CTD PMID:21795739 NCBI chr 6:31,420,062...31,431,703 JBrowse link
G Cenpf centromere protein F increases expression ISO Progesterone results in increased expression of CENPF mRNA CTD PMID:18070364 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cenpn centromere protein N increases expression ISO Progesterone results in increased expression of CENPN mRNA CTD PMID:18070364 NCBI chr19:44,971,265...44,994,019
Ensembl chr19:61,877,148...61,902,918 		JBrowse link
G Cenpq centromere protein Q increases expression ISO Progesterone results in increased expression of CENPQ mRNA CTD PMID:18070364 NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:27,454,252...27,469,366 		JBrowse link
G Cenpu centromere protein U increases expression
decreases expression 		ISO Progesterone results in increased expression of CENPU mRNA
Progesterone results in decreased expression of CENPU mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662 		JBrowse link
G Cenpv centromere protein V multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CENPV mRNA CTD PMID:20660070 NCBI chr10:47,214,479...47,228,552
Ensembl chr10:47,713,778...47,727,679 		JBrowse link
G Cep131 centrosomal protein 131 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CEP131 mRNA CTD PMID:21453500 NCBI chr10:105,346,015...105,370,380
Ensembl chr10:105,844,433...105,868,797 		JBrowse link
G Cep15 centrosomal protein 15 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CEP15 mRNA CTD PMID:21453500 NCBI chr15:12,815,159...12,835,115
Ensembl chr15:15,247,932...15,265,475 		JBrowse link
G Cep162 centrosomal protein 162 increases expression ISO Progesterone results in increased expression of CEP162 mRNA CTD PMID:18070364 NCBI chr 8:88,149,726...88,208,249
Ensembl chr 8:97,029,677...97,088,207 		JBrowse link
G Cep55 centrosomal protein 55 increases expression
decreases expression 		ISO Progesterone results in increased expression of CEP55 mRNA
Progesterone results in decreased expression of CEP55 mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890 		JBrowse link
G Cep57 centrosomal protein 57 increases expression ISO Progesterone results in increased expression of CEP57 mRNA CTD PMID:18070364 NCBI chr 8:10,669,588...10,689,257
Ensembl chr 8:18,932,808...18,970,890 		JBrowse link
G Cep76 centrosomal protein 76 increases expression ISO Progesterone results in increased expression of CEP76 mRNA CTD PMID:18070364 NCBI chr18:61,174,514...61,208,512
Ensembl chr18:63,443,746...63,478,358 		JBrowse link
G Cerk ceramide kinase multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CERK mRNA CTD PMID:20660070 NCBI chr 7:119,105,674...119,149,885
Ensembl chr 7:119,105,674...119,148,570 		JBrowse link
G Cers3 ceramide synthase 3 decreases expression ISO Progesterone results in decreased expression of CERS3 mRNA CTD PMID:22238285 NCBI chr 1:129,728,136...129,833,182
Ensembl chr 1:129,677,781...129,833,181 		JBrowse link
G Cers6 ceramide synthase 6 increases expression ISO Progesterone results in increased expression of CERS6 mRNA CTD PMID:20864642 NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:74,038,851...74,287,544 		JBrowse link
G Ces4a carboxylesterase 4A decreases expression ISO Progesterone results in decreased expression of CES4A mRNA CTD PMID:21540246 NCBI chr19:49,921,643...49,942,838
Ensembl chr19:49,921,608...49,939,461 		JBrowse link
G Cfb complement factor B decreases expression ISO Progesterone results in decreased expression of CFB mRNA CTD PMID:22238285 NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G Cfd complement factor D affects expression ISO Progesterone affects the expression of CFD mRNA CTD PMID:17251523 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cfh complement factor H increases expression
decreases expression 		ISO
EXP 		Progesterone results in increased expression of CFH mRNA
Progesterone results in decreased expression of CFH mRNA 		CTD PMID:20726854 PMID:20864642 PMID:21795739 NCBI chr13:51,512,376...51,613,829
Ensembl chr13:54,062,531...54,164,532 		JBrowse link
G Cfhr1 complement factor H-related 1 increases expression ISO Progesterone results in increased expression of CFHR1 mRNA CTD PMID:20864642 NCBI chr13:51,395,583...51,410,571
Ensembl chr13:53,919,927...53,961,303 		JBrowse link
G Cfi complement factor I decreases expression ISO Progesterone results in decreased expression of CFI mRNA CTD PMID:22238285 NCBI chr 2:221,062,206...221,104,790
Ensembl chr 2:221,062,212...221,104,786 		JBrowse link
G Cfl1 cofilin 1 multiple interactions ISO CFL1 protein affects the reaction [CGA protein results in increased secretion of Progesterone] CTD PMID:20610540 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator increases expression EXP Progesterone results in increased expression of CFLAR mRNA CTD PMID:21770760 NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434 		JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions
decreases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of CFTR mRNA
[Genistein co-treated with estradiol-17-benzoate co-treated with Progesterone] results in increased expression of CFTR mRNA; [Genistein co-treated with estradiol-17-benzoate co-treated with Progesterone] results in increased expression of CFTR protein
Progesterone results in decreased expression of CFTR mRNA; Progesterone results in decreased expression of CFTR protein 		CTD PMID:15471937 PMID:17404688 PMID:26529183 NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:47,526,735...47,694,643 		JBrowse link
G Cga glycoprotein hormones, alpha polypeptide multiple interactions
increases abundance
increases secretion 		EXP
ISO 		[[3,4',5-trimethoxystilbene co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [[resveratrol analog co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [[resveratrol co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; ADM protein inhibits the reaction [CGA protein results in increased secretion of Progesterone]; bifenthrin analog inhibits the reaction [CGA protein results in increased abundance of Progesterone]
[3,4',5-trimethoxystilbene co-treated with CGA protein] results in increased secretion of Progesterone; [CGA protein affects the secretion of Cyclic AMP] which results in increased secretion of Progesterone; [CGA protein co-treated with FSHB protein] results in increased abundance of Progesterone; [CGA protein co-treated with FSHB protein] results in increased secretion of Progesterone; [Resveratrol analog co-treated with CGA protein] results in increased secretion of Progesterone; [Resveratrol co-treated with CGA protein] results in increased secretion of Progesterone; [T0901317 co-treated with fatostatin] promotes the reaction [CGA protein results in increased secretion of Progesterone]; ADM protein modified form inhibits the reaction [ADM protein inhibits the reaction [CGA protein results in increased secretion of Progesterone]]; butylbenzyl phthalate inhibits the reaction [CGA protein results in increased secretion of Progesterone]; CFL1 protein affects the reaction [CGA protein results in increased secretion of Progesterone]; DDT inhibits the reaction [CGA protein results in increased secretion of Progesterone]; decabromobiphenyl ether inhibits the reaction [CGA protein results in increased secretion of Progesterone]; Dibutyl Phthalate inhibits the reaction [CGA protein results in increased secretion of Progesterone]; Diethylhexyl Phthalate inhibits the reaction [CGA protein results in increased secretion of Progesterone]; fatostatin promotes the reaction [CGA protein results in increased secretion of Progesterone]; T0901317 inhibits the reaction [[CGA protein co-treated with FSHB protein] results in increased abundance of Progesterone]
lead acetate inhibits the reaction [CGA protein results in increased abundance of Progesterone]; mono-(2-ethylhexyl)phthalate inhibits the reaction [CGA protein results in increased abundance of Progesterone] 		CTD PMID:11213355 PMID:12647776 PMID:18401014 PMID:19228890 PMID:19603415 More... NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464 		JBrowse link
G Ch25h cholesterol 25-hydroxylase decreases expression ISO Progesterone results in decreased expression of CH25H mRNA CTD PMID:21795739 PMID:22238285 NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 increases expression ISO Progesterone results in increased expression of CHAC1 mRNA CTD PMID:18037150 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361 		JBrowse link
G Chaf1a chromatin assembly factor 1 subunit A decreases expression ISO Progesterone results in decreased expression of CHAF1A mRNA CTD PMID:16966611 NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868 		JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B decreases expression ISO Progesterone results in decreased expression of CHAF1B mRNA CTD PMID:16966611 NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733 		JBrowse link
G Chat choline O-acetyltransferase multiple interactions ISO Progesterone inhibits the reaction [VPS54 gene mutant form results in decreased activity of CHAT protein]; Progesterone inhibits the reaction [VPS54 gene mutant form results in decreased expression of CHAT protein]; Progesterone inhibits the reaction [VPS54 mutant form results in decreased expression of CHAT protein] CTD PMID:17052708 PMID:19693665 NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,663,665...7,723,416 		JBrowse link
G Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 affects expression ISO Progesterone affects the expression of CHCHD10 mRNA CTD PMID:17251523 NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,277...12,745,677 		JBrowse link
G Chek1 checkpoint kinase 1 decreases expression
multiple interactions
increases phosphorylation 		EXP
ISO 		Progesterone results in decreased expression of CHEK1 mRNA
Mifepristone inhibits the reaction [Progesterone results in increased phosphorylation of CHEK1 protein] 		CTD PMID:20726854 PMID:22403396 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chga chromogranin A multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of CHGA mRNA
Progesterone results in decreased expression of CHGA mRNA 		CTD PMID:17404688 NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:127,460,854...127,472,237 		JBrowse link
G Chi3l1 chitinase 3 like 1 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of CHI3L1 mRNA
Progesterone results in increased expression of CHI3L1 mRNA 		CTD PMID:18497975 PMID:20660070 NCBI chr13:45,641,802...45,649,787
Ensembl chr13:48,193,800...48,201,825 		JBrowse link
G Chn1 chimerin 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CHN1 mRNA CTD PMID:20660070 NCBI chr 3:78,917,329...79,084,040
Ensembl chr 3:78,917,329...79,084,197 		JBrowse link
G Chn2 chimerin 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CHN2 mRNA CTD PMID:20660070 NCBI chr 4:84,478,989...84,738,068
Ensembl chr 4:84,704,862...84,738,068 		JBrowse link
G Chordc1 cysteine and histidine rich domain containing 1 increases expression ISO Progesterone results in increased expression of CHORDC1 mRNA CTD PMID:18037150 NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:23,650,865...23,677,696 		JBrowse link
G Chpt1 choline phosphotransferase 1 increases expression ISO Progesterone results in increased expression of CHPT1 mRNA CTD PMID:17404688 NCBI chr 7:24,753,880...24,802,529
Ensembl chr 7:24,750,343...24,802,521 		JBrowse link
G Chrdl1 chordin-like 1 increases expression ISO Progesterone results in increased expression of CHRDL1 mRNA CTD PMID:22238285 NCBI chr  X:106,889,125...106,992,937
Ensembl chr  X:111,685,866...111,789,661 		JBrowse link
G Chrdl2 chordin-like 2 increases expression ISO Progesterone results in increased expression of CHRDL2 mRNA CTD PMID:22238285 NCBI chr 1:163,755,316...163,782,758
Ensembl chr 1:163,755,316...163,782,757 		JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1 multiple interactions EXP Progesterone inhibits the reaction [Acetylcholine binds to CHRM1 protein]; Progesterone inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM1 protein] CTD PMID:15900516 NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602 		JBrowse link
G Chrm3 cholinergic receptor, muscarinic 3 multiple interactions EXP Progesterone inhibits the reaction [Acetylcholine binds to CHRM3 protein]; Progesterone inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein] CTD PMID:15900516 NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304 		JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions ISO [Progesterone co-treated with Acetylcholine] results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] CTD PMID:11517245 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105 		JBrowse link
G Chrna5 cholinergic receptor nicotinic alpha 5 subunit increases expression ISO Progesterone results in increased expression of CHRNA5 protein
Progesterone results in increased expression of CHRNA5 mRNA 		CTD PMID:19220484 NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:64,265,879...64,294,233 		JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit multiple interactions ISO [Progesterone co-treated with Acetylcholine] results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] CTD PMID:11517245 NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326 		JBrowse link
G Chrne cholinergic receptor nicotinic epsilon subunit decreases expression ISO Progesterone results in decreased expression of CHRNE mRNA CTD PMID:18070364 NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154 		JBrowse link
G Chst11 carbohydrate sulfotransferase 11 increases expression ISO Progesterone results in increased expression of CHST11 mRNA CTD PMID:21540246 NCBI chr 7:22,412,121...22,630,577
Ensembl chr 7:22,415,686...22,630,441 		JBrowse link
G Chst15 carbohydrate sulfotransferase 15 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CHST15 mRNA CTD PMID:20660070 NCBI chr 1:196,458,978...196,540,088
Ensembl chr 1:196,460,425...196,491,444 		JBrowse link
G Chst4 carbohydrate sulfotransferase 4 decreases expression ISO Progesterone results in decreased expression of CHST4 mRNA CTD PMID:21540246 NCBI chr19:54,900,914...54,911,735
Ensembl chr19:54,882,719...54,916,648 		JBrowse link
G Chst7 carbohydrate sulfotransferase 7 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CHST7 mRNA
Progesterone results in increased expression of CHST7 mRNA 		CTD PMID:17404688 PMID:20864642 NCBI chr  X:2,396,260...2,432,828
Ensembl chr  X:4,938,757...4,986,907 		JBrowse link
G Chst9 carbohydrate sulfotransferase 9 decreases expression ISO Progesterone results in decreased expression of CHST9 mRNA CTD PMID:22238285 NCBI chr18:6,850,874...7,125,222
Ensembl chr18:6,851,831...7,125,161 		JBrowse link
G Chsy3 chondroitin sulfate synthase 3 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of CHSY3 mRNA
Progesterone results in increased expression of CHSY3 mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr18:54,842,260...55,096,008
Ensembl chr18:54,842,180...55,095,981 		JBrowse link
G Cidec cell death-inducing DFFA-like effector c affects expression ISO Progesterone affects the expression of CIDEC mRNA CTD PMID:17251523 NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:148,124,925...148,137,806 		JBrowse link
G Cilp cartilage intermediate layer protein multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CILP mRNA CTD PMID:20660070 NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409 		JBrowse link
G Cish cytokine inducible SH2-containing protein multiple interactions EXP Progesterone inhibits the reaction [Estrogens results in increased expression of CISH mRNA]; Progesterone inhibits the reaction [PRL protein results in increased expression of CISH mRNA] CTD PMID:18325991 NCBI chr 8:116,850,969...116,855,917
Ensembl chr 8:116,850,773...116,855,986 		JBrowse link
G Cited1 Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 increases expression ISO Progesterone results in increased expression of CITED1 mRNA CTD PMID:22238285 NCBI chr  X:67,350,376...67,355,072
Ensembl chr  X:71,390,331...71,393,649 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CITED2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of CITED2 mRNA
[Progesterone results in increased activity of PGR protein] which results in increased expression of CITED2 mRNA 		CTD PMID:15845616 PMID:17404688 PMID:20660070 NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782 		JBrowse link
G Cited4 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 increases expression ISO Progesterone results in increased expression of CITED4 mRNA CTD PMID:22238285 NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 decreases expression ISO Progesterone results in decreased expression of CKAP2 mRNA CTD PMID:21795739 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Ckb creatine kinase B multiple interactions
affects expression
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of CKB mRNA; [Progesterone co-treated with Estradiol] results in increased expression of CKB mRNA
Progesterone affects the expression of CKB mRNA
Progesterone results in increased expression of CKB mRNA 		CTD PMID:17251523 PMID:17404688 PMID:20660070 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478 		JBrowse link
G Ckm creatine kinase, M-type increases expression EXP Progesterone results in increased expression of CKM mRNA CTD PMID:20726854 NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719 		JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CKS1B protein
[Estradiol co-treated with Progesterone] results in increased expression of CKS1B mRNA 		CTD PMID:18556351 PMID:23029392 NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365 		JBrowse link
G Clca1 chloride channel accessory 1 affects expression
decreases expression 		ISO Progesterone affects the expression of CLCA1 mRNA
Progesterone results in decreased expression of CLCA1 mRNA 		CTD PMID:17251523 PMID:22238285 NCBI chr 2:236,599,022...236,624,714
Ensembl chr 2:236,599,022...236,624,714 		JBrowse link
G Clca4 chloride channel accessory 4 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CLCA4 mRNA CTD PMID:17404688 NCBI chr 2:236,543,975...236,565,096
Ensembl chr 2:236,544,201...236,563,435 		JBrowse link
G Clcn4 chloride voltage-gated channel 4 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of CLCN4 mRNA CTD PMID:17404688 NCBI chr  X:27,290,769...27,356,967
Ensembl chr  X:27,290,868...27,356,939 		JBrowse link
G Cldn1 claudin 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CLDN1 mRNA CTD PMID:20660070 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529 		JBrowse link
G Cldn23 claudin 23 multiple interactions
increases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in increased expression of CLDN23 mRNA] CTD PMID:17556502 NCBI chr16:63,117,045...63,118,769
Ensembl chr16:63,116,781...63,118,957 		JBrowse link
G Cldn3 claudin 3 affects expression ISO Progesterone affects the expression of CLDN3 mRNA CTD PMID:17251523 NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841 		JBrowse link
G Cldn4 claudin 4 decreases expression
affects expression 		ISO Progesterone results in decreased expression of CLDN4 mRNA
Progesterone affects the expression of CLDN4 mRNA 		CTD PMID:17251523 PMID:18037150 NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958 		JBrowse link
G Cldn5 claudin 5 increases expression
multiple interactions 		ISO Progesterone results in increased expression of CLDN5 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of CLDN5 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322 		JBrowse link
G Cldn6 claudin 6 decreases expression ISO Progesterone results in decreased expression of CLDN6 mRNA CTD PMID:22238285 NCBI chr10:12,710,302...12,713,987
Ensembl chr10:13,213,956...13,218,581 		JBrowse link
G Cldn8 claudin 8 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CLDN8 mRNA CTD PMID:20660070 NCBI chr11:41,362,081...41,364,330 JBrowse link
G Cldnd1 claudin domain containing 1 affects expression ISO Progesterone affects the expression of CLDND1 mRNA CTD PMID:17251523 NCBI chr11:41,883,120...41,889,471
Ensembl chr11:55,352,321...55,358,907 		JBrowse link
G Clec3b C-type lectin domain family 3, member B multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CLEC3B mRNA
Progesterone results in increased expression of CLEC3B mRNA 		CTD PMID:20226447 NCBI chr 8:131,687,575...131,693,292 JBrowse link
G Clec4d C-type lectin domain family 4, member D affects expression ISO Progesterone affects the expression of CLEC4D mRNA CTD PMID:17251523 NCBI chr 4:158,275,287...158,286,978
Ensembl chr 4:158,275,341...158,287,055 		JBrowse link
G Clgn calmegin decreases expression ISO Progesterone results in decreased expression of CLGN mRNA CTD PMID:21540246 NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325 		JBrowse link
G Clic2 chloride intracellular channel 2 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CLIC2 mRNA CTD PMID:17404688 NCBI chr20:149,337...164,375
Ensembl chr20:154,255...169,648 		JBrowse link
G Clic3 chloride intracellular channel 3 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CLIC3 mRNA CTD PMID:17404688 NCBI chr 3:28,670,176...28,672,166
Ensembl chr 3:28,670,229...28,675,723 		JBrowse link
G Clic4 chloride intracellular channel 4 decreases expression ISO Progesterone results in decreased expression of CLIC4 mRNA CTD PMID:18070364 NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118 		JBrowse link
G Clic6 chloride intracellular channel 6 decreases expression ISO Progesterone results in decreased expression of CLIC6 mRNA CTD PMID:22238285 NCBI chr11:45,223,715...45,266,261
Ensembl chr11:45,223,669...45,267,344 		JBrowse link
G Clmn calmin multiple interactions
decreases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in decreased expression of CLMN mRNA] CTD PMID:17556502 NCBI chr 6:129,470,613...129,572,079
Ensembl chr 6:129,478,149...129,572,027 		JBrowse link
G Clstn2 calsyntenin 2 increases expression EXP
ISO 		Progesterone results in increased expression of CLSTN2 mRNA CTD PMID:20726854 PMID:22238285 NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:106,899,894...107,040,053 		JBrowse link
G Clu clusterin increases expression EXP Progesterone results in increased expression of CLU mRNA CTD PMID:20726854 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Cmbl carboxymethylenebutenolidase homolog multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CMBL mRNA CTD PMID:20660070 NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880 		JBrowse link
G Cmklr1 chemerin chemokine-like receptor 1 decreases expression EXP Progesterone results in decreased expression of CMKLR1 mRNA CTD PMID:20726854 NCBI chr12:48,634,929...48,687,833
Ensembl chr12:48,634,003...48,691,458 		JBrowse link
G Cmpk2 cytidine/uridine monophosphate kinase 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CMPK2 mRNA CTD PMID:20660070 NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:48,802,321...48,813,652 		JBrowse link
G Cmtm3 CKLF-like MARVEL transmembrane domain containing 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CMTM3 mRNA CTD PMID:20660070 NCBI chr19:629,000...637,152
Ensembl chr19:628,895...636,225 		JBrowse link
G Cndp2 carnosine dipeptidase 2 decreases expression ISO Progesterone results in decreased expression of CNDP2 mRNA CTD PMID:21540246 NCBI chr18:78,039,924...78,057,030
Ensembl chr18:80,314,801...80,331,900 		JBrowse link
G Cnga1 cyclic nucleotide gated channel subunit alpha 1 increases expression ISO Progesterone results in increased expression of CNGA1 mRNA CTD PMID:18497975 NCBI chr14:35,920,948...35,959,065
Ensembl chr14:35,926,854...35,959,056 		JBrowse link
G Cnih3 cornichon family AMPA receptor auxiliary protein 3 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of CNIH3 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of CNIH3 mRNA
Progesterone results in decreased expression of CNIH3 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr13:93,016,707...93,208,168
Ensembl chr13:95,598,998...95,772,064 		JBrowse link
G Cnn1 calponin 1 decreases expression ISO Progesterone results in decreased expression of CNN1 mRNA CTD PMID:21795739 NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482 		JBrowse link
G Cnot7 CCR4-NOT transcription complex, subunit 7 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CNOT7 mRNA CTD PMID:21453500 NCBI chr16:51,775,416...51,794,581
Ensembl chr16:58,478,900...58,498,046 		JBrowse link
G Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase increases expression EXP Progesterone results in increased expression of CNP mRNA CTD PMID:19853640 NCBI chr10:85,511,164...85,517,723
Ensembl chr10:86,011,495...86,018,063 		JBrowse link
G Cnr1 cannabinoid receptor 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CNR1 mRNA
Progesterone results in increased expression of CNR1 mRNA 		CTD PMID:17404688 PMID:20864642 NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252 		JBrowse link
G Cntn1 contactin 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CNTN1 mRNA CTD PMID:20660070 NCBI chr 7:125,142,638...125,440,397
Ensembl chr 7:125,142,696...125,440,391 		JBrowse link
G Cntn3 contactin 3 increases expression ISO Progesterone results in increased expression of CNTN3 mRNA CTD PMID:21795739 NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:136,398,572...136,770,717 		JBrowse link
G Cntnap2 contactin associated protein 2 decreases expression ISO Progesterone results in decreased expression of CNTNAP2 mRNA CTD PMID:22238285 NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:75,109,858...77,366,258 		JBrowse link
G Cntnap3 contactin associated protein family member 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CNTNAP3 mRNA CTD PMID:20660070 NCBI chr17:267,379...455,478
Ensembl chr17:273,137...461,233 		JBrowse link
G Coch cochlin increases expression ISO Progesterone results in increased expression of COCH mRNA CTD PMID:22238285 NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502 		JBrowse link
G Col11a1 collagen type XI alpha 1 chain decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of COL11A1 mRNA
[Progesterone co-treated with Estradiol] results in decreased expression of COL11A1 mRNA 		CTD PMID:18070364 PMID:20226447 NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264 		JBrowse link
G Col12a1 collagen type XII alpha 1 chain multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of COL12A1 mRNA CTD PMID:20226447 NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711 		JBrowse link
G Col13a1 collagen type XIII alpha 1 chain multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of COL13A1 mRNA CTD PMID:20660070 NCBI chr20:30,326,744...30,466,800
Ensembl chr20:30,326,744...30,466,800 		JBrowse link
G Col14a1 collagen type XIV alpha 1 chain multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of COL14A1 mRNA CTD PMID:20226447 NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:88,611,828...88,826,938 		JBrowse link
G Col15a1 collagen type XV alpha 1 chain multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of COL15A1 mRNA
Progesterone results in increased expression of COL15A1 mRNA 		CTD PMID:20226447 NCBI chr 5:66,297,546...66,403,172
Ensembl chr 5:66,297,461...66,403,170 		JBrowse link
G Col16a1 collagen type XVI alpha 1 chain decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of COL16A1 mRNA
[Progesterone co-treated with Estradiol] results in decreased expression of COL16A1 mRNA 		CTD PMID:18070364 PMID:20226447 NCBI chr 5:142,388,376...142,442,825
Ensembl chr 5:147,672,601...147,727,011 		JBrowse link
G Col1a1 collagen type I alpha 1 chain decreases expression
multiple interactions
affects expression 		ISO Progesterone results in decreased expression of COL1A1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of COL1A1 mRNA
Progesterone affects the expression of COL1A1 mRNA 		CTD PMID:17251523 PMID:18070364 PMID:19693291 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain multiple interactions
increases expression
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of COL1A2 mRNA
Progesterone results in increased expression of COL1A2 mRNA
Progesterone results in decreased expression of COL1A2 mRNA 		CTD PMID:18070364 PMID:18692832 PMID:20660070 PMID:21540246 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col23a1 collagen type XXIII alpha 1 chain increases expression ISO Progesterone results in increased expression of COL23A1 mRNA CTD PMID:22238285 NCBI chr10:36,050,327...36,337,279
Ensembl chr10:36,050,259...36,337,897 		JBrowse link
G Col3a1 collagen type III alpha 1 chain affects expression ISO Progesterone affects the expression of COL3A1 protein CTD PMID:20864640 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain decreases expression
increases expression 		ISO Progesterone results in decreased expression of COL4A1 mRNA
Progesterone results in increased expression of COL4A1 mRNA 		CTD PMID:18070364 PMID:20864642 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Col5a2 collagen type V alpha 2 chain decreases expression ISO Progesterone results in decreased expression of COL5A2 mRNA CTD PMID:18070364 NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain decreases expression ISO Progesterone results in decreased expression of COL6A1 mRNA CTD PMID:18070364 NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107 		JBrowse link
G Col6a3 collagen type VI alpha 3 chain affects expression ISO Progesterone affects the expression of COL6A3 protein CTD PMID:20864640 NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:98,809,171...98,886,990 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain affects expression ISO Progesterone affects the expression of COL7A1 mRNA CTD PMID:17251523 NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Col8a1 collagen type VIII alpha 1 chain decreases expression ISO Progesterone results in decreased expression of COL8A1 mRNA CTD PMID:22238285 NCBI chr11:42,776,851...42,906,432
Ensembl chr11:56,369,868...56,376,229 		JBrowse link
G Col8a2 collagen type VIII alpha 2 chain decreases expression ISO Progesterone results in decreased expression of COL8A2 mRNA CTD PMID:18070364 NCBI chr 5:138,586,201...138,613,627
Ensembl chr 5:143,870,742...143,897,884 		JBrowse link
G Colec12 collectin sub-family member 12 increases expression ISO Progesterone results in increased expression of COLEC12 mRNA CTD PMID:22238285 NCBI chr18:732,950...920,620
Ensembl chr18:1,005,741...1,195,297 		JBrowse link
G Comt catechol-O-methyltransferase decreases expression ISO Progesterone results in decreased expression of COMT protein CTD PMID:17138778 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Cops7a COP9 signalosome subunit 7A affects expression ISO Progesterone affects the expression of COPS7A mRNA CTD PMID:17251523 NCBI chr 4:157,766,626...157,792,632
Ensembl chr 4:159,452,897...159,460,315 		JBrowse link
G Corin corin, serine peptidase increases expression ISO Progesterone results in increased expression of CORIN mRNA CTD PMID:20864642 PMID:21795739 NCBI chr14:36,034,613...36,264,671
Ensembl chr14:36,034,993...36,264,649 		JBrowse link
G Coro6 coronin 6 increases expression EXP Progesterone results in increased expression of CORO6 mRNA CTD PMID:20726854 NCBI chr10:62,808,172...62,817,788
Ensembl chr10:62,809,689...62,817,787 		JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 decreases expression ISO Progesterone results in decreased expression of COTL1 mRNA CTD PMID:18037150 NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840 		JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4i1 increases abundance ISO COX4I1 protein results in increased abundance of Progesterone CTD PMID:21558439 NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 increases expression EXP Progesterone results in increased expression of COX6A2 mRNA CTD PMID:20726854 NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716 		JBrowse link
G Cox6b1 cytochrome c oxidase subunit 6B1 decreases expression ISO Progesterone results in decreased expression of COX6B1 mRNA CTD PMID:19693291 NCBI chr 1:95,002,513...95,011,516
Ensembl chr 1:95,001,707...95,011,431
Ensembl chr 5:95,001,707...95,011,431 		JBrowse link
G Cox7a1 cytochrome c oxidase subunit 7A1 decreases expression ISO Progesterone results in decreased expression of COX7A1 mRNA CTD PMID:18070364 NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:94,569,216...94,570,889 		JBrowse link
G Cox8b cytochrome c oxidase, subunit VIIIb increases expression EXP Progesterone results in increased expression of COX8H mRNA CTD PMID:20726854 NCBI chr 1:205,406,813...205,408,273
Ensembl chr 1:205,406,813...205,408,311 		JBrowse link
G Cp ceruloplasmin affects expression
increases expression
multiple interactions 		ISO
EXP 		Progesterone affects the expression of CP mRNA
Progesterone results in increased expression of CP mRNA
Mifepristone inhibits the reaction [Progesterone affects the expression of CP mRNA] 		CTD PMID:17251523 PMID:20726854 PMID:22414680 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CPEB2 mRNA CTD PMID:20660070 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263 		JBrowse link
G Cped1 cadherin-like and PC-esterase domain containing 1 increases expression ISO Progesterone results in increased expression of CPED1 mRNA CTD PMID:22238285 NCBI chr 4:50,516,712...50,789,651
Ensembl chr 4:51,482,545...51,755,442 		JBrowse link
G Cpm carboxypeptidase M decreases expression
increases expression
multiple interactions 		ISO Progesterone results in decreased expression of CPM mRNA
Progesterone results in increased expression of CPM mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of CPM mRNA 		CTD PMID:17404688 PMID:18070364 PMID:20660070 PMID:20864642 NCBI chr 7:55,111,599...55,172,114
Ensembl chr 7:55,111,599...55,172,114 		JBrowse link
G Cpq carboxypeptidase Q affects response to substance ISO CPQ gene SNP affects the susceptibility to Progesterone CTD PMID:25622337 NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:66,149,377...66,716,137 		JBrowse link
G Cpt1b carnitine palmitoyltransferase 1B increases expression EXP Progesterone results in increased expression of CPT1B mRNA CTD PMID:20726854 NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036 		JBrowse link
G Cpxm1 carboxypeptidase X (M14 family), member 1 affects expression ISO Progesterone affects the expression of CPXM1 mRNA CTD PMID:17251523 NCBI chr 3:138,041,645...138,048,443
Ensembl chr 3:138,041,645...138,048,857 		JBrowse link
G Cpz carboxypeptidase Z multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of CPZ mRNA
Progesterone results in increased expression of CPZ mRNA 		CTD PMID:17404688 PMID:20726854 NCBI chr14:75,223,692...75,246,946
Ensembl chr14:79,448,139...79,471,556 		JBrowse link
G Crabp1 cellular retinoic acid binding protein 1 decreases expression ISO Progesterone results in decreased expression of CRABP1 mRNA CTD PMID:22238285 NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:64,047,060...64,055,470 		JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of CRABP2 mRNA
Progesterone results in decreased expression of CRABP2 mRNA 		CTD PMID:17404688 PMID:22238285 NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 decreases expression EXP Progesterone results in decreased expression of CREB1 mRNA CTD PMID:21371490 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Creb5 cAMP responsive element binding protein 5 decreases expression ISO Progesterone results in decreased expression of CREB5 mRNA CTD PMID:21795739 NCBI chr 4:83,723,587...84,124,786
Ensembl chr 4:83,723,194...84,120,793 		JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CREG1 mRNA CTD PMID:20660070 NCBI chr13:80,552,779...80,565,272
Ensembl chr13:80,549,933...80,565,272 		JBrowse link
G Creld2 cysteine-rich with EGF-like domains 2 affects expression ISO Progesterone affects the expression of CRELD2 mRNA CTD PMID:17251523 NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:121,788,745...121,796,228 		JBrowse link
G Crh corticotropin releasing hormone multiple interactions
increases secretion
decreases abundance 		ISO
EXP 		CRH protein inhibits the reaction [Go 6976 results in increased abundance of Progesterone]; Progesterone promotes the reaction [[CRHR1 protein binds to and results in increased activity of CRH protein] which results in increased abundance of Cyclic AMP]; Progesterone promotes the reaction [CRHR1 protein binds to and results in increased activity of CRH protein]
CRH protein results in increased secretion of Progesterone
CRH protein results in decreased abundance of Progesterone 		CTD PMID:17170093 PMID:20702571 PMID:23133512 NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386 		JBrowse link
G Crhr1 corticotropin releasing hormone receptor 1 multiple interactions
increases expression 		ISO Progesterone promotes the reaction [[CRHR1 protein binds to and results in increased activity of CRH protein] which results in increased abundance of Cyclic AMP]; Progesterone promotes the reaction [CRHR1 protein binds to and results in increased activity of CRH protein]
Progesterone results in increased expression of CRHR1 mRNA 		CTD PMID:20702571 NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,540,192...89,583,466 		JBrowse link
G Crip1 cysteine rich protein 1 decreases expression ISO Progesterone results in decreased expression of CRIP1 mRNA CTD PMID:21540246 NCBI chr 6:138,047,801...138,055,672
Ensembl chr 6:138,047,801...138,055,672 		JBrowse link
G Crispld2 cysteine-rich secretory protein LCCL domain containing 2 multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in increased expression of CRISPLD2 mRNA
Progesterone results in increased expression of CRISPLD2 mRNA 		CTD PMID:17404688 PMID:20726854 PMID:20864642 PMID:21795739 NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349 		JBrowse link
G Crlf1 cytokine receptor-like factor 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CRLF1 mRNA
Progesterone results in increased expression of CRLF1 mRNA 		CTD PMID:17404688 PMID:19693291 NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,957,956...18,969,970 		JBrowse link
G Crtam cytotoxic and regulatory T cell molecule multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CRTAM mRNA CTD PMID:20660070 NCBI chr 8:50,237,210...50,274,472
Ensembl chr 8:50,237,210...50,274,472 		JBrowse link
G Cryab crystallin, alpha B multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in increased expression of CRYAB mRNA
Progesterone results in increased expression of CRYAB mRNA 		CTD PMID:17404688 PMID:20726854 NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:59,989,814...59,995,528 		JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 increases expression
decreases expression 		ISO Progesterone results in increased expression of CRYBG2 mRNA
Progesterone results in decreased expression of CRYBG2 mRNA 		CTD PMID:17404688 PMID:21540246 NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:151,570,540...151,602,163 		JBrowse link
G Crybg3 crystallin beta-gamma domain containing 3 increases expression ISO Progesterone results in increased expression of CRYBG3 mRNA CTD PMID:22238285 NCBI chr11:40,749,198...40,861,753
Ensembl chr11:54,208,444...54,330,960 		JBrowse link
G Csf2ra colony stimulating factor 2 receptor subunit alpha multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of CSF2RA mRNA CTD PMID:17404688 NCBI chr14:113,219...118,808
Ensembl chr14:113,225...118,117 		JBrowse link
G Csf3 colony stimulating factor 3 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CSF3 mRNA
Progesterone results in increased expression of CSF3 mRNA 		CTD PMID:17404688 PMID:21549006 NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860 		JBrowse link
G Csk C-terminal Src kinase decreases expression ISO Progesterone results in decreased expression of CSK mRNA CTD PMID:18037150 NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:66,925,651...66,930,274 		JBrowse link
G Csmd2 CUB and Sushi multiple domains 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CSMD2 mRNA CTD PMID:21453500 NCBI chr 5:140,342,352...140,912,422
Ensembl chr 5:145,626,845...146,196,812 		JBrowse link
G Cspg5 chondroitin sulfate proteoglycan 5 decreases expression ISO Progesterone results in decreased expression of CSPG5 mRNA CTD PMID:18037150 NCBI chr 8:110,220,506...110,234,766
Ensembl chr 8:119,098,925...119,143,907 		JBrowse link
G Csrnp2 cysteine and serine rich nuclear protein 2 increases expression ISO Progesterone results in increased expression of CSRNP2 mRNA CTD PMID:18037150 NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:133,473,027...133,488,868 		JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 decreases expression ISO Progesterone results in decreased expression of CSRP2 mRNA CTD PMID:21795739 NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238 		JBrowse link
G Csrp3 cysteine and glycine rich protein 3 increases expression EXP Progesterone results in increased expression of CSRP3 mRNA CTD PMID:20726854 NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:107,664,338...107,682,916 		JBrowse link
G Cst8 cystatin 8 affects response to substance ISO CST8 protein affects the susceptibility to Progesterone CTD PMID:20811015 NCBI chr 3:136,244,586...136,255,412
Ensembl chr 3:156,697,767...156,724,636 		JBrowse link
G Csta cystatin A decreases expression ISO Progesterone results in decreased expression of CSTA mRNA CTD PMID:18070364 NCBI chr11:78,125,813...78,136,818
Ensembl chr11:78,125,800...78,136,822 		JBrowse link
G Ctbp1 C-terminal binding protein 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CTBP1 mRNA CTD PMID:17404688 NCBI chr14:77,455,580...77,482,821
Ensembl chr14:81,679,765...81,707,554 		JBrowse link
G Ctdspl CTD small phosphatase like increases expression ISO Progesterone results in increased expression of CTDSPL mRNA CTD PMID:18497975 NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:127,520,499...127,644,999 		JBrowse link
G Cth cystathionine gamma-lyase increases expression ISO Progesterone results in increased expression of CTH mRNA CTD PMID:21795739 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Ctnna2 catenin alpha 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CTNNA2 mRNA CTD PMID:20660070 NCBI chr 4:110,852,265...112,001,351
Ensembl chr 4:110,852,265...112,001,365 		JBrowse link
G Ctnnb1 catenin beta 1 increases expression
decreases abundance
increases response to substance 		EXP
ISO 		Progesterone results in increased expression of CTNNB1 protein
CTNNB1 protein results in decreased abundance of Progesterone
CTNNB1 protein results in increased susceptibility to Progesterone 		CTD PMID:17170212 PMID:20610534 PMID:22958837 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctnnd2 catenin delta 2 decreases expression ISO Progesterone results in decreased expression of CTNND2 mRNA CTD PMID:22238285 NCBI chr 2:82,879,469...83,727,409
Ensembl chr 2:82,879,469...83,727,409 		JBrowse link
G Ctsd cathepsin D increases expression ISO Progesterone results in increased expression of CTSD mRNA CTD PMID:18497975 NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Ctse cathepsin E affects expression
increases expression 		ISO Progesterone affects the expression of CTSE mRNA
Progesterone results in increased expression of CTSE mRNA 		CTD PMID:17251523 PMID:17404688 NCBI chr13:45,644,168...45,666,722
Ensembl chr13:45,644,147...45,666,722 		JBrowse link
G Ctsh cathepsin H multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CTSH mRNA CTD PMID:20660070 NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:99,488,874...99,509,181 		JBrowse link
G Ctsk cathepsin K increases expression EXP Progesterone results in increased expression of CTSK mRNA CTD PMID:21770760 NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:185,747,165...185,765,582 		JBrowse link
G Ctsw cathepsin W multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of CTSW mRNA CTD PMID:17404688 NCBI chr 1:212,201,904...212,208,028
Ensembl chr 1:212,201,904...212,205,292 		JBrowse link
G Cux2 cut-like homeobox 2 multiple interactions
increases expression
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA
Progesterone results in increased expression of CUX2 mRNA
Progesterone results in decreased expression of CUX2 mRNA 		CTD PMID:17404688 PMID:18070364 NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528 		JBrowse link
G Cwh43 cell wall biogenesis 43 C-terminal homolog decreases expression
increases expression 		ISO Progesterone results in decreased expression of CWH43 mRNA
Progesterone results in increased expression of CWH43 mRNA 		CTD PMID:21540246 PMID:22238285 NCBI chr14:35,108,328...35,154,578
Ensembl chr14:35,108,338...35,154,863 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions
decreases expression 		ISO CX3CL1 protein promotes the reaction [CGB3 protein results in increased abundance of Progesterone]
Progesterone results in decreased expression of CX3CL1 mRNA 		CTD PMID:18292196 PMID:22238285 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression ISO Progesterone results in decreased expression of CXCL1 mRNA; Progesterone results in decreased expression of CXCL1 protein CTD PMID:22615136 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions
decreases expression
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CXCL10 mRNA
Progesterone results in decreased expression of CXCL10 mRNA; Progesterone results in decreased expression of CXCL10 protein
Progesterone results in increased expression of CXCL10 mRNA 		CTD PMID:15557169 PMID:17404688 PMID:21549006 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CXCL11 mRNA
Progesterone results in increased expression of CXCL11 mRNA 		CTD PMID:15557169 PMID:17404688 NCBI chr14:15,973,728...15,976,503
Ensembl chr14:15,973,720...15,976,567 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of CXCL12 mRNA
Progesterone results in increased expression of CXCL12 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of CXCL12 mRNA
Progesterone results in decreased expression of CXCL12 mRNA 		CTD PMID:18556351 PMID:20660070 PMID:20726854 PMID:21795739 PMID:22238285 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 affects expression
increases expression
multiple interactions 		ISO Progesterone affects the expression of CXCL14 mRNA
Progesterone results in increased expression of CXCL14 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of CXCL14 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of CXCL14 mRNA; Progesterone promotes the reaction [PGR protein results in increased expression of CXCL14 mRNA] 		CTD PMID:17251523 PMID:17404688 PMID:19903701 PMID:20660070 NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172 		JBrowse link
G Cxcl17 C-X-C motif chemokine ligand 17 increases expression ISO Progesterone results in increased expression of CXCL17 mRNA CTD PMID:22238285 NCBI chr 1:90,112,561...90,124,648
Ensembl chr 1:90,112,771...90,124,535 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 decreases expression
multiple interactions
increases expression 		ISO Progesterone results in decreased expression of CXCL2 mRNA; Progesterone results in decreased expression of CXCL2 protein
[Progesterone co-treated with 1-Naphthylisothiocyanate] results in increased expression of CXCL2 mRNA; [Progesterone co-treated with Dicloxacillin] results in increased expression of CXCL2 mRNA; [Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA; [Progesterone co-treated with Halothane] results in increased expression of CXCL2 protein; gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]; Progesterone promotes the reaction [Thioacetamide results in increased expression of CXCL2 mRNA]; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA]
Progesterone results in increased expression of CXCL2 mRNA 		CTD PMID:21501669 PMID:21795739 PMID:22157104 PMID:22615136 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression
increases expression
multiple interactions
affects expression 		ISO Progesterone results in decreased expression of CXCL1 mRNA; Progesterone results in decreased expression of CXCL1 protein
Progesterone results in increased expression of CXCL1 mRNA; Progesterone results in increased expression of CXCL1 protein
gadolinium chloride inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; gadolinium chloride inhibits the reaction [Progesterone results in increased expression of CXCL1 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; Mifepristone inhibits the reaction [Progesterone results in increased expression of CXCL1 mRNA]; Progesterone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA]; Progesterone promotes the reaction [Dicloxacillin results in increased expression of CXCL1 mRNA]; Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]; Progesterone promotes the reaction [Thioacetamide results in increased expression of CXCL1 mRNA]; U 0126 inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; U 0126 inhibits the reaction [Progesterone results in increased expression of CXCL1 mRNA]
Progesterone affects the expression of CXCL1 mRNA 		CTD PMID:17251523 PMID:21501669 PMID:22157104 PMID:22615136 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcl6 C-X-C motif chemokine ligand 6 affects expression ISO Progesterone affects the expression of CXCL5 mRNA CTD PMID:17251523 NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CXCL9 mRNA
Progesterone results in increased expression of CXCL9 mRNA 		CTD PMID:18692832 NCBI chr14:15,722,868...15,727,779
Ensembl chr14:16,007,204...16,014,299 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression
multiple interactions 		EXP
ISO 		Progesterone results in decreased expression of CXCR4 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of CXCR4 mRNA 		CTD PMID:20660070 PMID:20726854 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cxxc5 CXXC finger protein 5 affects expression ISO Progesterone affects the expression of CXXC5 mRNA CTD PMID:17251523 NCBI chr18:27,427,591...27,458,579
Ensembl chr18:27,701,188...27,732,635 		JBrowse link
G Cyb5a cytochrome b5 type A multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CYB5A mRNA CTD PMID:20660070 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyb5b cytochrome b5 type B increases expression ISO Progesterone results in increased expression of CYB5B mRNA CTD PMID:18070364 NCBI chr19:35,062,871...35,096,741
Ensembl chr19:51,972,547...52,026,980 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression ISO Progesterone results in increased expression of CYBA mRNA CTD PMID:16195479 NCBI chr19:50,487,598...50,495,669
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cycs cytochrome c, somatic multiple interactions EXP [Progesterone co-treated with Estradiol] results in increased expression of CYCS mRNA CTD PMID:18829022 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of CYFIP2 mRNA
Progesterone results in decreased expression of CYFIP2 mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 affects abundance
increases chemical synthesis
multiple interactions
affects chemical synthesis 		ISO
EXP 		CYP11A1 protein affects the abundance of Progesterone
CYP11A1 protein results in increased chemical synthesis of Progesterone
CYP11A1 mRNA affects the abundance of Progesterone
[2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased activity of CYP11A1 protein] which results in decreased chemical synthesis of Progesterone; [bisphenol A affects the expression of CYP11A1 mRNA] which affects the abundance of Progesterone; [Diethylstilbestrol results in decreased expression of CYP11A1 protein] which results in decreased abundance of Progesterone; [FSHB protein results in increased expression of CYP11A1 mRNA] which results in increased abundance of Progesterone; GH1 protein promotes the reaction [[FSHB protein results in increased expression of CYP11A1 mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of CYP11A1 mRNA] which results in increased abundance of Progesterone]; manganese chloride inhibits the reaction [CYP11A1 protein results in increased chemical synthesis of Progesterone]
CYP11A1 protein affects the chemical synthesis of Progesterone 		CTD PMID:10964264 PMID:11502818 PMID:12699903 PMID:15819722 PMID:18191889 More... NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions
increases hydroxylation
affects metabolic processing 		ISO
EXP 		[[abiraterone results in decreased activity of CYP17A1 protein] which results in decreased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone; [abiraterone results in decreased activity of CYP17A1 protein] which results in decreased hydroxylation of Progesterone; [CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 16-hydroxyprogesterone; [CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone; CYP17A1 protein binds to and affects the metabolism of Progesterone; Duloxetine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone]; Duloxetine Hydrochloride inhibits the reaction [CYP17A1 protein results in increased hydroxylation of Progesterone]; Venlafaxine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone]; Venlafaxine Hydrochloride inhibits the reaction [CYP17A1 protein results in increased hydroxylation of Progesterone]
[[3,4',5-trimethoxystilbene co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [[resveratrol analog co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [[resveratrol co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone
CYP17A1 protein affects the metabolism of Progesterone 		CTD PMID:14522586 PMID:15261307 PMID:15562394 PMID:16030167 PMID:16054388 More... NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 increases activity
multiple interactions
decreases expression 		ISO
EXP 		Progesterone results in increased activity of CYP19A1 protein
[FSHB protein results in increased expression of CYP19A1 mRNA] which results in increased abundance of Progesterone; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of CYP19A1 mRNA] which results in increased abundance of Progesterone]
Progesterone results in decreased expression of CYP19A1 mRNA 		CTD PMID:15862960 PMID:22067323 PMID:22130322 NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases hydroxylation
decreases activity
decreases expression
multiple interactions 		ISO
EXP 		CYP1A1 protein results in increased hydroxylation of Progesterone
Progesterone results in decreased activity of CYP1A1 protein
Progesterone results in decreased expression of CYP1A1 mRNA
Progesterone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]
[Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 protein]; [Estradiol co-treated with Progesterone] affects the expression of CYP1A1 mRNA; Progesterone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] 		CTD PMID:8674863 PMID:10975606 PMID:11281733 PMID:24777823 PMID:32668270 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases expression
decreases activity
increases expression
multiple interactions 		ISO
EXP 		Progesterone results in decreased expression of CYP1B1 mRNA
Progesterone results in decreased activity of CYP1B1 protein
Progesterone results in increased expression of CYP1B1 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of CYP1B1 mRNA; Progesterone promotes the reaction [laquinimod metabolite results in increased expression of CYP1B1 mRNA]
Progesterone results in decreased expression of CYP1B1 protein
[Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 protein]; Progesterone inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 protein]; Progesterone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] 		CTD PMID:8674863 PMID:18037150 PMID:20660070 PMID:20726854 PMID:32668270 More... NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of CYP24A1 mRNA CTD PMID:20660070 NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083 		JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 multiple interactions
affects expression
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of CYP26A1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA
Progesterone affects the expression of CYP26A1 mRNA
[Progesterone results in increased activity of PGR protein] which results in increased expression of CYP26A1 mRNA
Progesterone results in increased expression of CYP26A1 mRNA 		CTD PMID:15845616 PMID:17251523 PMID:17404688 PMID:20660070 NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657 		JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO CYP27A1 protein affects the metabolism of and affects the abundance of Progesterone
Progesterone results in increased expression of CYP27A1 mRNA 		CTD PMID:19671838 PMID:22238285 NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215 		JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 decreases expression ISO Progesterone results in decreased expression of CYP27B1 mRNA CTD PMID:17404688 NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions
increases expression
decreases expression 		ISO [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2B6 mRNA]; [Progesterone co-treated with Estradiol] inhibits the reaction [Phenobarbital results in increased expression of CYP2B6 mRNA]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2B6 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [Phenobarbital results in increased expression of CYP2B6 mRNA]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2B6 mRNA]; Progesterone inhibits the reaction [Phenobarbital results in increased expression of CYP2B6 mRNA]
Progesterone results in increased expression of CYP2B10 mRNA
Progesterone results in decreased expression of CYP2B10 mRNA
Progesterone results in increased expression of CYP2B6 mRNA 		CTD PMID:7771797 PMID:11075820 PMID:21768169 PMID:22837389 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 decreases expression ISO Progesterone results in decreased expression of CYP2C18 mRNA CTD PMID:18070364 NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 increases hydroxylation ISO CYP2C19 protein results in increased hydroxylation of Progesterone CTD PMID:18957504 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 increases expression ISO Progesterone results in increased expression of CYP2C8 mRNA CTD PMID:22837389
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 affects expression
multiple interactions 		ISO
EXP 		Progesterone affects the expression of CYP2E1 mRNA
Progesterone promotes the reaction [Benzene results in decreased activity of CYP2E1 protein] 		CTD PMID:17251523 PMID:18407866 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp2g1 cytochrome P450, family 2, subfamily g, polypeptide 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of CYP2G1 mRNA CTD PMID:19693291 NCBI chr 1:91,273,309...91,284,499
Ensembl chr 1:91,272,680...91,284,498 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
increases hydroxylation
multiple interactions 		ISO Progesterone results in increased expression of CYP3A4 mRNA
CYP3A4 protein results in increased hydroxylation of Progesterone
Progesterone promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] 		CTD PMID:18957504 PMID:19299527 PMID:22837389 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression EXP Progesterone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10707959 NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression ISO Progesterone results in increased expression of CYP3A5 mRNA CTD PMID:22837389 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyp46a1 cytochrome P450, family 46, subfamily a, polypeptide 1 increases hydroxylation ISO CYP46A1 protein results in increased hydroxylation of Progesterone CTD PMID:14640697 NCBI chr 6:133,011,948...133,039,167
Ensembl chr 6:133,011,989...133,041,971 		JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of CYP4B1 mRNA
Progesterone results in increased expression of CYP4B1 mRNA 		CTD PMID:17404688 NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116 		JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression ISO Progesterone results in increased expression of CYP51A1 mRNA CTD PMID:18070364 NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450 		JBrowse link
G Dab1 DAB adaptor protein 1 increases expression ISO Progesterone results in increased expression of DAB1 mRNA CTD PMID:22238285 NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:124,369,415...124,742,584 		JBrowse link
G Dach1 dachshund family transcription factor 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of DACH1 mRNA CTD PMID:20660070 NCBI chr15:80,936,063...81,317,746
Ensembl chr15:80,936,063...81,317,627 		JBrowse link
G Dact1 dishevelled-binding antagonist of beta-catenin 1 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of DACT1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of DACT1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of DACT1 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053 		JBrowse link
G Dap3 death associated protein 3 affects expression ISO Progesterone affects the expression of DAP3 mRNA CTD PMID:17251523 NCBI chr 2:174,319,341...174,347,489
Ensembl chr 2:176,617,155...176,644,270 		JBrowse link
G Dbi diazepam binding inhibitor affects expression ISO Progesterone affects the expression of DBI mRNA CTD PMID:17251523 NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450 		JBrowse link
G Dbn1 drebrin 1 multiple interactions
decreases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of DBN1 mRNA
Progesterone results in decreased expression of DBN1 mRNA 		CTD PMID:17404688 PMID:20726854 NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,155,787...9,170,122 		JBrowse link
G Dbndd2 dysbindin domain containing 2 increases expression ISO Progesterone results in increased expression of DBNDD2 mRNA CTD PMID:21795739 NCBI chr 3:153,216,300...153,220,651 JBrowse link
G Dbnl drebrin-like affects expression ISO Progesterone affects the expression of DBNL mRNA CTD PMID:17251523 NCBI chr14:80,666,115...80,681,155
Ensembl chr14:84,880,142...84,897,133 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor affects expression
decreases expression 		ISO
EXP 		Progesterone affects the expression of DBP mRNA
Progesterone results in decreased expression of DBP mRNA 		CTD PMID:17251523 PMID:20726854 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dcaf12 DDB1 and CUL4 associated factor 12 affects expression ISO Progesterone affects the expression of DCAF12 mRNA CTD PMID:17251523 NCBI chr 5:61,256,353...61,278,155
Ensembl chr 5:61,256,353...61,278,119 		JBrowse link
G Dcbld2 discoidin, CUB and LCCL domain containing 2 decreases expression ISO Progesterone results in decreased expression of DCBLD2 mRNA CTD PMID:21795739 NCBI chr11:55,594,691...55,649,113
Ensembl chr11:55,594,691...55,649,085 		JBrowse link
G Dchs1 dachsous cadherin-related 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of DCHS1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of DCHS1 mRNA CTD PMID:17404688 PMID:20660070 NCBI chr 1:160,104,931...160,138,958
Ensembl chr 1:169,516,762...169,536,639 		JBrowse link
G Dclk1 doublecortin-like kinase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of DCLK1 mRNA CTD PMID:19693291 NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090 		JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase increases expression EXP Progesterone results in increased expression of DCXR mRNA CTD PMID:20726854 NCBI chr10:106,504,730...106,506,619 JBrowse link
G Ddah1 dimethylarginine dimethylaminohydrolase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of DDAH1 mRNA CTD PMID:20660070 NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626 		JBrowse link
G Ddah2 DDAH family member 2, ADMA-independent multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of DDAH2 mRNA CTD PMID:17404688 NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,766,120...3,769,183 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO Progesterone results in increased expression of DDIT3 mRNA; Progesterone results in increased expression of DDIT3 protein CTD PMID:18037150 PMID:21525004 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression ISO Progesterone results in increased expression of DDIT4 mRNA CTD PMID:18037150 PMID:21795739 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Ddt D-dopachrome tautomerase increases expression EXP Progesterone results in increased expression of DDT mRNA CTD PMID:20726854 NCBI chr20:12,883,025...12,886,121 JBrowse link
G Ddx21 DExD-box helicase 21 affects expression ISO Progesterone affects the expression of DDX21 mRNA CTD PMID:17251523 NCBI chr20:30,534,319...30,554,513
Ensembl chr20:31,077,045...31,097,238 		JBrowse link
G Ddx39a DExD-box helicase 39A decreases expression EXP Progesterone results in decreased expression of DDX39A mRNA CTD PMID:20726854 NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306 		JBrowse link
G Ddx43 DEAD-box helicase 43 decreases expression ISO Progesterone results in decreased expression of DDX43 mRNA CTD PMID:21540246 NCBI chr 8:88,135,255...88,172,872
Ensembl chr 8:88,135,882...88,164,749 		JBrowse link
G Ddx6 DEAD-box helicase 6 affects expression ISO Progesterone affects the expression of DDX6 mRNA CTD PMID:17251523 NCBI chr 8:53,827,661...53,864,538
Ensembl chr 8:53,827,835...53,860,977 		JBrowse link
G Defb1 defensin beta 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of DEFB1 mRNA
[Progesterone co-treated with bazedoxifene] results in increased expression of DEFB1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of DEFB1 mRNA; [Progesterone co-treated with Lasofoxifene] results in increased expression of DEFB1 mRNA; [Progesterone co-treated with Raloxifene Hydrochloride] results in increased expression of DEFB1 mRNA 		CTD PMID:18367319 PMID:20660070 NCBI chr16:77,001,326...77,016,068
Ensembl chr16:77,001,326...77,016,068 		JBrowse link
G Defb5 defensin beta 5 multiple interactions
increases expression 		ISO Lipopolysaccharides inhibits the reaction [Progesterone results in increased expression of DEFB4A mRNA] CTD PMID:19819163 NCBI chr16:70,612,985...70,615,389
Ensembl chr16:77,315,424...77,317,828 		JBrowse link
G Dek DEK proto-oncogene increases expression ISO Progesterone results in increased expression of DEK protein CTD PMID:23071688 NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122 		JBrowse link
G Dennd1c DENN domain containing 1C decreases expression ISO Progesterone results in decreased expression of DENND1C mRNA CTD PMID:22238285 NCBI chr 9:1,904,040...1,916,329
Ensembl chr 9:1,991,039...2,003,151 		JBrowse link
G Dennd2a DENN domain containing 2A multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of DENND2A mRNA CTD PMID:17404688 NCBI chr 4:69,199,814...69,299,128
Ensembl chr 4:69,199,814...69,298,984 		JBrowse link
G Dennd2d DENN domain containing 2D decreases expression ISO Progesterone results in decreased expression of DENND2D mRNA CTD PMID:22238285 NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:196,661,345...196,682,397 		JBrowse link
G Depdc1 DEP domain containing 1 decreases expression ISO Progesterone results in decreased expression of DEPDC1 mRNA CTD PMID:21795739 NCBI chr 2:251,343,250...251,376,709
Ensembl chr 2:251,343,281...251,376,709 		JBrowse link
G Depdc1b DEP domain containing 1B increases expression ISO Progesterone results in increased expression of DEPDC1B mRNA CTD PMID:21540246 NCBI chr 2:41,605,686...41,697,207
Ensembl chr 2:41,624,922...41,697,202 		JBrowse link
G Depp1 DEPP autophagy regulator 1 multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Progesterone results in increased expression of DEPP1 mRNA] CTD PMID:16123073 PMID:18070364 PMID:20864642 NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:151,581,502...151,586,233 		JBrowse link
G Deptor DEP domain containing MTOR-interacting protein decreases expression ISO Progesterone results in decreased expression of DEPTOR mRNA CTD PMID:23541542 NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041 		JBrowse link
G Des desmin decreases expression
multiple interactions
increases expression 		ISO
EXP 		Progesterone results in decreased expression of DES mRNA
[Progesterone co-treated with Estradiol] results in decreased expression of DES mRNA
Progesterone results in increased expression of DES mRNA
[Estradiol co-treated with Progesterone] results in increased expression of DES mRNA 		CTD PMID:18070364 PMID:18692832 PMID:19089455 PMID:20726854 NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:84,298,447...84,307,347 		JBrowse link
G Dgkb diacylglycerol kinase, beta decreases expression ISO Progesterone results in decreased expression of DGKB mRNA CTD PMID:21795739 NCBI chr 6:60,368,101...61,124,420
Ensembl chr 6:60,368,519...61,124,420 		JBrowse link
G Dgkd diacylglycerol kinase, delta decreases expression ISO Progesterone results in decreased expression of DGKD mRNA CTD PMID:21540246 NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:95,964,148...96,055,160 		JBrowse link
G Dhcr7 7-dehydrocholesterol reductase increases expression ISO Progesterone results in increased expression of DHCR7 mRNA CTD PMID:18070364 NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 multiple interactions
increases expression 		ISO 7-propyl spirolactone inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; [Estradiol co-treated with Progesterone] results in decreased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein; Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; Mifepristone promotes the reaction [Progesterone affects the expression of DHRS3 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]
Progesterone results in increased expression of DHRS3 mRNA 		CTD PMID:20660070 PMID:21540246 PMID:22414680 PMID:23275455 NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653 		JBrowse link
G Dhx15 DEAH-box helicase 15 decreases expression ISO Progesterone results in decreased expression of DHX15 mRNA CTD PMID:18037150 NCBI chr14:62,999,886...63,037,829
Ensembl chr14:62,999,877...63,037,828 		JBrowse link
G Diaph1 diaphanous-related formin 1 decreases expression ISO Progesterone results in decreased expression of DIAPH1 mRNA CTD PMID:18037150 NCBI chr18:29,920,889...30,020,280
Ensembl chr18:29,920,889...30,020,280 		JBrowse link
G Diaph2 diaphanous-related formin 2 increases expression ISO Progesterone results in increased expression of DIAPH2 mRNA CTD PMID:20864642 NCBI chr  X:92,395,189...93,234,521
Ensembl chr  X:96,700,726...97,528,080 		JBrowse link
G Diaph3 diaphanous-related formin 3 decreases expression ISO Progesterone results in decreased expression of DIAPH3 mRNA CTD PMID:21795739 NCBI chr15:62,543,375...63,013,060
Ensembl chr15:68,951,989...69,421,552 		JBrowse link
G Dicer1 dicer 1 ribonuclease III increases expression ISO Progesterone results in increased expression of DICER1 mRNA CTD PMID:20852728 NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252 		JBrowse link
G Dio2 iodothyronine deiodinase 2 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of DIO2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of DIO2 mRNA
Progesterone results in decreased expression of DIO2 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:115,396,308...115,410,594 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions
increases expression
affects response to substance 		ISO [Estradiol co-treated with Progesterone] results in increased expression of DKK1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of DKK1 mRNA; Mifepristone inhibits the reaction [Progesterone results in increased expression of DKK1 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of DKK1 protein]
Progesterone results in increased expression of DKK1 mRNA; Progesterone results in increased expression of DKK1 protein
DKK1 protein affects the susceptibility to Progesterone 		CTD PMID:16449346 PMID:17404688 PMID:20660070 PMID:20864642 PMID:21546446 More... NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dkk3 dickkopf WNT signaling pathway inhibitor 3 decreases expression ISO Progesterone results in decreased expression of DKK3 mRNA CTD PMID:21273126 NCBI chr 1:175,672,834...175,715,867
Ensembl chr 1:175,672,834...175,715,186 		JBrowse link
G Dlc1 DLC1 Rho GTPase activating protein multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Progesterone results in increased expression of DLC1 mRNA] CTD PMID:15674352 NCBI chr16:61,954,177...62,374,819
Ensembl chr16:61,995,001...62,374,819 		JBrowse link
G Dld dihydrolipoamide dehydrogenase increases abundance EXP DLD protein results in increased abundance of Progesterone CTD PMID:25981801 NCBI chr 6:53,631,686...53,655,059
Ensembl chr 6:53,619,631...53,652,354 		JBrowse link
G Dleu7 deleted in lymphocytic leukemia, 7 increases expression ISO Progesterone results in increased expression of DLEU7 mRNA CTD PMID:22238285 NCBI chr15:40,655,563...40,671,759
Ensembl chr15:40,655,563...40,671,759 		JBrowse link
G Dlg5 discs large MAGUK scaffold protein 5 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of DLG5 mRNA
Progesterone results in increased expression of DLG5 mRNA 		CTD PMID:18497975 PMID:20660070 NCBI chr15:75,786...209,735
Ensembl chr15:125,290...237,332 		JBrowse link
G Dlgap1 DLG associated protein 1 decreases expression ISO Progesterone results in decreased expression of DLGAP1 mRNA CTD PMID:22238285 NCBI chr 9:117,304,144...118,173,463
Ensembl chr 9:117,614,061...118,173,463 		JBrowse link
G Dlgap5 DLG associated protein 5 decreases expression ISO Progesterone results in decreased expression of DLGAP5 mRNA CTD PMID:21795739 NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176 		JBrowse link
G Dlx2 distal-less homeobox 2 decreases expression ISO Progesterone results in decreased expression of DLX2 mRNA CTD PMID:21795739 NCBI chr 3:76,777,912...76,781,255
Ensembl chr 3:76,777,912...76,781,255 		JBrowse link
G Dlx4 distal-less homeobox 4 increases expression ISO Progesterone results in increased expression of DLX4 mRNA CTD PMID:18070364 NCBI chr10:80,085,037...80,090,434
Ensembl chr10:80,582,303...80,587,294 		JBrowse link
G Dlx5 distal-less homeobox 5 decreases expression ISO Progesterone results in decreased expression of DLX5 mRNA CTD PMID:22238285 NCBI chr 4:35,965,579...35,969,973
Ensembl chr 4:35,965,579...35,969,845 		JBrowse link
G Dmac2l distal membrane arm assembly component 2 like multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of DMAC2L mRNA CTD PMID:17404688 NCBI chr 6:93,941,605...93,959,932
Ensembl chr 6:93,941,690...93,960,662 		JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of DMBT1 mRNA CTD PMID:17404688 NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:195,047,713...195,126,704 		JBrowse link
G Dmd dystrophin multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of DMD mRNA CTD PMID:20660070 NCBI chr  X:47,272,324...49,504,219
Ensembl chr  X:51,070,273...53,437,835 		JBrowse link
G Dmp1 dentin matrix acidic phosphoprotein 1 increases expression ISO Progesterone results in increased expression of DMP1 mRNA CTD PMID:19000923 NCBI chr14:5,833,111...5,867,154
Ensembl chr14:5,833,111...5,843,993 		JBrowse link
G Dmpk DM1 protein kinase affects expression ISO Progesterone affects the expression of DMPK mRNA CTD PMID:17251523 NCBI chr 1:87,858,294...87,868,624
Ensembl chr 1:87,858,316...87,868,910 		JBrowse link
G Dnaaf2 dynein, axonemal, assembly factor 2 increases expression ISO Progesterone results in increased expression of DNAAF2 mRNA CTD PMID:18070364 NCBI chr 6:87,661,101...87,670,267
Ensembl chr 6:93,397,164...93,406,323 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression ISO Progesterone results in increased expression of DNAJB1 mRNA CTD PMID:18037150 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 affects expression ISO Progesterone affects the expression of DNAJB11 mRNA CTD PMID:17251523 NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression ISO Progesterone results in increased expression of DNAJB9 mRNA CTD PMID:18037150 PMID:18070364 NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344 		JBrowse link
G Dnajc15 DnaJ heat shock protein family (Hsp40) member C15 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of DNAJC15 mRNA CTD PMID:20660070 NCBI chr15:53,182,060...53,249,675
Ensembl chr15:59,594,314...59,658,987 		JBrowse link
G Dnajc8 DnaJ heat shock protein family (Hsp40) member C8 affects expression ISO Progesterone affects the expression of DNAJC8 mRNA CTD PMID:17251523 NCBI chr 5:144,745,055...144,763,106
Ensembl chr 5:150,026,286...150,047,117 		JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of DNAJC9 mRNA CTD PMID:20660070 NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304 		JBrowse link
G Dner delta/notch-like EGF repeat containing multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of DNER mRNA CTD PMID:20660070 NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:93,035,108...93,350,568 		JBrowse link
G Dnm3 dynamin 3 decreases expression ISO Progesterone results in decreased expression of DNM3 mRNA CTD PMID:21795739 NCBI chr13:74,359,043...74,838,135
Ensembl chr13:76,892,171...77,371,350 		JBrowse link
G Dnmbp dynamin binding protein multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of DNMBP mRNA CTD PMID:19693291 NCBI chr 1:242,736,189...242,829,431
Ensembl chr 1:252,685,406...252,778,688 		JBrowse link
G Dnttip1 deoxynucleotidyltransferase, terminal, interacting protein 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of DNTTIP1 mRNA CTD PMID:18556351 NCBI chr 3:173,901,070...173,924,742
Ensembl chr 3:173,900,945...173,925,098 		JBrowse link
G Doc2b double C2 domain beta increases expression ISO Progesterone results in increased expression of DOC2B mRNA CTD PMID:22238285 NCBI chr10:61,126,295...61,151,533
Ensembl chr10:61,126,295...61,151,533 		JBrowse link
G Dock4 dedicator of cytokinesis 4 decreases expression ISO Progesterone results in decreased expression of DOCK4 mRNA CTD PMID:21795739 NCBI chr 6:63,240,050...63,629,772
Ensembl chr 6:63,240,136...63,629,772 		JBrowse link
G Dpep1 dipeptidase 1 increases expression EXP Progesterone results in increased expression of DPEP1 mRNA CTD PMID:20726854 NCBI chr19:68,118,270...68,143,781
Ensembl chr19:68,118,453...68,143,775 		JBrowse link
G Dpp4 dipeptidylpeptidase 4 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of DPP4 mRNA
Progesterone results in increased expression of DPP4 mRNA 		CTD PMID:17404688 PMID:21540246 PMID:21795739 NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422 		JBrowse link
G Dpp6 dipeptidyl peptidase like 6 increases expression EXP Progesterone results in increased expression of DPP6 mRNA CTD PMID:20726854 NCBI chr 4:7,589,386...8,508,666
Ensembl chr 4:8,324,843...9,242,209 		JBrowse link
G Dpp7 dipeptidylpeptidase 7 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of DPP7 mRNA CTD PMID:18556351 NCBI chr 3:28,563,240...28,567,492
Ensembl chr 3:28,563,240...28,567,492 		JBrowse link
G Dpt dermatopontin increases expression ISO Progesterone results in increased expression of DPT mRNA CTD PMID:22238285 NCBI chr13:79,656,341...79,684,759
Ensembl chr13:79,655,985...79,684,758 		JBrowse link
G Drd4 dopamine receptor D4 increases expression ISO Progesterone results in increased expression of DRD4 mRNA CTD PMID:22238285 NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458 		JBrowse link
G Dsp desmoplakin multiple interactions
decreases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in decreased expression of DSP mRNA] CTD PMID:17556502 PMID:22238285 NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121 		JBrowse link
G Dst dystonin decreases expression ISO Progesterone results in decreased expression of DST mRNA CTD PMID:18070364 NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533 		JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase homolog decreases expression ISO Progesterone results in decreased expression of DTL mRNA CTD PMID:21795739 NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174 		JBrowse link
G Duox1 dual oxidase 1 decreases expression ISO Progesterone results in decreased expression of DUOX1 mRNA CTD PMID:21540246 NCBI chr 3:129,714,125...129,749,186
Ensembl chr 3:129,714,149...129,749,187 		JBrowse link
G Dus1l dihydrouridine synthase 1-like increases expression EXP Progesterone results in increased expression of DUS1L mRNA CTD PMID:16376865 NCBI chr10:106,055,519...106,062,656
Ensembl chr10:106,553,238...106,561,285 		JBrowse link
G Dus3l dihydrouridine synthase 3-like decreases expression ISO Progesterone results in decreased expression of DUS3L mRNA CTD PMID:18037150 NCBI chr 9:1,680,619...1,685,784
Ensembl chr 9:1,675,819...1,686,367 		JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of DUSP1 mRNA
Progesterone results in increased expression of DUSP1 mRNA 		CTD PMID:17404688 PMID:21795739 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dusp22 dual specificity phosphatase 22 increases expression ISO Progesterone results in increased expression of DUSP22 mRNA CTD PMID:18037150 NCBI chr17:33,780,980...33,831,241
Ensembl chr17:33,989,637...34,039,895 		JBrowse link
G Dusp26 dual specificity phosphatase 26 increases expression ISO Progesterone results in increased expression of DUSP26 mRNA CTD PMID:22238285 NCBI chr16:67,744,830...67,752,673
Ensembl chr16:67,744,842...67,752,101 		JBrowse link
G Dusp5 dual specificity phosphatase 5 increases expression ISO Progesterone results in increased expression of DUSP5 mRNA CTD PMID:18037150 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression
decreases expression
multiple interactions 		ISO Progesterone results in increased expression of DUSP6 mRNA
Progesterone results in decreased expression of DUSP6 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of DUSP6 mRNA 		CTD PMID:18037150 PMID:20660070 PMID:20864642 NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833 		JBrowse link
G Dxo decapping exoribonuclease multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of DXO mRNA
Progesterone results in increased expression of DXO mRNA 		CTD PMID:18692832 NCBI chr20:3,997,953...4,000,115
Ensembl chr20:3,997,955...4,000,037 		JBrowse link
G Dynlrb1 dynein light chain roadblock-type 1 affects expression ISO Progesterone affects the expression of DYNLRB1 mRNA CTD PMID:17251523 NCBI chr 3:143,742,427...143,764,227
Ensembl chr 3:164,202,953...164,224,409 		JBrowse link
G Dyrk2 dual specificity tyrosine phosphorylation regulated kinase 2 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of DYRK2 mRNA CTD PMID:17404688 NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:56,235,276...56,265,942 		JBrowse link
G E2f1 E2F transcription factor 1 decreases expression ISO Progesterone results in decreased expression of E2F1 mRNA CTD PMID:16966611 NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:163,524,739...163,535,563 		JBrowse link
G E2f8 E2F transcription factor 8 decreases expression ISO Progesterone results in decreased expression of E2F8 mRNA CTD PMID:21795739 NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009 		JBrowse link
G Eaf2 ELL associated factor 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of EAF2 mRNA CTD PMID:20660070 NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993 		JBrowse link
G Ebi3 Epstein-Barr virus induced 3 increases expression
multiple interactions 		ISO Progesterone results in increased expression of EBI3 mRNA
TGFB1 protein promotes the reaction [Progesterone results in increased expression of EBI3 mRNA] 		CTD PMID:21768398 NCBI chr 9:861,441...874,731
Ensembl chr 9:870,792...874,973 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase increases expression ISO Progesterone results in increased expression of EBP mRNA CTD PMID:18070364 NCBI chr  X:16,971,372...16,977,782
Ensembl chr  X:16,971,405...16,977,781 		JBrowse link
G Ece2 endothelin-converting enzyme 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ECE2 mRNA CTD PMID:21453500 NCBI chr11:93,767,559...93,782,896
Ensembl chr11:93,767,559...93,793,292 		JBrowse link
G Ech1 enoyl-CoA hydratase 1 increases expression EXP Progesterone results in increased expression of ECH1 mRNA CTD PMID:20726854 NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440 		JBrowse link
G Echdc2 enoyl CoA hydratase domain containing 2 decreases expression ISO Progesterone results in decreased expression of ECHDC2 mRNA CTD PMID:21540246 NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:128,144,425...128,163,610 		JBrowse link
G Echs1 enoyl-CoA hydratase, short chain 1 increases expression EXP Progesterone results in increased expression of ECHS1 mRNA CTD PMID:20726854 NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:204,324,682...204,333,506 		JBrowse link
G Ecm1 extracellular matrix protein 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of ECM1 mRNA CTD PMID:20226447 NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606 		JBrowse link
G Edn1 endothelin 1 multiple interactions
increases expression
decreases expression 		ISO
EXP 		Progesterone inhibits the reaction [Estradiol results in increased expression of EDN1 mRNA]; Progesterone inhibits the reaction [Estradiol results in increased secretion of EDN1 protein]
Progesterone results in increased expression of EDN1 mRNA
Progesterone results in decreased expression of EDN1 mRNA 		CTD PMID:20726854 PMID:21795739 PMID:22238285 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Edn3 endothelin 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of EDN3 mRNA CTD PMID:20660070 NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329 		JBrowse link
G Ednra endothelin receptor type A decreases expression ISO Progesterone results in decreased expression of EDNRA mRNA CTD PMID:21795739 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Ednrb endothelin receptor type B multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of EDNRB mRNA
Progesterone results in increased expression of EDNRB mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of EEF2K mRNA CTD PMID:20660070 NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:184,824,420...184,888,048 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of EFEMP1 mRNA CTD PMID:20660070 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Efhd1 EF-hand domain family, member D1 increases expression ISO Progesterone results in increased expression of EFHD1 mRNA CTD PMID:20864642 NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798 		JBrowse link
G Efna1 ephrin A1 increases expression ISO Progesterone results in increased expression of EFNA1 mRNA CTD PMID:18037150 NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:176,979,434...176,988,726 		JBrowse link
G Efnb2 ephrin B2 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of EFNB2 mRNA
Progesterone results in decreased expression of EFNB2 mRNA 		CTD PMID:17404688 NCBI chr16:80,783,389...80,827,420
Ensembl chr16:87,485,198...87,529,208 		JBrowse link
G Efs embryonal Fyn-associated substrate multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of EFS mRNA CTD PMID:17404688 NCBI chr15:32,362,401...32,374,490
Ensembl chr15:32,361,843...32,371,743 		JBrowse link
G Egf epidermal growth factor multiple interactions
increases expression 		ISO
EXP 		Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]; Progesterone promotes the reaction [EGF protein affects the localization of FOS protein]; Progesterone promotes the reaction [EGF protein results in increased expression of FOS mRNA]; Progesterone promotes the reaction [EGF protein results in increased expression of FOS protein]; Progesterone promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]; U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]
Progesterone results in increased expression of EGF mRNA 		CTD PMID:16175315 PMID:18591650 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfl6 EGF-like-domain, multiple 6 decreases expression ISO Progesterone results in decreased expression of EGFL6 mRNA CTD PMID:22238285 NCBI chr  X:31,515,752...31,573,699
Ensembl chr  X:31,515,767...31,574,632 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in increased expression of EGFR mRNA; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [FSHB protein results in increased chemical synthesis of Progesterone]; Progesterone promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]
[Estrogens co-treated with Progesterone] results in increased expression of EGFR mRNA; [Estrogens co-treated with Progesterone] results in increased expression of EGFR protein
Progesterone results in increased expression of EGFR mRNA
Estradiol promotes the reaction [Progesterone inhibits the reaction [perfluorooctanoic acid results in decreased expression of EGFR protein]]; Progesterone inhibits the reaction [perfluorooctanoic acid results in decreased expression of EGFR protein]; Progesterone promotes the reaction [Estradiol inhibits the reaction [perfluorooctanoic acid results in decreased expression of EGFR protein]]
Progesterone results in increased expression of EGFR protein 		CTD PMID:16175315 PMID:18591650 PMID:18692832 PMID:21258428 PMID:21520325 More... NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 increases expression EXP Progesterone results in increased expression of EGLN3 mRNA CTD PMID:20726854 NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015 		JBrowse link
G Egr1 early growth response 1 multiple interactions
decreases expression
increases expression
affects expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of EGR1 mRNA
Mifepristone inhibits the reaction [Progesterone inhibits the reaction [bisphenol A results in increased expression of EGR1 mRNA]]; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA]]; Progesterone inhibits the reaction [bisphenol A results in increased expression of EGR1 mRNA]; Progesterone inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA]
Progesterone results in decreased expression of EGR1 mRNA
Progesterone results in increased expression of EGR1 mRNA
Progesterone affects the expression of EGR1 mRNA 		CTD PMID:17404688 PMID:20726854 PMID:21795739 PMID:23461915 PMID:25461906 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Egr2 early growth response 2 increases expression
multiple interactions 		EXP
ISO 		Progesterone results in increased expression of EGR2 mRNA; Progesterone results in increased expression of EGR2 protein
[Estradiol co-treated with Progesterone] results in decreased expression of EGR2 mRNA 		CTD PMID:17478888 PMID:20660070 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Egr3 early growth response 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of EGR3 mRNA CTD PMID:20660070 NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712 		JBrowse link
G Ehbp1 EH domain binding protein 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of EHBP1 mRNA CTD PMID:20660070 NCBI chr14:96,093,327...96,380,502
Ensembl chr14:100,294,585...100,546,579 		JBrowse link
G Ehd1 EH-domain containing 1 decreases expression ISO Progesterone results in decreased expression of EHD1 mRNA CTD PMID:18037150 NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485 		JBrowse link
G Ehd2 EH-domain containing 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of EHD2 mRNA CTD PMID:20660070 NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:85,768,667...85,786,943 		JBrowse link
G Ehf ets homologous factor multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of EHF mRNA
Progesterone results in decreased expression of EHF mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 3:110,094,770...110,134,991
Ensembl chr 3:110,096,756...110,134,928 		JBrowse link
G Eif1 eukaryotic translation initiation factor 1 increases expression ISO Progesterone results in increased expression of EIF1 mRNA CTD PMID:21795739 NCBI chr10:85,246,751...85,248,842
Ensembl chr 5:25,895,968...25,896,654
Ensembl chr10:25,895,968...25,896,654 		JBrowse link
G Eif2s3 eukaryotic translation initiation factor 2 subunit gamma multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of EIF2S3 mRNA CTD PMID:17404688 NCBI chr  X:58,916,513...58,939,923
Ensembl chr  X:62,910,293...62,934,489 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of EIF4EBP1 protein CTD PMID:22465879 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Eif4ebp2 eukaryotic translation initiation factor 4E binding protein 2 affects expression ISO Progesterone affects the expression of EIF4EBP2 mRNA CTD PMID:17251523 NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,922,260...29,942,922 		JBrowse link
G Eif4g3 eukaryotic translation initiation factor 4 gamma, 3 affects expression ISO Progesterone affects the expression of EIF4G3 mRNA CTD PMID:17251523 NCBI chr 5:150,197,410...150,418,862
Ensembl chr 5:155,481,378...155,702,194 		JBrowse link
G Eif5 eukaryotic translation initiation factor 5 increases expression ISO Progesterone results in increased expression of EIF5 mRNA CTD PMID:18037150 NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821 		JBrowse link
G Elf3 E74 like ETS transcription factor 3 increases expression ISO Progesterone results in increased expression of ELF3 mRNA CTD PMID:18497975 NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380 		JBrowse link
G Ell3 elongation factor for RNA polymerase II 3 decreases expression ISO Progesterone results in decreased expression of ELL3 mRNA CTD PMID:22238285 NCBI chr 3:128,866,755...128,870,896
Ensembl chr 3:128,864,777...128,870,852 		JBrowse link
G Eloa elongin A increases expression EXP Progesterone results in increased expression of ELOA mRNA CTD PMID:20726854 NCBI chr 5:148,231,600...148,246,760
Ensembl chr 5:153,515,066...153,530,916 		JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 decreases expression ISO Progesterone results in decreased expression of ELOVL1 mRNA CTD PMID:18037150 NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:137,246,849...137,251,352 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression ISO
EXP 		Progesterone results in increased expression of ELOVL6 mRNA
Progesterone results in increased expression of ELOVL6 protein 		CTD PMID:18070364 PMID:23180365 NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549 		JBrowse link
G Elovl7 ELOVL fatty acid elongase 7 decreases expression ISO Progesterone results in decreased expression of ELOVL7 mRNA CTD PMID:22238285 NCBI chr 2:41,522,695...41,592,021
Ensembl chr 2:41,522,738...41,592,020 		JBrowse link
G Emb embigin decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of EMB mRNA
NCOA2 protein affects the reaction [Progesterone results in decreased expression of EMB mRNA] 		CTD PMID:17556502 NCBI chr 2:50,803,468...50,858,001
Ensembl chr 2:50,801,973...50,862,920 		JBrowse link
G Emp2 epithelial membrane protein 2 increases expression ISO Progesterone results in increased expression of EMP2 mRNA CTD PMID:20864642 NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532 		JBrowse link
G Enc1 ectodermal-neural cortex 1 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ENC1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ENC1 mRNA
Progesterone results in decreased expression of ENC1 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721 		JBrowse link
G Eng endoglin multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Progesterone results in increased expression of ENG mRNA] CTD PMID:20431248 NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933 		JBrowse link
G Enpep glutamyl aminopeptidase increases expression ISO Progesterone results in increased expression of ENPEP mRNA CTD PMID:17404688 PMID:20864642 PMID:21540246 NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218 		JBrowse link
G Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 increases expression ISO Progesterone results in increased expression of ENPP1 mRNA CTD PMID:20864642 NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 affects expression ISO Progesterone affects the expression of ENPP2 mRNA CTD PMID:17251523 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957 		JBrowse link
G Enpp3 ectonucleotide pyrophosphatase/phosphodiesterase 3 increases expression ISO Progesterone results in increased expression of ENPP3 mRNA CTD PMID:22238285 NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:22,382,964...22,454,314 		JBrowse link
G Enpp4 ectonucleotide pyrophosphatase/phosphodiesterase 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ENPP4 mRNA CTD PMID:20660070 NCBI chr 9:16,888,923...16,898,860
Ensembl chr 9:24,360,272...24,396,152 		JBrowse link
G Entpd8 ectonucleoside triphosphate diphosphohydrolase 8 decreases expression ISO Progesterone results in decreased expression of ENTPD8 mRNA CTD PMID:22238285 NCBI chr 3:28,283,392...28,295,686
Ensembl chr 3:28,285,777...28,293,686 		JBrowse link
G Entrep1 endosomal transmembrane epsin interactor 1 increases expression ISO Progesterone results in increased expression of ENTREP1 mRNA CTD PMID:22238285 NCBI chr 1:231,018,987...231,073,474
Ensembl chr 1:231,018,987...231,102,708 		JBrowse link
G Epb41l4a erythrocyte membrane protein band 4.1 like 4A multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of EPB41L4A mRNA CTD PMID:17404688 NCBI chr18:25,680,169...25,890,998
Ensembl chr18:25,680,171...25,888,498 		JBrowse link
G Epb41l4b erythrocyte membrane protein band 4.1 like 4B multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of EPB41L4B mRNA
Progesterone results in decreased expression of EPB41L4B mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 5:76,486,886...76,647,752
Ensembl chr 5:76,486,902...76,647,752 		JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 decreases expression ISO Progesterone results in decreased expression of EPB41L5 mRNA CTD PMID:22238285 NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133 		JBrowse link
G Epha3 Eph receptor A3 increases expression ISO Progesterone results in increased expression of EPHA3 mRNA CTD PMID:21795739 NCBI chr11:14,585,041...14,920,721
Ensembl chr11:14,586,727...14,920,425 		JBrowse link
G Epha6 Eph receptor A6 decreases expression EXP Progesterone results in decreased expression of EPHA6 mRNA CTD PMID:21770760 NCBI chr11:39,757,501...40,708,901
Ensembl chr11:53,226,954...54,166,987 		JBrowse link
G Epha7 Eph receptor A7 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of EPHA7 mRNA CTD PMID:20660070 NCBI chr 5:47,771,776...47,925,189
Ensembl chr 5:47,771,865...47,925,058 		JBrowse link
G Epha8 Eph receptor A8 increases expression ISO Progesterone results in increased expression of EPHA8 mRNA CTD PMID:22238285 NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:154,449,566...154,476,966 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 decreases expression ISO Progesterone results in decreased expression of ERBB4 mRNA CTD PMID:22238285 NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:76,973,227...78,045,772 		JBrowse link
G Erbin erbb2 interacting protein increases expression ISO Progesterone results in increased expression of ERBIN mRNA CTD PMID:18037150 NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:36,660,399...36,762,153 		JBrowse link
G Erc2 ELKS/RAB6-interacting/CAST family member 2 increases expression ISO Progesterone results in increased expression of ERC2 mRNA CTD PMID:22238285 NCBI chr16:2,819,399...3,680,258
Ensembl chr16:2,819,512...3,680,258 		JBrowse link
G Erp27 endoplasmic reticulum protein 27 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ERP27 mRNA CTD PMID:20660070 NCBI chr 4:171,535,845...171,552,848
Ensembl chr 4:171,535,847...171,553,072 		JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 affects expression
increases expression 		ISO Progesterone affects the expression of ERRFI1 mRNA
Progesterone results in increased expression of ERRFI1 mRNA 		CTD PMID:17251523 PMID:20864642 PMID:21795739 NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432 		JBrowse link
G Esr1 estrogen receptor 1 decreases expression
increases activity
decreases activity
multiple interactions 		ISO
EXP 		Progesterone results in decreased expression of ESR1 mRNA
Progesterone results in increased activity of ESR1 protein
Progesterone results in decreased activity of ESR1 protein
ESR1 protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased expression of IHH mRNA]; ESR1 protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased expression of LIF mRNA]; Progesterone inhibits the reaction [ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]]
Progesterone results in decreased expression of ESR1 mRNA; Progesterone results in decreased expression of ESR1 mRNA alternative form; Progesterone results in decreased expression of ESR1 protein
ESR1 protein affects the reaction [Progesterone results in increased expression of GREB1 mRNA]; ESR1 protein affects the reaction [Progesterone results in increased expression of SGK1 mRNA]; Fulvestrant inhibits the reaction [Progesterone results in increased activity of ESR1 protein]
[Estradiol co-treated with Progesterone] results in decreased expression of ESR1 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of ESR1 mRNA alternative form; [Estradiol co-treated with Progesterone] results in increased expression of ESR1 mRNA; bisphenol A inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ESR1 protein]; Diethylstilbestrol inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ESR1 protein]; Progesterone inhibits the reaction [Estradiol results in increased expression of ESR1 mRNA] 		CTD PMID:16002535 PMID:17974624 PMID:18037150 PMID:18653720 PMID:19094096 More... NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 increases expression
decreases expression
multiple interactions
affects binding 		ISO
EXP 		Progesterone metabolite results in increased expression of ESR2 mRNA
Progesterone results in decreased expression of ESR2 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of ESR2 mRNA; Progesterone inhibits the reaction [Estradiol results in increased expression of ESR2 mRNA]
Progesterone binds to ESR2 protein
ESR2 affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of OXT mRNA]; Progesterone inhibits the reaction [ESR2 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] 		CTD PMID:12834440 PMID:17683929 PMID:17974624 PMID:19094096 PMID:19913605 More... NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Esrra estrogen related receptor, alpha increases expression ISO Progesterone results in increased expression of ESRRA mRNA CTD PMID:15968320 NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811 		JBrowse link
G Etl4 enhancer trap locus 4 increases expression ISO Progesterone results in increased expression of KIAA1217 mRNA CTD PMID:20864642 NCBI chr17:82,841,075...83,304,868
Ensembl chr17:87,403,819...88,213,158 		JBrowse link
G Etv1 ETS variant transcription factor 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of ETV1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of ETV1 mRNA 		CTD PMID:18070364 PMID:20660070 NCBI chr 6:61,316,836...61,408,985
Ensembl chr 6:61,317,429...61,408,959 		JBrowse link
G Etv5 ETS variant transcription factor 5 decreases expression ISO Progesterone results in decreased expression of ETV5 mRNA CTD PMID:20864642 NCBI chr11:92,113,171...92,170,758
Ensembl chr11:92,113,224...92,170,767 		JBrowse link
G Evi2a ecotropic viral integration site 2A increases expression
multiple interactions 		ISO Progesterone results in increased expression of EVI2A mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of EVI2A mRNA 		CTD PMID:18070364 PMID:20660070 NCBI chr10:64,983,727...64,987,627
Ensembl chr10:64,983,705...64,999,516 		JBrowse link
G Exo1 exonuclease 1 decreases expression ISO Progesterone results in decreased expression of EXO1 mRNA CTD PMID:22238285 NCBI chr13:87,809,725...87,834,654
Ensembl chr13:90,342,018...90,366,861 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit increases expression ISO Progesterone results in increased expression of EZH2 mRNA CTD PMID:18070364 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G F10 coagulation factor X increases expression ISO Progesterone results in increased expression of F10 mRNA CTD PMID:18497975 NCBI chr16:83,170,973...83,190,280
Ensembl chr16:83,170,977...83,190,280 		JBrowse link
G F13a1 coagulation factor XIII A1 chain multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of F13A1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of F13A1 mRNA CTD PMID:17404688 PMID:20660070 NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948 		JBrowse link
G F2 coagulation factor II, thrombin multiple interactions ISO [Hirudins binds to and results in decreased activity of F2 protein] promotes the reaction [CGB3 protein results in increased chemical synthesis of Progesterone]
[Hirudins binds to and results in decreased activity of F2 protein] which results in increased chemical synthesis of Progesterone 		CTD PMID:22207716 NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246 		JBrowse link
G F2r coagulation factor II (thrombin) receptor affects expression
increases expression
multiple interactions 		ISO
EXP 		Progesterone affects the expression of F2R mRNA
Progesterone results in increased expression of F2R mRNA
[N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamine binds to and results in decreased activity of F2R protein] which results in increased chemical synthesis of Progesterone
[C186 65 binds to and results in increased activity of F2R protein] inhibits the reaction [CGB3 protein results in increased chemical synthesis of Progesterone]; [N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamine binds to and results in decreased activity of F2R protein] promotes the reaction [CGB3 protein results in increased chemical synthesis of Progesterone] 		CTD PMID:11733402 PMID:17251523 PMID:21770760 PMID:22207716 NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:28,604,066...28,620,579 		JBrowse link
G F2rl1 F2R like trypsin receptor 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of F2RL1 mRNA CTD PMID:20660070 NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954 		JBrowse link
G F2rl2 coagulation factor II (thrombin) receptor-like 2 decreases expression ISO Progesterone results in decreased expression of F2RL2 mRNA CTD PMID:20864642 NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:28,706,501...28,712,473 		JBrowse link
G F2rl3 F2R like thrombin or trypsin receptor 3 multiple interactions ISO [GYPGKF-NH(2) binds to and results in increased activity of F2RL3 protein] inhibits the reaction [CGB3 protein results in increased chemical synthesis of Progesterone] CTD PMID:22207716 NCBI chr16:17,151,516...17,153,509
Ensembl chr16:17,151,516...17,153,823 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of F3 mRNA; Mifepristone inhibits the reaction [Progesterone results in increased expression of F3 protein]
Progesterone results in increased expression of F3 mRNA
Progesterone results in increased expression of F3 mRNA; Progesterone results in increased expression of F3 protein 		CTD PMID:15562024 PMID:20660070 PMID:20726854 PMID:21795739 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Faah fatty acid amide hydrolase increases expression
increases activity 		ISO Progesterone results in increased expression of FAAH mRNA; Progesterone results in increased expression of FAAH protein
Progesterone results in increased activity of FAAH protein 		CTD PMID:16154199 NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:134,716,545...134,735,396 		JBrowse link
G Fabp3 fatty acid binding protein 3 increases expression EXP Progesterone results in increased expression of FABP3 mRNA CTD PMID:20726854 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881 		JBrowse link
G Fabp4 fatty acid binding protein 4 increases expression ISO
EXP 		Progesterone results in increased expression of FABP4 mRNA CTD PMID:15713686 PMID:21770760 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fabp5 fatty acid binding protein 5 decreases expression ISO Progesterone results in decreased expression of FABP5 mRNA CTD PMID:19693291 NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127 		JBrowse link
G Fadd Fas associated via death domain increases expression ISO Progesterone results in increased expression of FADD mRNA CTD PMID:21549006 NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976 		JBrowse link
G Fads1 fatty acid desaturase 1 increases expression ISO Progesterone results in increased expression of FADS1 mRNA CTD PMID:18070364 NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615 		JBrowse link
G Fads2 fatty acid desaturase 2 increases expression ISO Progesterone results in increased expression of FADS2 mRNA CTD PMID:18070364 NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066 		JBrowse link
G Fads3 fatty acid desaturase 3 increases expression ISO Progesterone results in increased expression of FADS3 mRNA CTD PMID:21795739 NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758 		JBrowse link
G Faim Fas apoptotic inhibitory molecule multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of FAIM mRNA
Progesterone results in increased expression of FAIM mRNA 		CTD PMID:17404688 NCBI chr 8:99,543,877...99,569,499
Ensembl chr 8:108,423,221...108,440,151 		JBrowse link
G Fam107a family with sequence similarity 107, member A increases expression ISO Progesterone results in increased expression of FAM107A mRNA CTD PMID:17404688 NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219 		JBrowse link
G Fam110c family with sequence similarity 110, member C decreases expression ISO Progesterone results in decreased expression of FAM110C mRNA CTD PMID:21540246 NCBI chr 6:53,366,013...53,372,270
Ensembl chr 6:53,352,870...53,401,117 		JBrowse link
G Fam171b family with sequence similarity 171, member B multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of FAM171B mRNA CTD PMID:20660070 NCBI chr 3:89,337,566...89,392,973
Ensembl chr 3:89,337,661...89,392,971 		JBrowse link
G Fam181b family with sequence similarity 181, member B increases expression ISO Progesterone results in increased expression of FAM181B mRNA CTD PMID:21540246 NCBI chr 1:156,578,821...156,580,318
Ensembl chr 1:156,491,094...156,595,845 		JBrowse link
G Fam43a family with sequence similarity 43, member A decreases expression ISO Progesterone results in decreased expression of FAM43A mRNA CTD PMID:20864642 NCBI chr11:83,633,165...83,636,313
Ensembl chr11:83,633,154...83,695,297 		JBrowse link
G Fam83g family with sequence similarity 83, member G decreases expression ISO Progesterone results in decreased expression of FAM83G mRNA CTD PMID:22238285 NCBI chr10:46,363,029...46,388,030
Ensembl chr10:46,862,369...46,886,277 		JBrowse link
G Fanci FA complementation group I increases expression ISO Progesterone results in increased expression of FANCI mRNA CTD PMID:18070364 NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:142,736,653...142,792,999 		JBrowse link
G Fat2 FAT atypical cadherin 2 decreases expression ISO Progesterone results in decreased expression of FAT2 mRNA CTD PMID:18037150 PMID:22238285 NCBI chr10:39,864,765...39,957,027
Ensembl chr10:39,864,766...39,956,902 		JBrowse link
G Faxdc2 fatty acid hydroxylase domain containing 2 increases expression ISO Progesterone results in increased expression of FAXDC2 mRNA CTD PMID:18070364 NCBI chr10:42,245,808...42,271,679
Ensembl chr10:42,747,524...42,781,458 		JBrowse link
G Fbln1 fibulin 1 increases expression ISO Progesterone results in increased expression of FBLN1 mRNA CTD PMID:15774544 NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965 		JBrowse link
G Fbln2 fibulin 2 increases expression ISO Progesterone results in increased expression of FBLN2 mRNA CTD PMID:17404688 NCBI chr 4:125,261,464...125,321,030
Ensembl chr 4:125,261,607...125,321,029 		JBrowse link
G Fbln5 fibulin 5 increases expression ISO Progesterone results in increased expression of FBLN5 mRNA CTD PMID:21795739 NCBI chr 6:126,664,100...126,742,847
Ensembl chr 6:126,664,100...126,746,296 		JBrowse link
G Fbn2 fibrillin 2 increases expression EXP Progesterone results in increased expression of FBN2 mRNA CTD PMID:20726854 NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191 		JBrowse link
G Fbxl7 F-box and leucine-rich repeat protein 7 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of FBXL7 mRNA CTD PMID:20660070 NCBI chr 2:78,870,236...79,239,697
Ensembl chr 2:78,871,287...79,239,697 		JBrowse link
G Fbxo11 F-box protein 11 increases expression ISO Progesterone results in increased expression of FBXO11 mRNA CTD PMID:18037150 NCBI chr 6:12,240,348...12,316,223
Ensembl chr 6:12,239,801...12,316,221 		JBrowse link
G Fbxo32 F-box protein 32 multiple interactions ISO [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA] CTD PMID:23275455 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fcgr3a Fc gamma receptor 3A increases expression ISO Progesterone results in increased expression of FCGR3A mRNA CTD PMID:21540246 NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651 		JBrowse link
G Fcsk fucose kinase affects response to substance ISO FCSK gene SNP affects the susceptibility to Progesterone CTD PMID:25622337 NCBI chr19:38,849,130...38,874,497
Ensembl chr19:55,739,842...55,800,496 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 increases expression ISO Progesterone results in increased expression of FDFT1 mRNA CTD PMID:18070364 NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168 		JBrowse link
G Fdps farnesyl diphosphate synthase increases expression
affects expression 		ISO Progesterone results in increased expression of FDPS mRNA
Progesterone affects the expression of FDPS mRNA 		CTD PMID:17251523 PMID:18070364 NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 decreases expression ISO Progesterone results in decreased expression of FEN1 mRNA CTD PMID:16966611 NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016 		JBrowse link
G Fermt1 FERM domain containing kindlin 1 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of FERMT1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of FERMT1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of FERMT1 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 3:120,171,301...120,213,555
Ensembl chr 3:140,624,434...140,666,419 		JBrowse link
G Fermt2 FERM domain containing kindlin 2 increases expression ISO Progesterone results in increased expression of FERMT2 mRNA CTD PMID:20864642 NCBI chr15:18,682,927...18,751,959
Ensembl chr15:21,162,605...21,258,115 		JBrowse link
G Fga fibrinogen alpha chain multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of FGA mRNA CTD PMID:17404688 PMID:18692832 NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:170,672,012...170,679,577 		JBrowse link
G Fgb fibrinogen beta chain increases expression ISO Progesterone results in increased expression of FGB mRNA CTD PMID:21540246 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434 		JBrowse link
G Fgd4 FYVE, RhoGEF and PH domain containing 4 increases expression ISO Progesterone results in increased expression of FGD4 mRNA CTD PMID:21795739 NCBI chr11:84,399,989...84,551,013
Ensembl chr11:97,904,182...98,055,190 		JBrowse link
G Fgf13 fibroblast growth factor 13 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of FGF13 mRNA CTD PMID:18692832 NCBI chr  X:137,276,498...137,800,056
Ensembl chr  X:142,312,391...142,423,536 		JBrowse link
G Fgf18 fibroblast growth factor 18 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of FGF18 mRNA
Progesterone results in decreased expression of FGF18 mRNA 		CTD PMID:17404688 PMID:18037150 NCBI chr10:18,210,240...18,241,929
Ensembl chr10:18,210,512...18,240,933 		JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of FGF2 mRNA CTD PMID:18692832 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fgf4 fibroblast growth factor 4 decreases expression EXP Progesterone results in decreased expression of FGF4 mRNA CTD PMID:21770760 NCBI chr 1:209,453,229...209,457,085
Ensembl chr 1:209,453,229...209,457,085 		JBrowse link
G Fgf9 fibroblast growth factor 9 multiple interactions
decreases expression 		ISO [FGF9 protein co-treated with FSHB protein] affects the abundance of Progesterone; [Progesterone co-treated with Estradiol] results in decreased expression of FGF9 mRNA; FGF9 protein inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased abundance of Progesterone]; FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone]]; FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Colforsin results in increased abundance of Progesterone]]; FGF9 protein inhibits the reaction [IGF1 protein results in increased abundance of Progesterone]; FGF9 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone]
Progesterone results in decreased expression of FGF9 mRNA 		CTD PMID:17404688 PMID:22238285 PMID:22798350 NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926 		JBrowse link
G Fgfbp1 fibroblast growth factor binding protein 1 decreases expression ISO Progesterone results in decreased expression of FGFBP1 mRNA CTD PMID:18037150 NCBI chr14:71,316,171...71,319,965
Ensembl chr14:71,317,065...71,320,309 		JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 affects expression
multiple interactions 		ISO Progesterone affects the expression of FGFR2 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of FGFR2 mRNA 		CTD PMID:17251523 PMID:20660070 NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914 		JBrowse link
G Fgl1 fibrinogen-like 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of FGL1 mRNA CTD PMID:20660070 NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429 		JBrowse link
G Fgl2 fibrinogen-like 2 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of FGL2 mRNA
Progesterone results in increased expression of FGL2 mRNA 		CTD PMID:17404688 PMID:22238285 NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405 		JBrowse link
G Fh fumarate hydratase decreases expression ISO Progesterone results in decreased expression of FH mRNA CTD PMID:18037150 NCBI chr13:90,056,565...90,082,450
Ensembl chr13:90,056,570...90,089,627 		JBrowse link
G Fhl2 four and a half LIM domains 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of FHL2 mRNA CTD PMID:20660070 NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326 		JBrowse link
G Fhod3 formin homology 2 domain containing 3 decreases expression ISO Progesterone results in decreased expression of FHOD3 mRNA CTD PMID:20864642 NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508 		JBrowse link
G Fibin fin bud initiation factor homolog increases expression ISO Progesterone results in increased expression of FIBIN mRNA CTD PMID:22238285 NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479 		JBrowse link
G Filip1l filamin A interacting protein 1-like increases expression ISO Progesterone results in increased expression of FILIP1L mRNA CTD PMID:21540246 NCBI chr11:56,403,467...56,646,422
Ensembl chr11:56,410,582...56,646,402 		JBrowse link
G Fjx1 four-jointed box kinase 1 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of FJX1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of FJX1 mRNA
Progesterone results in decreased expression of FJX1 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:20864642 NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:109,227,170...109,232,479 		JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 affects expression ISO Progesterone affects the expression of FKBP11 mRNA CTD PMID:17251523 NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of FKBP5 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of FKBP5 mRNA; Arsenic inhibits the reaction [Progesterone results in increased expression of FKBP5 mRNA] CTD PMID:17404688 PMID:18037150 PMID:19693291 PMID:20660070 PMID:20864642 More... NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Flrt2 fibronectin leucine rich transmembrane protein 2 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of FLRT2 mRNA CTD PMID:17404688 NCBI chr 6:120,507,998...120,603,133
Ensembl chr 6:120,507,689...120,609,004 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 affects expression ISO Progesterone affects the expression of FLT1 mRNA CTD PMID:17251523 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Fmn1 formin 1 decreases expression ISO Progesterone results in decreased expression of FMN1 mRNA CTD PMID:21795739 NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:120,555,431...120,933,124 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 increases expression EXP Progesterone results in increased expression of FMO3 mRNA CTD PMID:20726854 NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256 		JBrowse link
G Fn1 fibronectin 1 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of FN1 mRNA
[Progesterone co-treated with Estradiol] results in decreased expression of FN1 mRNA 		CTD PMID:18070364 PMID:20226447 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fndc1 fibronectin type III domain containing 1 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of FNDC1 mRNA
Progesterone results in decreased expression of FNDC1 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 1:47,281,839...47,364,247
Ensembl chr 1:49,686,856...49,769,263 		JBrowse link
G Fndc3a fibronectin type III domain containing 3a increases expression ISO Progesterone results in increased expression of FNDC3A mRNA CTD PMID:18037150 NCBI chr15:47,689,909...47,867,354
Ensembl chr15:54,099,510...54,276,407 		JBrowse link
G Folr1 folate receptor alpha multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of FOLR1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of FOLR1 mRNA CTD PMID:18692832 PMID:20660070 NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:165,631,462...165,642,669 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of FOS mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of FOS mRNA; Progesterone promotes the reaction [EGF protein affects the localization of FOS protein]; Progesterone promotes the reaction [EGF protein results in increased expression of FOS mRNA]; Progesterone promotes the reaction [EGF protein results in increased expression of FOS protein]
[Estrogens co-treated with Progesterone] results in increased expression of FOS protein
[estradiol 3-benzoate co-treated with Progesterone] results in increased abundance of FOS protein; [Estradiol co-treated with Progesterone] results in increased expression of FOS mRNA
Progesterone results in increased expression of FOS mRNA
Progesterone results in decreased expression of FOS mRNA 		CTD PMID:16175315 PMID:16376865 PMID:18556351 PMID:18692832 PMID:19847363 More... NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of FOSB mRNA CTD PMID:20660070 NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Progesterone results in increased expression of FOSL1 mRNA CTD PMID:19000923 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Foxa2 forkhead box A2 decreases expression ISO Progesterone results in decreased expression of FOXA2 mRNA CTD PMID:22238285 NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757 		JBrowse link
G Foxo1 forkhead box O1 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [FOXO1 protein binds to G6PC1 promoter]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]; Progesterone promotes the reaction [Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [FOXO1 protein binds to G6PC1 promoter]]]
Progesterone results in increased expression of FOXO1 mRNA; Progesterone results in increased expression of FOXO1A mRNA 		CTD PMID:20864642 PMID:21768169 PMID:21795739 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Foxp3 forkhead box P3 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of FOXP3 mRNA
[Progesterone co-treated with Estradiol] inhibits the reaction [Vaccines, Virus-Like Particle results in decreased expression of FOXP3 protein]; Progesterone inhibits the reaction [Vaccines, Virus-Like Particle results in decreased expression of FOXP3 protein]
[Estradiol co-treated with Progesterone] results in decreased expression of FOXP3 mRNA 		CTD PMID:19693291 PMID:20130130 NCBI chr  X:17,580,380...17,601,181
Ensembl chr  X:17,580,380...17,595,894 		JBrowse link
G Fpr1 formyl peptide receptor 1 affects expression ISO Progesterone affects the expression of FPR1 mRNA CTD PMID:17251523 NCBI chr 1:67,417,991...67,429,813
Ensembl chr 1:67,421,313...67,422,520 		JBrowse link
G Frmd3 FERM domain containing 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of FRMD3 mRNA CTD PMID:20660070 NCBI chr 5:87,764,755...88,031,091
Ensembl chr 5:92,810,736...93,077,325 		JBrowse link
G Frmd4a FERM domain containing 4A decreases expression ISO Progesterone results in decreased expression of FRMD4A mRNA CTD PMID:18070364 NCBI chr17:73,667,787...74,258,487
Ensembl chr17:78,579,277...79,167,663 		JBrowse link
G Frmd6 FERM domain containing 6 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of FRMD6 mRNA CTD PMID:20660070 NCBI chr 6:89,345,983...89,419,579
Ensembl chr 6:95,081,985...95,155,560 		JBrowse link
G Fry FRY microtubule binding protein decreases expression ISO Progesterone results in decreased expression of FRY mRNA CTD PMID:20864642 NCBI chr12:9,530,360...9,773,391
Ensembl chr12:9,530,360...9,897,603 		JBrowse link
G Frzb frizzled-related protein decreases expression ISO Progesterone results in decreased expression of FRZB mRNA CTD PMID:19693291 NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:85,739,165...85,772,096 		JBrowse link
G Fscn1 fascin actin-bundling protein 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of FSCN1 mRNA CTD PMID:17404688 NCBI chr12:11,597,042...11,610,183
Ensembl chr12:16,710,601...16,723,734 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions
increases abundance
increases secretion
increases chemical synthesis
decreases expression
increases expression 		ISO
EXP 		1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [TGFB1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased activity of [SMAD2 protein co-treated with SMAD3 protein]] promotes the reaction [FSHB protein results in increased chemical synthesis of Progesterone]; [6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride results in decreased activity of SMAD3 protein] inhibits the reaction [FSHB protein results in increased chemical synthesis of Progesterone]; [CGA protein co-treated with FSHB protein] results in increased abundance of Progesterone; [CGA protein co-treated with FSHB protein] results in increased secretion of Progesterone; [FGF9 protein co-treated with FSHB protein] affects the abundance of Progesterone; [FSHB protein co-treated with Testosterone] results in increased chemical synthesis of Progesterone; [IGF1 protein co-treated with FSHB protein] results in increased abundance of Progesterone; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [FSHB protein results in increased chemical synthesis of Progesterone]; Carbaryl inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; FGF9 protein inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased abundance of Progesterone]; finrozole inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; Fulvestrant inhibits the reaction [TGFB1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]]; GDF9 protein inhibits the reaction [INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]]; INHA mutant form inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; INHA mutant form inhibits the reaction [GDF9 protein inhibits the reaction [INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]]]; INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; Lipopolysaccharides inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[FSHB protein co-treated with Testosterone] results in increased chemical synthesis of Progesterone]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; PHB1 protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; T-2 Toxin inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; T0901317 inhibits the reaction [[CGA protein co-treated with FSHB protein] results in increased abundance of Progesterone]; TGFB1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]; Trichlorfon inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; U 0126 inhibits the reaction [Lipopolysaccharides inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]
NOG protein inhibits the reaction [Octreotide inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; NOG protein inhibits the reaction [pasireotide inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]
Progesterone results in decreased expression of FSHB protein
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [[FSHB protein co-treated with TGFB1 protein] results in increased abundance of Progesterone]; [BMP15 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; [BMP2 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; [BMP4 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; [BMP6 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; [BMP7 protein results in decreased expression of STAR mRNA] inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased abundance of Progesterone]; [FSHB protein co-treated with TGFB1 protein] results in increased abundance of Progesterone; [FSHB protein results in increased expression of CYP11A1 mRNA] which results in increased abundance of Progesterone; [FSHB protein results in increased expression of CYP19A1 mRNA] which results in increased abundance of Progesterone; [FSHB protein results in increased expression of HSD3B2 mRNA] which results in increased abundance of Progesterone; [FSHB protein results in increased expression of STAR mRNA] which results in increased abundance of Progesterone; [Triclosan co-treated with FSHB protein] results in increased secretion of Progesterone; AG 538 inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [FSHB protein results in increased abundance of Progesterone]; Dihydrotestosterone inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; GH1 protein inhibits the reaction [BMP4 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; GH1 protein inhibits the reaction [BMP6 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; GH1 protein inhibits the reaction [BMP7 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; GH1 protein promotes the reaction [[FSHB protein results in increased expression of CYP11A1 mRNA] which results in increased abundance of Progesterone]; GH1 protein promotes the reaction [[FSHB protein results in increased expression of HSD3B2 mRNA] which results in increased abundance of Progesterone]; GH1 protein promotes the reaction [[FSHB protein results in increased expression of STAR mRNA] which results in increased abundance of Progesterone]; GH1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]; IGF1 protein inhibits the reaction [BMP15 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP2 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP4 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP6 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP7 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of CYP11A1 mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of CYP19A1 mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of HSD3B2 mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of STAR mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]; INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; Metformin inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; Methoxychlor metabolite inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; NOG protein promotes the reaction [GH1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]]; Octreotide inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; pasireotide inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; pyrazolanthrone inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; RARRES2 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; tyrphostin AG 1024 inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; U 0126 inhibits the reaction [FSHB protein results in increased abundance of Progesterone]
Progesterone results in increased expression of FSHB mRNA 		CTD PMID:15781295 PMID:15967414 PMID:16413094 PMID:16574160 PMID:16675544 More... NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Fst follistatin multiple interactions
increases expression 		ISO FST protein inhibits the reaction [BMP6 protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]]; FST protein inhibits the reaction [INHBA protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]]
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of FST mRNA
Progesterone results in increased expression of FST mRNA; Progesterone results in increased expression of FST mRNA alternative form 		CTD PMID:18936084 PMID:22238285 PMID:22285243 PMID:32186404 NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491 		JBrowse link
G Fxyd3 FXYD domain-containing ion transport regulator 3 increases expression ISO Progesterone results in increased expression of FXYD3 mRNA CTD PMID:18497975 NCBI chr 1:86,305,531...86,312,455
Ensembl chr 1:95,432,919...95,439,702 		JBrowse link
G Fxyd4 FXYD domain-containing ion transport regulator 4 decreases expression
increases expression 		ISO Progesterone results in decreased expression of FXYD4 mRNA
Progesterone results in increased expression of FXYD4 mRNA 		CTD PMID:21540246 PMID:22238285 NCBI chr 4:151,109,779...151,113,659
Ensembl chr 4:152,782,181...152,786,039 		JBrowse link
G Fxyd5 FXYD domain-containing ion transport regulator 5 decreases expression EXP Progesterone results in decreased expression of FXYD5 mRNA CTD PMID:20726854 NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:95,395,146...95,405,364 		JBrowse link
G Fxyd6 FXYD domain-containing ion transport regulator 6 decreases expression EXP Progesterone results in decreased expression of FXYD6 mRNA CTD PMID:20726854 NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:54,575,591...54,602,715 		JBrowse link
G Fzd10 frizzled class receptor 10 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of FZD10 mRNA
Progesterone results in decreased expression of FZD10 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr12:28,098,371...28,101,566
Ensembl chr12:33,734,364...33,741,646 		JBrowse link
G Fzd5 frizzled class receptor 5 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of FZD5 mRNA CTD PMID:20660070 NCBI chr 9:73,606,860...73,614,039
Ensembl chr 9:73,606,860...73,618,612 		JBrowse link
G Fzd7 frizzled class receptor 7 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of FZD7 mRNA CTD PMID:20660070 NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585 		JBrowse link
G Fzr1 fizzy and cell division cycle 20 related 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of FZR1 protein; FZR1 mutant form inhibits the reaction [Progesterone affects the localization of CDKN1B protein] CTD PMID:23029392 NCBI chr 7:8,982,765...8,994,689
Ensembl chr 7:8,989,769...8,995,199 		JBrowse link
G G0s2 G0/G1switch 2 increases expression
affects expression
multiple interactions 		ISO Progesterone results in increased expression of G0S2 mRNA
Progesterone affects the expression of G0S2 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of G0S2 mRNA; perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of G0S2 mRNA]; Progesterone inhibits the reaction [perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of G0S2 mRNA]] 		CTD PMID:20660070 PMID:21795739 PMID:31896193 NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions ISO [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in decreased expression of G6PC1 mRNA]; [Progesterone co-treated with Estradiol] inhibits the reaction [Phenobarbital results in decreased expression of G6PC1 mRNA]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in decreased expression of G6PC1 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [Phenobarbital results in decreased expression of G6PC1 mRNA]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [FOXO1 protein binds to G6PC1 promoter]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in decreased expression of G6PC1 mRNA]; Progesterone inhibits the reaction [Phenobarbital results in decreased expression of G6PC1 mRNA]; Progesterone promotes the reaction [Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [FOXO1 protein binds to G6PC1 promoter]]]
1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [[Progesterone co-treated with Estradiol] results in increased expression of G6PC1 mRNA]; [Progesterone co-treated with Estradiol] results in increased expression of G6PC1 mRNA 		CTD PMID:21768169 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033 		JBrowse link
G Gabbr1 gamma-aminobutyric acid type B receptor subunit 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GABBR1 mRNA CTD PMID:20660070 NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607 		JBrowse link
G Gabpa GA binding protein transcription factor subunit alpha multiple interactions EXP [Progesterone co-treated with Norepinephrine] results in increased expression of GABPA mRNA CTD PMID:16954335 NCBI chr11:23,888,586...23,917,612
Ensembl chr11:37,375,084...37,404,059 		JBrowse link
G Gabra2 gamma-aminobutyric acid type A receptor subunit alpha 2 increases expression ISO Progesterone results in increased expression of GABRA2 mRNA CTD PMID:16000229 NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,450,683...37,587,457 		JBrowse link
G Gabra4 gamma-aminobutyric acid type A receptor subunit alpha 4 affects expression
multiple interactions
affects response to substance 		EXP Progesterone affects the expression of GABRA4 protein
[Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of GABRA4 mRNA
GABRA4 protein affects the susceptibility to Progesterone 		CTD PMID:12522171 PMID:15834956 PMID:19394921 NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,944,388...37,021,648 		JBrowse link
G Gabra5 gamma-aminobutyric acid type A receptor subunit alpha 5 decreases expression ISO Progesterone results in decreased expression of GABRA5 mRNA CTD PMID:16000229 NCBI chr 1:108,268,728...108,381,670
Ensembl chr 1:117,404,494...117,516,635 		JBrowse link
G Gabrb1 gamma-aminobutyric acid type A receptor subunit beta1 affects expression EXP Progesterone affects the expression of GABRB1 protein CTD PMID:15834956 NCBI chr14:36,434,339...36,917,920
Ensembl chr14:36,434,352...36,902,893 		JBrowse link
G Gabrd gamma-aminobutyric acid type A receptor subunit delta affects expression
decreases expression
multiple interactions 		EXP Progesterone affects the expression of GABRD mRNA; Progesterone affects the expression of GABRD protein; Progesterone metabolite affects the expression of GABRD mRNA
Progesterone results in decreased expression of GABRD protein
Finasteride inhibits the reaction [Progesterone affects the expression of GABRD mRNA]; Finasteride inhibits the reaction [Progesterone affects the expression of GABRD protein] 		CTD PMID:15834956 PMID:16879715 PMID:16914187 NCBI chr 5:165,958,508...165,970,407
Ensembl chr 5:171,240,789...171,253,094 		JBrowse link
G Gabre gamma-aminobutyric acid type A receptor subunit epsilon multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GABRE mRNA CTD PMID:20660070 NCBI chr  X:150,060,035...150,078,773
Ensembl chr  X:155,102,083...155,120,735 		JBrowse link
G Gabrg3 gamma-aminobutyric acid type A receptor subunit gamma 3 increases expression ISO Progesterone results in increased expression of GABRG3 mRNA CTD PMID:16000229 NCBI chr 1:116,763,332...117,386,770
Ensembl chr 1:116,763,129...117,382,536 		JBrowse link
G Gabrp gamma-aminobutyric acid type A receptor subunit pi multiple interactions
decreases expression
increases expression
affects localization 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of GABRP mRNA; HOXA10 protein affects the reaction [Progesterone affects the localization of GABRP protein]; HOXA10 protein affects the reaction [Progesterone results in increased expression of GABRP mRNA]
Progesterone results in decreased expression of GABRP mRNA 		CTD PMID:20103740 PMID:20660070 PMID:22238285 NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression
multiple interactions 		ISO
EXP 		Progesterone results in increased expression of GADD45A mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of GADD45A mRNA 		CTD PMID:18037150 PMID:20660070 PMID:20726854 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma affects expression ISO Progesterone affects the expression of GADD45G mRNA CTD PMID:17251523 NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369 		JBrowse link
G Gal galanin and GMAP prepropeptide multiple interactions EXP [Estradiol co-treated with Progesterone] results in increased expression of GAL mRNA; [Estrogens co-treated with Progesterone] results in increased expression of GAL mRNA; Dizocilpine Maleate inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of GAL mRNA]; Pentobarbital inhibits the reaction [[Estrogens co-treated with Progesterone] results in increased expression of GAL mRNA]; Phenoxybenzamine inhibits the reaction [[Estrogens co-treated with Progesterone] results in increased expression of GAL mRNA] CTD PMID:7512492 PMID:8730651 NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:210,079,702...210,084,229 		JBrowse link
G Galk2 galactokinase 2 increases expression ISO Progesterone results in increased expression of GALK2 mRNA CTD PMID:18070364 NCBI chr 3:113,110,057...113,243,014
Ensembl chr 3:133,563,538...133,696,528 		JBrowse link
G Galm galactose mutarotase affects expression ISO Progesterone affects the expression of GALM mRNA CTD PMID:17251523 NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:20,589,776...20,644,417 		JBrowse link
G Galnt10 polypeptide N-acetylgalactosaminyltransferase 10 affects response to substance ISO GALNT10 gene SNP affects the susceptibility to Progesterone CTD PMID:25622337 NCBI chr10:41,821,216...41,967,618
Ensembl chr10:42,322,161...42,468,087 		JBrowse link
G Gap43 growth associated protein 43 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of GAP43 mRNA
Progesterone inhibits the reaction [VPS54 mutant form results in increased expression of GAP43 mRNA] 		CTD PMID:17404688 PMID:19693665 NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase increases expression EXP Progesterone results in increased expression of GAPDH mRNA CTD PMID:16376865 NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377 		JBrowse link
G Gar1 GAR1 ribonucleoprotein decreases expression ISO Progesterone results in decreased expression of GAR1 mRNA CTD PMID:18037150 NCBI chr 2:221,049,471...221,056,749
Ensembl chr 2:221,049,473...221,056,749 		JBrowse link
G Gars1 glycyl-tRNA synthetase 1 increases expression ISO Progesterone results in increased expression of GARS1 mRNA CTD PMID:18037150 NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876 		JBrowse link
G Gas1 growth arrest-specific 1 increases expression ISO Progesterone results in increased expression of GAS1 mRNA CTD PMID:21540246 NCBI chr17:4,487,716...4,490,701
Ensembl chr17:4,484,283...4,497,657 		JBrowse link
G Gas2l3 growth arrest-specific 2 like 3 decreases expression ISO Progesterone results in decreased expression of GAS2L3 mRNA CTD PMID:21795739 NCBI chr 7:25,690,929...25,726,806
Ensembl chr 7:25,693,660...25,716,942 		JBrowse link
G Gas6 growth arrest specific 6 multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of GAS6 mRNA
Progesterone results in increased expression of GAS6 mRNA 		CTD PMID:20660070 PMID:20726854 PMID:22238285 NCBI chr16:76,045,430...76,075,904
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gask1b golgi associated kinase 1B increases expression ISO Progesterone results in increased expression of GASK1B mRNA CTD PMID:21795739 NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:167,345,809...167,410,603 		JBrowse link
G Gast gastrin multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of GAST mRNA CTD PMID:17404688 NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,765,216...85,767,880 		JBrowse link
G Gata2 GATA binding protein 2 multiple interactions ISO [Progesterone results in increased activity of PGR protein] which results in increased expression of GATA2 mRNA CTD PMID:15845616 NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055 		JBrowse link
G Gata4 GATA binding protein 4 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of GATA4 mRNA
Mifepristone inhibits the reaction [Progesterone results in decreased expression of GATA4 mRNA] 		CTD PMID:27264040 PMID:31566189 NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609 		JBrowse link
G Gata6 GATA binding protein 6 increases expression ISO Progesterone results in increased expression of GATA6 mRNA CTD PMID:21540246 NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,458,253...2,492,322 		JBrowse link
G Gatm glycine amidinotransferase decreases expression EXP
ISO 		Progesterone results in decreased expression of GATM mRNA CTD PMID:20726854 PMID:22238285 NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355 		JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GBP2 mRNA CTD PMID:20660070 NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810 		JBrowse link
G Gbp4 guanylate binding protein 4 decreases expression ISO Progesterone results in decreased expression of GBP4 mRNA CTD PMID:20864642 NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit decreases expression ISO Progesterone results in decreased expression of GCLC mRNA CTD PMID:22238285 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gcnt1 glucosaminyl (N-acetyl) transferase 1 increases expression
multiple interactions 		EXP
ISO 		Progesterone results in increased expression of GCNT1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of GCNT1 mRNA 		CTD PMID:20660070 PMID:20726854 PMID:20864642 PMID:21795739 NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:224,141,108...224,185,741 		JBrowse link
G Gcsam germinal center-associated, signaling and motility affects expression ISO Progesterone affects the expression of GCSAM mRNA CTD PMID:17251523 NCBI chr11:55,195,757...55,207,011
Ensembl chr11:68,660,438...68,669,584 		JBrowse link
G Gda guanine deaminase increases expression EXP Progesterone results in increased expression of GDA mRNA CTD PMID:20726854 NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Progesterone results in increased expression of GDF15 mRNA
Progesterone results in decreased expression of GDF15 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of GDF15 mRNA 		CTD PMID:18037150 PMID:20660070 PMID:20726854 PMID:22238285 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gdf5 growth differentiation factor 5 increases expression ISO Progesterone results in increased expression of GDF5 mRNA CTD PMID:22238285 NCBI chr 3:164,914,401...164,918,593
Ensembl chr 3:164,914,401...164,918,593 		JBrowse link
G Gdf9 growth differentiation factor 9 multiple interactions ISO GDF9 protein inhibits the reaction [INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]]; GDF9 protein inhibits the reaction [INHBA protein results in decreased secretion of Progesterone]; INHA mutant form inhibits the reaction [GDF9 protein inhibits the reaction [INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]]] CTD PMID:20660033 NCBI chr10:37,589,200...37,599,970
Ensembl chr10:38,089,878...38,100,797 		JBrowse link
G Gdnf glial cell derived neurotrophic factor increases expression ISO Progesterone results in increased expression of GDNF mRNA CTD PMID:22238285 NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240 		JBrowse link
G Gdpd2 glycerophosphodiester phosphodiesterase domain containing 2 increases expression ISO Progesterone results in increased expression of GDPD2 mRNA CTD PMID:22238285 NCBI chr  X:69,866,395...69,875,419
Ensembl chr  X:69,866,799...69,875,414 		JBrowse link
G Gem GTP binding protein overexpressed in skeletal muscle multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of GEM mRNA
Progesterone results in increased expression of GEM mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542 		JBrowse link
G Gemin6 gem (nuclear organelle) associated protein 6 decreases expression ISO Progesterone results in decreased expression of GEMIN6 mRNA CTD PMID:18037150 NCBI chr 6:14,786,090...14,790,617
Ensembl chr 6:20,538,325...20,542,852 		JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] promotes the reaction [Cuprizone results in increased expression of GFAP mRNA]
Progesterone results in increased expression of GFAP mRNA
Progesterone results in decreased expression of GFAP protein
Finasteride inhibits the reaction [Progesterone results in increased expression of GFAP mRNA] 		CTD PMID:19031445 PMID:19360904 PMID:21770760 PMID:23157231 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685 		JBrowse link
G Gfi1 growth factor independent 1 transcriptional repressor increases expression
multiple interactions 		ISO Progesterone results in increased expression of GFI1 mRNA
TGFB1 protein promotes the reaction [Progesterone results in increased expression of GFI1 mRNA] 		CTD PMID:21768398 NCBI chr14:2,185,489...2,204,191
Ensembl chr14:2,187,286...2,196,730 		JBrowse link
G Gfpt2 glutamine-fructose-6-phosphate transaminase 2 increases expression ISO Progesterone results in increased expression of GFPT2 mRNA CTD PMID:18037150 NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419 		JBrowse link
G Gfra2 GDNF family receptor alpha 2 increases expression ISO Progesterone results in increased expression of GFRA2 mRNA CTD PMID:22238285 NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782 		JBrowse link
G Gga1 golgi associated, gamma adaptin ear containing, ARF binding protein 1 affects expression ISO Progesterone affects the expression of GGA1 mRNA CTD PMID:17251523 NCBI chr 7:110,436,071...110,451,790
Ensembl chr 7:112,315,449...112,332,249 		JBrowse link
G Ggt5 gamma-glutamyltransferase 5 increases expression
affects expression 		ISO Progesterone results in increased expression of GGT5 mRNA
Progesterone affects the expression of GGT5 mRNA 		CTD PMID:17251523 PMID:21540246 NCBI chr20:13,042,694...13,070,960
Ensembl chr20:13,042,696...13,070,892 		JBrowse link
G Ggt6 gamma-glutamyl transferase 6 increases expression ISO Progesterone results in increased expression of GGT6 mRNA CTD PMID:22238285 NCBI chr10:57,550,447...57,553,461
Ensembl chr10:57,550,492...57,553,460 		JBrowse link
G Ggta1 glycoprotein alpha-galactosyltransferase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of GGTA1 mRNA; Mifepristone inhibits the reaction [Progesterone affects the expression of GGTA1 mRNA] CTD PMID:20660070 PMID:22414680 NCBI chr 3:18,732,985...18,824,916
Ensembl chr 3:39,130,467...39,206,870 		JBrowse link
G Gh1 growth hormone 1 multiple interactions
increases secretion 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in increased secretion of GH1 protein
GH1 protein inhibits the reaction [BMP4 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; GH1 protein inhibits the reaction [BMP6 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; GH1 protein inhibits the reaction [BMP7 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; GH1 protein promotes the reaction [[FSHB protein results in increased expression of CYP11A1 mRNA] which results in increased abundance of Progesterone]; GH1 protein promotes the reaction [[FSHB protein results in increased expression of HSD3B2 mRNA] which results in increased abundance of Progesterone]; GH1 protein promotes the reaction [[FSHB protein results in increased expression of STAR mRNA] which results in increased abundance of Progesterone]; GH1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]; NOG protein promotes the reaction [GH1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]]
Progesterone results in increased secretion of GH1 protein 		CTD PMID:15772906 PMID:22067323 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Ghr growth hormone receptor increases expression EXP Progesterone results in increased expression of GHR mRNA CTD PMID:20726854 NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331 		JBrowse link
G Gipc2 GIPC PDZ domain containing family, member 2 decreases expression ISO Progesterone results in decreased expression of GIPC2 mRNA CTD PMID:22238285 NCBI chr 2:243,690,742...243,770,199
Ensembl chr 2:243,690,748...243,770,199 		JBrowse link
G Gja1 gap junction protein, alpha 1 increases expression
decreases expression 		EXP
ISO 		Progesterone results in increased expression of GJA1 mRNA
Progesterone results in decreased expression of GJA1 protein 		CTD PMID:20726854 PMID:21558462 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gja4 gap junction protein, alpha 4 multiple interactions
increases expression
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of GJA4 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of GJA4 mRNA
Progesterone results in increased expression of GJA4 mRNA
Progesterone results in decreased expression of GJA4 mRNA 		CTD PMID:17404688 PMID:18692832 PMID:20660070 NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216 		JBrowse link
G Gja5 gap junction protein, alpha 5 increases expression EXP Progesterone results in increased expression of GJA5 mRNA CTD PMID:20726854 NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:187,234,674...187,318,512 		JBrowse link
G Gjb2 gap junction protein, beta 2 affects expression
decreases expression
multiple interactions 		ISO Progesterone affects the expression of GJB2 mRNA
Progesterone results in decreased expression of GJB2 mRNA
Progesterone results in decreased expression of GJB2 protein
[Estradiol co-treated with Progesterone] results in increased expression of GJB2 mRNA 		CTD PMID:17251523 PMID:20660070 PMID:21558462 PMID:22238285 NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877 		JBrowse link
G Gjb3 gap junction protein, beta 3 decreases expression ISO Progesterone results in decreased expression of GJB3 mRNA CTD PMID:22238285 NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:144,933,696...144,940,280 		JBrowse link
G Gjb6 gap junction protein, beta 6 affects expression
decreases expression 		ISO Progesterone affects the expression of GJB6 mRNA
Progesterone results in decreased expression of GJB6 mRNA 		CTD PMID:17251523 PMID:22238285 NCBI chr15:31,284,561...31,294,552
Ensembl chr15:35,398,770...35,410,849 		JBrowse link
G Gk glycerol kinase increases expression ISO Progesterone results in increased expression of GK mRNA CTD PMID:18070364 NCBI chr  X:54,106,708...54,189,940
Ensembl chr  X:54,112,214...54,196,701 		JBrowse link
G Glb1l2 galactosidase, beta 1-like 2 increases expression ISO Progesterone results in increased expression of GLB1L2 mRNA CTD PMID:20864642 NCBI chr 8:25,115,462...25,166,843
Ensembl chr 8:33,390,678...33,442,695 		JBrowse link
G Gldc glycine decarboxylase increases expression ISO Progesterone results in increased expression of GLDC mRNA CTD PMID:22238285 NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604 		JBrowse link
G Gli1 GLI family zinc finger 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of GLI1 mRNA CTD PMID:22958837 NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540 		JBrowse link
G Gli2 GLI family zinc finger 2 affects expression ISO Progesterone affects the expression of GLI2 mRNA CTD PMID:17251523 NCBI chr13:29,946,882...30,163,589
Ensembl chr13:32,499,678...32,716,418 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of GLIPR1 mRNA
Progesterone results in increased expression of GLIPR1 mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640 		JBrowse link
G Glis2 GLIS family zinc finger 2 decreases expression ISO Progesterone results in decreased expression of GLIS2 mRNA CTD PMID:18037150 NCBI chr10:11,457,594...11,484,948
Ensembl chr10:11,457,792...11,477,995 		JBrowse link
G Glt1d1 glycosyltransferase 1 domain containing 1 increases expression ISO Progesterone results in increased expression of GLT1D1 mRNA CTD PMID:21540246 NCBI chr12:34,611,942...34,685,591
Ensembl chr12:34,612,643...34,685,468 		JBrowse link
G Gltp glycolipid transfer protein multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of GLTP mRNA CTD PMID:20660070 NCBI chr12:41,907,168...41,927,321
Ensembl chr12:47,567,770...47,587,946 		JBrowse link
G Glul glutamate-ammonia ligase increases expression EXP Progesterone results in increased expression of GLUL mRNA CTD PMID:20726854 NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520 		JBrowse link
G Glyat glycine-N-acyltransferase multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of GLYAT mRNA
Progesterone results in increased expression of GLYAT mRNA 		CTD PMID:17404688 NCBI chr 1:219,128,798...219,149,615
Ensembl chr 1:219,128,811...219,150,774 		JBrowse link
G Gmnn geminin, DNA replication inhibitor decreases expression ISO Progesterone results in decreased expression of GMNN mRNA CTD PMID:18037150 NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,729,824...40,738,068 		JBrowse link
G Gmpr guanosine monophosphate reductase decreases expression ISO Progesterone results in decreased expression of GMPR mRNA CTD PMID:21540246 NCBI chr17:19,357,992...19,395,807
Ensembl chr17:19,357,992...19,431,655 		JBrowse link
G Gna11 G protein subunit alpha 11 affects expression ISO Progesterone affects the expression of GNA11 mRNA CTD PMID:17251523 NCBI chr 7:8,814,285...8,828,628
Ensembl chr 7:8,814,327...8,830,558 		JBrowse link
G Gnai3 G protein subunit alpha i3 multiple interactions
decreases expression 		ISO CAV3 mutant form inhibits the reaction [Progesterone results in decreased expression of GNAI3 protein]; Cholesterol inhibits the reaction [Progesterone results in decreased expression of GNAI3 protein] CTD PMID:19221014 NCBI chr 2:198,430,920...198,468,874 JBrowse link
G Gnao1 G protein subunit alpha o1 increases expression EXP Progesterone results in increased expression of GNAO1 mRNA CTD PMID:20726854 NCBI chr19:11,040,788...11,198,437
Ensembl chr19:11,040,788...11,198,437 		JBrowse link
G Gnas GNAS complex locus increases expression
multiple interactions 		EXP
ISO 		Progesterone results in increased expression of GNAS protein
CAV3 mutant form inhibits the reaction [Progesterone results in increased expression of GNAS protein]; Cholesterol inhibits the reaction [Progesterone results in increased expression of GNAS protein] 		CTD PMID:15469997 PMID:19221014 NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536 		JBrowse link
G Gng11 G protein subunit gamma 11 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of GNG11 mRNA CTD PMID:20660070 NCBI chr 4:32,977,681...32,983,121
Ensembl chr 4:32,977,664...32,984,438 		JBrowse link
G Gng12 G protein subunit gamma 12 affects expression ISO Progesterone affects the expression of GNG12 mRNA CTD PMID:17251523 NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:97,340,472...97,464,476 		JBrowse link
G Gng2 G protein subunit gamma 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GNG2 mRNA CTD PMID:20660070 NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,365,135...4,466,059 		JBrowse link
G Gng4 G protein subunit gamma 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GNG4 mRNA CTD PMID:20660070 NCBI chr17:93,432,791...93,481,709
Ensembl chr17:93,433,195...93,481,709 		JBrowse link
G Gnl2 G protein nucleolar 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GNL2 mRNA CTD PMID:21453500 NCBI chr 5:137,293,141...137,318,528
Ensembl chr 5:142,577,731...142,603,178 		JBrowse link
G Gnrh1 gonadotropin releasing hormone 1 multiple interactions
decreases abundance 		ISO [Progesterone co-treated with Estradiol] results in increased secretion of GNRH1 protein; Tamoxifen inhibits the reaction [[Progesterone co-treated with Estradiol] results in increased secretion of GNRH1 protein]
GNRH1 protein results in decreased abundance of Progesterone 		CTD PMID:10566683 PMID:19261682 NCBI chr15:46,147,878...46,152,086
Ensembl chr15:46,148,301...46,148,977
Ensembl chr15:46,148,301...46,148,977 		JBrowse link
G Gnrhr gonadotropin releasing hormone receptor multiple interactions ISO [Estradiol co-treated with Progesterone] inhibits the reaction [Triptorelin Pamoate affects the expression of GNRHR mRNA]; [Estradiol co-treated with Progesterone] results in decreased expression of GNRHR mRNA; Progesterone promotes the reaction [Triptorelin Pamoate affects the expression of GNRHR mRNA] CTD PMID:17185802 NCBI chr14:21,856,871...21,874,861 JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases expression
multiple interactions 		ISO
EXP 		Progesterone results in increased expression of GOT1 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of GOT1 mRNA 		CTD PMID:18037150 PMID:20660070 PMID:20726854 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871 		JBrowse link
G Gp1bb glycoprotein Ib platelet subunit beta decreases expression EXP Progesterone results in decreased expression of GP1BB mRNA CTD PMID:20726854 NCBI chr11:95,882,561...95,883,738 JBrowse link
G Gpaa1 glycosylphosphatidylinositol anchor attachment 1 affects expression ISO Progesterone affects the expression of GPAA1 mRNA CTD PMID:17251523 NCBI chr 7:109,932,556...109,936,139
Ensembl chr 7:109,932,544...109,936,138 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 affects expression ISO Progesterone affects the expression of GPD1 mRNA CTD PMID:17251523 NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:132,721,915...132,730,368 		JBrowse link
G Gpd1l glycerol-3-phosphate dehydrogenase 1 like multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of GPD1L mRNA; [Progesterone co-treated with Estradiol] results in increased expression of GPD1L mRNA CTD PMID:17404688 PMID:20660070 NCBI chr 8:114,591,103...114,620,771
Ensembl chr 8:123,466,667...123,498,908 		JBrowse link
G Gpd2 glycerol-3-phosphate dehydrogenase 2 increases expression ISO Progesterone results in increased expression of GPD2 mRNA CTD PMID:19693291 NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:62,210,814...62,346,593 		JBrowse link
G Gpr149 G protein-coupled receptor 149 decreases expression EXP Progesterone results in decreased expression of GPR149 mRNA CTD PMID:20726854 NCBI chr 2:146,909,710...146,981,924
Ensembl chr 2:149,059,336...149,130,785 		JBrowse link
G Gpr155 G protein-coupled receptor 155 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GPR155 mRNA CTD PMID:20660070 NCBI chr 3:78,623,931...78,677,803
Ensembl chr 3:78,607,976...78,677,803 		JBrowse link
G Gpr17 G protein-coupled receptor 17 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of GPR17 mRNA
[Progesterone co-treated with Estradiol] results in decreased expression of GPR17 mRNA 		CTD PMID:17404688 NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,850,107...23,857,702 		JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GPRC5A mRNA CTD PMID:20660070 NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:169,634,748...169,653,625 		JBrowse link
G Gprc5b G protein-coupled receptor, class C, group 5, member B multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of GPRC5B mRNA
Progesterone results in increased expression of GPRC5B mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757 		JBrowse link
G Gprc5c G protein-coupled receptor, class C, group 5, member C multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GPRC5C mRNA CTD PMID:19693291 NCBI chr10:99,886,900...99,908,928
Ensembl chr10:100,383,631...100,426,962 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions EXP [Progesterone co-treated with Estradiol] results in decreased activity of GPT protein CTD PMID:15820610 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions
affects expression
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of GPX2 mRNA
Progesterone affects the expression of GPX2 mRNA
Progesterone results in decreased expression of GPX2 mRNA 		CTD PMID:17251523 PMID:17404688 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862 		JBrowse link
G Gpx3 glutathione peroxidase 3 affects expression
multiple interactions
increases expression 		ISO
EXP 		Progesterone affects the expression of GPX3 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of GPX3 mRNA
Progesterone results in increased expression of GPX3 mRNA 		CTD PMID:17251523 PMID:18556351 PMID:19693291 PMID:20726854 PMID:20864642 NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,529,448...39,537,405 		JBrowse link
G Grb10 growth factor receptor bound protein 10 increases expression ISO Progesterone results in increased expression of GRB10 mRNA CTD PMID:21795739 NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387 		JBrowse link
G Grb2 growth factor receptor bound protein 2 multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of GRB2 mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of GRB2 protein CTD PMID:22465879 NCBI chr10:100,881,404...100,949,193
Ensembl chr10:101,380,356...101,448,138 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions
decreases expression
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of GREB1 mRNA; ESR1 protein affects the reaction [Progesterone results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [Progesterone results in increased expression of GREB1 mRNA]
Progesterone results in decreased expression of GREB1 mRNA 		CTD PMID:17404688 PMID:20864642 PMID:22238285 PMID:33405908 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist multiple interactions
decreases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of GREM1 mRNA
Progesterone results in decreased expression of GREM1 mRNA 		CTD PMID:17404688 PMID:20726854 PMID:20864642 NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:120,966,623...120,979,089 		JBrowse link
G Grhl1 grainyhead-like transcription factor 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of GRHL1 mRNA CTD PMID:20660070 NCBI chr 6:46,935,947...46,986,126
Ensembl chr 6:46,935,967...46,980,264 		JBrowse link
G Grhl3 grainyhead-like transcription factor 3 decreases expression ISO Progesterone results in decreased expression of GRHL3 mRNA CTD PMID:22238285 NCBI chr 5:153,057,760...153,089,890
Ensembl chr 5:153,057,760...153,089,890 		JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of GRIA1 mRNA
[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA] 		CTD PMID:21795739 PMID:23275455 NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309 		JBrowse link
G Grp gastrin releasing peptide increases expression ISO Progesterone results in increased expression of GRP mRNA CTD PMID:22238285 NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037 		JBrowse link
G Grpel1 GrpE-like 1, mitochondrial decreases expression ISO Progesterone results in decreased expression of GRPEL1 mRNA CTD PMID:18037150 NCBI chr14:74,292,023...74,298,243
Ensembl chr14:78,517,052...78,522,861 		JBrowse link
G Grwd1 glutamate-rich WD repeat containing 1 decreases expression ISO Progesterone results in decreased expression of GRWD1 mRNA CTD PMID:18037150 NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:105,437,709...105,443,825 		JBrowse link
G Gsdme gasdermin E multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GSDME mRNA CTD PMID:20660070 NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions
decreases expression
decreases phosphorylation
increases phosphorylation 		ISO
EXP 		Mifepristone inhibits the reaction [Progesterone results in increased phosphorylation of GSK3B protein]
Progesterone results in decreased expression of GSK3B mRNA; Progesterone results in decreased expression of GSK3B protein
Progesterone results in decreased phosphorylation of GSK3B protein
Estradiol inhibits the reaction [Progesterone results in decreased expression of GSK3B mRNA]
Progesterone inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] 		CTD PMID:15845746 PMID:16882987 PMID:17170212 PMID:17443805 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gsn gelsolin multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of GSN mRNA CTD PMID:18556351 NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:38,982,671...39,035,850 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 increases chemical synthesis
increases expression 		ISO
EXP 		GSTA1 protein results in increased chemical synthesis of Progesterone
Progesterone results in increased expression of GSTA1 mRNA 		CTD PMID:20726854 PMID:23650189 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 multiple interactions
increases expression 		EXP [Progesterone co-treated with Estradiol] affects the expression of GSTA2 mRNA
Progesterone results in increased expression of GSTA2 mRNA 		CTD PMID:11502894 PMID:24777823 NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092 		JBrowse link
G Gstk1 glutathione S-transferase kappa 1 increases expression EXP Progesterone results in increased expression of GSTK1 mRNA CTD PMID:20726854 NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:72,085,531...72,089,927 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 affects expression ISO Progesterone affects the expression of GSTM2 mRNA; Progesterone affects the expression of GSTM5 mRNA CTD PMID:17251523 NCBI chr 2:198,312,179...198,316,962 JBrowse link
G Gsto1 glutathione S-transferase omega 1 increases expression ISO Progesterone results in increased expression of GSTO1 mRNA CTD PMID:22238285 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of GSTT1 mRNA CTD PMID:17404688 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019 		JBrowse link
G Gstt2 glutathione S-transferase theta 2 increases expression EXP Progesterone results in increased expression of GSTT2 mRNA CTD PMID:20726854 NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,818,540...12,822,718 		JBrowse link
G Gsx1 GS homeobox 1 increases expression ISO Progesterone results in increased expression of GSX1 mRNA CTD PMID:18070364 NCBI chr12:7,880,663...7,882,947
Ensembl chr12:12,994,588...12,996,874 		JBrowse link
G Gtf2ird1 GTF2I repeat domain containing 1 increases expression ISO Progesterone results in increased expression of GTF2IRD1 mRNA CTD PMID:18037150 NCBI chr12:22,254,113...22,361,052
Ensembl chr12:27,890,675...27,997,494 		JBrowse link
G Gtse1 G-2 and S-phase expressed 1 decreases expression ISO Progesterone results in decreased expression of GTSE1 mRNA CTD PMID:21795739 NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:118,829,903...118,846,661 		JBrowse link
G Guca2b guanylate cyclase activator 2B affects expression ISO Progesterone affects the expression of GUCA2B mRNA CTD PMID:17251523 NCBI chr 5:138,532,160...138,534,210
Ensembl chr 5:138,532,178...138,534,235 		JBrowse link
G Gucy1a1 guanylate cyclase 1 soluble subunit alpha 1 decreases expression EXP Progesterone results in decreased expression of GUCY1A1 mRNA CTD PMID:20726854 NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737 		JBrowse link
G Gyg1 glycogenin 1 increases expression EXP Progesterone results in increased expression of GYG1 mRNA CTD PMID:20726854 NCBI chr 2:104,540,927...104,583,038
Ensembl chr 2:104,540,533...104,582,818 		JBrowse link
G Gzmb granzyme B affects expression
increases expression 		ISO
EXP 		Progesterone affects the expression of GZMB mRNA
Progesterone results in increased expression of GZMB mRNA 		CTD PMID:17251523 PMID:21770760 NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469 		JBrowse link
G H19 H19 imprinted maternally expressed transcript affects expression ISO Progesterone affects the expression of H19 mRNA CTD PMID:17251523 NCBI chr 1:197,730,698...197,733,374 JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression
multiple interactions 		ISO Progesterone results in increased expression of H1F2 mRNA
[Progesterone co-treated with Estradiol] results in increased expression of H1-2 mRNA 		CTD PMID:17404688 PMID:22238285 NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317 		JBrowse link
G H1f5 H1.5 linker histone, cluster member decreases expression ISO Progesterone results in decreased expression of H1F5 mRNA CTD PMID:22238285 NCBI chr17:47,421,875...47,422,905
Ensembl chr17:47,421,843...47,477,387 		JBrowse link
G H2ac18 H2A clustered histone 18 increases expression ISO Progesterone results in increased expression of H2AC18 mRNA CTD PMID:22238285 NCBI chr 2:183,808,398...183,808,992 JBrowse link
G H2az1 H2A.Z variant histone 1 decreases expression EXP Progesterone results in decreased expression of H2AZ1 mRNA CTD PMID:20726854 NCBI chr 2:229,026,464...229,031,411
Ensembl chr 2:229,028,843...229,031,411 		JBrowse link
G H2az2 H2A.Z variant histone 2 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of H2AZ2 mRNA CTD PMID:17404688 NCBI chr14:81,293,304...81,312,209
Ensembl chr14:85,507,228...85,526,207
Ensembl chr16:85,507,228...85,526,207 		JBrowse link
G H2bc14 H2B clustered histone 14 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of H2BC5 mRNA CTD PMID:17404688 NCBI chr17:42,792,887...42,793,268 JBrowse link
G H2bc4 H2B clustered histone 4 increases expression ISO Progesterone results in increased expression of H2BC4 mRNA CTD PMID:22238285 NCBI chr17:47,388,085...47,392,349
Ensembl chr17:47,404,375...47,419,020 		JBrowse link
G H2bc9 H2B clustered histone 9 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of H2BC9 mRNA CTD PMID:17404688 NCBI chr17:42,470,593...42,478,590 JBrowse link
G Habp2 hyaluronan binding protein 2 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of HABP2 mRNA
Progesterone results in increased expression of HABP2 mRNA 		CTD PMID:17404688 PMID:21540246 NCBI chr 1:255,315,870...255,350,161
Ensembl chr 1:265,303,172...265,355,374 		JBrowse link
G Hacd1 3-hydroxyacyl-CoA dehydratase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of HACD1 mRNA CTD PMID:20660070 NCBI chr17:81,992,284...82,014,676
Ensembl chr17:81,992,292...82,014,592 		JBrowse link
G Hacd4 3-hydroxyacyl-CoA dehydratase 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of HACD4 mRNA CTD PMID:20660070 NCBI chr 5:107,935,514...107,961,271
Ensembl chr 5:107,934,937...107,962,836 		JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of HADH mRNA CTD PMID:20660070 NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446 		JBrowse link
G Hand2 heart and neural crest derivatives expressed 2 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of HAND2 mRNA
Progesterone results in increased expression of HAND2 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of HAND2 protein; [Progesterone co-treated with S-Adenosylmethionine] results in increased methylation of HAND2 promoter; S-Adenosylmethionine inhibits the reaction [Progesterone results in increased expression of HAND2 mRNA] 		CTD PMID:17404688 PMID:18070364 PMID:20864642 PMID:25210133 PMID:30892605 NCBI chr16:32,917,448...32,920,791
Ensembl chr16:37,928,145...37,931,488 		JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 decreases expression
increases expression 		ISO Progesterone results in decreased expression of HAPLN1 mRNA
Progesterone results in increased expression of HAPLN1 mRNA 		CTD PMID:21540246 PMID:21795739 NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098 		JBrowse link
G Has1 hyaluronan synthase 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of HAS1 mRNA CTD PMID:20226447 NCBI chr 1:67,366,460...67,378,686
Ensembl chr 1:67,366,460...67,378,444 		JBrowse link
G Has3 hyaluronan synthase 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of HAS3 mRNA CTD PMID:20660070 NCBI chr19:34,768,421...34,782,170 JBrowse link
G Hba-a1 hemoglobin alpha, adult chain 1 affects expression ISO Progesterone affects the expression of HBA-A1 mRNA CTD PMID:17251523 NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,841,763...15,842,603 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of HBA1 mRNA
Progesterone results in increased expression of HBA1 mRNA 		CTD PMID:17404688 NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141 		JBrowse link
G Hba-a3 hemoglobin alpha, adult chain 3 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of HBA2 mRNA
Progesterone results in increased expression of HBA2 mRNA 		CTD PMID:17404688 NCBI chr10:15,816,099...15,816,943
Ensembl chr10:15,816,096...15,817,167 		JBrowse link
G Hbb hemoglobin subunit beta multiple interactions
affects expression
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of HBB mRNA
Progesterone affects the expression of HBB-B1 mRNA
Progesterone results in increased expression of HBB mRNA 		CTD PMID:17251523 PMID:17404688 PMID:18070364 NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873 		JBrowse link
G Hbb-b1 hemoglobin, beta adult major chain multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of HBD mRNA
Progesterone results in increased expression of HBD mRNA 		CTD PMID:17404688 PMID:18070364 NCBI chr 1:158,224,175...158,231,675 JBrowse link
G Hbb-b2 hemoglobin, beta adult minor chain affects expression ISO Progesterone affects the expression of HBB-B2 mRNA CTD PMID:17251523 NCBI chr 1:158,243,696...158,245,076 JBrowse link
G Hbg1 hemoglobin subunit gamma 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of HBG1 mRNA CTD PMID:17404688 NCBI chr 1:158,271,871...158,273,426
Ensembl chr 1:167,683,760...167,706,139 		JBrowse link
G Hbp1 HMG-box transcription factor 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of HBP1 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of HBP1 mRNA 		CTD PMID:18070364 PMID:18556351 NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:54,256,864...54,283,366 		JBrowse link
G Hbs1l HBS1-like translational GTPase increases expression ISO Progesterone results in increased expression of HBS1L mRNA CTD PMID:18070364 NCBI chr 1:16,092,529...16,170,082
Ensembl chr 1:17,912,070...17,989,646 		JBrowse link
G Hcls1 hematopoietic cell specific Lyn substrate 1 increases expression ISO Progesterone results in increased expression of HCLS1 mRNA CTD PMID:21540246 NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387 		JBrowse link
G Hcrt hypocretin neuropeptide precursor decreases secretion EXP HCRT protein results in decreased secretion of Progesterone CTD PMID:22749989 NCBI chr10:85,689,979...85,691,214
Ensembl chr10:86,189,775...86,191,524 		JBrowse link
G Hdac1 histone deacetylase 1 decreases expression ISO Progesterone results in decreased expression of HDAC1 mRNA CTD PMID:18037150 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Hdc histidine decarboxylase affects expression ISO Progesterone affects the expression of HDC; Progesterone affects the expression of HDC mRNA CTD PMID:16794005 PMID:17251523 NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711 		JBrowse link
G Heg1 heart development protein with EGF-like domains 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of HEG1 mRNA CTD PMID:20660070 NCBI chr11:67,006,954...67,095,020
Ensembl chr11:80,512,096...80,600,092 		JBrowse link
G Hells helicase, lymphoid specific decreases expression ISO Progesterone results in decreased expression of HELLS mRNA CTD PMID:16966611 PMID:21795739 PMID:22238285 NCBI chr 1:246,113,580...246,159,230
Ensembl chr 1:246,114,096...246,159,228 		JBrowse link
G Heph hephaestin multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of HEPH mRNA CTD PMID:19693291 NCBI chr  X:61,151,131...61,402,980
Ensembl chr  X:65,305,773...65,412,453 		JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression ISO Progesterone results in increased expression of HERPUD1 mRNA CTD PMID:18037150 NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of HES1 mRNA CTD PMID:20660070 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061 		JBrowse link
G Hes5 hes family bHLH transcription factor 5 decreases expression ISO Progesterone results in decreased expression of HES5 mRNA CTD PMID:21540246 NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021 		JBrowse link
G Hgd homogentisate 1, 2-dioxygenase multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of HGD mRNA
Progesterone results in decreased expression of HGD mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr11:76,592,202...76,643,776
Ensembl chr11:76,592,204...76,643,767 		JBrowse link
G Hgf hepatocyte growth factor multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of HGF mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of HGF mRNA
Progesterone results in increased expression of HGF mRNA 		CTD PMID:17404688 PMID:20660070 PMID:22238285 NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851 		JBrowse link
G Hibadh 3-hydroxyisobutyrate dehydrogenase increases expression EXP Progesterone results in increased expression of HIBADH mRNA CTD PMID:20726854 NCBI chr 4:82,979,759...83,077,819
Ensembl chr 4:82,979,765...83,111,242 		JBrowse link
G Hibch 3-hydroxyisobutyryl-CoA hydrolase multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of HIBCH mRNA CTD PMID:20660070 NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886 		JBrowse link
G Hic1 HIC ZBTB transcriptional repressor 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with TGFB1 protein] results in increased expression of HIC1 mRNA
Progesterone results in increased expression of HIC1 mRNA 		CTD PMID:21768398 NCBI chr10:60,512,855...60,517,812
Ensembl chr10:60,500,565...60,523,448 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases expression ISO Progesterone results in increased expression of HIF1A CTD PMID:15845616 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hip1r huntingtin interacting protein 1 related affects expression ISO Progesterone affects the expression of HIP1R mRNA CTD PMID:17251523 NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654 		JBrowse link
G Hipk2 homeodomain interacting protein kinase 2 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of HIPK2 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of HIPK2 mRNA 		CTD PMID:18070364 PMID:20660070 NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:68,369,099...68,586,108 		JBrowse link
G Hjurp Holliday junction recognition protein increases expression ISO Progesterone results in increased expression of HJURP mRNA CTD PMID:18070364 NCBI chr 9:96,301,183...96,315,587
Ensembl chr 9:96,302,530...96,315,657 		JBrowse link
G Hmcn1 hemicentin 1 decreases expression ISO Progesterone results in decreased expression of HMCN1 mRNA CTD PMID:21795739 NCBI chr13:65,165,532...65,634,681
Ensembl chr13:65,165,532...65,634,519 		JBrowse link
G Hmga1 high mobility group AT-hook 1 multiple interactions
decreases expression 		ISO 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of HMGA1 mRNA]; [Estradiol co-treated with Progesterone] results in decreased expression of HMGA1 mRNA; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of HMGA1 mRNA]; pepstatin inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of HMGA1 mRNA]
Progesterone results in decreased expression of HMGA1 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:22238285 NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,613,471...5,620,593 		JBrowse link
G Hmga2 high mobility group AT-hook 2 multiple interactions
decreases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in decreased expression of HMGA2 mRNA] CTD PMID:17556502 NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:57,765,675...57,880,341 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein]; Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CXCL8 protein]; Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of IL6 protein]; Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of TLR4 mRNA] CTD PMID:22014880 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmgb2 high mobility group box 2 increases expression
decreases expression 		ISO
EXP 		Progesterone results in increased expression of HMGB2 mRNA
Progesterone results in decreased expression of HMGB2 mRNA 		CTD PMID:18070364 PMID:20726854 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hmgcl 3-hydroxy-3-methylglutaryl-CoA lyase multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of HMGCL mRNA CTD PMID:18556351 NCBI chr 5:153,461,738...153,475,552
Ensembl chr 5:153,461,769...153,475,604 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase increases expression ISO Progesterone results in increased expression of HMGCR mRNA CTD PMID:18070364 NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression ISO Progesterone results in increased expression of HMGCS1 mRNA CTD PMID:18070364 NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802 		JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 increases expression EXP Progesterone results in increased expression of HMGCS2 mRNA CTD PMID:20726854 NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242 		JBrowse link
G Hmgn3 high mobility group nucleosomal binding domain 3 increases expression ISO Progesterone results in increased expression of HMGN3 mRNA CTD PMID:18070364 NCBI chr 8:84,022,493...84,059,329 JBrowse link
G Hmmr hyaluronan-mediated motility receptor increases expression
decreases expression 		ISO Progesterone results in increased expression of HMMR mRNA
Progesterone results in decreased expression of HMMR mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
affects expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of HMOX1 mRNA
Progesterone results in increased expression of HMOX1 mRNA
HMOX1 protein inhibits the reaction [POMC protein results in increased abundance of Progesterone]
Progesterone affects the expression of HMOX1 mRNA 		CTD PMID:17251523 PMID:17404688 PMID:18070364 PMID:19489000 PMID:21770760 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha multiple interactions ISO [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [HNF4A protein binds to PCK1 promoter]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]; Progesterone promotes the reaction [Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [HNF4A protein binds to PCK1 promoter]]] CTD PMID:21768169 NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758 		JBrowse link
G Hnrnpab heterogeneous nuclear ribonucleoprotein A/B decreases expression EXP Progesterone results in decreased expression of HNRNPAB mRNA CTD PMID:20726854 NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307 		JBrowse link
G Hnrnph1 heterogeneous nuclear ribonucleoprotein H1 decreases expression EXP Progesterone results in decreased expression of HNRNPH1 mRNA CTD PMID:20726854 NCBI chr10:35,187,412...35,203,909
Ensembl chr10:35,193,890...35,203,906 		JBrowse link
G Homer2 homer scaffold protein 2 decreases expression ISO Progesterone results in decreased expression of HOMER2 mRNA CTD PMID:22238285 NCBI chr 1:135,558,977...135,659,780
Ensembl chr 1:144,976,436...145,068,997 		JBrowse link
G Homer3 homer scaffold protein 3 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of HOMER3 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of HOMER3 mRNA 		CTD PMID:19693291 PMID:20660070 NCBI chr16:19,132,177...19,142,739
Ensembl chr16:19,165,482...19,176,640 		JBrowse link
G Hopx HOP homeobox affects expression
increases expression 		ISO
EXP 		Progesterone affects the expression of HOPX mRNA
Progesterone results in increased expression of HOPX mRNA 		CTD PMID:17251523 PMID:20726854 NCBI chr14:31,410,235...31,437,189
Ensembl chr14:31,410,221...31,437,188 		JBrowse link
G Hoxa10 homeobox A10 decreases expression
increases expression
multiple interactions 		ISO
EXP 		Progesterone results in decreased expression of HOXA10 mRNA
Progesterone results in increased expression of HOXA10
[Estradiol co-treated with Progesterone] results in increased expression of HOXA10 mRNA; [Estradiol co-treated with Progesterone] results in increased expression of HOXA10 protein
[Progesterone co-treated with Estrogens] results in decreased expression of HOXA10 mRNA; Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of HOXA10 mRNA]; HOXA10 protein affects the reaction [Progesterone affects the localization of GABRP protein]; HOXA10 protein affects the reaction [Progesterone results in increased expression of GABRP mRNA] 		CTD PMID:15845616 PMID:18037150 PMID:18653720 PMID:20103740 PMID:32004626 NCBI chr 4:81,331,591...81,340,878
Ensembl chr 4:82,662,204...82,665,922 		JBrowse link
G Hoxa11 homeobox A11 multiple interactions ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of HOXA11 mRNA
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of HOXA11 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of HOXA11 mRNA 		CTD PMID:17404688 PMID:18653720 PMID:32186404 NCBI chr 4:81,342,527...81,346,189
Ensembl chr 4:82,673,140...82,676,844 		JBrowse link
G Hoxa11-as HOXA11 antisense RNA increases expression ISO Progesterone results in increased expression of HOXA11OS mRNA CTD PMID:22238285 NCBI chr 4:81,346,416...81,350,190
Ensembl chr 4:82,677,028...82,680,791 		JBrowse link
G Hp haptoglobin affects expression
multiple interactions 		ISO Progesterone affects the expression of HP mRNA
[Estradiol co-treated with Progesterone] results in increased expression of HP mRNA 		CTD PMID:17251523 PMID:20660070 NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518 		JBrowse link
G Hras HRas proto-oncogene, GTPase increases expression ISO Progesterone results in increased expression of HRAS mRNA CTD PMID:21549006 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hrk harakiri, BCL2 interacting protein increases expression ISO Progesterone results in increased expression of HRK mRNA CTD PMID:22238285 NCBI chr12:38,387,484...38,409,652
Ensembl chr12:44,048,402...44,070,561 		JBrowse link
G Hs3st3b1 heparan sulfate-glucosamine 3-sulfotransferase 3B1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of HS3ST3B1 mRNA CTD PMID:20660070 NCBI chr10:49,060,693...49,093,185
Ensembl chr10:49,060,693...49,093,185 		JBrowse link
G Hs6st1 heparan sulfate 6-O-sulfotransferase 1 decreases expression ISO Progesterone results in decreased expression of HS6ST1 mRNA CTD PMID:18037150 NCBI chr 9:45,779,402...45,818,583
Ensembl chr 9:45,779,019...45,818,582 		JBrowse link
G Hs6st2 heparan sulfate 6-O-sulfotransferase 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of HS6ST2 mRNA CTD PMID:20660070 NCBI chr  X:135,887,224...136,182,388
Ensembl chr  X:135,888,472...136,182,353 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 affects expression
multiple interactions
increases expression 		EXP
ISO 		Progesterone affects the expression of HSD11B1 mRNA; Progesterone affects the expression of HSD11B1 protein
4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA]; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of HSD11B1 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA; Hydrocortisone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA]; Progesterone inhibits the reaction [HSD11B1 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]
Progesterone results in increased expression of HSD11B1 mRNA 		CTD PMID:19208548 PMID:20726854 PMID:21795739 PMID:23275455 PMID:28257955 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions
decreases expression
increases expression
decreases activity 		ISO [Estradiol co-treated with Progesterone] results in increased expression of HSD11B2 mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Progesterone results in increased expression of HSD11B2 mRNA]; Masoprocol inhibits the reaction [Progesterone results in decreased activity of HSD11B2 protein]; Mifepristone inhibits the reaction [Progesterone results in decreased activity of HSD11B2 protein]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of HSD11B2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of HSD11B2 protein]
Progesterone results in decreased expression of HSD11B2 mRNA; Progesterone results in decreased expression of HSD11B2 protein 		CTD PMID:15857753 PMID:18032417 PMID:18070364 PMID:20660070 PMID:21540246 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsd17b10 hydroxysteroid (17-beta) dehydrogenase 10 multiple interactions ISO [Progesterone co-treated with NAD] binds to HSD17B10 protein CTD PMID:25526675 NCBI chr  X:24,568,551...24,571,012
Ensembl chr  X:24,568,551...24,574,681 		JBrowse link
G Hsd17b11 hydroxysteroid (17-beta) dehydrogenase 11 increases expression ISO Progesterone results in increased expression of HSD17B11 mRNA CTD PMID:18070364 PMID:20864642 NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of HSD17B2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of HSD17B2 mRNA
Progesterone results in decreased expression of HSD17B2 mRNA; Progesterone results in decreased expression of HSD17B2 protein 		CTD PMID:17404688 PMID:20660070 PMID:23183084 NCBI chr19:45,753,576...45,825,203
Ensembl chr19:62,662,098...62,733,943 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 affects metabolic processing
multiple interactions
increases expression
increases chemical synthesis 		EXP
ISO 		HSD3B1 protein affects the metabolism of Progesterone
[HSD3B2 protein results in increased metabolism of Pregnenolone] which results in increased abundance of Progesterone
Progesterone results in increased expression of HSD3B1 protein
HSD3B1 protein results in increased chemical synthesis of Progesterone 		CTD PMID:15261307 PMID:16054388 PMID:21558439 PMID:31771930 NCBI chr 2:188,858,574...188,864,694 JBrowse link
G Hsd3b2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 multiple interactions ISO
EXP 		[galaxolide results in decreased expression of [HSD3B2 co-treated with CYP21A2]] which results in decreased chemical synthesis of Progesterone
[FSHB protein results in increased expression of HSD3B2 mRNA] which results in increased abundance of Progesterone; GH1 protein promotes the reaction [[FSHB protein results in increased expression of HSD3B2 mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of HSD3B2 mRNA] which results in increased abundance of Progesterone] 		CTD PMID:22067323 PMID:23084589 NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:188,784,614...188,790,569 		JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 affects expression ISO Progesterone affects the expression of HSP90AA1 mRNA CTD PMID:17251523 NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 affects expression ISO Progesterone affects the expression of HSP90B1 mRNA CTD PMID:17251523 NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A affects expression
increases expression 		EXP
ISO 		Progesterone affects the expression of HSPA1A protein
Progesterone results in increased expression of HSPA1A mRNA 		CTD PMID:16797538 PMID:21549006 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression
affects expression 		ISO Progesterone results in increased expression of HSPA1B mRNA
Progesterone affects the expression of HSPA1B mRNA 		CTD PMID:17251523 PMID:18037150 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa4 heat shock protein family A (Hsp70) member 4 increases expression EXP Progesterone results in increased expression of HSPA4 mRNA CTD PMID:16376865 NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like affects expression ISO Progesterone affects the expression of HSPA4L mRNA CTD PMID:17251523 NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 affects expression ISO Progesterone affects the expression of HSPA5 mRNA CTD PMID:17251523 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspa6l-ps1 heat shock protein family A (Hsp70) member 6 like, pseudogene 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of HSPA6 mRNA CTD PMID:17404688 NCBI chr13:83,273,176...83,274,317 JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 multiple interactions EXP [estradiol 3-benzoate co-treated with Progesterone] results in increased expression of HSPA8 mRNA; Progesterone promotes the reaction [estradiol 3-benzoate results in increased expression of HSPA8 mRNA] CTD PMID:9990085 NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 increases expression EXP Progesterone results in increased expression of HSPB1 mRNA CTD PMID:20726854 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Hspb6 heat shock protein family B (small) member 6 increases expression EXP Progesterone results in increased expression of HSPB6 mRNA CTD PMID:20726854 NCBI chr 1:85,806,898...85,809,072
Ensembl chr 1:94,933,543...94,936,512 		JBrowse link
G Hspb8 heat shock protein family B (small) member 8 increases expression
multiple interactions 		EXP
ISO 		Progesterone results in increased expression of HSPB8 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of HSPB8 mRNA 		CTD PMID:20660070 PMID:20726854 NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937 		JBrowse link
G Htr2a 5-hydroxytryptamine receptor 2A increases expression ISO
EXP 		Progesterone results in increased expression of HTR2A mRNA CTD PMID:20726854 PMID:21540246 NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619 		JBrowse link
G Htr2b 5-hydroxytryptamine receptor 2B decreases expression ISO Progesterone results in decreased expression of HTR2B mRNA CTD PMID:21795739 NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087 		JBrowse link
G Hyal2 hyaluronidase 2 decreases expression ISO Progesterone results in decreased expression of HYAL2 mRNA CTD PMID:18037150 NCBI chr 8:108,241,895...108,246,853
Ensembl chr 8:117,121,787...117,125,493 		JBrowse link
G Hyou1 hypoxia up-regulated 1 increases expression ISO Progesterone results in increased expression of HYOU1 mRNA CTD PMID:18037150 NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of ICAM1 protein; [Progesterone co-treated with Estradiol] results in increased expression of ICAM1 mRNA; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]]; MPO gene polymorphism affects the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of ICAM1 protein]; Org 31710 inhibits the reaction [Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]
[Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA; gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of ICAM1 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of ICAM1 mRNA]; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA]
Progesterone results in decreased expression of ICAM1 mRNA; Progesterone results in decreased expression of ICAM1 protein 		CTD PMID:15358673 PMID:17868700 PMID:20226447 PMID:21242819 PMID:21501669 More... NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Icmt isoprenylcysteine carboxyl methyltransferase affects expression ISO Progesterone affects the expression of ICMT mRNA CTD PMID:17251523 NCBI chr 5:162,804,368...162,811,129
Ensembl chr 5:168,086,057...168,093,094 		JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression
decreases expression 		ISO Progesterone results in increased expression of ID1 mRNA
Progesterone results in decreased expression of ID1 mRNA
Progesterone results in decreased expression of ID1 protein 		CTD PMID:18037150 PMID:18045962 PMID:22238285 NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Id2 inhibitor of DNA binding 2 increases expression
multiple interactions 		ISO Progesterone results in increased expression of ID2 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of ID2 mRNA 		CTD PMID:18037150 PMID:20660070 NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961 		JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression ISO Progesterone results in increased expression of ID3 mRNA CTD PMID:18037150 PMID:20864642 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Id4 inhibitor of DNA binding 4 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ID4 mRNA
Progesterone results in increased expression of ID4 mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr17:16,595,724...16,598,293
Ensembl chr17:16,595,724...16,598,492 		JBrowse link
G Idh1 isocitrate dehydrogenase (NADP(+)) 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of IDH1 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of IDH1 mRNA 		CTD PMID:18070364 PMID:20660070 NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 increases expression ISO Progesterone results in increased expression of IDI1 mRNA CTD PMID:18070364 NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524 		JBrowse link
G Ier3 immediate early response 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of IER3 mRNA CTD PMID:20660070 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ier5l immediate early response 5-like increases expression ISO Progesterone results in increased expression of IER5L mRNA CTD PMID:18037150 NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452 		JBrowse link
G Ifi44l interferon-induced protein 44-like multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of IFI44L mRNA CTD PMID:17404688 NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:243,328,723...243,366,404 		JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 multiple interactions
increases expression 		ISO [Progesterone co-treated with TGFB1 protein] results in increased expression of IFIT3 mRNA
Progesterone results in increased expression of IFIT3 mRNA 		CTD PMID:21768398 NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521 		JBrowse link
G Ifitm1 interferon induced transmembrane protein 1 increases expression EXP Progesterone results in increased expression of IFITM1 mRNA CTD PMID:21770760 NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:205,496,807...205,498,776 		JBrowse link
G Ifitm2 interferon induced transmembrane protein 2 increases expression EXP Progesterone results in increased expression of IFITM2 mRNA CTD PMID:21770760 NCBI chr 1:196,051,539...196,052,719 JBrowse link
G Ifnar2 interferon alpha and beta receptor subunit 2 increases expression ISO Progesterone results in increased expression of IFNAR2 mRNA CTD PMID:18070364 NCBI chr11:44,099,574...44,131,941
Ensembl chr11:44,099,753...44,131,937 		JBrowse link
G Ifnb1 interferon beta 1 multiple interactions ISO Progesterone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IFNB1 mRNA]; Progesterone inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA] CTD PMID:22546503 NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487 		JBrowse link
G Ifng interferon gamma increases expression
multiple interactions 		ISO Progesterone results in increased expression of IFNG protein
[Progesterone co-treated with Estradiol] inhibits the reaction [Vaccines, Virus-Like Particle results in increased expression of IFNG protein]; Progesterone inhibits the reaction [Vaccines, Virus-Like Particle results in increased expression of IFNG protein]
Progesterone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] 		CTD PMID:11063824 PMID:15804489 PMID:20130130 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Ifngr1 interferon gamma receptor 1 decreases expression
increases expression 		ISO Progesterone results in decreased expression of IFNGR1 mRNA
Progesterone results in increased expression of IFNGR1 mRNA 		CTD PMID:18692832 PMID:21540246 NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:16,152,879...16,171,437 		JBrowse link
G Ifrd1 interferon-related developmental regulator 1 increases expression ISO Progesterone results in increased expression of IFRD1 mRNA CTD PMID:18037150 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131 		JBrowse link
G Ift70a2 intraflagellar transport 70A2 increases expression ISO Progesterone results in increased expression of IFT70A mRNA CTD PMID:18070364 NCBI chr 3:60,899,193...60,901,634
Ensembl chr 3:81,307,245...81,320,093 		JBrowse link
G Ift74 intraflagellar transport 74 increases expression ISO Progesterone results in increased expression of IFT74 mRNA CTD PMID:18070364 NCBI chr 5:109,460,372...109,563,839
Ensembl chr 5:114,593,397...114,679,581 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions
increases abundance
increases expression
affects expression
increases secretion 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased secretion of IGF1 protein; [IGF1 protein co-treated with FSHB protein] results in increased abundance of Progesterone; ADIPOQ protein promotes the reaction [IGF1 protein results in increased abundance of Progesterone]; FGF9 protein inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased abundance of Progesterone]; FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone]]; FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Colforsin results in increased abundance of Progesterone]]; FGF9 protein inhibits the reaction [IGF1 protein results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [Colforsin results in increased abundance of Progesterone]; Mifepristone inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of IGF1 protein]; Mifepristone inhibits the reaction [Progesterone results in increased secretion of IGF1 protein]; NAMPT protein promotes the reaction [IGF1 protein results in increased abundance of Progesterone]; Tamoxifen inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of IGF1 protein]
IGF1 protein inhibits the reaction [BMP15 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP2 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP4 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP6 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein inhibits the reaction [BMP7 protein inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of CYP11A1 mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of CYP19A1 mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of HSD3B2 mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [[FSHB protein results in increased expression of STAR mRNA] which results in increased abundance of Progesterone]; IGF1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]; RETN protein promotes the reaction [IGF1 protein results in increased abundance of Progesterone]
Progesterone results in increased expression of IGF1 mRNA
[Estradiol co-treated with Progesterone] promotes the reaction [Cuprizone results in increased expression of IGF1 mRNA]; Estradiol promotes the reaction [Progesterone results in increased expression of IGF1 mRNA]; IGF1 protein affects the susceptibility to [Progesterone co-treated with Estrogens]; IGF1 protein inhibits the reaction [[Progesterone co-treated with Estrogens] results in increased expression of IGFBP3 mRNA]; IGF1 protein inhibits the reaction [[Progesterone co-treated with Estrogens] results in increased expression of RBP1 mRNA]; IGF1 protein inhibits the reaction [[Progesterone co-treated with Estrogens] results in increased expression of TGFB1 mRNA]; IGF1 protein inhibits the reaction [[Progesterone co-treated with Estrogens] results in increased expression of TRP53 mRNA]; Progesterone promotes the reaction [Estradiol results in increased expression of IGF1 mRNA]
Progesterone affects the expression of IGF1 mRNA 		CTD PMID:8390853 PMID:15809018 PMID:17251523 PMID:18562952 PMID:19031445 More... NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression
increases expression
multiple interactions 		ISO
EXP 		Progesterone results in decreased expression of IGF1R mRNA
Progesterone results in increased expression of IGF1R mRNA
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of IGF1R mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of IGF1R protein 		CTD PMID:18070364 PMID:19853640 PMID:22465879 NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igf2 insulin-like growth factor 2 increases expression ISO Progesterone results in increased expression of IGF2 mRNA CTD PMID:18497975 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 affects expression
increases secretion
increases expression
multiple interactions 		ISO Progesterone affects the expression of IGFBP1 mRNA; Progesterone affects the expression of IGFBP1 protein
Progesterone results in increased secretion of IGFBP1 protein
Progesterone results in increased expression of IGFBP1 mRNA
4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]]; [Cyclic AMP co-treated with Estradiol co-treated with Progesterone] results in increased expression of IGFBP1 mRNA; [Estradiol co-treated with Progesterone] results in increased expression of IGFBP1 mRNA; [Estradiol co-treated with Progesterone] results in increased secretion of IGFBP1 protein; [Progesterone co-treated with bisphenol A] results in increased expression of IGFBP1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of IGFBP1 mRNA; [Progesterone co-treated with Triclosan] results in increased expression of IGFBP1 mRNA; BMP7 protein inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of IGFBP1 mRNA]; BMP7 protein inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of IGFBP1 protein]; Hydrocortisone promotes the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]]; Mifepristone inhibits the reaction [Progesterone results in increased secretion of IGFBP1 protein]; Progesterone inhibits the reaction [Estradiol results in increased expression of IGFBP1 protein]; Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; Progesterone promotes the reaction [Triclosan results in increased secretion of IGFBP1 protein] 		CTD PMID:15501902 PMID:17404688 PMID:17484513 PMID:18815356 PMID:20085912 More... NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 multiple interactions
increases expression
increases secretion
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased secretion of IGFBP2 protein
Progesterone results in increased expression of IGFBP2 mRNA
Progesterone results in increased secretion of IGFBP2 protein
Progesterone results in decreased expression of IGFBP2 mRNA 		CTD PMID:15809018 PMID:18070364 PMID:19853640 NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:81,864,783...81,892,171 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions
increases expression
affects expression
decreases secretion
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of IGFBP3 mRNA; [Estradiol co-treated with Progesterone] results in decreased secretion of IGFBP3 protein; [Progesterone affects the activity of PGR protein alternative form] which affects the expression of IGFBP3 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of IGFBP3 mRNA
Progesterone results in increased expression of IGFBP3 mRNA
[Progesterone co-treated with Estrogens] results in increased expression of IGFBP3 mRNA; IGF1 protein inhibits the reaction [[Progesterone co-treated with Estrogens] results in increased expression of IGFBP3 mRNA]
Progesterone affects the expression of IGFBP3; Progesterone affects the expression of IGFBP3 mRNA
Progesterone results in decreased secretion of IGFBP3 protein
Progesterone results in decreased expression of IGFBP3 mRNA 		CTD PMID:15178747 PMID:15809018 PMID:15866122 PMID:17251523 PMID:17404688 More... NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of IGFBP4 mRNA CTD PMID:20660070 NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of IGFBP5 mRNA
Progesterone results in decreased expression of IGFBP5 mRNA 		CTD PMID:18070364 PMID:20660070 PMID:20864642 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of IGFBP6 mRNA
Progesterone results in increased expression of IGFBP6 mRNA 		CTD PMID:19853640 PMID:20864642 PMID:22238285 NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795 		JBrowse link
G Igkc immunoglobulin kappa constant increases expression
multiple interactions 		ISO Progesterone results in increased expression of IGKC mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of IGKC mRNA 		CTD PMID:17404688 PMID:20660070
G Ihh Indian hedgehog signaling molecule affects expression
multiple interactions
increases expression 		ISO Progesterone affects the expression of IHH
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of IHH mRNA; [Estradiol co-treated with Progesterone] results in increased expression of IHH mRNA; ESR1 protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased expression of IHH mRNA]
[Estradiol co-treated with Progesterone] results in decreased expression of IHH mRNA
Progesterone results in increased expression of IHH; Progesterone results in increased expression of IHH mRNA 		CTD PMID:16794005 PMID:20232216 PMID:20660070 PMID:22238285 PMID:22958837 More... NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:83,952,986...83,959,203 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta increases expression ISO Progesterone results in increased expression of IKBKB mRNA CTD PMID:21549006 NCBI chr16:69,319,487...69,373,251
Ensembl chr16:76,022,008...76,081,911 		JBrowse link
G Ikbkg inhibitor of nuclear factor kappa B kinase regulatory subunit gamma multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of IKBKG mRNA CTD PMID:18556351 NCBI chr  X:157,358,279...157,397,563
Ensembl chr  X:157,367,639...157,392,757 		JBrowse link
G Il10 interleukin 10 decreases expression
increases expression
multiple interactions 		ISO Progesterone results in decreased expression of IL10 protein
Progesterone results in increased expression of IL10 mRNA
[Progesterone co-treated with Estradiol] promotes the reaction [Vaccines, Virus-Like Particle results in increased expression of IL10 protein]; Progesterone promotes the reaction [Vaccines, Virus-Like Particle results in increased expression of IL10 protein]
Progesterone results in increased expression of IL10 protein 		CTD PMID:15804489 PMID:20130130 PMID:21856019 PMID:22615136 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il11 interleukin 11 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased secretion of IL11 protein; IL11 protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of PRL protein]; IL11 protein promotes the reaction [INHBA protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of PRL protein]]; INHBA protein promotes the reaction [IL11 protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of PRL protein]] CTD PMID:20074812 NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915 		JBrowse link
G Il12a interleukin 12A multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of IL12A mRNA
[Progesterone co-treated with Estradiol] inhibits the reaction [Vaccines, Virus-Like Particle results in increased expression of [IL12A protein binds to IL12B protein]]; Progesterone inhibits the reaction [Vaccines, Virus-Like Particle results in increased expression of [IL12A protein binds to IL12B protein]]; Progesterone results in increased expression of [IL12A protein binds to IL12B protein] 		CTD PMID:19693291 PMID:20130130 NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with IL4 protein] results in increased expression of IL12B mRNA]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]
[Progesterone co-treated with Estradiol] inhibits the reaction [Vaccines, Virus-Like Particle results in increased expression of [IL12A protein binds to IL12B protein]]; Progesterone inhibits the reaction [Vaccines, Virus-Like Particle results in increased expression of [IL12A protein binds to IL12B protein]]; Progesterone results in increased expression of [IL12A protein binds to IL12B protein] 		CTD PMID:20130130 PMID:21977998 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il13ra1 interleukin 13 receptor subunit alpha 1 decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of IL13RA1 mRNA
Progesterone results in increased expression of IL13RA1 mRNA 		CTD PMID:21770760 PMID:21795739 NCBI chr  X:120,213,670...120,294,777
Ensembl chr  X:120,214,075...120,274,461 		JBrowse link
G Il13ra2 interleukin 13 receptor subunit alpha 2 multiple interactions
decreases expression 		ISO 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of IL13RA2 mRNA]; [Estradiol co-treated with Progesterone] results in decreased expression of IL13RA2 mRNA; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of IL13RA2 mRNA]; U 0126 promotes the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of IL13RA2 mRNA]
Progesterone results in decreased expression of IL13RA2 mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr  X:115,814,620...115,886,080
Ensembl chr  X:115,814,622...115,841,455 		JBrowse link
G Il15 interleukin 15 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of IL15 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of IL15 mRNA
Progesterone results in increased expression of IL15 mRNA 		CTD PMID:17404688 PMID:18692832 PMID:20660070 NCBI chr19:25,640,025...25,706,818
Ensembl chr19:42,545,346...42,611,348 		JBrowse link
G Il15ra interleukin 15 receptor subunit alpha multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of IL15RA mRNA CTD PMID:18692832 NCBI chr17:71,712,141...71,742,072
Ensembl chr17:71,712,141...71,742,149 		JBrowse link
G Il17a interleukin 17A multiple interactions ISO Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL17A protein]]; Progesterone promotes the reaction [Budesonide inhibits the reaction [Ozone results in increased expression of IL17A protein]]; Progesterone promotes the reaction [Halothane results in increased expression of IL17A protein] CTD PMID:21501669 PMID:28279894 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il17rb interleukin 17 receptor B multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of IL17RB mRNA
Progesterone results in decreased expression of IL17RB mRNA 		CTD PMID:20660070 PMID:21273126 NCBI chr16:5,186,961...5,200,657
Ensembl chr16:5,186,961...5,200,694 		JBrowse link
G Il17rd interleukin 17 receptor D multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of IL17RD mRNA CTD PMID:20660070 NCBI chr16:2,235,172...2,489,827
Ensembl chr16:2,235,169...2,301,850 		JBrowse link
G Il17re interleukin 17 receptor E decreases expression ISO Progesterone results in decreased expression of IL17RE mRNA CTD PMID:22238285 NCBI chr 4:148,160,384...148,173,830
Ensembl chr 4:148,159,475...148,173,827 		JBrowse link
G Il18 interleukin 18 multiple interactions ISO [fulvestrant co-treated with Mifepristone] inhibits the reaction [[Progesterone co-treated with Estrogens] inhibits the reaction [Lipopolysaccharides results in increased expression of IL18 mRNA]]; [Progesterone co-treated with Estrogens] inhibits the reaction [Lipopolysaccharides results in increased expression of IL18 mRNA]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of IL18 mRNA] CTD PMID:17850464 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il18r1 interleukin 18 receptor 1 decreases expression ISO Progesterone results in decreased expression of IL18R1 mRNA CTD PMID:22238285 NCBI chr 9:50,223,274...50,257,370
Ensembl chr 9:50,223,200...50,257,367 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases expression
increases expression
decreases activity
affects expression 		ISO
EXP 		[[IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]] which affects the abundance of Lipids; [[IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]] which affects the abundance of Reactive Oxygen Species; [[IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]] which affects the expression of ALB protein; [[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the abundance of Lipids; [[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the abundance of Reactive Oxygen Species; [[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the expression of ALB protein; [Estrogens co-treated with Progesterone co-treated with IL1B protein] results in increased expression of MMP14 mRNA; [Estrogens co-treated with Progesterone co-treated with IL1B protein] results in increased expression of MMP3 mRNA; [IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]; [Progesterone co-treated with IL1B protein] results in increased expression of INHBA mRNA; [Progesterone co-treated with IL1B protein] results in increased secretion of [INHBA protein binds to INHBA protein]; [Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]; Progesterone inhibits the reaction [IL1B protein results in increased degradation of NFKBIA protein]; Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP1 protein modified form]; Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP2 protein modified form]; Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP3 protein modified form]; Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP9 protein modified form]; Progesterone inhibits the reaction [Vaccines, Virus-Like Particle results in increased expression of IL1B protein]
Progesterone results in decreased expression of IL1B mRNA
Progesterone results in increased expression of IL1B mRNA; Progesterone results in increased expression of IL1B protein
Progesterone results in decreased activity of IL1B protein
Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL1B mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of IL1B mRNA]
Progesterone results in decreased expression of IL1B protein
Progesterone affects the expression of IL1B mRNA 		CTD PMID:17251523 PMID:17437195 PMID:17636213 PMID:17868700 PMID:18570937 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1r1 interleukin 1 receptor type 1 increases expression ISO
EXP 		Progesterone results in increased expression of IL1R1 mRNA CTD PMID:20726854 PMID:20864642 PMID:21795739 NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579 		JBrowse link
G Il1r2 interleukin 1 receptor type 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of IL1R2 mRNA CTD PMID:19693291 NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:49,877,266...49,920,374 		JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Progesterone results in increased expression of IL1RL1 mRNA
[Progesterone co-treated with Estradiol] results in increased expression of IL1RL1 mRNA
Progesterone results in decreased expression of IL1RL1 mRNA 		CTD PMID:17404688 PMID:18692832 PMID:19000923 PMID:20726854 NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891 		JBrowse link
G Il1rn interleukin 1 receptor antagonist increases expression EXP Progesterone results in increased expression of IL1RN mRNA CTD PMID:21770760 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il2 interleukin 2 multiple interactions ISO Progesterone promotes the reaction [IL2 protein results in increased phosphorylation of STAT5A protein]; Progesterone promotes the reaction [IL2 protein results in increased phosphorylation of STAT5B protein] CTD PMID:21768398 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il20ra interleukin 20 receptor subunit alpha multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of IL20RA mRNA; [Progesterone co-treated with Estradiol] results in increased expression of IL20RA mRNA
Progesterone results in increased expression of IL20RA mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 1:16,243,683...16,313,229
Ensembl chr 1:16,243,801...16,313,221 		JBrowse link
G Il24 interleukin 24 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of IL24 mRNA
Progesterone results in decreased expression of IL24 mRNA 		CTD PMID:17404688 NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760 		JBrowse link
G Il2rb interleukin 2 receptor subunit beta multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of IL2RB mRNA CTD PMID:17404688 NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:111,913,828...111,928,537 		JBrowse link
G Il33 interleukin 33 multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of IL33 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of IL33 mRNA
Progesterone results in increased expression of IL33 mRNA
Progesterone results in decreased expression of IL33 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:21770760 NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901 		JBrowse link
G Il36a interleukin 36, alpha decreases expression ISO Progesterone results in decreased expression of IL36A mRNA CTD PMID:22238285 NCBI chr 3:27,395,146...27,399,695
Ensembl chr 3:27,395,146...27,399,695 		JBrowse link
G Il4 interleukin 4 decreases expression
increases expression
multiple interactions 		ISO Progesterone results in decreased expression of IL4 protein
Progesterone results in increased expression of IL4 mRNA
Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with IL4 protein] results in increased expression of ARG1 mRNA]; Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with IL4 protein] results in increased expression of IL12B mRNA]; Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with IL4 protein] results in increased expression of NOS2 mRNA]; Progesterone inhibits the reaction [IL4 protein results in increased expression of ARG1 mRNA]; Progesterone inhibits the reaction [IL4 protein results in increased expression of MRC1 mRNA]; Progesterone inhibits the reaction [IL4 protein results in increased expression of RETNLA mRNA]; Progesterone promotes the reaction [[IL4 protein co-treated with Lipopolysaccharides] results in increased expression of CHIL3 mRNA]; Progesterone promotes the reaction [[IL4 protein co-treated with Lipopolysaccharides] results in increased expression of RETNLA mRNA]; Progesterone promotes the reaction [IL4 protein results in increased expression of CHIL3 mRNA] 		CTD PMID:15804489 PMID:21977998 PMID:22615136 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il4r interleukin 4 receptor multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of IL4R mRNA CTD PMID:20660070 NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636 		JBrowse link
G Il6 interleukin 6 decreases secretion
multiple interactions
increases expression
decreases expression
affects expression 		ISO
EXP 		Progesterone results in decreased secretion of IL6 protein
[Estradiol co-treated with Progesterone] results in decreased expression of IL6 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of IL6 protein
Progesterone results in increased expression of IL6 mRNA
Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL6 mRNA]]; MIR155 mRNA inhibits the reaction [Progesterone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 protein]]; Progesterone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 protein]; Progesterone promotes the reaction [Budesonide inhibits the reaction [Ozone results in increased expression of IL6 protein]]; Progesterone promotes the reaction [Halothane results in increased expression of IL6 mRNA]
Progesterone results in decreased expression of IL6 protein
Progesterone affects the expression of IL6 mRNA
[[IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]] which affects the abundance of Lipids; [[IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]] which affects the abundance of Reactive Oxygen Species; [[IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]] which affects the expression of ALB protein; [[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the abundance of Lipids; [[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the abundance of Reactive Oxygen Species; [[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the expression of ALB protein; [IL6 protein co-treated with IL1B protein co-treated with TNF protein] affects the susceptibility to [Testosterone co-treated with Estradiol co-treated with Progesterone]; [Proteoglycans co-treated with Progesterone] inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; [Proteoglycans co-treated with Progesterone] inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; [Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]; Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of IL6 protein]; Progesterone inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]; Progesterone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; Progesterone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] 		CTD PMID:15804489 PMID:16134523 PMID:17000234 PMID:17251523 PMID:20621171 More... NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Il6r interleukin 6 receptor decreases expression ISO Progesterone results in decreased expression of IL6R mRNA; Progesterone results in decreased expression of IL6R protein CTD PMID:21768398 NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221 		JBrowse link
G Il6st interleukin 6 cytokine family signal transducer multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of IL6ST mRNA CTD PMID:17404688 NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182 		JBrowse link
G Il7r interleukin 7 receptor decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of IL7R mRNA
Progesterone results in increased expression of IL7R mRNA 		CTD PMID:21770760 PMID:21795739 NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027 		JBrowse link
G Impa2 inositol monophosphatase 2 increases expression ISO Progesterone results in increased expression of IMPA2 mRNA CTD PMID:20864642 PMID:21540246 PMID:21795739 NCBI chr18:60,834,206...60,867,575
Ensembl chr18:63,104,083...63,137,543 		JBrowse link
G Inha inhibin subunit alpha multiple interactions
increases expression
decreases abundance 		ISO
EXP 		INHA mutant form inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; INHA mutant form inhibits the reaction [GDF9 protein inhibits the reaction [INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]]]
Progesterone results in increased expression of INHA mRNA
INHA protein results in decreased abundance of Progesterone 		CTD PMID:18992787 PMID:20660033 PMID:22285243 NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:84,443,109...84,446,009 		JBrowse link
G Inhba inhibin subunit beta A multiple interactions
increases expression
decreases expression
decreases secretion 		ISO
EXP 		4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of INHBA mRNA]; [Estradiol co-treated with Progesterone] results in decreased expression of INHBA mRNA; [Progesterone co-treated with IL1B protein] results in increased expression of INHBA mRNA; [Progesterone co-treated with IL1B protein] results in increased secretion of [INHBA protein binds to INHBA protein]; FST protein inhibits the reaction [INHBA protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]]; GDF9 protein inhibits the reaction [INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]]; GDF9 protein inhibits the reaction [INHBA protein results in decreased secretion of Progesterone]; IL11 protein promotes the reaction [INHBA protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of PRL protein]]; INHA mutant form inhibits the reaction [GDF9 protein inhibits the reaction [INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]]]; INHBA protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]; INHBA protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone]; INHBA protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of PRL protein]; INHBA protein promotes the reaction [IL11 protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of PRL protein]]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of INHBA mRNA]; pepstatin inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of INHBA mRNA]; Progesterone results in increased secretion of [INHBA protein binds to INHBA protein]
Progesterone results in increased expression of INHBA mRNA
Progesterone results in decreased expression of INHBA mRNA 		CTD PMID:17636213 PMID:17954979 PMID:18070364 PMID:18936084 PMID:20074812 More... NCBI chr17:49,091,635...49,111,573
Ensembl chr17:53,791,444...53,804,508 		JBrowse link
G Inhbb inhibin subunit beta B increases expression ISO Progesterone results in increased expression of INHBB mRNA CTD PMID:21795739 NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609 		JBrowse link
G Inmt indolethylamine N-methyltransferase affects expression
increases expression 		ISO Progesterone affects the expression of INMT mRNA
Progesterone results in increased expression of INMT mRNA 		CTD PMID:17251523 PMID:22238285 NCBI chr 4:85,648,459...85,652,755
Ensembl chr 4:85,648,459...85,652,755 		JBrowse link
G Inpp4b inositol polyphosphate-4-phosphatase type II B multiple interactions
decreases expression 		ISO Progesterone inhibits the reaction [Estradiol results in increased expression of INPP4B mRNA]
Progesterone results in decreased expression of INPP4B mRNA 		CTD PMID:20864642 PMID:21795739 NCBI chr19:42,824,710...43,575,039
Ensembl chr19:42,829,871...43,185,091 		JBrowse link
G Ins1 insulin 1 multiple interactions ISO 1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [[Progesterone co-treated with Estradiol] results in increased expression of INS1 protein]; [Progesterone co-treated with Estradiol] results in increased expression of INS1 protein; Progesterone inhibits the reaction [INS1 protein results in increased transport of Glucose] CTD PMID:18615583 PMID:21768169 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Ins2 insulin 2 decreases expression EXP Progesterone results in decreased expression of INS2 mRNA CTD PMID:21770760 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Insig1 insulin induced gene 1 increases expression ISO Progesterone results in increased expression of INSIG1 mRNA CTD PMID:18070364 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Insr insulin receptor decreases phosphorylation
increases expression
multiple interactions 		EXP
ISO 		Progesterone results in decreased phosphorylation of INSR protein
Progesterone results in increased expression of INSR mRNA
Progesterone affects the reaction [Streptozocin affects the expression of INSR protein] 		CTD PMID:17068109 PMID:20864642 NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803 		JBrowse link
G Insyn1 inhibitory synaptic factor 1 decreases expression ISO Progesterone results in decreased expression of INSYN1 mRNA CTD PMID:21540246 NCBI chr 8:58,904,153...58,914,850
Ensembl chr 8:67,799,304...67,814,536 		JBrowse link
G Ipo4 importin 4 decreases expression ISO Progesterone results in decreased expression of IPO4 mRNA CTD PMID:18037150 NCBI chr15:29,117,365...29,127,382
Ensembl chr15:33,087,321...33,097,241 		JBrowse link
G Iqgap2 IQ motif containing GTPase activating protein 2 increases expression ISO Progesterone results in increased expression of IQGAP2 mRNA CTD PMID:21795739 NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:28,629,558...28,904,649 		JBrowse link
G Iqgap3 IQ motif containing GTPase activating protein 3 decreases expression ISO Progesterone results in decreased expression of IQGAP3 mRNA CTD PMID:21795739 NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:175,839,949...175,881,797 		JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 increases expression ISO Progesterone results in increased expression of IRAK1 mRNA CTD PMID:17701593 NCBI chr  X:151,768,621...151,778,521
Ensembl chr  X:156,920,081...156,929,825 		JBrowse link
G Irak2 interleukin-1 receptor-associated kinase 2 increases expression ISO Progesterone results in increased expression of IRAK2 protein
Progesterone results in increased expression of IRAK2 mRNA 		CTD PMID:17701593 PMID:21549006 NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210 		JBrowse link
G Irak3 interleukin-1 receptor-associated kinase 3 increases expression ISO Progesterone results in increased expression of IRAK3 mRNA CTD PMID:17404688 NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:57,539,557...57,598,706 		JBrowse link
G Irak4 interleukin-1 receptor-associated kinase 4 increases expression ISO Progesterone results in increased expression of IRAK4 protein CTD PMID:17701593 NCBI chr 7:127,561,777...127,588,762
Ensembl chr 7:127,561,717...127,597,109 		JBrowse link
G Irf1 interferon regulatory factor 1 increases expression ISO Progesterone results in increased expression of IRF1 mRNA CTD PMID:21549006 NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947 		JBrowse link
G Irf6 interferon regulatory factor 6 increases expression ISO Progesterone results in increased expression of IRF6 mRNA CTD PMID:20864642 NCBI chr13:104,672,179...104,691,386
Ensembl chr13:107,200,731...107,220,049 		JBrowse link
G Irs1 insulin receptor substrate 1 decreases phosphorylation
increases phosphorylation 		ISO Progesterone results in decreased phosphorylation of IRS1 protein
Progesterone results in increased phosphorylation of IRS1 protein 		CTD PMID:15604210 PMID:15949379 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538 		JBrowse link
G Irs2 insulin receptor substrate 2 multiple interactions
increases expression
increases phosphorylation 		ISO [Progesterone co-treated with Estradiol] results in increased expression of IRS2 mRNA; Estradiol promotes the reaction [Progesterone results in increased expression of IRS2 mRNA]; Estradiol promotes the reaction [Progesterone results in increased expression of IRS2 protein]; Estradiol promotes the reaction [Progesterone results in increased phosphorylation of IRS2 protein]
Progesterone results in increased expression of IRS2 mRNA; Progesterone results in increased expression of IRS2 protein 		CTD PMID:15949379 PMID:17404688 PMID:20864642 PMID:21795739 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543 		JBrowse link
G Irs3 insulin receptor substrate 3 increases expression EXP Progesterone results in increased expression of IRS3 mRNA CTD PMID:20726854 NCBI chr12:19,053,148...19,055,286
Ensembl chr12:24,689,909...24,692,068 		JBrowse link
G Irx2 iroquois homeobox 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of IRX2 mRNA CTD PMID:18556351 NCBI chr 1:32,489,512...32,494,930
Ensembl chr 1:32,489,512...32,494,930 		JBrowse link
G Irx4 iroquois homeobox 4 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of IRX4 mRNA
Progesterone results in increased expression of IRX4 mRNA 		CTD PMID:17404688 NCBI chr 1:30,030,561...30,039,549
Ensembl chr 1:31,859,101...31,868,089 		JBrowse link
G Isg20 interferon stimulated exonuclease gene 20 affects expression ISO Progesterone affects the expression of ISG20 mRNA CTD PMID:17251523 NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401 		JBrowse link
G Ism1 isthmin 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ISM1 mRNA CTD PMID:20660070 NCBI chr 3:127,023,296...127,102,228
Ensembl chr 3:147,475,533...147,555,908 		JBrowse link
G Isoc1 isochorismatase domain containing 1 decreases expression ISO Progesterone results in decreased expression of ISOC1 mRNA CTD PMID:20864642 NCBI chr18:54,356,757...54,377,170
Ensembl chr18:54,356,734...54,377,170 		JBrowse link
G Itga1 integrin subunit alpha 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of ITGA1 protein; PGR protein affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ITGA1]; resveratrol inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ITGA1 protein]; resveratrol inhibits the reaction [PGR protein affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ITGA1]] CTD PMID:11507064 NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:48,386,249...48,545,284 		JBrowse link
G Itga10 integrin subunit alpha 10 increases expression ISO Progesterone results in increased expression of ITGA10 mRNA CTD PMID:20864642 PMID:21795739 NCBI chr 2:186,871,711...186,891,012
Ensembl chr 2:186,871,711...186,891,012 		JBrowse link
G Itga2 integrin subunit alpha 2 multiple interactions
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of ITGA2 mRNA
Mifepristone inhibits the reaction [Progesterone results in decreased expression of ITGA2 protein] 		CTD PMID:20660070 PMID:20959644 NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509 		JBrowse link
G Itga3 integrin subunit alpha 3 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of ITGA3 mRNA
Progesterone results in increased expression of ITGA3 mRNA 		CTD PMID:20226447 NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901 		JBrowse link
G Itga4 integrin subunit alpha 4 decreases expression ISO Progesterone results in decreased expression of ITGA4 mRNA CTD PMID:21795739 NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:84,560,369...84,641,039 		JBrowse link
G Itga5 integrin subunit alpha 5 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of ITGA5 mRNA
Progesterone results in increased expression of ITGA5 mRNA 		CTD PMID:20226447 PMID:21795739 NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305 		JBrowse link
G Itga6 integrin subunit alpha 6 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of ITGA6 mRNA CTD PMID:20226447 NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:77,017,766...77,097,076 		JBrowse link
G Itga7 integrin subunit alpha 7 increases expression ISO Progesterone results in increased expression of ITGA7 mRNA CTD PMID:18037150 NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,944,460...1,973,339 		JBrowse link
G Itga8 integrin subunit alpha 8 multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of ITGA8 mRNA
Progesterone results in increased expression of ITGA8 mRNA 		CTD PMID:20226447 PMID:20726854 NCBI chr17:80,213,139...80,410,633
Ensembl chr17:80,213,143...80,410,633 		JBrowse link
G Itgam integrin subunit alpha M decreases expression ISO Progesterone results in decreased expression of ITGAM protein CTD PMID:21558462 NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943 		JBrowse link
G Itgb1 integrin subunit beta 1 increases expression EXP Progesterone results in increased expression of ITGB1 mRNA CTD PMID:21770760 NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269 		JBrowse link
G Itgb1bp1 integrin subunit beta 1 binding protein 1 decreases expression ISO Progesterone results in decreased expression of ITGB1BP1 mRNA CTD PMID:18037150 NCBI chr 6:46,549,994...46,564,735
Ensembl chr 6:46,549,999...46,564,398 		JBrowse link
G Itgb2 integrin subunit beta 2 affects expression
increases expression
multiple interactions 		ISO Progesterone affects the expression of ITGB2 mRNA
Progesterone results in increased expression of ITGB2 mRNA
[Progesterone co-treated with Estradiol] results in increased expression of ITGB2 mRNA 		CTD PMID:17251523 PMID:20226447 PMID:21540246 NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182 		JBrowse link
G Itgb3 integrin subunit beta 3 multiple interactions
decreases expression
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of ITGB3 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ITGB3 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ITGB3 mRNA
Progesterone results in decreased expression of ITGB3 mRNA
Progesterone results in increased expression of ITGB3 mRNA 		CTD PMID:16403803 PMID:17404688 PMID:20226447 PMID:20660070 NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800 		JBrowse link
G Itgb4 integrin subunit beta 4 multiple interactions
increases expression 		ISO [Progesterone affects the activity of PGR protein alternative form] which affects the expression of ITGB4 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ITGB4 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ITGB4 mRNA
Progesterone results in increased expression of ITGB4 mRNA 		CTD PMID:15866122 PMID:20226447 NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932 		JBrowse link
G Itgb6 integrin subunit beta 6 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ITGB6 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ITGB6 mRNA CTD PMID:17404688 PMID:20660070 NCBI chr 3:65,454,964...65,579,179
Ensembl chr 3:65,456,713...65,530,333 		JBrowse link
G Itgb8 integrin subunit beta 8 multiple interactions
affects expression 		ISO perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of ITGB8 mRNA]; Progesterone inhibits the reaction [perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of ITGB8 mRNA]] CTD PMID:31896193 NCBI chr 6:146,267,982...146,351,245
Ensembl chr 6:146,165,484...146,351,245 		JBrowse link
G Itgbl1 integrin subunit beta like 1 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of ITGBL1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ITGBL1 mRNA; Progesterone inhibits the reaction [Estradiol results in decreased expression of ITGBL1 mRNA]
Progesterone results in increased expression of ITGBL1 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:21795739 NCBI chr15:107,186,792...107,448,335
Ensembl chr15:107,186,689...107,451,098 		JBrowse link
G Itm2a integral membrane protein 2A multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of ITM2A mRNA CTD PMID:17404688 NCBI chr  X:72,486,383...72,492,344
Ensembl chr  X:76,559,181...76,565,437 		JBrowse link
G Itm2c integral membrane protein 2C multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of ITM2C mRNA CTD PMID:17404688 NCBI chr 9:86,545,927...86,559,745
Ensembl chr 9:93,993,895...94,007,704 		JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of ITPR1 mRNA CTD PMID:20660070 NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504 		JBrowse link
G Ivd isovaleryl-CoA dehydrogenase increases expression EXP Progesterone results in increased expression of IVD mRNA CTD PMID:20726854 NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:126,305,364...126,328,160 		JBrowse link
G Ivns1abp influenza virus NS1A binding protein decreases expression ISO Progesterone results in decreased expression of IVNS1ABP mRNA CTD PMID:21795739 NCBI chr13:65,977,069...65,996,685
Ensembl chr13:65,977,045...65,997,547 		JBrowse link
G Jade1 jade family PHD finger 1 increases expression ISO Progesterone results in increased expression of JADE1 mRNA CTD PMID:20864642 PMID:21795739 NCBI chr 2:126,471,124...126,524,252
Ensembl chr 2:126,471,124...126,524,252 		JBrowse link
G Jak2 Janus kinase 2 increases expression ISO Progesterone results in increased expression of JAK2 mRNA CTD PMID:20864642 NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762 		JBrowse link
G Jam2 junctional adhesion molecule 2 increases expression ISO Progesterone results in increased expression of JAM2 mRNA CTD PMID:22238285 NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510 		JBrowse link
G Jchain joining chain of multimeric IgA and IgM affects expression ISO Progesterone affects the expression of JCHAIN mRNA CTD PMID:17251523 NCBI chr14:19,822,976...19,831,072
Ensembl chr14:19,822,976...19,838,307 		JBrowse link
G Jdp2 Jun dimerization protein 2 increases expression
multiple interactions 		ISO Progesterone results in increased expression of JDP2 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of JDP2 mRNA 		CTD PMID:18037150 PMID:18556351 NCBI chr 6:110,988,927...111,033,392
Ensembl chr 6:110,992,806...111,033,392 		JBrowse link
G Jmy junction mediating and regulatory protein, p53 cofactor decreases expression ISO Progesterone results in decreased expression of JMY mRNA CTD PMID:21795739 NCBI chr 2:24,662,104...24,730,955
Ensembl chr 2:26,409,969...26,465,649 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression
decreases expression 		EXP
ISO 		[Estrogens co-treated with Progesterone] results in increased phosphorylation of JUN protein; Progesterone promotes the reaction [Hydrogen Peroxide results in increased activity of JUN protein]
Progesterone results in increased expression of JUN mRNA
Progesterone results in decreased expression of JUN mRNA 		CTD PMID:16284289 PMID:17170212 PMID:21258428 PMID:21549006 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit increases expression ISO Progesterone results in increased expression of JUND mRNA CTD PMID:18037150 NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148 		JBrowse link
G Jup junction plakoglobin affects expression
multiple interactions 		ISO Progesterone affects the expression of JUP mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of JUP mRNA 		CTD PMID:17251523 PMID:20660070 NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,800,814...85,827,429 		JBrowse link
G Kansl1l KAT8 regulatory NSL complex subunit 1-like increases expression ISO Progesterone results in increased expression of KANSL1L mRNA CTD PMID:18070364 NCBI chr 9:75,660,865...75,766,730
Ensembl chr 9:75,661,233...75,766,745 		JBrowse link
G Kazald1 Kazal-type serine peptidase inhibitor domain 1 decreases expression ISO Progesterone results in decreased expression of KAZALD1 mRNA CTD PMID:21540246 NCBI chr 1:253,888,639...253,892,211
Ensembl chr 1:253,888,783...253,892,305 		JBrowse link
G Kazn kazrin, periplakin interacting protein multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of KAZN mRNA CTD PMID:20660070 NCBI chr 5:159,675,803...160,666,084
Ensembl chr 5:159,675,803...160,664,154 		JBrowse link
G Kbtbd11 kelch repeat and BTB domain containing 11 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of KBTBD11 mRNA CTD PMID:17404688 NCBI chr16:81,318,596...81,340,334
Ensembl chr16:81,313,093...81,340,390 		JBrowse link
G Kcna5 potassium voltage-gated channel subfamily A member 5 decreases activity ISO Progesterone results in decreased activity of KCNA5 protein CTD PMID:18068743 NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:160,996,950...161,044,408 		JBrowse link
G Kcnd2 potassium voltage-gated channel subfamily D member 2 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of KCND2 mRNA
Progesterone results in increased expression of KCND2 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:50,742,839...51,243,522 		JBrowse link
G Kcnd3 potassium voltage-gated channel subfamily D member 3 increases expression ISO Progesterone results in increased expression of KCND3 mRNA CTD PMID:22238285 NCBI chr 2:195,626,316...195,843,690
Ensembl chr 2:195,626,316...195,843,690 		JBrowse link
G Kcne1 potassium voltage-gated channel subfamily E regulatory subunit 1 increases expression EXP Progesterone results in increased expression of KCNE1 mRNA CTD PMID:20726854 NCBI chr11:45,066,875...45,080,024
Ensembl chr11:45,064,162...45,081,247 		JBrowse link
G Kcne3 potassium voltage-gated channel subfamily E regulatory subunit 3 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of KCNE3 mRNA
Progesterone results in decreased expression of KCNE3 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 1:163,936,035...163,942,998
Ensembl chr 1:163,935,991...163,950,162 		JBrowse link
G Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of KCNE4 mRNA
Progesterone results in increased expression of KCNE4 mRNA 		CTD PMID:20660070 PMID:21795739 NCBI chr 9:87,674,264...87,699,088
Ensembl chr 9:87,650,462...87,704,131 		JBrowse link
G Kcng1 potassium voltage-gated channel modifier subfamily G member 1 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of KCNG1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of KCNG1 mRNA
Progesterone results in increased expression of KCNG1 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:21795739 NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:177,392,031...177,411,507 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 multiple interactions EXP 2-Hydroxypropyl-beta-cyclodextrin inhibits the reaction [Progesterone results in decreased localization of KCNH2 protein]; E 4031 inhibits the reaction [Progesterone results in decreased localization of KCNH2 protein]; Progesterone results in decreased glycosylation of and results in decreased localization of and results in decreased activity of KCNH2 protein CTD PMID:21525004 NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421 		JBrowse link
G Kcnip4 potassium voltage-gated channel interacting protein 4 increases expression ISO Progesterone results in increased expression of KCNIP4 mRNA CTD PMID:22238285 NCBI chr14:65,593,297...66,743,994
Ensembl chr14:65,593,366...66,743,993 		JBrowse link
G Kcnj13 potassium inwardly-rectifying channel, subfamily J, member 13 decreases expression EXP Progesterone results in decreased expression of KCNJ13 mRNA CTD PMID:21770760 NCBI chr 9:95,509,228...95,528,400
Ensembl chr 9:95,510,877...95,520,817 		JBrowse link
G Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 increases expression ISO Progesterone results in increased expression of KCNJ16 mRNA CTD PMID:18070364 NCBI chr10:96,489,329...96,520,745
Ensembl chr10:96,460,331...96,566,075 		JBrowse link
G Kcnj8 potassium inwardly-rectifying channel, subfamily J, member 8 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of KCNJ8 mRNA
Progesterone results in increased expression of KCNJ8 mRNA 		CTD PMID:17404688 NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531 		JBrowse link
G Kcnk3 potassium two pore domain channel subfamily K member 3 decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of KCNK3 mRNA
Progesterone results in increased expression of KCNK3 mRNA 		CTD PMID:18070364 PMID:20726854 NCBI chr 6:31,483,129...31,519,061
Ensembl chr 6:31,483,140...31,519,061 		JBrowse link
G Kcnk6 potassium two pore domain channel subfamily K member 6 increases expression ISO Progesterone results in increased expression of KCNK6 mRNA CTD PMID:20864642 NCBI chr 1:93,652,888...93,661,419 JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 multiple interactions
increases expression
decreases activity 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of KCNMA1 mRNA; Progesterone inhibits the reaction [Estradiol results in increased activity of KCNMA1 protein]
Progesterone results in increased expression of KCNMA1 mRNA; Progesterone results in increased expression of KCNMA1 protein
Progesterone results in decreased activity of KCNMA1 protein
Progesterone results in increased expression of KCNMA1 mRNA; Progesterone results in increased expression of KCNMA1 mRNA alternative form 		CTD PMID:16102753 PMID:18068743 PMID:20660070 PMID:21795739 NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117 		JBrowse link
G Kcnmb2 potassium calcium-activated channel subfamily M regulatory beta subunit 2 decreases expression ISO Progesterone results in decreased expression of KCNMB2 mRNA CTD PMID:21795739 NCBI chr 2:114,670,027...114,975,374
Ensembl chr 2:116,599,387...116,903,854 		JBrowse link
G Kcnn4 potassium calcium-activated channel subfamily N member 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of KCNN4 mRNA CTD PMID:20660070 NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:89,086,814...89,102,275 		JBrowse link
G Kcns3 potassium voltage-gated channel, modifier subfamily S, member 3 increases expression ISO Progesterone results in increased expression of KCNS3 mRNA CTD PMID:21795739 NCBI chr 6:33,808,314...33,865,018
Ensembl chr 6:39,523,777...39,618,848 		JBrowse link
G Kcnt2 potassium sodium-activated channel subfamily T member 2 increases expression ISO Progesterone results in increased expression of KCNT2 mRNA CTD PMID:21795739 NCBI chr13:54,214,831...54,609,889
Ensembl chr13:54,215,307...54,607,924 		JBrowse link
G Kctd12 potassium channel tetramerization domain containing 12 increases expression ISO Progesterone results in increased expression of KCTD12 mRNA CTD PMID:21795739 PMID:22238285 NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539 		JBrowse link
G Kdm4a lysine demethylase 4A increases expression ISO Progesterone results in increased expression of KDM4A mRNA CTD PMID:18037150 NCBI chr 5:131,672,754...131,719,534
Ensembl chr 5:136,958,178...137,004,951 		JBrowse link
G Kdr kinase insert domain receptor increases expression EXP
ISO 		Progesterone results in increased expression of KDR mRNA CTD PMID:18692832 PMID:20726854 NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192 		JBrowse link
G Kdsr 3-ketodihydrosphingosine reductase increases expression ISO Progesterone results in increased expression of KDSR mRNA CTD PMID:18070364 NCBI chr13:23,374,101...23,408,779
Ensembl chr13:23,376,779...23,408,897 		JBrowse link
G Khdrbs1 KH RNA binding domain containing, signal transduction associated 1 affects expression ISO Progesterone affects the expression of KHDRBS1 mRNA CTD PMID:17251523 NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:147,347,904...147,373,448 		JBrowse link
G Kif13b kinesin family member 13B increases expression ISO Progesterone results in increased expression of KIF13B mRNA CTD PMID:21795739 NCBI chr15:43,084,059...43,241,719
Ensembl chr15:43,080,910...43,241,719 		JBrowse link
G Kif14 kinesin family member 14 decreases expression ISO Progesterone results in decreased expression of KIF14 mRNA CTD PMID:21795739 NCBI chr13:50,478,646...50,542,256
Ensembl chr13:50,478,721...50,542,248 		JBrowse link
G Kif20a kinesin family member 20A increases expression
decreases expression 		ISO Progesterone results in increased expression of KIF20A mRNA
Progesterone results in decreased expression of KIF20A mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909 		JBrowse link
G Kif4a kinesin family member 4A increases expression
decreases expression 		ISO Progesterone results in increased expression of KIF4A mRNA
Progesterone results in decreased expression of KIF4A mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr  X:69,761,803...69,864,335
Ensembl chr  X:69,761,883...69,864,335 		JBrowse link
G Kiss1 KiSS-1 metastasis-suppressor multiple interactions
increases abundance 		EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [KISS1 protein results in increased abundance of Progesterone]; KISS1 protein promotes the reaction [CGB3 protein results in increased abundance of Progesterone] CTD PMID:23312234 NCBI chr13:44,775,106...44,780,707
Ensembl chr13:47,327,004...47,332,906 		JBrowse link
G Kiz kizuna centrosomal protein increases expression ISO Progesterone results in increased expression of KIZ mRNA CTD PMID:18037150 NCBI chr 3:154,730,873...154,838,410
Ensembl chr 3:154,730,634...154,838,410 		JBrowse link
G Klf10 KLF transcription factor 10 decreases expression ISO
EXP 		Progesterone results in decreased expression of KLF10 mRNA CTD PMID:18037150 PMID:20726854 NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948 		JBrowse link
G Klf15 KLF transcription factor 15 increases expression EXP Progesterone results in increased expression of KLF15 mRNA CTD PMID:20726854 NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373 		JBrowse link
G Klf4 KLF transcription factor 4 multiple interactions ISO Progesterone promotes the reaction [Estradiol results in increased expression of KLF4 mRNA] CTD PMID:21795739 NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592 		JBrowse link
G Klf5 KLF transcription factor 5 increases expression
multiple interactions
affects expression 		ISO Progesterone results in increased expression of KLF5 mRNA
perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of KLF5 mRNA]; Progesterone inhibits the reaction [perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of KLF5 mRNA]] 		CTD PMID:18037150 PMID:18070364 PMID:31896193 NCBI chr15:82,472,081...82,487,267
Ensembl chr15:82,472,065...82,487,262 		JBrowse link
G Klf6 KLF transcription factor 6 increases expression ISO Progesterone results in increased expression of KLF6 mRNA CTD PMID:18070364 PMID:20864642 PMID:21795739 NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601 		JBrowse link
G Klf9 KLF transcription factor 9 increases expression EXP Progesterone results in increased expression of KLF9 mRNA CTD PMID:20726854 NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641 		JBrowse link
G Klhl14 kelch-like family member 14 decreases expression ISO Progesterone results in decreased expression of KLHL14 mRNA CTD PMID:22238285 NCBI chr18:12,804,253...12,917,828
Ensembl chr18:13,079,159...13,193,557 		JBrowse link
G Klhl24 kelch-like family member 24 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of KLHL24 mRNA CTD PMID:20660070 NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050 		JBrowse link
G Klhl29 kelch-like family member 29 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of KLHL29 mRNA CTD PMID:20660070 NCBI chr 6:33,805,922...34,110,055
Ensembl chr 6:33,805,922...34,110,055 		JBrowse link
G Klhl31 kelch-like family member 31 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of KLHL31 mRNA
Progesterone results in decreased expression of KLHL31 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 8:87,395,878...87,419,236
Ensembl chr 8:87,395,869...87,419,258 		JBrowse link
G Klk10 kallikrein related-peptidase 10 multiple interactions ISO [Estrogens co-treated with Progesterone] results in increased expression of KLK10 mRNA CTD PMID:20686372 NCBI chr 1:103,371,638...103,375,918
Ensembl chr 1:103,371,638...103,375,918 		JBrowse link
G Klk11 kallikrein related-peptidase 11 decreases expression ISO Progesterone results in decreased expression of KLK11 mRNA CTD PMID:22238285 NCBI chr 1:94,228,741...94,233,281
Ensembl chr 1:103,365,290...103,369,830 		JBrowse link
G Klk5 kallikrein related-peptidase 5 multiple interactions ISO [Progesterone results in increased activity of PGR protein] which results in increased expression of KLK5 mRNA CTD PMID:15845616 NCBI chr 1:94,296,574...94,304,768
Ensembl chr 1:103,433,065...103,441,305 		JBrowse link
G Klk6 kallikrein related-peptidase 6 multiple interactions ISO [Progesterone results in increased activity of PGR protein] which results in increased expression of KLK6 mRNA CTD PMID:15845616 NCBI chr 1:94,278,863...94,286,136
Ensembl chr 1:103,416,886...103,422,690 		JBrowse link
G Klrb1a killer cell lectin like receptor B1A multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of KLRB1 mRNA CTD PMID:17404688 NCBI chr 4:163,576,672...163,590,201
Ensembl chr 4:163,576,672...163,619,374 		JBrowse link
G Klrc3 killer cell lectin like receptor C3 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of KLRC3 mRNA
Progesterone results in increased expression of KLRC3 mRNA 		CTD PMID:17404688 PMID:21540246 NCBI chr 4:163,105,081...163,112,737
Ensembl chr 4:164,791,128...164,798,758 		JBrowse link
G Kng1 kininogen 1 increases expression EXP Progesterone results in increased expression of KNG1 mRNA CTD PMID:21770760 NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148 		JBrowse link
G Knl1 kinetochore scaffold 1 decreases expression ISO Progesterone results in decreased expression of KNL1 mRNA CTD PMID:21795739 NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774 		JBrowse link
G Krt12 keratin 12 increases expression ISO Progesterone results in increased expression of KRT12 mRNA CTD PMID:22238285 NCBI chr10:84,370,803...84,378,103
Ensembl chr10:84,866,965...84,874,265 		JBrowse link
G Krt15 keratin 15 decreases expression ISO Progesterone results in decreased expression of KRT15 mRNA CTD PMID:22238285 NCBI chr10:85,567,197...85,571,014
Ensembl chr10:85,567,202...85,571,142 		JBrowse link
G Krt17 keratin 17 decreases expression ISO Progesterone results in decreased expression of KRT17 mRNA CTD PMID:18037150 PMID:22238285 NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,679,070...85,683,787 		JBrowse link
G Krt18 keratin 18 multiple interactions
decreases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in decreased expression of KRT18 mRNA] CTD PMID:17556502 PMID:21795739 NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848 		JBrowse link
G Krt23 keratin 23 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of KRT23 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of KRT23 mRNA
Progesterone results in decreased expression of KRT23 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:21540246 NCBI chr10:84,930,603...84,946,929
Ensembl chr10:84,930,603...84,946,929 		JBrowse link
G Krt34 keratin 34 decreases expression ISO Progesterone results in decreased expression of KRT34 mRNA CTD PMID:20864642 NCBI chr10:84,969,988...84,974,098
Ensembl chr10:85,470,391...85,474,501 		JBrowse link
G Krt7 keratin 7 increases expression ISO Progesterone results in increased expression of KRT7 mRNA CTD PMID:18497975 NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:134,407,584...134,423,786 		JBrowse link
G Krt8 keratin 8 decreases expression ISO Progesterone results in decreased expression of KRT8 mRNA CTD PMID:21540246 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Krt86 keratin 86 increases expression ISO Progesterone results in increased expression of KRT86 mRNA CTD PMID:21540246 NCBI chr 7:132,591,489...132,598,142
Ensembl chr 7:134,470,224...134,476,873 		JBrowse link
G Krtcap3 keratinocyte associated protein 3 decreases expression ISO Progesterone results in decreased expression of KRTCAP3 mRNA CTD PMID:21540246 NCBI chr 6:30,840,906...30,842,500
Ensembl chr 6:30,840,906...30,842,475 		JBrowse link
G Kynu kynureninase multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of KYNU mRNA CTD PMID:20660070 NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:48,188,182...48,339,014 		JBrowse link
G L1cam L1 cell adhesion molecule decreases expression ISO Progesterone results in decreased expression of L1CAM mRNA CTD PMID:18070364 NCBI chr  X:156,748,597...156,775,116
Ensembl chr  X:156,748,597...156,775,077 		JBrowse link
G L2hgdh L-2-hydroxyglutarate dehydrogenase decreases expression ISO Progesterone results in decreased expression of L2HGDH mRNA CTD PMID:22238285 NCBI chr 6:93,900,427...93,941,534
Ensembl chr 6:93,900,427...93,941,534 		JBrowse link
G Lama2 laminin subunit alpha 2 increases expression ISO Progesterone results in increased expression of LAMA2 mRNA CTD PMID:22238285 NCBI chr 1:19,492,126...20,140,056
Ensembl chr 1:19,244,599...20,140,056 		JBrowse link
G Lama3 laminin subunit alpha 3 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of LAMA3 mRNA CTD PMID:17404688 NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449 		JBrowse link
G Lama4 laminin subunit alpha 4 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of LAMA4 mRNA
Progesterone results in increased expression of LAMA4 mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr20:42,392,268...42,533,347
Ensembl chr20:43,946,898...44,087,972 		JBrowse link
G Lamb3 laminin subunit beta 3 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of LAMB3 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of LAMB3 mRNA
Progesterone results in increased expression of LAMB3 mRNA 		CTD PMID:20226447 PMID:20660070 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081 		JBrowse link
G Lamc1 laminin subunit gamma 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of LAMC1 mRNA CTD PMID:20226447 NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986 		JBrowse link
G Lamc2 laminin subunit gamma 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of LAMC2 mRNA CTD PMID:20660070 NCBI chr13:67,835,199...67,894,694
Ensembl chr13:67,835,199...67,895,102 		JBrowse link
G Lamc3 laminin subunit gamma 3 increases expression ISO Progesterone results in increased expression of LAMC3 mRNA CTD PMID:22238285 NCBI chr 3:15,165,220...15,226,697
Ensembl chr 3:35,562,713...35,624,460 		JBrowse link
G Large2 LARGE xylosyl- and glucuronyltransferase 2 decreases expression ISO Progesterone results in decreased expression of LARGE2 mRNA CTD PMID:21540246 NCBI chr 3:98,791,543...98,800,251
Ensembl chr 3:98,791,543...98,797,782 		JBrowse link
G Larp4 La ribonucleoprotein 4 increases expression ISO Progesterone results in increased expression of LARP4 mRNA CTD PMID:18070364 NCBI chr 7:131,104,470...131,152,692
Ensembl chr 7:132,980,385...133,029,633 		JBrowse link
G Lbp lipopolysaccharide binding protein increases expression ISO Progesterone results in increased expression of LBP mRNA CTD PMID:21540246 NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518 		JBrowse link
G Lce3e late cornified envelope 3E decreases expression ISO Progesterone results in decreased expression of LCE3B mRNA CTD PMID:22238285 NCBI chr 2:178,578,488...178,579,661
Ensembl chr 2:181,274,092...181,275,265 		JBrowse link
G Lck LCK proto-oncogene, Src family tyrosine kinase multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of LCK mRNA CTD PMID:17404688 NCBI chr 5:147,172,642...147,201,267
Ensembl chr 5:147,172,642...147,201,267 		JBrowse link
G Lcn2 lipocalin 2 affects expression ISO Progesterone affects the expression of LCN2 mRNA CTD PMID:17251523 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Lcp1 lymphocyte cytosolic protein 1 increases expression ISO Progesterone results in increased expression of LCP1 mRNA CTD PMID:20864642 PMID:21540246 NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092 		JBrowse link
G Lct lactase increases expression ISO Progesterone results in increased expression of LCT mRNA CTD PMID:22238285 NCBI chr13:42,334,347...42,376,872
Ensembl chr13:42,334,347...42,376,872 		JBrowse link
G Ldb2 LIM domain binding 2 decreases expression
increases expression
multiple interactions 		ISO Progesterone results in decreased expression of LDB2 mRNA
Progesterone results in increased expression of LDB2 mRNA
NCOA2 protein affects the reaction [Progesterone results in decreased expression of LDB2 mRNA] 		CTD PMID:17556502 PMID:22238285 NCBI chr14:70,489,243...70,810,573
Ensembl chr14:70,489,620...70,810,574 		JBrowse link
G Ldha lactate dehydrogenase A decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of LDHA mRNA
Progesterone results in increased expression of LDHA mRNA 		CTD PMID:18037150 PMID:21770760 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521 		JBrowse link
G Ldhb lactate dehydrogenase B increases expression EXP Progesterone results in increased expression of LDHB mRNA CTD PMID:20726854 NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408 		JBrowse link
G Ldlr low density lipoprotein receptor affects expression
increases expression 		ISO
EXP 		Progesterone affects the expression of LDLR mRNA
Progesterone results in increased expression of LDLR mRNA 		CTD PMID:17170212 PMID:17251523 PMID:18037150 PMID:18070364 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675 		JBrowse link
G Ldlrad4 low density lipoprotein receptor class A domain containing 4 increases expression ISO Progesterone results in increased expression of LDLRAD4 mRNA CTD PMID:17404688 NCBI chr18:61,519,253...61,848,403
Ensembl chr18:63,790,440...64,113,064 		JBrowse link
G Lefty1 left right determination factor 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of LEFTY1 mRNA
[Progesterone co-treated with Triclosan] results in increased expression of LEFTY1 mRNA 		CTD PMID:26604029 NCBI chr13:95,188,091...95,191,488
Ensembl chr13:95,188,091...95,191,488 		JBrowse link
G Lemd1 LEM domain containing 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of LEMD1 mRNA CTD PMID:20660070 NCBI chr13:43,631,705...43,697,765
Ensembl chr13:46,218,085...46,250,562 		JBrowse link
G Lep leptin decreases secretion
multiple interactions
increases expression 		ISO Progesterone results in decreased secretion of LEP protein
LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]]
Progesterone results in increased expression of LEP mRNA 		CTD PMID:15713686 PMID:16048798 PMID:19849856 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661 		JBrowse link
G Lepr leptin receptor multiple interactions ISO LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]] CTD PMID:19849856 NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215 		JBrowse link
G Lfng LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of LFNG mRNA CTD PMID:20660070 NCBI chr12:19,144,474...19,152,951
Ensembl chr12:19,124,662...19,152,918 		JBrowse link
G Lgals1 galectin 1 affects metabolic processing ISO LGALS1 protein affects the metabolism of Progesterone CTD PMID:17242467 NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800 		JBrowse link
G Lgals3 galectin 3 affects metabolic processing
multiple interactions 		ISO LGALS3 protein affects the metabolism of Progesterone
[Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA 		CTD PMID:17242467 PMID:20660070 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Lgals8 galectin 8 increases expression ISO Progesterone results in increased expression of LGALS8 mRNA CTD PMID:18070364 NCBI chr17:58,024,652...58,052,764
Ensembl chr17:62,719,828...62,744,482 		JBrowse link
G Lgalsl galectin-like decreases expression ISO Progesterone results in decreased expression of LGALSL mRNA CTD PMID:20864642 NCBI chr14:99,198,340...99,205,846
Ensembl chr14:99,198,339...99,206,487 		JBrowse link
G Lgi1 leucine-rich, glioma inactivated 1 decreases expression ISO Progesterone results in decreased expression of LGI1 mRNA CTD PMID:22238285 NCBI chr 1:236,043,269...236,084,617
Ensembl chr 1:245,455,599...245,499,095 		JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 decreases expression ISO Progesterone results in decreased expression of LGR5 mRNA CTD PMID:22238285 NCBI chr 7:52,973,151...53,107,964
Ensembl chr 7:52,974,332...53,108,163 		JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions
increases chemical synthesis
increases abundance
increases secretion
decreases abundance 		EXP
ISO 		2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [CGB3 protein results in increased chemical synthesis of Progesterone]; 7-Ala-angiotensin (1-7) inhibits the reaction [LHB protein results in increased secretion of Progesterone]; [Estradiol co-treated with Progesterone] results in decreased secretion of LHB protein; [Estradiol co-treated with Progesterone] results in increased expression of LHB protein; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased abundance of Progesterone]; Atrazine inhibits the reaction [[estradiol 3-benzoate co-treated with Progesterone] results in increased secretion of LHB protein]; KISS1 protein promotes the reaction [CGB3 protein results in increased abundance of Progesterone]; nociceptin (1-13) amide inhibits the reaction [PNOC protein inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of LHB protein]]; PNOC protein inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of LHB protein]
LHB protein results in increased abundance of Progesterone
LHB protein results in decreased abundance of Progesterone
[estradiol 3-benzoate co-treated with Progesterone] results in increased abundance of LHB protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased secretion of Progesterone]; Reactive Oxygen Species promotes the reaction [LHB protein results in increased abundance of Progesterone]
[LHB protein affects the secretion of Cyclic AMP] which results in increased secretion of Progesterone; ADCYAP1R1 protein promotes the reaction [LHB protein results in increased abundance of Progesterone]; DDT inhibits the reaction [LHB protein results in increased secretion of Progesterone]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LHB protein results in increased secretion of Progesterone] 		CTD PMID:15056801 PMID:15525572 PMID:15967414 PMID:16574160 PMID:17640482 More... NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445 		JBrowse link
G Lhfpl6 LHFPL tetraspan subfamily member 6 increases expression ISO Progesterone results in increased expression of LHFPL6 mRNA CTD PMID:20864642 PMID:21540246 NCBI chr 2:137,126,485...137,324,442
Ensembl chr 2:139,276,789...139,474,737 		JBrowse link
G Lif LIF, interleukin 6 family cytokine affects expression
multiple interactions
increases expression
affects response to substance 		ISO Progesterone affects the expression of LIF; Progesterone affects the expression of LIF mRNA
[Estradiol co-treated with Progesterone] results in increased expression of LIF mRNA; [NR5A1 protein co-treated with LIF protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Tretinoin] results in increased abundance of Progesterone; [Progesterone co-treated with Estradiol] affects the expression of LIF; ESR1 protein promotes the reaction [[Estradiol co-treated with Progesterone] results in increased expression of LIF mRNA]; LIF protein affects the reaction [Progesterone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased abundance of Nitric Oxide]]
[Estradiol co-treated with Progesterone] results in decreased expression of LIF mRNA
Progesterone results in increased expression of LIF mRNA
LIF protein affects the susceptibility to Progesterone 		CTD PMID:15639816 PMID:17307916 PMID:20660070 PMID:21610156 PMID:23407384 More... NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053 		JBrowse link
G Lifr LIF receptor subunit alpha increases expression EXP Progesterone results in increased expression of LIFR mRNA CTD PMID:21770760 NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:57,952,975...58,020,364 		JBrowse link
G Lig1 DNA ligase 1 decreases expression ISO
EXP 		Progesterone results in decreased expression of LIG1 mRNA CTD PMID:16966611 PMID:20726854 NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708 		JBrowse link
G Lima1 LIM domain and actin binding 1 decreases expression ISO Progesterone results in decreased expression of LIMA1 mRNA CTD PMID:18037150 PMID:20864642 NCBI chr 7:132,780,556...132,880,343
Ensembl chr 7:132,780,556...132,880,386 		JBrowse link
G Lin7b lin-7 homolog B, crumbs cell polarity complex component increases expression ISO Progesterone results in increased expression of LIN7B mRNA CTD PMID:22238285 NCBI chr 1:104,983,368...104,986,795
Ensembl chr 1:104,982,771...104,986,078 		JBrowse link
G Lipa lipase A, lysosomal acid type increases expression EXP Progesterone results in increased expression of LIPA mRNA CTD PMID:21770760 NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:241,437,524...241,470,740 		JBrowse link
G Lipg lipase G, endothelial type increases expression ISO Progesterone results in increased expression of LIPG mRNA CTD PMID:18070364 NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260 		JBrowse link
G Lmcd1 LIM and cysteine-rich domains 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of LMCD1 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of LMCD1 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:21795739 NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875 		JBrowse link
G Lmnb1 lamin B1 decreases expression ISO Progesterone results in decreased expression of LMNB1 mRNA CTD PMID:21795739 NCBI chr18:52,373,939...52,413,284
Ensembl chr18:52,373,757...52,413,283 		JBrowse link
G Lmo4 LIM domain only 4 increases expression ISO Progesterone results in increased expression of LMO4 mRNA CTD PMID:18037150 NCBI chr 2:235,924,574...235,941,609
Ensembl chr 2:235,924,403...235,941,275 		JBrowse link
G Lmod1 leiomodin 1 increases expression ISO Progesterone results in increased expression of LMOD1 mRNA CTD PMID:20864642 NCBI chr13:46,754,048...46,796,186
Ensembl chr13:49,305,830...49,348,116 		JBrowse link
G Lox lysyl oxidase increases expression ISO Progesterone results in increased expression of LOX mRNA CTD PMID:22238285 NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810 		JBrowse link
G Loxl2 lysyl oxidase-like 2 decreases expression ISO Progesterone results in decreased expression of LOXL2 mRNA CTD PMID:18070364 NCBI chr15:51,091,547...51,182,843
Ensembl chr15:51,069,997...51,182,842 		JBrowse link
G Loxl4 lysyl oxidase-like 4 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of LOXL4 mRNA; [Estradiol co-treated with Progesterone] results in increased expression of LOXL4 mRNA; Progesterone inhibits the reaction [Estradiol results in increased expression of LOXL4 mRNA]
Progesterone results in decreased expression of LOXL4 mRNA 		CTD PMID:20660070 PMID:20864642 PMID:21795739 NCBI chr 1:251,345,445...251,365,640
Ensembl chr 1:251,347,238...251,365,577 		JBrowse link
G Lpar1 lysophosphatidic acid receptor 1 increases expression EXP Progesterone results in increased expression of LPAR1 mRNA CTD PMID:20726854 NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:78,024,139...78,142,188 		JBrowse link
G Lpar3 lysophosphatidic acid receptor 3 increases expression
multiple interactions 		ISO Progesterone results in increased expression of LPAR3 mRNA
Estrogens inhibits the reaction [Progesterone results in increased expression of LPAR3 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of LPAR3 mRNA] 		CTD PMID:16815476 PMID:17404688 NCBI chr 2:237,785,371...237,854,199
Ensembl chr 2:237,787,766...237,854,197 		JBrowse link
G Lpcat3 lysophosphatidylcholine acyltransferase 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of LPCAT3 mRNA CTD PMID:20660070 NCBI chr 4:159,154,690...159,196,176
Ensembl chr 4:159,154,158...159,196,358 		JBrowse link
G Lpin1 lipin 1 increases expression ISO Progesterone results in increased expression of LPIN1 mRNA CTD PMID:18070364 NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991 		JBrowse link
G Lpl lipoprotein lipase affects expression
increases expression
multiple interactions
decreases expression 		ISO
EXP 		Progesterone affects the expression of LPL mRNA
Progesterone results in increased expression of LPL mRNA
Progesterone inhibits the reaction [Dexamethasone results in increased activity of LPL protein]
Progesterone results in decreased expression of LPL mRNA
Progesterone inhibits the reaction [ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]]; Progesterone inhibits the reaction [ESR2 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]]; Progesterone inhibits the reaction [Estradiol results in increased expression of LPL mRNA] 		CTD PMID:12906939 PMID:17251523 PMID:17974624 PMID:20726854 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107 		JBrowse link
G Lrig1 leucine-rich repeats and immunoglobulin-like domains 1 increases expression ISO Progesterone results in increased expression of LRIG1 mRNA CTD PMID:20864642 NCBI chr 4:128,687,723...128,788,219
Ensembl chr 4:128,687,723...128,788,219 		JBrowse link
G Lrp2 LDL receptor related protein 2 affects expression ISO Progesterone affects the expression of LRP2 mRNA CTD PMID:17251523 NCBI chr 3:74,597,148...74,754,535
Ensembl chr 3:74,597,148...74,754,535 		JBrowse link
G Lrp4 LDL receptor related protein 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of LRP4 mRNA CTD PMID:20660070 NCBI chr 3:77,429,600...77,483,593
Ensembl chr 3:97,885,400...97,939,370 		JBrowse link
G Lrp8 LDL receptor related protein 8 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of LRP8 mRNA CTD PMID:20660070 NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207 		JBrowse link
G Lrrc1 leucine rich repeat containing 1 increases expression
decreases expression
multiple interactions 		ISO Progesterone results in increased expression of LRRC1 mRNA
Progesterone results in decreased expression of LRRC1 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of LRRC1 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:21540246 NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:87,119,975...87,286,853 		JBrowse link
G Lrrc17 leucine rich repeat containing 17 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of LRRC17 mRNA
Progesterone results in decreased expression of LRRC17 mRNA 		CTD PMID:20660070 PMID:21795739 NCBI chr 4:14,393,632...14,424,048
Ensembl chr 4:14,393,640...14,424,048 		JBrowse link
G Lrrc32 leucine rich repeat containing 32 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of LRRC32 mRNA CTD PMID:17404688 NCBI chr 1:162,196,995...162,209,563
Ensembl chr 1:162,197,653...162,209,563 		JBrowse link
G Lrrc36 leucine rich repeat containing 36 increases expression ISO Progesterone results in increased expression of LRRC36 mRNA CTD PMID:22238285 NCBI chr19:50,201,944...50,252,338
Ensembl chr19:50,201,987...50,252,338 		JBrowse link
G Lrrc8c leucine rich repeat containing 8 VRAC subunit C multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of LRRC8C mRNA CTD PMID:20660070 NCBI chr14:4,528,721...4,621,259
Ensembl chr14:4,531,823...4,620,049 		JBrowse link
G Lrrc8d leucine rich repeat containing 8 VRAC subunit D multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of LRRC8D mRNA CTD PMID:17404688 NCBI chr14:4,335,114...4,411,549
Ensembl chr14:4,332,130...4,445,639 		JBrowse link
G Lrrn1 leucine rich repeat neuronal 1 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of LRRN1 mRNA
Progesterone results in increased expression of LRRN1 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr 4:142,032,805...142,072,320
Ensembl chr 4:142,032,041...142,074,760 		JBrowse link
G Lrrtm1 leucine rich repeat transmembrane neuronal 1 decreases expression ISO Progesterone results in decreased expression of LRRTM1 mRNA CTD PMID:22238285 NCBI chr 4:111,246,213...111,295,638
Ensembl chr 4:111,235,054...111,276,818 		JBrowse link
G Lsr lipolysis stimulated lipoprotein receptor multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of LSR mRNA
Progesterone results in decreased expression of LSR mRNA 		CTD PMID:18556351 PMID:22238285 NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354 		JBrowse link
G Lss lanosterol synthase increases expression
multiple interactions 		ISO Progesterone results in increased expression of LSS mRNA
[Estradiol co-treated with Progesterone] results in increased expression of LSS mRNA 		CTD PMID:18070364 PMID:20660070 NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253 		JBrowse link
G Lta lymphotoxin alpha increases expression ISO Progesterone results in increased expression of LTA mRNA CTD PMID:21549006 NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533 		JBrowse link
G Ltb lymphotoxin beta increases expression ISO Progesterone results in increased expression of LTB mRNA CTD PMID:22615136 NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054 		JBrowse link
G Ltbp1 latent transforming growth factor beta binding protein 1 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of LTBP1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of LTBP1 mRNA
Progesterone results in increased expression of LTBP1 mRNA 		CTD PMID:17404688 PMID:20660070 PMID:21795739 NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:25,781,638...26,454,036 		JBrowse link
G Ltf lactotransferrin affects expression ISO Progesterone affects the expression of LTF mRNA CTD PMID:17251523 NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:119,878,344...119,901,189 		JBrowse link
G Lum lumican increases expression ISO Progesterone results in increased expression of LUM mRNA CTD PMID:21540246 NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508 		JBrowse link
G Lxn latexin multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of LXN mRNA CTD PMID:17404688 NCBI chr 2:154,037,604...154,043,473
Ensembl chr 2:154,037,292...154,043,488 		JBrowse link
G Ly6e lymphocyte antigen 6 family member E multiple interactions
decreases expression 		ISO Mifepristone inhibits the reaction [Progesterone results in decreased expression of LY6E mRNA] CTD PMID:27264040 PMID:31566189 NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443 		JBrowse link
G Ly86 lymphocyte antigen 86 increases expression ISO Progesterone results in increased expression of LY86 mRNA CTD PMID:21549006 NCBI chr17:27,621,313...27,705,336
Ensembl chr17:27,621,313...27,692,743 		JBrowse link
G Lypd1 Ly6/Plaur domain containing 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of LYPD1 mRNA
Progesterone results in increased expression of LYPD1 mRNA 		CTD PMID:17404688 PMID:22238285 NCBI chr13:39,874,937...39,922,385
Ensembl chr13:39,879,096...39,922,338 		JBrowse link
G Lypd2 Ly6/Plaur domain containing 2 decreases expression ISO Progesterone results in decreased expression of LYPD2 mRNA CTD PMID:22238285 NCBI chr 7:106,617,561...106,619,598
Ensembl chr 7:108,506,545...108,508,582 		JBrowse link
G Lyset lysosomal enzyme trafficking factor increases expression ISO Progesterone results in increased expression of LYSET mRNA CTD PMID:18070364 NCBI chr 6:121,884,577...121,886,319
Ensembl chr 6:127,649,450...127,652,661 		JBrowse link
G Lyz2 lysozyme 2 multiple interactions
affects expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of LYZ mRNA
Progesterone affects the expression of LYZ mRNA 		CTD PMID:17251523 PMID:20660070 NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011 		JBrowse link
G Lztfl1 leucine zipper transcription factor-like 1 multiple interactions
increases expression 		ISO [Progesterone co-treated with TGFB1 protein] results in increased expression of LZTFL1 mRNA
Progesterone results in increased expression of LZTFL1 mRNA 		CTD PMID:21768398 NCBI chr 8:123,344,085...123,360,245
Ensembl chr 8:132,222,342...132,237,684 		JBrowse link
G Macc1 MET transcriptional regulator MACC1 decreases expression ISO Progesterone results in decreased expression of MACC1 mRNA CTD PMID:22238285 NCBI chr 6:146,495,544...146,574,254
Ensembl chr 6:146,495,861...146,574,260 		JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 decreases expression ISO Progesterone results in decreased expression of MAD2L1 mRNA CTD PMID:16966611 NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222 		JBrowse link
G Maf MAF bZIP transcription factor increases expression
multiple interactions 		ISO Progesterone results in increased expression of MAF mRNA
[Estradiol co-treated with Progesterone] results in increased expression of MAF mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr19:60,259,200...60,622,145
Ensembl chr19:60,269,541...60,621,378 		JBrowse link
G Mafb MAF bZIP transcription factor B multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of MAFB mRNA CTD PMID:20660070 NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975 		JBrowse link
G Mal mal, T-cell differentiation protein decreases expression ISO Progesterone results in decreased expression of MAL mRNA CTD PMID:22238285 NCBI chr 3:135,317,664...135,341,423
Ensembl chr 3:135,317,664...135,341,423 		JBrowse link
G Mal2 mal, T-cell differentiation protein 2 decreases expression ISO Progesterone results in decreased expression of MAL2 mRNA CTD PMID:22238285 NCBI chr 7:87,790,239...87,823,219
Ensembl chr 7:87,790,239...87,850,403 		JBrowse link
G Mamdc2 MAM domain containing 2 increases expression ISO Progesterone results in increased expression of MAMDC2 mRNA CTD PMID:21795739 NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:230,290,499...230,442,711 		JBrowse link
G Man2b2 mannosidase, alpha, class 2B, member 2 decreases expression ISO Progesterone results in decreased expression of MAN2B2 mRNA CTD PMID:21540246 NCBI chr14:73,969,079...73,994,089
Ensembl chr14:78,193,725...78,227,724 		JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor affects expression
increases expression 		ISO Progesterone affects the expression of MANF mRNA
Progesterone results in increased expression of MANF mRNA 		CTD PMID:17251523 PMID:18037150 NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910 		JBrowse link
G Maoa monoamine oxidase A multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of MAOA mRNA; [Progesterone co-treated with Estradiol] results in increased expression of MAOA mRNA
Progesterone results in increased expression of MAOA mRNA 		CTD PMID:17404688 PMID:20660070 PMID:20864642 NCBI chr  X:8,615,239...8,681,372
Ensembl chr  X:8,615,239...8,682,631 		JBrowse link
G Maob monoamine oxidase B multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of MAOB mRNA; [Progesterone co-treated with Estradiol] results in increased expression of MAOB mRNA
Progesterone results in increased expression of MAOB mRNA 		CTD PMID:17404688 PMID:20660070 PMID:20864642 PMID:22238285 NCBI chr  X:8,490,405...8,594,065
Ensembl chr  X:8,490,344...8,594,375 		JBrowse link
G Map1b microtubule-associated protein 1B increases expression EXP Progesterone results in increased expression of MAP1B mRNA CTD PMID:20726854 NCBI chr 2:32,551,423...32,644,471
Ensembl chr 2:32,551,423...32,657,094 		JBrowse link
G Map2 microtubule-associated protein 2 increases expression
decreases expression 		ISO
EXP 		Progesterone results in increased expression of MAP2 mRNA
Progesterone results in decreased expression of MAP2 mRNA
Progesterone results in increased expression of MAP2 protein 		CTD PMID:16054770 PMID:18037150 PMID:21795739 NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459 		JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA
Progesterone results in increased expression of MAP2K6 mRNA 		CTD PMID:17404688 NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721 		JBrowse link
G Map3k4 mitogen activated protein kinase kinase kinase 4 increases expression
multiple interactions 		ISO Progesterone results in increased expression of MAP3K4 mRNA
[Progesterone co-treated with Estradiol] results in increased expression of MAP3K4 mRNA 		CTD PMID:18692832 PMID:20864642 NCBI chr 1:50,977,870...51,067,117
Ensembl chr 1:50,979,586...51,067,117 		JBrowse link
G Map3k7cl MAP3K7 C-terminal like multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MAP3K7CL mRNA
Progesterone results in decreased expression of MAP3K7CL mRNA 		CTD PMID:17404688 NCBI chr11:40,276,839...40,321,848
Ensembl chr11:40,277,688...40,321,847 		JBrowse link
G Map3k8 mitogen-activated protein kinase kinase kinase 8 increases expression ISO Progesterone results in increased expression of MAP3K8 mRNA CTD PMID:18070364 NCBI chr17:58,078,175...58,098,455
Ensembl chr17:58,078,320...58,098,452 		JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MAP4K4 mRNA CTD PMID:20660070 NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353 		JBrowse link
G Map7 microtubule-associated protein 7 increases expression ISO Progesterone results in increased expression of MAP7 mRNA CTD PMID:18070364 NCBI chr 1:14,910,433...15,037,574
Ensembl chr 1:16,730,075...16,857,170 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
decreases phosphorylation 		ISO
EXP 		Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein]]; Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]
Progesterone results in increased phosphorylation of MAPK1 protein
[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK1 protein; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK1 protein]
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MAPK1 protein; [Progesterone co-treated with Estrogens] results in increased phosphorylation of MAPK1 protein; Progesterone promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]
Progesterone results in decreased phosphorylation of MAPK1 protein 		CTD PMID:15358673 PMID:16175315 PMID:16284289 PMID:17492661 PMID:21258428 More... NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions EXP
ISO 		Progesterone promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein]
Progesterone inhibits the reaction [Ozone results in increased phosphorylation of MAPK14 protein] 		CTD PMID:16284289 PMID:28279894 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
decreases phosphorylation 		ISO
EXP 		Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK3 protein]]; Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]
Progesterone results in increased phosphorylation of MAPK3 protein
[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK3 protein; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK3 protein]
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MAPK3 protein; [Progesterone co-treated with Estrogens] results in increased phosphorylation of MAPK3 protein; Progesterone promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]
Progesterone results in decreased phosphorylation of MAPK3 protein 		CTD PMID:15358673 PMID:16175315 PMID:16284289 PMID:17492661 PMID:21258428 More... NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions EXP Progesterone promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein] CTD PMID:16284289 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 increases expression EXP Progesterone results in increased expression of MAPK9 mRNA CTD PMID:17170212 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228 		JBrowse link
G Mapt microtubule-associated protein tau increases phosphorylation
decreases expression 		EXP Progesterone results in increased phosphorylation of MAPT protein
Progesterone results in decreased expression of MAPT protein 		CTD PMID:17443805 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate multiple interactions
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of MARCKS mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MARCKS mRNA
Progesterone results in decreased expression of MARCKS mRNA 		CTD PMID:17404688 PMID:20660070 PMID:20726854 NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882 		JBrowse link
G Marcksl1 MARCKS-like 1 decreases expression ISO Progesterone results in decreased expression of MARCKSL1 mRNA CTD PMID:21795739 NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:147,134,514...147,138,417 		JBrowse link
G Mars1 methionyl-tRNA synthetase 1 increases expression ISO Progesterone results in increased expression of MARS1 mRNA CTD PMID:18037150 NCBI chr 7:65,006,456...65,023,880
Ensembl chr 7:64,998,544...65,023,753 		JBrowse link
G Mat2a methionine adenosyltransferase 2A decreases expression ISO Progesterone results in decreased expression of MAT2A mRNA CTD PMID:18037150 NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:106,038,254...106,053,645 		JBrowse link
G Matcap2 microtubule associated tyrosine carboxypeptidase 2 increases expression ISO Progesterone results in increased expression of MATCAP2 mRNA CTD PMID:18070364 NCBI chr 8:20,921,637...20,971,076
Ensembl chr 8:29,196,927...29,247,058 		JBrowse link
G Matk megakaryocyte-associated tyrosine kinase increases expression ISO Progesterone results in increased expression of MATK mRNA; Progesterone results in increased expression of MATK protein CTD PMID:17492661 NCBI chr 7:9,107,711...9,116,864
Ensembl chr 7:9,107,722...9,112,746 		JBrowse link
G Matn2 matrilin 2 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of MATN2 mRNA
Progesterone results in increased expression of MATN2 mRNA 		CTD PMID:20660070 PMID:21795739 NCBI chr 7:67,380,140...67,529,767
Ensembl chr 7:67,380,168...67,530,153 		JBrowse link
G Matn4 matrilin 4 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MATN4 mRNA CTD PMID:17404688 NCBI chr 3:173,539,966...173,554,984
Ensembl chr 3:173,539,966...173,554,984 		JBrowse link
G Mboat1 membrane bound O-acyltransferase domain containing 1 decreases expression ISO Progesterone results in decreased expression of MBOAT1 mRNA CTD PMID:22238285 NCBI chr17:34,540,032...34,653,705
Ensembl chr17:34,540,041...34,653,698 		JBrowse link
G Mbp myelin basic protein multiple interactions ISO
EXP 		[Progesterone co-treated with Estradiol] inhibits the reaction [Cuprizone results in decreased expression of MBP mRNA]
Progesterone inhibits the reaction [Streptozocin results in decreased expression of MBP mRNA] 		CTD PMID:19031445 PMID:20349157 NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174 		JBrowse link
G Mc2r melanocortin 2 receptor multiple interactions
increases secretion 		EXP MC2R protein promotes the reaction [PRL protein results in increased secretion of Progesterone]; PRL protein promotes the reaction [MC2R protein results in increased secretion of Progesterone] CTD PMID:18609294 NCBI chr18:62,001,980...62,015,567
Ensembl chr18:64,277,360...64,291,881 		JBrowse link
G Mc4r melanocortin 4 receptor decreases expression ISO Progesterone results in decreased expression of MC4R mRNA CTD PMID:22238285 NCBI chr18:60,419,832...60,421,719 JBrowse link
G Mcm2 minichromosome maintenance complex component 2 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] affects the localization of MCM2 protein; [Progesterone co-treated with Estradiol] results in decreased expression of MCM2 protein
Progesterone results in decreased expression of MCM2 mRNA 		CTD PMID:16966611 NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094 		JBrowse link
G Mcm3 minichromosome maintenance complex component 3 multiple interactions
decreases expression
affects localization 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MCM3 protein; Estradiol promotes the reaction [Progesterone affects the localization of MCM3 protein]
Progesterone results in decreased expression of MCM3 mRNA 		CTD PMID:16966611 NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746 		JBrowse link
G Mcm4 minichromosome maintenance complex component 4 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MCM4 protein
Progesterone results in decreased expression of MCM4 mRNA 		CTD PMID:16966611 NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536 		JBrowse link
G Mcm5 minichromosome maintenance complex component 5 affects expression
decreases expression 		ISO Progesterone affects the expression of MCM5 mRNA
Progesterone results in decreased expression of MCM5 mRNA 		CTD PMID:16966611 PMID:17251523 PMID:21795739 NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 multiple interactions
decreases expression
affects localization 		ISO
EXP 		Estradiol inhibits the reaction [Progesterone affects the localization of MCM6 protein]
Progesterone results in decreased expression of MCM6 mRNA 		CTD PMID:16966611 PMID:20726854 NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Mcm7 minichromosome maintenance complex component 7 multiple interactions
affects localization 		ISO Estradiol inhibits the reaction [Progesterone affects the localization of MCM7 protein] CTD PMID:16966611 NCBI chr12:17,042,207...17,049,470
Ensembl chr12:22,155,921...22,163,771 		JBrowse link
G Mcub mitochondrial calcium uniporter dominant negative subunit beta decreases expression ISO Progesterone results in decreased expression of MCUB mRNA CTD PMID:22238285 NCBI chr 2:221,153,525...221,223,814
Ensembl chr 2:221,153,525...221,223,814 		JBrowse link
G Mdm1 Mdm1 nuclear protein increases expression ISO Progesterone results in increased expression of MDM1 mRNA CTD PMID:18070364 NCBI chr 7:55,615,459...55,651,889
Ensembl chr 7:55,615,608...55,651,888 		JBrowse link
G Mdn1 midasin AAA ATPase 1 affects expression ISO Progesterone affects the expression of MDN1 mRNA CTD PMID:17251523 NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:51,851,809...51,982,688 		JBrowse link
G Meak7 MTOR associated protein, eak-7 homolog increases expression ISO Progesterone results in increased expression of MEAK7 mRNA CTD PMID:17404688 NCBI chr19:47,813,899...47,836,830
Ensembl chr19:64,722,528...64,751,330 		JBrowse link
G Med27 mediator complex subunit 27 affects expression ISO Progesterone affects the expression of MED27 mRNA CTD PMID:17251523 NCBI chr 3:12,629,593...12,803,340
Ensembl chr 3:33,027,525...33,201,240 		JBrowse link
G Medag mesenteric estrogen-dependent adipogenesis increases expression ISO Progesterone results in increased expression of MEDAG mRNA CTD PMID:21795739 NCBI chr12:5,613,191...5,634,583
Ensembl chr12:10,649,526...10,692,756 		JBrowse link
G Megf10 multiple EGF-like domains 10 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of MEGF10 mRNA CTD PMID:20660070 NCBI chr18:50,605,231...50,755,441
Ensembl chr18:52,847,781...52,950,675 		JBrowse link
G Meig1 meiosis/spermiogenesis associated 1 increases expression ISO Progesterone results in increased expression of MEIG1 mRNA CTD PMID:22238285 NCBI chr17:79,718,630...79,737,604
Ensembl chr17:79,723,811...79,737,533 		JBrowse link
G Meltf melanotransferrin decreases expression ISO Progesterone results in decreased expression of MELTF mRNA CTD PMID:22238285 NCBI chr11:68,884,446...68,906,300
Ensembl chr11:82,389,420...82,411,270 		JBrowse link
G Metap2 methionyl aminopeptidase 2 decreases expression ISO Progesterone results in decreased expression of METAP2 mRNA CTD PMID:18070364 NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:30,299,433...30,327,521 		JBrowse link
G Mex3a mex-3 RNA binding family member A multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MEX3A mRNA CTD PMID:20660070 NCBI chr 2:173,990,098...173,999,567
Ensembl chr 2:176,287,900...176,297,369 		JBrowse link
G Mfap2 microfibril associated protein 2 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MFAP2 mRNA CTD PMID:17404688 NCBI chr 5:158,595,121...158,603,283
Ensembl chr 5:158,597,512...158,610,656 		JBrowse link
G Mfap4 microfibril associated protein 4 increases expression ISO Progesterone results in increased expression of MFAP4 mRNA CTD PMID:21540246 NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,655,722...46,669,740 		JBrowse link
G Mfap5 microfibril associated protein 5 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MFAP5 mRNA CTD PMID:17404688 NCBI chr 4:155,727,925...155,750,458
Ensembl chr 4:157,395,597...157,422,448 		JBrowse link
G Mfng MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase increases expression ISO Progesterone results in increased expression of MFNG mRNA CTD PMID:21540246 NCBI chr 7:112,191,288...112,209,129
Ensembl chr 7:112,161,071...112,209,129 		JBrowse link
G Mgat3 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase decreases expression ISO Progesterone results in decreased expression of MGAT3 mRNA CTD PMID:19693291 NCBI chr 7:113,614,011...113,640,201
Ensembl chr 7:113,598,059...113,643,481 		JBrowse link
G Mgp matrix Gla protein decreases expression
increases expression 		ISO Progesterone results in decreased expression of MGP mRNA
Progesterone results in increased expression of MGP mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:171,497,471...171,500,859 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions
increases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in increased expression of MGST1 mRNA
Progesterone results in increased expression of MGST1 mRNA 		CTD PMID:20660070 PMID:20726854 NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875 		JBrowse link
G Mia MIA SH3 domain containing decreases expression ISO Progesterone results in decreased expression of MIA mRNA CTD PMID:22238285 NCBI chr 1:82,473,677...82,476,378
Ensembl chr 1:91,601,327...91,603,019 		JBrowse link
G Mical2 microtubule associated monooxygenase, calponin and LIM domain containing 2 decreases expression ISO Progesterone results in decreased expression of MICAL2 mRNA CTD PMID:18070364 NCBI chr 1:175,780,441...175,965,157
Ensembl chr 1:175,825,596...175,905,155 		JBrowse link
G Mid1 midline 1 decreases expression ISO Progesterone results in decreased expression of MID1 mRNA CTD PMID:21795739 NCBI chr  X:24,116,674...24,491,205
Ensembl chr  X:27,681,867...27,906,105 		JBrowse link
G Mir100 microRNA 100 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of MIR100 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of MIR100 mRNA 		CTD PMID:22950660 PMID:30328349 NCBI chr 8:41,901,225...41,901,304
Ensembl chr 8:50,798,295...50,798,374 		JBrowse link
G Mir106b microRNA 106b decreases expression ISO Progesterone results in decreased expression of MIR106B mRNA CTD PMID:22950660 NCBI chr12:17,043,344...17,043,425 JBrowse link
G Mir10a microRNA 10a multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MIR10A mRNA CTD PMID:30328349 NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,779,709...81,779,818 		JBrowse link
G Mir122 microRNA 122 decreases expression ISO Progesterone results in decreased expression of MIR122 mRNA CTD PMID:22950660 NCBI chr18:58,758,703...58,758,787 JBrowse link
G Mir128-2 microRNA 128-2 increases expression ISO Progesterone results in increased expression of MIR128-2 mRNA CTD PMID:22950660 NCBI chr 8:112,085,467...112,085,550 JBrowse link
G Mir134 microRNA 134 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR134 mRNA CTD PMID:22950660 NCBI chr 6:128,748,908...128,748,980 JBrowse link
G Mir135b microRNA 135b multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR135B mRNA CTD PMID:22950660 NCBI chr13:43,638,857...43,638,953
Ensembl chr13:46,191,018...46,191,114 		JBrowse link
G Mir142 microRNA 142 decreases expression ISO Progesterone results in decreased expression of MIR142 mRNA CTD PMID:22950660 NCBI chr10:72,557,864...72,557,950
Ensembl chr10:73,055,097...73,055,207 		JBrowse link
G Mir144 microRNA 144 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of MIR144 mRNA
[Progesterone co-treated with Estradiol] results in increased expression of MIR144 mRNA 		CTD PMID:22950660 NCBI chr10:63,459,397...63,459,479
Ensembl chr10:63,459,397...63,459,479 		JBrowse link
G Mir145 microRNA 145 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MIR145 mRNA CTD PMID:30328349 NCBI chr18:57,369,983...57,370,070 JBrowse link
G Mir146a microRNA 146a decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of MIR146A mRNA
Progesterone promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MIR146 mRNA] 		CTD PMID:22546503 PMID:22950660 NCBI chr10:27,848,516...27,848,610 JBrowse link
G Mir146b microRNA 146b decreases expression ISO Progesterone results in decreased expression of MIR146B mRNA CTD PMID:22950660 NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:255,144,860...255,144,947 		JBrowse link
G Mir148a microRNA 148a decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of MIR148A mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of MIR148A mRNA 		CTD PMID:30328349 NCBI chr 4:80,333,762...80,333,858 JBrowse link
G Mir148b microRNA 148b decreases expression ISO Progesterone results in decreased expression of MIR148B mRNA CTD PMID:30328349 NCBI chr 7:134,421,398...134,421,494
Ensembl chr 7:136,299,870...136,299,966 		JBrowse link
G Mir151 microRNA 151 decreases expression ISO Progesterone results in decreased expression of MIR151A mRNA CTD PMID:30328349 NCBI chr 7:105,172,377...105,172,473 JBrowse link
G Mir151b microRNA 151b decreases expression ISO Progesterone results in decreased expression of MIR151B mRNA CTD PMID:30328349 NCBI chr 7:105,172,377...105,172,496
Ensembl chr 7:107,061,380...107,061,499 		JBrowse link
G Mir155 microRNA 155 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of MIR155 mRNA
MIR155 mRNA inhibits the reaction [Progesterone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 protein]]; MIR155 mRNA inhibits the reaction [Progesterone inhibits the reaction [Poly I-C results in increased expression of MIR155 mRNA]]; Progesterone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MIR155 mRNA]; Progesterone inhibits the reaction [Poly I-C results in increased expression of MIR155 mRNA]
Progesterone results in increased expression of MIR155 mRNA 		CTD PMID:22546503 PMID:22950660 NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178 		JBrowse link
G Mir155hg Mir155 host gene multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of BIC mRNA CTD PMID:20660070 NCBI chr11:23,773,468...23,775,697 JBrowse link
G Mir15b microRNA 15b decreases expression
increases expression 		ISO Progesterone results in decreased expression of MIR15B mRNA
Progesterone results in increased expression of MIR15B mRNA 		CTD PMID:22950660 PMID:30328349 NCBI chr 2:153,245,200...153,245,297
Ensembl chr 2:155,555,178...155,555,275 		JBrowse link
G Mir181c microRNA 181c increases expression ISO Progesterone results in increased expression of MIR181C mRNA CTD PMID:22950660 NCBI chr19:23,983,523...23,983,628
Ensembl chr19:40,888,291...40,888,396 		JBrowse link
G Mir181d microRNA 181d increases expression
multiple interactions 		ISO Progesterone results in increased expression of MIR181D mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of MIR181D mRNA 		CTD PMID:22950660 PMID:30328349 NCBI chr19:23,983,706...23,983,788
Ensembl chr19:40,888,474...40,888,556 		JBrowse link
G Mir186 microRNA 186 increases expression
decreases expression 		ISO Progesterone results in increased expression of MIR186 mRNA
Progesterone results in decreased expression of MIR186 mRNA 		CTD PMID:22950660 PMID:30328349 NCBI chr 2:246,582,806...246,582,891
Ensembl chr 2:249,241,650...249,241,735 		JBrowse link
G Mir191 microRNA 191 increases expression ISO Progesterone results in increased expression of MIR191 mRNA CTD PMID:22950660 NCBI chr 8:109,264,098...109,264,188 JBrowse link
G Mir195 microRNA 195 decreases expression ISO Progesterone results in decreased expression of MIR195 mRNA CTD PMID:22950660 NCBI chr10:54,951,838...54,951,924
Ensembl chr10:55,450,495...55,450,581 		JBrowse link
G Mir196b microRNA 196b multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR196B mRNA CTD PMID:22950660 NCBI chr 4:81,330,487...81,330,571 JBrowse link
G Mir202 microRNA 202 increases expression ISO Progesterone results in increased expression of MIR202 mRNA CTD PMID:22950660 NCBI chr 1:194,754,730...194,754,801 JBrowse link
G Mir204 microRNA 204 increases expression ISO Progesterone results in increased expression of MIR204 mRNA CTD PMID:22950660 NCBI chr 1:229,743,461...229,743,570
Ensembl chr 1:229,743,461...229,743,570 		JBrowse link
G Mir206 microRNA 206 increases expression ISO Progesterone results in increased expression of MIR206 mRNA CTD PMID:22950660 NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:30,590,697...30,590,780 		JBrowse link
G Mir20b microRNA 20b decreases expression ISO Progesterone results in decreased expression of MIR20B mRNA CTD PMID:22950660 PMID:30328349 NCBI chr  X:132,422,211...132,422,282 JBrowse link
G Mir21 microRNA 21 increases expression ISO Progesterone results in increased expression of MIR21 mRNA CTD PMID:30328349 NCBI chr10:71,902,600...71,902,691 JBrowse link
G Mir22 microRNA 22 decreases expression ISO Progesterone results in decreased expression of MIR22 mRNA CTD PMID:30328349 NCBI chr10:60,805,331...60,805,425
Ensembl chr10:60,805,331...60,805,425 		JBrowse link
G Mir221 microRNA 221 decreases expression ISO Progesterone results in decreased expression of MIR221 mRNA CTD PMID:22950660 NCBI chr  X:3,429,465...3,429,573
Ensembl chr  X:6,023,182...6,023,290 		JBrowse link
G Mir23a microRNA 23a increases expression ISO Progesterone results in increased expression of MIR23A mRNA CTD PMID:30328349 NCBI chr19:23,954,997...23,955,071 JBrowse link
G Mir23b microRNA 23b increases expression ISO Progesterone results in increased expression of MIR23B mRNA CTD PMID:30328349 NCBI chr17:1,813,667...1,813,763 JBrowse link
G Mir25 microRNA 25 increases expression ISO Progesterone results in increased expression of MIR25 mRNA CTD PMID:22950660 NCBI chr12:17,042,932...17,043,015 JBrowse link
G Mir26b microRNA 26b multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of MIR26B mRNA CTD PMID:22950660 NCBI chr 9:75,976,596...75,976,680
Ensembl chr 9:83,425,709...83,425,793 		JBrowse link
G Mir27a microRNA 27a multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of MIR27A mRNA
Progesterone results in decreased expression of MIR27A mRNA 		CTD PMID:30328349 NCBI chr19:23,954,831...23,954,917 JBrowse link
G Mir27b microRNA 27b decreases expression ISO Progesterone results in decreased expression of MIR27B mRNA CTD PMID:30328349 NCBI chr17:1,819,147...1,819,243 JBrowse link
G Mir296 microRNA 296 increases expression ISO Progesterone results in increased expression of MIR296 mRNA CTD PMID:22950660 NCBI chr 3:163,051,838...163,051,915 JBrowse link
G Mir299a microRNA 299B increases expression ISO Progesterone results in increased expression of MIR299 mRNA CTD PMID:22950660 NCBI chr 6:128,723,635...128,723,752 JBrowse link
G Mir29a microRNA 29a decreases expression ISO Progesterone results in decreased expression of MIR29A mRNA CTD PMID:30328349 NCBI chr 4:59,650,608...59,650,695 JBrowse link
G Mir30d microRNA 30d increases expression ISO Progesterone results in increased expression of MIR30D mRNA CTD PMID:22950660 NCBI chr 7:100,136,391...100,136,472 JBrowse link
G Mir30e microRNA 30e decreases expression ISO Progesterone results in decreased expression of MIR30E mRNA CTD PMID:22950660 NCBI chr 5:134,352,232...134,352,323
Ensembl chr 5:139,637,450...139,637,541 		JBrowse link
G Mir320a microRNA 320a increases expression ISO Progesterone results in increased expression of MIR320A mRNA CTD PMID:30328349 NCBI chr15:45,516,392...45,516,473
Ensembl chr15:51,926,088...51,926,169 		JBrowse link
G Mir322 microRNA 322 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of MIR424 mRNA
Progesterone results in decreased expression of MIR424 mRNA 		CTD PMID:30328349 NCBI chr  X:132,806,594...132,806,688 JBrowse link
G Mir328 microRNA 328 increases expression ISO Progesterone results in increased expression of MIR328 mRNA CTD PMID:22950660 NCBI chr19:33,184,766...33,184,849 JBrowse link
G Mir337 microRNA 337 increases expression ISO Progesterone results in increased expression of MIR337 mRNA CTD PMID:22950660 NCBI chr 6:128,538,903...128,538,999
Ensembl chr 6:134,321,141...134,321,237 		JBrowse link
G Mir345 microRNA 345 increases expression ISO Progesterone results in increased expression of MIR345 mRNA CTD PMID:22950660 NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:133,518,403...133,518,498 		JBrowse link
G Mir346 microRNA 346 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of MIR346 mRNA
Progesterone results in increased expression of MIR346 mRNA 		CTD PMID:22950660 NCBI chr16:10,218,118...10,218,215
Ensembl chr16:10,224,300...10,224,397 		JBrowse link
G Mir34b microRNA 34b multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR34B mRNA CTD PMID:22950660 NCBI chr 8:60,306,609...60,306,692 JBrowse link
G Mir361 microRNA 361 decreases expression ISO Progesterone results in decreased expression of MIR361 mRNA CTD PMID:30328349 NCBI chr  X:78,246,206...78,246,275 JBrowse link
G Mir363 microRNA 363 increases expression ISO Progesterone results in increased expression of MIR363 mRNA CTD PMID:22950660 NCBI chr  X:132,421,791...132,421,877 JBrowse link
G Mir411 microRNA 411 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of MIR411 mRNA
[Progesterone co-treated with Estradiol] results in decreased expression of MIR411 mRNA 		CTD PMID:22950660 NCBI chr 6:128,723,189...128,723,264
Ensembl chr 6:134,544,589...134,544,684 		JBrowse link
G Mir412 microRNA 412 increases expression ISO Progesterone results in increased expression of MIR412 mRNA CTD PMID:22950660 NCBI chr 6:128,757,932...128,758,001
Ensembl chr 6:134,579,331...134,579,410 		JBrowse link
G Mir423 microRNA 423 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of MIR423 mRNA
Progesterone results in increased expression of MIR423 mRNA 		CTD PMID:30328349 NCBI chr10:61,914,142...61,914,220 JBrowse link
G Mir425 microRNA 425 increases expression
decreases expression 		ISO Progesterone results in increased expression of MIR425 mRNA
Progesterone results in decreased expression of MIR425 mRNA 		CTD PMID:22950660 PMID:30328349 NCBI chr 8:118,143,084...118,143,166
Ensembl chr 8:118,143,084...118,143,166 		JBrowse link
G Mir448 microRNA 448 increases expression ISO Progesterone results in increased expression of MIR448 mRNA CTD PMID:22950660 NCBI chr  X:115,641,955...115,642,066
Ensembl chr  X:115,641,955...115,642,066 		JBrowse link
G Mir449a microRNA 449a multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR449A mRNA
Progesterone results in decreased expression of MIR449A mRNA 		CTD PMID:22950660 NCBI chr 2:44,670,714...44,670,804
Ensembl chr 2:46,403,910...46,404,000 		JBrowse link
G Mir455 microRNA 455 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR455 mRNA
Progesterone results in decreased expression of MIR455 mRNA 		CTD PMID:22950660 NCBI chr 5:76,689,313...76,689,390
Ensembl chr 5:81,704,834...81,704,911 		JBrowse link
G Mir486 microRNA 486 decreases expression ISO Progesterone results in decreased expression of MIR486-1 mRNA CTD PMID:22950660
G Mir500 microRNA 500 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR502 mRNA
Progesterone results in increased expression of MIR502 mRNA 		CTD PMID:22950660 NCBI chr  X:15,258,778...15,258,857
Ensembl chr  X:17,930,637...17,930,728 		JBrowse link
G Mir503 microRNA 503 multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in increased expression of MIR503 mRNA
Progesterone results in increased expression of MIR503 mRNA 		CTD PMID:22950660 NCBI chr  X:132,806,303...132,806,373 JBrowse link
G Mir504 microRNA 504 increases expression ISO Progesterone results in increased expression of MIR504 mRNA CTD PMID:22950660 NCBI chr  X:137,318,540...137,318,616 JBrowse link
G Mir542 microRNA 542 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR542 mRNA CTD PMID:22950660 NCBI chr  X:132,802,623...132,802,701 JBrowse link
G Mir592 microRNA 592 increases expression ISO Progesterone results in increased expression of MIR592 mRNA CTD PMID:22950660 NCBI chr 4:56,505,280...56,505,375 JBrowse link
G Mir632 microRNA 632 increases expression ISO Progesterone results in increased expression of MIR632 mRNA CTD PMID:22950660 NCBI chr10:65,385,757...65,385,834
Ensembl chr10:65,883,580...65,883,657 		JBrowse link
G Mir671 microRNA 671 increases expression ISO Progesterone results in increased expression of MIR671 mRNA CTD PMID:22950660 NCBI chr 4:10,580,747...10,580,827 JBrowse link
G Mir675 microRNA 675 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of MIR675 mRNA CTD PMID:22950660 NCBI chr 1:207,161,752...207,161,835 JBrowse link
G Mir876 microRNA 876 increases expression
multiple interactions 		ISO Progesterone results in increased expression of MIR876 mRNA
[Progesterone co-treated with Estradiol] results in increased expression of MIR876 mRNA 		CTD PMID:22950660 NCBI chr 5:51,337,191...51,337,269 JBrowse link
G Mir92b microRNA 92b increases expression ISO Progesterone results in increased expression of MIR92B mRNA CTD PMID:22950660 NCBI chr 2:174,633,890...174,633,972 JBrowse link
G Mir93 microRNA 93 decreases expression ISO Progesterone results in decreased expression of MIR93 mRNA CTD PMID:22950660 NCBI chr12:22,156,844...22,156,930 JBrowse link
G Mir99a microRNA 99a multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of MIR99A mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MIR99A mRNA
Progesterone results in decreased expression of MIR99A mRNA 		CTD PMID:22950660 PMID:30328349 NCBI chr11:16,200,443...16,200,523
Ensembl chr11:29,687,392...29,687,472 		JBrowse link
G Mir99b microRNA 99b decreases expression ISO Progesterone results in decreased expression of MIR99B mRNA CTD PMID:30328349 NCBI chr 1:58,677,015...58,677,084
Ensembl chr 1:67,350,060...67,350,139 		JBrowse link
G Mirlet7b microRNA let-7b increases expression ISO Progesterone results in increased expression of MIRLET7B mRNA CTD PMID:30328349 NCBI chr 7:116,804,186...116,804,270
Ensembl chr 7:118,684,038...118,684,122 		JBrowse link
G Mirlet7c1 microRNA let-7c-1 increases expression ISO Progesterone results in increased expression of MIRLET7C mRNA CTD PMID:30328349 NCBI chr11:16,201,163...16,201,256
Ensembl chr11:29,688,107...29,688,214 		JBrowse link
G Mirlet7d microRNA let-7d increases expression ISO Progesterone results in increased expression of MIRLET7D mRNA CTD PMID:30328349 NCBI chr17:16,115,893...16,115,990
Ensembl chr17:16,322,260...16,322,357 		JBrowse link
G Mirlet7i microRNA let-7i increases expression ISO Progesterone results in increased expression of MIRLET7I mRNA CTD PMID:30328349 NCBI chr 7:58,642,485...58,642,569 JBrowse link
G Mitf melanocyte inducing transcription factor increases expression ISO Progesterone results in increased expression of MITF mRNA CTD PMID:20864642 NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:131,965,714...132,177,790 		JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression
multiple interactions
affects expression
decreases expression 		ISO
EXP 		Progesterone results in increased expression of MKI67 mRNA
Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]; Lead inhibits the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]
[Estrogens co-treated with Progesterone] results in increased expression of MKI67 protein
Progesterone affects the expression of MKI67 mRNA; Progesterone affects the expression of MKI67 protein
Progesterone results in decreased expression of MKI67 mRNA
Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]]; Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein] 		CTD PMID:15845746 PMID:16800253 PMID:16888808 PMID:16966611 PMID:17251523 More... NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mknk2 MAPK interacting serine/threonine kinase 2 increases expression ISO Progesterone results in increased expression of MKNK2 mRNA CTD PMID:18037150 NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,690,421...9,701,529 		JBrowse link
G Mllt11 MLLT11, transcription factor 7 cofactor increases expression ISO Progesterone results in increased expression of MLLT11 mRNA CTD PMID:21540246 NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:185,484,793...185,493,961 		JBrowse link
G Mlph melanophilin increases expression ISO Progesterone results in increased expression of MLPH mRNA CTD PMID:21540246 NCBI chr 9:98,955,036...98,990,566
Ensembl chr 9:98,955,141...98,990,556 		JBrowse link
G Mmd monocyte to macrophage differentiation-associated increases expression ISO Progesterone results in increased expression of MMD mRNA CTD PMID:20864642 NCBI chr10:75,570,366...75,598,610
Ensembl chr10:75,570,397...75,598,609 		JBrowse link
G Mme membrane metallo-endopeptidase decreases expression
increases expression
affects expression 		ISO Progesterone results in decreased expression of MME mRNA
Progesterone results in increased expression of MME mRNA
Progesterone affects the expression of MME mRNA 		CTD PMID:17251523 PMID:18070364 PMID:21795739 NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463 		JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MMP1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MMP1 mRNA; Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP1 protein modified form] CTD PMID:17404688 PMID:20660070 PMID:22219637 NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:12,943,453...12,963,964 		JBrowse link
G Mmp10 matrix metallopeptidase 10 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of MMP10 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of MMP10 mRNA
Progesterone results in increased expression of MMP10 mRNA 		CTD PMID:20226447 PMID:20660070 NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613 		JBrowse link
G Mmp11 matrix metallopeptidase 11 multiple interactions
decreases expression
affects expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of MMP11 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MMP11 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of MMP11 mRNA; Progesterone inhibits the reaction [Estradiol results in increased expression of MMP11 mRNA]
Progesterone results in decreased expression of MMP11 mRNA
Progesterone affects the expression of MMP11 mRNA 		CTD PMID:17251523 PMID:17404688 PMID:20226447 PMID:20660070 PMID:20864642 More... NCBI chr20:12,730,284...12,739,067
Ensembl chr20:12,730,277...12,739,290 		JBrowse link
G Mmp12 matrix metallopeptidase 12 affects expression ISO Progesterone affects the expression of MMP12 mRNA CTD PMID:17251523 NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions ISO Progesterone inhibits the reaction [Estradiol results in increased expression of MMP13 mRNA] CTD PMID:19416213 NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:12,782,813...12,793,105 		JBrowse link
G Mmp14 matrix metallopeptidase 14 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of MMP14 protein; [Estrogens co-treated with Progesterone co-treated with IL1B protein] results in increased expression of MMP14 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MMP14 mRNA; Estradiol inhibits the reaction [Progesterone results in increased expression of MMP14 mRNA] CTD PMID:17404688 PMID:18570937 PMID:18692832 PMID:18829229 PMID:26604029 NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893 		JBrowse link
G Mmp16 matrix metallopeptidase 16 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MMP16 mRNA
Progesterone results in decreased expression of MMP16 mRNA 		CTD PMID:20226447 NCBI chr 5:36,109,265...36,353,252
Ensembl chr 5:36,109,265...36,353,252 		JBrowse link
G Mmp2 matrix metallopeptidase 2 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of MMP2 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of and results in increased activity of MMP2 protein; Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP2 protein modified form] 		CTD PMID:18070364 PMID:18829229 PMID:22219637 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp27 matrix metallopeptidase 27 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MMP27 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MMP27 mRNA CTD PMID:17404688 PMID:20660070 NCBI chr 8:13,030,752...13,040,671
Ensembl chr 8:13,030,746...13,040,671 		JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions
decreases expression
decreases secretion 		ISO [Estradiol co-treated with Progesterone] results in decreased secretion of MMP3 protein; [Estrogens co-treated with Progesterone co-treated with IL1B protein] results in increased expression of MMP3 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MMP3 mRNA; Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP3 protein modified form]; Tetrachlorodibenzodioxin inhibits the reaction [Progesterone results in decreased secretion of MMP3 protein]; Triclosan inhibits the reaction [Progesterone results in decreased expression of MMP3 mRNA]
Mifepristone inhibits the reaction [Progesterone results in decreased expression of MMP3 mRNA]; Progesterone inhibits the reaction [Estradiol results in increased expression of MMP3 mRNA] 		CTD PMID:16009159 PMID:17404688 PMID:18570937 PMID:19416213 PMID:22219637 More... NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826 		JBrowse link
G Mmp7 matrix metallopeptidase 7 multiple interactions
decreases expression
affects expression
decreases secretion 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of MMP7 mRNA; [Estradiol co-treated with Progesterone] results in decreased secretion of MMP7 protein; Tetrachlorodibenzodioxin inhibits the reaction [Progesterone results in decreased secretion of MMP7 protein]
Progesterone results in decreased expression of MMP7 mRNA
Progesterone affects the expression of MMP7 mRNA 		CTD PMID:16009159 PMID:17251523 PMID:20660070 PMID:22238285 NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:13,133,043...13,140,755 		JBrowse link
G Mmp8 matrix metallopeptidase 8 increases expression EXP Progesterone results in increased expression of MMP8 mRNA CTD PMID:21770760 NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:13,008,890...13,018,729 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
increases expression 		ISO
EXP 		[Progesterone co-treated with Estradiol] results in decreased expression of MMP9 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of MMP9 mRNA; [Progesterone co-treated with Triclosan] results in increased expression of MMP9 mRNA; Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP9 protein modified form]
Progesterone results in increased expression of MMP9 mRNA
Progesterone inhibits the reaction [Estradiol results in increased expression of MMP9 mRNA] 		CTD PMID:17404688 PMID:19416213 PMID:20226447 PMID:21770760 PMID:22219637 More... NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mmrn1 multimerin 1 increases expression ISO Progesterone results in increased expression of MMRN1 mRNA CTD PMID:21540246 NCBI chr 4:89,875,408...89,950,814
Ensembl chr 4:91,233,240...91,280,861 		JBrowse link
G Mob3b MOB kinase activator 3B increases expression ISO Progesterone results in increased expression of MOB3B mRNA CTD PMID:20864642 NCBI chr 5:54,342,509...54,534,164
Ensembl chr 5:54,338,056...54,454,678 		JBrowse link
G Mogat1 monoacylglycerol O-acyltransferase 1 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of MOGAT1 mRNA
Progesterone results in decreased expression of MOGAT1 mRNA 		CTD PMID:19693291 PMID:22238285 NCBI chr 9:87,429,427...87,436,977
Ensembl chr 9:87,405,119...87,436,977 		JBrowse link
G Mogat2 monoacylglycerol O-acyltransferase 2 decreases expression ISO Progesterone results in decreased expression of MOGAT2 mRNA CTD PMID:22238285 NCBI chr 1:153,521,813...153,545,756
Ensembl chr 1:162,933,966...162,957,896 		JBrowse link
G Mok MOK protein kinase increases expression ISO Progesterone results in increased expression of MOK mRNA CTD PMID:22238285 NCBI chr 6:135,645,018...135,675,894
Ensembl chr 6:135,645,018...135,676,174 		JBrowse link
G Mon2 MON2 homolog, regulator of endosome-to-Golgi trafficking increases expression ISO Progesterone results in increased expression of MON2 mRNA CTD PMID:18070364 NCBI chr 7:58,649,378...58,728,102
Ensembl chr 7:60,534,772...60,613,467 		JBrowse link
G Mpc1 mitochondrial pyruvate carrier 1 increases expression EXP Progesterone results in increased expression of MPC1 mRNA CTD PMID:20726854 NCBI chr 1:54,985,305...54,996,979
Ensembl chr 1:54,985,301...54,997,064 		JBrowse link
G Mpo myeloperoxidase multiple interactions ISO MPO gene polymorphism affects the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of ICAM1 protein] CTD PMID:21242819 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Mpp1 MAGUK p55 scaffold protein 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MPP1 mRNA CTD PMID:20660070
G Mpz myelin protein zero increases expression
multiple interactions 		EXP Progesterone results in increased expression of MPZ mRNA
Progesterone inhibits the reaction [Streptozocin results in decreased expression of MPZ mRNA] 		CTD PMID:16787508 PMID:17187935 NCBI chr13:86,103,290...86,109,156
Ensembl chr13:86,103,290...86,109,155 		JBrowse link
G Mpzl2 myelin protein zero-like 2 increases expression
decreases expression
multiple interactions 		ISO Progesterone results in increased expression of MPZL2 mRNA
Progesterone results in decreased expression of MPZL2 mRNA
NCOA2 protein affects the reaction [Progesterone results in decreased expression of MPZL2 mRNA] 		CTD PMID:17404688 PMID:17556502 PMID:21540246 NCBI chr 8:54,244,920...54,256,064
Ensembl chr 8:54,243,556...54,256,074 		JBrowse link
G Mrap melanocortin 2 receptor accessory protein affects expression ISO Progesterone affects the expression of MRAP mRNA CTD PMID:17251523 NCBI chr11:29,991,974...30,003,024
Ensembl chr11:43,478,001...43,489,118 		JBrowse link
G Mras muscle RAS oncogene homolog multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of MRAS mRNA CTD PMID:20660070 NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:108,823,374...108,875,911 		JBrowse link
G Mrc1 mannose receptor, C type 1 multiple interactions ISO Progesterone inhibits the reaction [IL4 protein results in increased expression of MRC1 mRNA] CTD PMID:21977998 NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410 		JBrowse link
G Mrpl27 mitochondrial ribosomal protein L27 decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of MRPL27 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of MRPL27 mRNA 		CTD PMID:18037150 PMID:21453500 NCBI chr10:79,595,459...79,601,242
Ensembl chr10:80,092,324...80,098,085 		JBrowse link
G Mrpl30 mitochondrial ribosomal protein L30 affects expression ISO Progesterone affects the expression of MRPL30 mRNA CTD PMID:17251523 NCBI chr 9:40,125,352...40,136,189
Ensembl chr 9:47,621,227...47,633,484 		JBrowse link
G Mrpl49 mitochondrial ribosomal protein L49 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MRPL49 mRNA CTD PMID:21453500 NCBI chr 1:212,775,357...212,779,364
Ensembl chr 1:212,775,357...212,779,888 		JBrowse link
G Mrps28 mitochondrial ribosomal protein S28 decreases expression ISO Progesterone results in decreased expression of MRPS28 mRNA CTD PMID:18037150 NCBI chr 2:92,820,676...92,951,302
Ensembl chr 2:94,762,904...94,766,152 		JBrowse link
G Mrps6 mitochondrial ribosomal protein S6 increases expression ISO Progesterone results in increased expression of MRPS6 mRNA CTD PMID:18037150 NCBI chr11:44,778,667...44,834,420
Ensembl chr11:44,781,554...44,834,962 		JBrowse link
G Mrto4 MRT4 homolog, ribosome maturation factor decreases expression ISO Progesterone results in decreased expression of MRTO4 mRNA CTD PMID:18037150 NCBI chr 5:151,601,780...151,608,533
Ensembl chr 5:156,884,985...156,891,738 		JBrowse link
G Msln mesothelin increases expression ISO Progesterone results in increased expression of MSLN mRNA CTD PMID:17404688 NCBI chr10:15,276,489...15,285,921
Ensembl chr10:15,275,659...15,282,153 		JBrowse link
G Msmo1 methylsterol monooxygenase 1 increases expression ISO Progesterone results in increased expression of MSMO1 mRNA CTD PMID:18070364 NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445 		JBrowse link
G Mstn myostatin multiple interactions
decreases expression 		EXP estradiol 3-benzoate promotes the reaction [Progesterone results in decreased expression of MSTN mRNA] CTD PMID:18845635 NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:55,944,513...55,950,913 		JBrowse link
G Msx2 msh homeobox 2 multiple interactions
decreases expression
increases expression 		ISO [Estrogens co-treated with Progesterone] results in increased expression of MSX2 mRNA
Progesterone results in decreased expression of MSX2 mRNA
Progesterone results in increased expression of MSX2 mRNA 		CTD PMID:17546050 PMID:22238285 NCBI chr17:11,097,214...11,102,879
Ensembl chr17:11,102,247...11,107,945 		JBrowse link
G Mt-atp8 mitochondrially encoded ATP synthase membrane subunit 8 increases expression EXP Progesterone results in increased expression of ATP8 mRNA CTD PMID:21770760 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,743...7,946 		JBrowse link
G Mt1-ps3 metallothionein 1, pseudogene 3 increases expression ISO Progesterone results in increased expression of MT1E mRNA CTD PMID:18037150 NCBI chr17:74,786,652...74,787,040
Ensembl chr17:79,695,809...79,696,200 		JBrowse link
G Mt1a metallothionein 1A increases expression
affects expression 		EXP
ISO 		Progesterone results in increased expression of MT1A mRNA
Progesterone affects the expression of MT1 mRNA 		CTD PMID:17251523 PMID:18037150 PMID:20726854 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mt2 metallothionein 2 increases expression
affects expression 		ISO Progesterone results in increased expression of MT2A mRNA
Progesterone results in increased expression of MT2 mRNA
Progesterone affects the expression of MT2 mRNA 		CTD PMID:17251523 PMID:18037150 PMID:21795739 PMID:22238285 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mta1 metastasis associated 1 increases expression ISO Progesterone results in increased expression of MTA1 mRNA CTD PMID:16888808 NCBI chr 6:137,999,845...138,038,696
Ensembl chr 6:137,999,915...138,038,696 		JBrowse link
G Mtarc1 mitochondrial amidoxime reducing component 1 decreases expression ISO Progesterone results in decreased expression of MTARC1 mRNA CTD PMID:21540246 NCBI chr13:96,324,377...96,362,677
Ensembl chr13:98,871,289...98,894,252 		JBrowse link
G Mtf2 metal response element binding transcription factor 2 increases expression ISO Progesterone results in increased expression of MTF2 mRNA CTD PMID:18070364 NCBI chr14:1,639,256...1,683,513
Ensembl chr14:1,783,627...1,828,414 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression
affects expression 		ISO Progesterone results in increased expression of MTHFD2 mRNA
Progesterone affects the expression of MTHFD2 mRNA 		CTD PMID:17251523 PMID:18037150 NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350 		JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases expression
multiple interactions 		ISO
EXP 		Progesterone results in decreased expression of MTOR mRNA
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MTOR protein 		CTD PMID:22465879 PMID:23541542 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435 		JBrowse link
G Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase increases expression ISO Progesterone results in increased expression of MTR mRNA CTD PMID:20864642 NCBI chr17:62,911,705...62,996,544
Ensembl chr17:62,911,771...62,996,541 		JBrowse link
G Mtus1 microtubule associated scaffold protein 1 increases expression EXP Progesterone results in increased expression of MTUS1 mRNA CTD PMID:20726854 NCBI chr16:57,905,991...58,051,466
Ensembl chr16:57,906,128...58,051,474 		JBrowse link
G Mtx1 Metaxin 1 affects expression ISO Progesterone affects the expression of MTX1 mRNA CTD PMID:17251523 NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:176,913,225...176,918,824 		JBrowse link
G Muc1 mucin 1, cell surface associated affects expression ISO Progesterone affects the expression of MUC1 protein CTD PMID:15971251 NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:176,933,047...176,938,491 		JBrowse link
G Muc20 mucin 20, cell surface associated decreases expression ISO Progesterone results in decreased expression of MUC20 mRNA CTD PMID:22238285 NCBI chr11:81,492,844...81,506,571
Ensembl chr11:81,492,891...81,506,571 		JBrowse link
G Muc4 mucin 4, cell surface associated multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MUC4 mRNA
Progesterone results in decreased expression of MUC4 mRNA 		CTD PMID:17404688 PMID:22238285 NCBI chr11:81,513,321...81,575,200 JBrowse link
G Muc5b mucin 5B, oligomeric mucus/gel-forming increases expression ISO Progesterone results in increased expression of MUC5B mRNA CTD PMID:18070364 NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:206,346,400...206,378,367 		JBrowse link
G Mvk mevalonate kinase increases expression ISO Progesterone results in increased expression of MVK mRNA CTD PMID:18070364 NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503 		JBrowse link
G Myadm myeloid-associated differentiation marker increases expression ISO Progesterone results in increased expression of MYADM mRNA CTD PMID:21795739 NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:74,775,698...74,789,710 		JBrowse link
G Myb MYB proto-oncogene, transcription factor decreases expression ISO Progesterone results in decreased expression of MYB mRNA CTD PMID:16966611 PMID:18497975 PMID:22238285 NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:17,759,309...17,792,547 		JBrowse link
G Mybl1 MYB proto-oncogene like 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of MYBL1 mRNA
Fulvestrant inhibits the reaction [Progesterone results in increased expression of MYBL1 mRNA] 		CTD PMID:33405908 NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588 		JBrowse link
G Mybl2 MYB proto-oncogene like 2 decreases expression ISO Progesterone results in decreased expression of MYBL2 mRNA CTD PMID:16966611 NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:172,116,550...172,153,221 		JBrowse link
G Mybpc1 myosin binding protein C1 decreases expression ISO Progesterone results in decreased expression of MYBPC1 mRNA CTD PMID:22238285 NCBI chr 7:22,930,350...23,015,981
Ensembl chr 7:24,817,561...24,903,544 		JBrowse link
G Mybpc2 myosin binding protein C2 decreases expression ISO Progesterone results in decreased expression of MYBPC2 mRNA CTD PMID:22238285 NCBI chr 1:104,130,642...104,154,101
Ensembl chr 1:104,131,323...104,154,101 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor decreases expression
increases expression
multiple interactions 		ISO Progesterone results in decreased expression of MYC protein
Progesterone results in increased expression of MYC mRNA; Progesterone results in increased expression of MYC protein
[5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one results in decreased activity of MYC protein] inhibits the reaction [Progesterone results in increased expression of RRM2 mRNA]; [Estradiol co-treated with Progesterone] results in increased expression of MYC mRNA; MYC protein promotes the reaction [Progesterone results in increased expression of RRM2 mRNA]; Progesterone promotes the reaction [Estradiol results in increased expression of MYC mRNA] 		CTD PMID:8390853 PMID:18045962 PMID:18556351 PMID:19847363 PMID:21795739 More... NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Mycl MYCL proto-oncogene, bHLH transcription factor affects expression ISO Progesterone affects the expression of MYCL mRNA CTD PMID:17251523 NCBI chr 5:140,559,843...140,566,704
Ensembl chr 5:140,560,152...140,566,699 		JBrowse link
G Mycn MYCN proto-oncogene, bHLH transcription factor multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of MYCN mRNA
Progesterone results in decreased expression of MYCN mRNA 		CTD PMID:17404688 PMID:22238285 NCBI chr 6:41,446,683...41,452,584
Ensembl chr 6:41,446,684...41,452,508 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor increases expression ISO Progesterone results in increased expression of MYD88 mRNA CTD PMID:21549006 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230 		JBrowse link
G Myh1 myosin heavy chain 1 decreases expression ISO Progesterone results in decreased expression of MYH1 mRNA CTD PMID:18070364 NCBI chr10:52,384,810...52,408,698
Ensembl chr10:52,384,908...52,409,047 		JBrowse link
G Myh10 myosin heavy chain 10 decreases expression ISO Progesterone results in decreased expression of MYH10 mRNA CTD PMID:21795739 NCBI chr10:53,393,901...53,525,174
Ensembl chr10:53,893,166...54,024,036 		JBrowse link
G Myh11 myosin heavy chain 11 increases expression EXP Progesterone results in increased expression of MYH11 mRNA CTD PMID:20726854 NCBI chr10:743,364...838,459
Ensembl chr10:1,263,194...1,345,678 		JBrowse link
G Myh3 myosin heavy chain 3 decreases expression EXP Progesterone results in decreased expression of MYH3 mRNA CTD PMID:20726854 NCBI chr10:51,770,177...51,793,994
Ensembl chr10:52,269,185...52,293,000 		JBrowse link
G Myh6 myosin heavy chain 6 increases expression EXP
ISO 		Progesterone results in increased expression of MYH6 mRNA CTD PMID:20726854 PMID:22238285 NCBI chr15:32,388,102...32,413,663
Ensembl chr15:32,387,487...32,411,333 		JBrowse link
G Myh7 myosin heavy chain 7 increases expression EXP Progesterone results in increased expression of MYH7 mRNA CTD PMID:20726854 NCBI chr15:32,416,525...32,439,851
Ensembl chr15:32,416,527...32,438,194 		JBrowse link
G Myl1 myosin, light chain 1 increases expression EXP Progesterone results in increased expression of MYL1 mRNA CTD PMID:20726854 Ensembl chr 9:75,887,227...75,907,971 JBrowse link
G Myl6b myosin light chain 6B decreases expression ISO Progesterone results in decreased expression of MYL6B mRNA CTD PMID:21795739 NCBI chr  X:40,572,012...40,572,991 JBrowse link
G Myl9 myosin light chain 9 decreases expression ISO Progesterone results in decreased expression of MYL9 mRNA CTD PMID:18037150 PMID:18070364 NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:165,742,046...165,748,410 		JBrowse link
G Mylip myosin regulatory light chain interacting protein increases expression
decreases expression 		ISO Progesterone results in increased expression of MYLIP mRNA
Progesterone results in decreased expression of MYLIP mRNA 		CTD PMID:18037150 PMID:21795739 NCBI chr17:19,492,826...19,514,490
Ensembl chr17:19,492,826...19,514,471 		JBrowse link
G Mylk myosin light chain kinase multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of MYLK mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MYLK mRNA CTD PMID:17404688 PMID:20660070 NCBI chr11:65,783,008...66,030,239
Ensembl chr11:79,288,243...79,535,659 		JBrowse link
G Mylk3 myosin light chain kinase 3 multiple interactions
decreases expression 		ISO Mifepristone inhibits the reaction [Progesterone results in decreased expression of MYLK3 mRNA] CTD PMID:27264040 PMID:31566189 NCBI chr19:37,858,298...37,916,805
Ensembl chr19:37,865,141...37,915,827 		JBrowse link
G Myo16 myosin XVI increases expression ISO Progesterone results in increased expression of MYO16 mRNA CTD PMID:17404688 NCBI chr16:85,586,428...86,066,537
Ensembl chr16:85,586,429...85,973,879 		JBrowse link
G Myo1b myosin Ib decreases expression ISO Progesterone results in decreased expression of MYO1B mRNA CTD PMID:20864642 NCBI chr 9:57,182,059...57,344,335
Ensembl chr 9:57,181,987...57,344,328 		JBrowse link
G Myocd myocardin increases expression ISO Progesterone results in increased expression of MYOCD mRNA CTD PMID:20864642 NCBI chr10:50,332,356...50,426,819
Ensembl chr10:50,332,356...50,426,819 		JBrowse link
G Myof myoferlin decreases expression
multiple interactions 		ISO Progesterone results in decreased expression of MYOF mRNA
[Estradiol co-treated with Progesterone] results in increased expression of MYOF mRNA 		CTD PMID:18037150 PMID:20660070 NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:245,086,109...245,234,768 		JBrowse link
G Myrip myosin VIIA and Rab interacting protein multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of MYRIP mRNA CTD PMID:20660070 NCBI chr 8:128,895,371...129,062,420
Ensembl chr 8:128,895,371...129,062,420 		JBrowse link
G Naaa N-acylethanolamine acid amidase increases expression
multiple interactions 		ISO Progesterone results in increased expression of NAAA mRNA
[Estradiol co-treated with Progesterone] results in increased expression of NAAA mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr14:16,061,599...16,080,703
Ensembl chr14:16,061,583...16,080,702 		JBrowse link
G Nacc2 NACC family member 2 affects expression
increases expression 		ISO Progesterone affects the expression of NACC2 mRNA
Progesterone results in increased expression of NACC2 mRNA 		CTD PMID:17251523 PMID:22238285 NCBI chr 3:8,879,952...8,946,660
Ensembl chr 3:29,281,190...29,344,840 		JBrowse link
G Nalcn sodium leak channel, non-selective increases expression ISO Progesterone results in increased expression of NALCN mRNA CTD PMID:21795739 NCBI chr15:100,398,583...100,741,243
Ensembl chr15:106,805,209...107,147,858 		JBrowse link
G Nalf1 NALCN channel auxiliary factor 1 increases expression ISO Progesterone results in increased expression of NALF1 mRNA CTD PMID:22238285 NCBI chr16:79,713,577...80,236,295
Ensembl chr16:86,415,488...86,938,150 		JBrowse link
G Nampt nicotinamide phosphoribosyltransferase multiple interactions ISO [Estradiol co-treated with Progesterone] promotes the reaction [Estriol results in increased expression of NAMPT mRNA]
NAMPT protein promotes the reaction [IGF1 protein results in increased abundance of Progesterone] 		CTD PMID:20004694 PMID:23315983 NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544 		JBrowse link
G Nanos1 nanos C2HC-type zinc finger 1 decreases expression ISO Progesterone results in decreased expression of NANOS1 mRNA CTD PMID:18037150 NCBI chr 1:269,883,713...269,887,611
Ensembl chr 1:269,883,536...269,895,417 		JBrowse link
G Napsa napsin A aspartic peptidase affects expression ISO Progesterone affects the expression of NAPSA mRNA CTD PMID:17251523 NCBI chr 1:104,200,967...104,213,603
Ensembl chr 1:104,200,960...104,213,608 		JBrowse link
G Nat1 N-acetyltransferase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of NAT1 mRNA CTD PMID:20660070 NCBI chr16:26,984,882...27,005,194
Ensembl chr16:26,982,625...26,986,527 		JBrowse link
G Nav3 neuron navigator 3 decreases expression ISO Progesterone results in decreased expression of NAV3 mRNA CTD PMID:20864642 NCBI chr 7:46,938,577...47,726,839
Ensembl chr 7:46,940,670...47,504,893 		JBrowse link
G Ncapg non-SMC condensin I complex, subunit G increases expression
decreases expression 		ISO Progesterone results in increased expression of NCAPG mRNA
Progesterone results in decreased expression of NCAPG mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445 		JBrowse link
G Ncf2 neutrophil cytosolic factor 2 increases expression
multiple interactions 		ISO Progesterone results in increased expression of NCF2 mRNA
Estradiol inhibits the reaction [Progesterone results in increased expression of NCF2 mRNA] 		CTD PMID:16195479 NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149 		JBrowse link
G Nck1 NCK adaptor protein 1 increases expression EXP Progesterone results in increased expression of NCK1 mRNA CTD PMID:21770760 NCBI chr 8:101,018,610...101,079,237
Ensembl chr 8:109,897,724...109,958,247 		JBrowse link
G Ncmap noncompact myelin associated protein multiple interactions
decreases expression 		ISO Mifepristone promotes the reaction [Progesterone affects the expression of NCMAP mRNA]
Progesterone results in decreased expression of NCMAP mRNA 		CTD PMID:22238285 PMID:22414680 NCBI chr 5:152,893,173...152,921,175
Ensembl chr 5:152,894,316...152,902,414 		JBrowse link
G Ncoa1 nuclear receptor coactivator 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of NCOA1 protein
[Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]] 		CTD PMID:17556502 PMID:21768169 NCBI chr 6:32,952,090...33,229,829
Ensembl chr 6:32,952,090...33,195,924 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions
increases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in decreased expression of BMP2 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of CALB1 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of CDKL1 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of CLMN mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of DSP mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of EMB mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of HMGA2 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of KRT18 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of LDB2 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of MPZL2 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of POF1B mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of RHPN2 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of S100G mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of SLC44A3 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of SOX7 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of TJP3 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of TSPAN8 mRNA]; NCOA2 protein affects the reaction [Progesterone results in decreased expression of WNT7A mRNA]; NCOA2 protein affects the reaction [Progesterone results in increased expression of ATP2C2 mRNA]; NCOA2 protein affects the reaction [Progesterone results in increased expression of CLDN23 mRNA]; NCOA2 protein affects the reaction [Progesterone results in increased expression of SLCO5A1 mRNA]; NCOA2 protein affects the reaction [Progesterone results in increased expression of TTR mRNA]; NCOA2 protein affects the reaction [Progesterone results in increased expression of TUBB2A mRNA]
Progesterone results in increased expression of NCOA2 protein 		CTD PMID:17556502 NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:10,618,722...10,852,776 		JBrowse link
G Ncoa4 nuclear receptor coactivator 4 decreases expression ISO Progesterone results in decreased expression of NCOA4 mRNA CTD PMID:18037150 NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,401,802...7,415,840 		JBrowse link
G Ncr2 natural cytotoxicity triggering receptor 2 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of NCR2 mRNA CTD PMID:18692832 NCBI chr 9:12,777,195...12,828,437 JBrowse link
G Ndc80 NDC80 kinetochore complex component increases expression ISO Progesterone results in increased expression of NDC80 mRNA CTD PMID:18070364 NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568 		JBrowse link
G Ndp norrin cystine knot growth factor NDP multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of NDP mRNA; [Progesterone co-treated with Estradiol] results in increased expression of NDP mRNA
Progesterone results in increased expression of NDP mRNA 		CTD PMID:17404688 PMID:20660070 PMID:22238285 NCBI chr  X:5,796,487...5,820,934
Ensembl chr  X:8,379,569...8,406,802 		JBrowse link
G Ndrg1 N-myc downstream regulated 1 increases expression ISO Progesterone results in increased expression of NDRG1 mRNA CTD PMID:21795739 NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:100,573,523...100,614,913 		JBrowse link
G Ndrg2 NDRG family member 2 decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of NDRG2 mRNA
Progesterone results in increased expression of NDRG2 mRNA 		CTD PMID:20726854 PMID:21540246 NCBI chr15:27,074,481...27,087,376
Ensembl chr15:27,074,481...27,083,125 		JBrowse link
G Ndrg4 NDRG family member 4 increases expression EXP Progesterone results in increased expression of NDRG4 mRNA CTD PMID:20726854 NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,357,470...9,392,972 		JBrowse link
G Ndufb7 NADH:ubiquinone oxidoreductase subunit B7 increases expression ISO Progesterone results in increased expression of NDUFB7 mRNA CTD PMID:38992643 NCBI chr19:41,472,953...41,477,291
Ensembl chr19:41,472,953...41,477,291 		JBrowse link
G Nebl nebulette multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of NEBL mRNA CTD PMID:20660070 NCBI chr17:85,022,953...85,374,848
Ensembl chr17:85,022,963...85,374,172 		JBrowse link
G Nefh neurofilament heavy chain decreases expression ISO Progesterone results in decreased expression of NEFH mRNA CTD PMID:18070364 NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417 		JBrowse link
G Nefm neurofilament medium chain decreases expression ISO Progesterone results in decreased expression of NEFM mRNA CTD PMID:20864642 NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163 		JBrowse link
G Negr1 neuronal growth regulator 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of NEGR1 mRNA CTD PMID:21453500 NCBI chr 2:245,624,460...246,359,605
Ensembl chr 2:248,283,353...249,018,410 		JBrowse link
G Nek2 NIMA-related kinase 2 decreases expression ISO Progesterone results in decreased expression of NEK2 mRNA CTD PMID:21795739 NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056 		JBrowse link
G Nell2 neural EGFL like 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of NELL2 mRNA CTD PMID:20660070 NCBI chr 7:128,222,333...128,542,127
Ensembl chr 7:128,078,103...128,651,917 		JBrowse link
G Neo1 neogenin 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of NEO1 mRNA CTD PMID:20660070 NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:68,169,716...68,322,152 		JBrowse link
G Nes nestin decreases expression ISO
EXP 		Progesterone results in decreased expression of NES mRNA CTD PMID:20726854 PMID:21795739 NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228 		JBrowse link
G Neu3 neuraminidase 3 increases expression EXP Progesterone results in increased expression of NEU3 mRNA CTD PMID:20726854 NCBI chr 1:163,549,834...163,560,997
Ensembl chr 1:163,549,738...163,561,049 		JBrowse link
G Nexn nexilin (F actin binding protein) increases expression EXP Progesterone results in increased expression of NEXN mRNA CTD PMID:20726854 NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:243,846,433...243,887,114 		JBrowse link
G Nfat5 nuclear factor of activated T-cells 5 decreases expression EXP Progesterone results in decreased expression of NFAT5 mRNA CTD PMID:21371490 NCBI chr19:52,108,982...52,196,418
Ensembl chr19:52,109,483...52,196,418 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 affects expression EXP Progesterone affects the expression of NFE2L2 mRNA CTD PMID:24777823 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfib nuclear factor I/B multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of NFIB mRNA; [Progesterone co-treated with Estradiol] results in increased expression of NFIB mRNA
Progesterone results in increased expression of NFIB mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 5:101,805,168...102,020,618
Ensembl chr 5:101,805,168...102,019,945 		JBrowse link
G Nfic nuclear factor I/C affects expression ISO Progesterone affects the expression of NFIC mRNA CTD PMID:17251523 NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,904,117...8,963,409 		JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated increases expression ISO Progesterone results in increased expression of NFIL3 mRNA CTD PMID:20864642 PMID:21795739 NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826 		JBrowse link
G Nfix nuclear factor I X affects expression ISO Progesterone affects the expression of NFIX mRNA CTD PMID:17251523 NCBI chr19:40,259,873...40,356,966
Ensembl chr19:40,260,084...40,353,092 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO Mifepristone inhibits the reaction [Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]]; Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein] CTD PMID:15866594 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 increases expression ISO Progesterone results in increased expression of NFKB2 mRNA CTD PMID:21549006 NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases expression 		ISO
EXP 		Progesterone inhibits the reaction [IL1B protein results in increased degradation of NFKBIA protein]
Progesterone results in increased expression of NFKBIA mRNA
Progesterone promotes the reaction [Hydrogen Peroxide results in increased degradation of NFKBIA protein] 		CTD PMID:16284289 PMID:17437195 PMID:18037150 PMID:21795739 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nfkbil1 NFKB inhibitor like 1 increases expression ISO Progesterone results in increased expression of NFKBIL1 mRNA CTD PMID:21549006 NCBI chr20:3,595,319...3,610,295
Ensembl chr20:3,595,284...3,610,294 		JBrowse link
G Nfkbiz NFKB inhibitor zeta increases expression ISO Progesterone results in increased expression of NFKBIZ mRNA CTD PMID:21795739 NCBI chr11:58,251,720...58,279,767
Ensembl chr11:58,251,721...58,279,767 		JBrowse link
G Nfxl1 nuclear transcription factor, X-box binding-like 1 increases expression ISO Progesterone results in increased expression of NFXL1 mRNA CTD PMID:21795739 NCBI chr14:35,626,086...35,667,505
Ensembl chr14:35,980,057...36,023,281 		JBrowse link
G Ngf nerve growth factor multiple interactions EXP [Estradiol co-treated with Progesterone] results in decreased expression of NGF mRNA; [VIP protein results in increased secretion of Progesterone] which results in decreased expression of NGF mRNA; Progesterone inhibits the reaction [Estradiol results in increased expression of NGF protein] CTD PMID:15570173 PMID:20150881 PMID:21277368 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834 		JBrowse link
G Ngly1 N-glycanase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of NGLY1 mRNA CTD PMID:20660070 NCBI chr15:9,153,738...9,210,228
Ensembl chr15:11,584,475...11,635,328 		JBrowse link
G Nherf1 NHERF family PDZ scaffold protein 1 decreases expression ISO Progesterone results in decreased expression of NHERF1 mRNA CTD PMID:18037150 NCBI chr10:100,902,165...100,919,265
Ensembl chr10:100,901,227...100,919,579 		JBrowse link
G Niban1 niban apoptosis regulator 1 decreases expression ISO Progesterone results in decreased expression of NIBAN1 mRNA CTD PMID:22238285 NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724 		JBrowse link
G Nid1 nidogen 1 decreases expression ISO Progesterone results in decreased expression of NID1 mRNA CTD PMID:19693291 NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386 		JBrowse link
G Nit1 nitrilase 1 affects expression ISO Progesterone affects the expression of NIT1 mRNA CTD PMID:17251523 NCBI chr13:86,302,334...86,305,770
Ensembl chr13:86,298,387...86,305,770 		JBrowse link
G Nkg7 natural killer cell granule protein 7 increases expression ISO Progesterone results in increased expression of NKG7 mRNA CTD PMID:18070364 NCBI chr 1:102,981,497...102,982,564
Ensembl chr 1:102,981,450...102,982,562 		JBrowse link
G Nlrp5 NLR family, pyrin domain containing 5 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of NLRP5 mRNA CTD PMID:20660070 NCBI chr 1:67,778,037...67,810,941
Ensembl chr 1:76,810,108...77,077,580 		JBrowse link
G Nmb neuromedin B decreases expression ISO Progesterone results in decreased expression of NMB mRNA CTD PMID:17404688 NCBI chr 1:144,278,678...144,290,523
Ensembl chr 1:144,278,453...144,281,422 		JBrowse link
G Nme2 NME/NM23 nucleoside diphosphate kinase 2 increases expression
multiple interactions 		ISO Progesterone results in increased expression of NME2 mRNA
Mifepristone inhibits the reaction [Progesterone results in increased expression of NME2 mRNA] 		CTD PMID:15674352 NCBI chr10:79,394,999...79,400,418
Ensembl chr20:11,179,066...11,179,497
Ensembl chr10:11,179,066...11,179,497 		JBrowse link
G Nmt1 N-myristoyltransferase 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of NMT1 mRNA CTD PMID:17404688 NCBI chr10:87,988,826...88,025,405
Ensembl chr10:88,488,990...88,522,729 		JBrowse link
G Nmu neuromedin U increases abundance EXP NMU protein results in increased abundance of Progesterone CTD PMID:23423171 NCBI chr14:31,844,564...31,872,196
Ensembl chr14:32,198,943...32,226,632 		JBrowse link
G Nodal nodal growth differentiation factor decreases expression EXP Progesterone results in decreased expression of NODAL mRNA CTD PMID:21770760 NCBI chr20:29,911,258...29,919,659
Ensembl chr20:29,911,258...29,919,659 		JBrowse link
G Nog noggin multiple interactions ISO
EXP 		NOG protein inhibits the reaction [BMP2 protein results in decreased abundance of Progesterone]; Progesterone promotes the reaction [Estradiol results in increased expression of NOG mRNA]
NOG protein promotes the reaction [GH1 protein promotes the reaction [FSHB protein results in increased abundance of Progesterone]]
NOG protein inhibits the reaction [Octreotide inhibits the reaction [FSHB protein results in increased abundance of Progesterone]]; NOG protein inhibits the reaction [pasireotide inhibits the reaction [FSHB protein results in increased abundance of Progesterone]] 		CTD PMID:20639315 PMID:21795739 PMID:22067323 PMID:23137853 NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,625,875...74,628,103 		JBrowse link
G Nop56 NOP56 ribonucleoprotein decreases expression ISO Progesterone results in decreased expression of NOP56 mRNA CTD PMID:18037150 NCBI chr 3:137,926,187...137,934,971
Ensembl chr 3:137,929,646...137,934,959 		JBrowse link
G Nos1 nitric oxide synthase 1 multiple interactions
decreases expression 		EXP
ISO 		[Progesterone co-treated with estradiol 3-benzoate] results in increased expression of NOS1 protein
Progesterone results in decreased expression of NOS1 protein 		CTD PMID:15347845 PMID:22486171 NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
decreases expression
affects response to substance
increases expression 		ISO
EXP 		Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS2 protein]
Progesterone results in decreased expression of NOS2 mRNA
[VIP protein results in increased secretion of Progesterone] which results in decreased expression of NOS2 protein
Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with IL4 protein] results in increased expression of NOS2 mRNA]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
NOS2 protein affects the susceptibility to Progesterone
Progesterone results in increased expression of NOS2 mRNA; Progesterone results in increased expression of NOS2 protein 		CTD PMID:11063824 PMID:15869954 PMID:16399999 PMID:18710710 PMID:20150881 More... NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions
decreases expression
increases expression
increases activity
increases phosphorylation 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Progesterone results in increased activity of NOS3 protein]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]]; Mifepristone inhibits the reaction [Progesterone results in increased expression of and results in increased phosphorylation of NOS3 protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS3 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS3 protein]; Org 31710 inhibits the reaction [Progesterone results in increased expression of NOS3 protein]; Org 31710 inhibits the reaction [Progesterone results in increased phosphorylation of NOS3 protein]; Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]; Progesterone results in increased expression of and results in increased phosphorylation of NOS3 protein; U 0126 inhibits the reaction [Progesterone results in increased phosphorylation of NOS3 protein]; Wortmannin inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]]; Wortmannin inhibits the reaction [Progesterone results in increased activity of NOS3 protein]; Wortmannin inhibits the reaction [Progesterone results in increased phosphorylation of NOS3 protein]
Progesterone results in decreased expression of NOS3 protein
Progesterone results in increased expression of NOS3 mRNA; Progesterone results in increased expression of NOS3 protein 		CTD PMID:15358673 PMID:18710710 PMID:21558462 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Notch1 notch receptor 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of NOTCH1 mRNA CTD PMID:19693291 NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613 		JBrowse link
G Notch2 notch receptor 2 decreases expression ISO Progesterone results in decreased expression of NOTCH2 mRNA CTD PMID:18070364 NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:188,299,336...188,432,823 		JBrowse link
G Nox3 NADPH oxidase 3 decreases expression ISO Progesterone results in decreased expression of NOX3 mRNA CTD PMID:18070364 NCBI chr 1:44,238,012...44,302,851
Ensembl chr 1:46,642,564...46,708,109 		JBrowse link
G Noxa1 NADPH oxidase activator 1 decreases expression ISO Progesterone results in decreased expression of NOXA1 mRNA CTD PMID:22238285 NCBI chr 3:28,293,643...28,309,828
Ensembl chr 3:28,293,658...28,304,022 		JBrowse link
G Npas2 neuronal PAS domain protein 2 increases expression ISO Progesterone results in increased expression of NPAS2 mRNA CTD PMID:21795739 NCBI chr 9:48,959,225...49,138,036
Ensembl chr 9:48,959,148...49,138,037 		JBrowse link
G Npc1 NPC intracellular cholesterol transporter 1 multiple interactions ISO Progesterone inhibits the reaction [NPC1 protein results in increased secretion of Cholesterol]; Progesterone inhibits the reaction [NPC1 protein results in increased secretion of Daunorubicin] CTD PMID:16174794 NCBI chr18:3,654,237...3,699,853
Ensembl chr18:3,654,237...3,699,800 		JBrowse link
G Npl N-acetylneuraminate pyruvate lyase affects expression ISO Progesterone affects the expression of NPL mRNA CTD PMID:17251523 NCBI chr13:68,205,602...68,247,940
Ensembl chr13:68,205,603...68,247,999 		JBrowse link
G Npm3 nucleophosmin/nucleoplasmin, 3 affects expression ISO Progesterone affects the expression of NPM3 mRNA CTD PMID:17251523 NCBI chr 1:254,544,664...254,546,649
Ensembl chr 1:254,544,664...254,546,649 		JBrowse link
G Nppa natriuretic peptide A increases expression
multiple interactions 		EXP
ISO 		Progesterone results in increased expression of NPPA mRNA
[Progesterone co-treated with Estradiol] results in increased expression of NPPA mRNA 		CTD PMID:18692832 PMID:20726854 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493 		JBrowse link
G Nppb natriuretic peptide B increases expression EXP Progesterone results in increased expression of NPPB mRNA CTD PMID:20726854 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310 		JBrowse link
G Nppc natriuretic peptide C multiple interactions
increases expression 		ISO Progesterone inhibits the reaction [Estradiol results in increased expression of NPPC protein]
Progesterone results in increased expression of NPPC mRNA 		CTD PMID:9435603 PMID:22238285 NCBI chr 9:94,767,986...94,772,186
Ensembl chr 9:94,767,986...94,772,186 		JBrowse link
G Npr3 natriuretic peptide receptor 3 increases expression ISO Progesterone results in increased expression of NPR3 mRNA CTD PMID:20864642 NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066 		JBrowse link
G Nptx2 neuronal pentraxin 2 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of NPTX2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of NPTX2 mRNA
Progesterone results in increased expression of NPTX2 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr12:10,037,435...10,048,345
Ensembl chr12:15,151,136...15,162,045 		JBrowse link
G Npy neuropeptide Y increases expression
decreases expression
increases secretion 		ISO
EXP 		Progesterone results in increased expression of NPY mRNA
Progesterone results in decreased expression of NPY mRNA
NPY protein results in increased secretion of Progesterone 		CTD PMID:18070364 PMID:20150881 PMID:22238285 NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310 		JBrowse link
G Npy1r neuropeptide Y receptor Y1 increases expression ISO Progesterone results in increased expression of NPY1R mRNA CTD PMID:18070364 NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions
increases expression 		EXP Dicumarol inhibits the reaction [Progesterone results in increased activity of NQO1 protein]; Progesterone results in increased expression of and results in increased activity of NQO1 protein
Progesterone results in increased expression of NQO1 mRNA 		CTD PMID:20726854 PMID:21770760 PMID:21947872 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr0b1 nuclear receptor subfamily 0, group B, member 1 multiple interactions ISO [[NR0B1 protein binds to STAR promoter] which results in decreased expression of STAR mRNA] which results in decreased abundance of Progesterone; NR0B1 protein inhibits the reaction [[Bucladesine results in increased expression of STAR protein] which results in increased abundance of Progesterone]; NR0B1 protein inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of STAR protein] which results in increased abundance of Progesterone] CTD PMID:18787026 NCBI chr  X:50,756,886...50,761,014
Ensembl chr  X:54,707,639...54,712,083 		JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 increases expression EXP Progesterone results in increased expression of NR1D1 mRNA CTD PMID:20726854 NCBI chr10:84,224,599...84,231,812
Ensembl chr10:84,224,540...84,231,812 		JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 affects expression ISO Progesterone affects the expression of NR1D2 mRNA CTD PMID:17251523 NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions
increases activity 		ISO
EXP 		[Progesterone co-treated with NR1I2 protein] results in increased expression of UGT1A1 mRNA; Progesterone binds to and results in increased activity of NR1I2 protein
Progesterone metabolite results in increased activity of NR1I2 protein
Progesterone results in increased activity of NR1I2 protein 		CTD PMID:14613717 PMID:15650019 PMID:15846226 PMID:16054614 PMID:18098064 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions
decreases activity 		ISO Estradiol inhibits the reaction [Progesterone results in decreased activity of NR1I3 protein]; Estrone inhibits the reaction [Progesterone results in decreased activity of NR1I3 protein]
[Estradiol co-treated with Progesterone] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased activity of NR1I3 protein]; [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]; [Progesterone co-treated with Estradiol] inhibits the reaction [Phenobarbital results in increased activity of NR1I3 protein]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in decreased expression of G6PC1 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in decreased expression of SREBF1 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2B6 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [Phenobarbital results in decreased expression of G6PC1 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [Phenobarbital results in decreased expression of SREBF1 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [Phenobarbital results in increased expression of CYP2B6 mRNA]]; NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]; Progesterone inhibits the reaction [Phenobarbital results in increased activity of NR1I3 protein] 		CTD PMID:11075820 PMID:21768169 NCBI chr13:83,632,940...83,638,193
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Nr2c2 nuclear receptor subfamily 2, group C, member 2 increases expression ISO Progesterone results in increased expression of NR2C2 mRNA CTD PMID:21549006 NCBI chr 4:126,167,350...126,223,942
Ensembl chr 4:126,168,085...126,223,942 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
increases expression
affects binding
affects expression
increases phosphorylation 		ISO
EXP 		[Hydrocortisone co-treated with Progesterone] results in increased expression of NR3C1 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of NR3C1 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 mRNA; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of ZNF486 mRNA]; NR3C1 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA]; Progesterone binds to and results in increased activity of NR3C1 protein
Progesterone results in increased expression of NR3C1 mRNA
NR3C1 protein binds to Progesterone
Progesterone affects the expression of NR3C1 mRNA
Progesterone binds to NR3C1 protein
Progesterone binds to and results in increased activity of NR3C1 protein; Progesterone inhibits the reaction [Ozone results in decreased expression of NR3C1 protein]
Progesterone results in increased phosphorylation of NR3C1 protein 		CTD PMID:1597467 PMID:16507850 PMID:17509631 PMID:18060946 PMID:18483179 More... NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 affects binding
multiple interactions
increases activity 		EXP
ISO 		Progesterone binds to NR3C2 protein
[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of NR3C2 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 mRNA; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA]
Progesterone results in increased activity of NR3C2 protein 		CTD PMID:14667981 PMID:15362971 PMID:23275455 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of NR4A1 mRNA
NR4A1 protein mutant form inhibits the reaction [bisphenol A results in increased abundance of Progesterone]; NR4A1 protein promotes the reaction [bisphenol A diglycidyl ether affects the abundance of Progesterone]; NR4A1 protein promotes the reaction [bisphenol A results in increased abundance of Progesterone] 		CTD PMID:12021184 PMID:18037150 PMID:18525235 NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041 		JBrowse link
G Nr5a1 nuclear receptor subfamily 5, group A, member 1 multiple interactions
increases abundance 		ISO [NR5A1 protein co-treated with 20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Progesterone; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Progesterone; [NR5A1 protein co-treated with LIF protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Tretinoin] results in increased abundance of Progesterone
NR5A1 protein results in increased abundance of Progesterone 		CTD PMID:20045459 PMID:21610156 NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:42,875,221...42,896,046 		JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 decreases abundance
increases abundance 		ISO NR5A2 gene mutant form results in decreased abundance of Progesterone
NR5A2 protein results in increased abundance of Progesterone 		CTD PMID:17409375 PMID:18628394 NCBI chr13:50,865,253...50,985,107
Ensembl chr13:50,867,920...50,984,938 		JBrowse link
G Nrg1 neuregulin 1 multiple interactions ISO NRG1 protein promotes the reaction [AREG protein results in increased abundance of Progesterone] CTD PMID:21047912 NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849 		JBrowse link
G Nrp1 neuropilin 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of NRP1 mRNA CTD PMID:20660070 NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702 		JBrowse link
G Nrxn3 neurexin 3 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of NRXN3 mRNA
Progesterone results in decreased expression of NRXN3 mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr 6:107,641,760...109,272,849
Ensembl chr 6:113,443,524...115,002,540 		JBrowse link
G Nsdhl NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL increases expression ISO Progesterone results in increased expression of NSDHL mRNA CTD PMID:18070364 NCBI chr  X:155,817,301...155,848,224
Ensembl chr  X:155,817,340...155,848,220 		JBrowse link
G Nsg1 neuronal vesicle trafficking associated 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of NSG1 mRNA CTD PMID:17404688 NCBI chr14:76,861,079...76,882,822
Ensembl chr14:76,860,746...76,883,390 		JBrowse link
G Nt5c3b 5'-nucleotidase, cytosolic IIIB affects expression ISO Progesterone affects the expression of NT5C3B mRNA CTD PMID:17251523 NCBI chr10:85,358,483...85,376,340
Ensembl chr10:85,862,512...85,875,992 		JBrowse link
G Nt5e 5' nucleotidase, ecto increases expression
decreases expression 		EXP
ISO 		Progesterone results in increased expression of NT5E mRNA
Progesterone results in decreased expression of NT5E mRNA 		CTD PMID:20726854 PMID:20864642 NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:98,150,900...98,195,645 		JBrowse link
G Ntf3 neurotrophin 3 multiple interactions EXP Progesterone inhibits the reaction [Estradiol results in increased expression of NTF3 protein] CTD PMID:15570173 NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:160,600,770...160,676,349 		JBrowse link
G Ntm neurotrimin decreases expression ISO Progesterone results in decreased expression of NTM mRNA CTD PMID:18070364 NCBI chr 8:27,376,582...28,366,604
Ensembl chr 8:35,635,640...36,624,807 		JBrowse link
G Ntng1 netrin G1 increases expression ISO Progesterone results in increased expression of NTNG1 mRNA CTD PMID:22238285 NCBI chr 2:197,462,785...197,827,681
Ensembl chr 2:200,151,979...200,515,031 		JBrowse link
G Ntrk1 neurotrophic receptor tyrosine kinase 1 multiple interactions EXP [VIP protein results in increased secretion of Progesterone] which results in decreased expression of NTRK1 mRNA CTD PMID:20150881 NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787 		JBrowse link
G Ntrk3 neurotrophic receptor tyrosine kinase 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of NTRK3 mRNA CTD PMID:20660070 NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:141,542,569...141,913,004 		JBrowse link
G Nts neurotensin multiple interactions ISO Progesterone inhibits the reaction [Estradiol results in increased expression of NTS mRNA] CTD PMID:21795739 NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961 		JBrowse link
G Nudt6 nudix hydrolase 6 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of NUDT6 mRNA CTD PMID:17404688 NCBI chr 2:122,218,031...122,234,488
Ensembl chr 2:122,217,861...122,234,344 		JBrowse link
G Nuf2 NUF2 component of NDC80 kinetochore complex decreases expression ISO Progesterone results in decreased expression of NUF2 mRNA CTD PMID:21795739 NCBI chr13:84,226,448...84,290,957
Ensembl chr13:84,226,509...84,255,598 		JBrowse link
G Numa1 nuclear mitotic apparatus protein 1 increases expression ISO Progesterone results in increased expression of NUMA1 mRNA CTD PMID:18497975 NCBI chr 1:156,297,907...156,372,855
Ensembl chr 1:165,709,905...165,784,848 		JBrowse link
G Nup153 nucleoporin 153 decreases expression EXP Progesterone results in decreased expression of NUP153 mRNA CTD PMID:20726854 NCBI chr17:18,178,434...18,231,109
Ensembl chr17:18,178,456...18,231,109 		JBrowse link
G Nup160 nucleoporin 160 increases expression ISO Progesterone results in increased expression of NUP160 mRNA CTD PMID:18070364 NCBI chr 3:76,665,786...76,729,296
Ensembl chr 3:97,121,628...97,180,720 		JBrowse link
G Nup54 nucleoporin 54 increases expression ISO Progesterone results in increased expression of NUP54 mRNA CTD PMID:19000923 NCBI chr14:15,617,630...15,636,029
Ensembl chr14:15,901,991...15,920,334 		JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 increases expression
decreases expression 		ISO Progesterone results in increased expression of NUSAP1 mRNA
Progesterone results in decreased expression of NUSAP1 mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237 		JBrowse link
G Oas1a 2'-5' oligoadenylate synthetase 1A multiple interactions
increases expression 		ISO TGFB1 protein promotes the reaction [Progesterone results in increased expression of OAS1 mRNA] CTD PMID:21768398 NCBI chr12:41,330,423...41,341,130
Ensembl chr12:41,285,211...41,341,128 		JBrowse link
G Ociad2 OCIA domain containing 2 decreases expression ISO Progesterone results in decreased expression of OCIAD2 mRNA CTD PMID:21540246 NCBI chr14:35,225,291...35,243,306
Ensembl chr14:35,225,255...35,243,311 		JBrowse link
G Ocln occludin decreases expression ISO Progesterone results in decreased expression of OCLN mRNA CTD PMID:22238285 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411 		JBrowse link
G Odc1 ornithine decarboxylase 1 decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of ODC1 mRNA
Progesterone results in increased expression of ODC1 mRNA 		CTD PMID:18037150 PMID:21770760 NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146 		JBrowse link
G Ogfod1 2-oxoglutarate and iron-dependent oxygenase domain containing 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of OGFOD1 mRNA CTD PMID:20660070 NCBI chr19:10,945,031...10,974,602
Ensembl chr19:10,950,060...10,980,519 		JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase decreases expression
increases expression 		ISO Progesterone results in decreased expression of OGT mRNA
Progesterone results in increased expression of OGT mRNA 		CTD PMID:18037150 PMID:18070364 NCBI chr  X:70,811,317...70,856,123
Ensembl chr  X:70,811,319...70,856,123 		JBrowse link
G Olah oleoyl-ACP hydrolase increases expression ISO Progesterone results in increased expression of OLAH mRNA CTD PMID:22238285 NCBI chr17:79,786,441...79,811,692
Ensembl chr17:79,786,832...79,811,688 		JBrowse link
G Olfm1 olfactomedin 1 decreases expression ISO Progesterone results in decreased expression of OLFM1 mRNA CTD PMID:18037150 NCBI chr 3:31,918,512...31,956,261
Ensembl chr 3:31,918,573...31,956,260 		JBrowse link
G Olfml1 olfactomedin-like 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of OLFML1 mRNA CTD PMID:20660070 NCBI chr 1:161,478,129...161,502,541
Ensembl chr 1:170,889,980...170,915,762 		JBrowse link
G Olfml2b olfactomedin-like 2B increases expression ISO Progesterone results in increased expression of OLFML2B mRNA CTD PMID:20864642 NCBI chr13:85,402,151...85,439,342
Ensembl chr13:85,402,169...85,439,342 		JBrowse link
G Olfml3 olfactomedin-like 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of OLFML3 mRNA CTD PMID:20660070 NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:193,932,665...193,935,494 		JBrowse link
G Olr1 oxidized low density lipoprotein receptor 1 decreases expression EXP Progesterone results in decreased expression of OLR1 mRNA CTD PMID:20726854 NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:164,612,463...164,634,598 		JBrowse link
G Omd osteomodulin increases expression ISO
EXP 		Progesterone results in increased expression of OMD mRNA CTD PMID:20726854 PMID:20864642 PMID:21795739 NCBI chr17:15,266,646...15,274,870
Ensembl chr17:15,266,646...15,274,870 		JBrowse link
G Oplah 5-oxoprolinase (ATP-hydrolysing) increases expression EXP Progesterone results in increased expression of OPLAH mRNA CTD PMID:20726854 NCBI chr 7:109,892,136...109,932,403
Ensembl chr 7:109,891,405...109,915,979 		JBrowse link
G Opn3 opsin 3 increases expression ISO Progesterone results in increased expression of OPN3 mRNA CTD PMID:18037150 NCBI chr13:87,589,333...87,619,847
Ensembl chr13:90,121,560...90,152,076 		JBrowse link
G Oprk1 opioid receptor, kappa 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of OPRK1 mRNA CTD PMID:20660070 NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:18,657,871...18,675,671 		JBrowse link
G Orai2 ORAI calcium release-activated calcium modulator 2 decreases expression ISO Progesterone results in decreased expression of ORAI2 mRNA CTD PMID:21540246 NCBI chr12:26,136,922...26,157,041
Ensembl chr12:26,132,193...26,157,041 		JBrowse link
G Orc2 origin recognition complex, subunit 2 increases expression ISO Progesterone results in increased expression of ORC2 mRNA CTD PMID:18497975 NCBI chr 9:60,001,631...60,038,301
Ensembl chr 9:67,496,825...67,526,649 		JBrowse link
G Orc4 origin recognition complex, subunit 4 increases expression ISO Progesterone results in increased expression of ORC4 mRNA CTD PMID:18070364 NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:53,703,615...53,742,264 		JBrowse link
G Orm1 orosomucoid 1 multiple interactions
increases expression
affects expression
decreases expression
affects binding 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of ORM1 mRNA; Progesterone inhibits the reaction [Warfarin binds to ORM1 protein alternative form]
Progesterone results in increased expression of ORM1 mRNA
Progesterone affects the expression of ORM1 mRNA
Progesterone results in decreased expression of ORM1 mRNA
Progesterone binds to ORM1 protein; Progesterone binds to ORM1 protein alternative form 		CTD PMID:8946472 PMID:16901474 PMID:17251523 PMID:17404688 PMID:19000923 NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:81,788,395...81,791,667 		JBrowse link
G Osbpl11 oxysterol binding protein-like 11 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of OSBPL11 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of OSBPL11 mRNA CTD PMID:17404688 PMID:20660070 NCBI chr11:67,533,669...67,616,795
Ensembl chr11:81,038,985...81,101,299 		JBrowse link
G Osr1 odd-skipped related transcription factor 1 increases expression ISO Progesterone results in increased expression of OSR1 mRNA CTD PMID:22238285 NCBI chr 6:38,088,688...38,100,010
Ensembl chr 6:38,093,011...38,100,021 		JBrowse link
G Osr2 odd-skipped related transcription factor 2 increases expression
multiple interactions 		ISO Progesterone results in increased expression of OSR2 mRNA
Progesterone inhibits the reaction [Estradiol results in increased expression of OSR2 mRNA] 		CTD PMID:20864642 PMID:21795739 NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:68,373,049...68,380,805 		JBrowse link
G Otub1 OTU deubiquitinase, ubiquitin aldehyde binding 1 affects expression ISO Progesterone affects the expression of OTUB1 mRNA CTD PMID:17251523 NCBI chr 1:213,816,400...213,824,679
Ensembl chr 1:213,816,400...213,824,679 		JBrowse link
G Otulinl OTU deubiquitinase with linear linkage specificity like multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of OTULINL mRNA
Progesterone results in increased expression of OTULINL mRNA 		CTD PMID:18070364 PMID:20660070 PMID:21795739 NCBI chr 2:80,136,411...80,164,290
Ensembl chr 2:80,139,262...80,166,962 		JBrowse link
G Ovol1 ovo like transcriptional repressor 1 decreases expression ISO Progesterone results in decreased expression of OVOL1 mRNA CTD PMID:22238285 NCBI chr 1:212,284,601...212,296,106
Ensembl chr 1:212,284,605...212,296,106 		JBrowse link
G Oxt oxytocin/neurophysin I prepropeptide multiple interactions EXP
ISO 		Progesterone inhibits the reaction [Estradiol results in increased expression of OXT mRNA]
[Estradiol co-treated with Progesterone] results in increased expression of OXT mRNA; ESR2 affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of OXT mRNA] 		CTD PMID:12834440 PMID:17400809 NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:138,235,754...138,236,594 		JBrowse link
G Oxtr oxytocin receptor decreases expression ISO Progesterone results in decreased expression of OXTR mRNA CTD PMID:18070364 NCBI chr 4:147,154,374...147,171,723
Ensembl chr 4:147,154,374...147,170,750 		JBrowse link
G P2rx3 purinergic receptor P2X 3 multiple interactions
decreases activity 		EXP Mifepristone inhibits the reaction [Progesterone results in decreased activity of P2RX3 protein] CTD PMID:21178388 NCBI chr 3:90,487,506...90,531,315
Ensembl chr 3:90,487,506...90,531,794 		JBrowse link
G P2ry14 purinergic receptor P2Y14 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of P2RY14 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of P2RY14 mRNA
Progesterone inhibits the reaction [Estradiol results in increased expression of P2RY14 mRNA]
Progesterone results in increased expression of P2RY14 mRNA 		CTD PMID:17404688 PMID:18367319 PMID:20660070 PMID:20864642 NCBI chr 2:143,372,697...143,413,213
Ensembl chr 2:145,516,390...145,564,788 		JBrowse link
G P3h2 prolyl 3-hydroxylase 2 increases expression
multiple interactions 		ISO Progesterone results in increased expression of P3H2 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of P3H2 mRNA 		CTD PMID:20660070 PMID:21540246 NCBI chr11:88,139,086...88,280,221
Ensembl chr11:88,139,078...88,281,203 		JBrowse link
G P4ha2 prolyl 4-hydroxylase subunit alpha 2 affects expression ISO Progesterone affects the expression of P4HA2 mRNA CTD PMID:17251523 NCBI chr10:38,743,894...38,772,741
Ensembl chr10:38,743,894...38,772,993 		JBrowse link
G Padi2 peptidyl arginine deiminase 2 decreases expression ISO Progesterone results in decreased expression of PADI2 mRNA CTD PMID:22238285 NCBI chr 5:158,492,087...158,534,662
Ensembl chr 5:158,492,066...158,534,662 		JBrowse link
G Paep progestagen associated endometrial protein multiple interactions
increases metabolic processing
increases abundance 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of PAEP mRNA; [Estradiol co-treated with Progesterone] results in increased expression of PAEP mRNA
PAEP protein modified form results in increased metabolism of Progesterone
PAEP protein modified form results in increased abundance of Progesterone; PAEP protein results in increased abundance of Progesterone 		CTD PMID:15852231 PMID:17649829 PMID:20660070 PMID:23029392 NCBI chr 3:8,531,136...8,534,430 JBrowse link
G Pag1 phosphoprotein membrane anchor with glycosphingolipid microdomains 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PAG1 mRNA CTD PMID:20660070 NCBI chr 2:93,842,747...93,984,314
Ensembl chr 2:93,964,594...93,977,227 		JBrowse link
G Pak1ip1 PAK1 interacting protein 1 decreases expression ISO Progesterone results in decreased expression of PAK1IP1 mRNA CTD PMID:18037150 NCBI chr17:23,742,217...23,753,325
Ensembl chr17:23,939,509...23,959,055 		JBrowse link
G Palmd palmdelphin multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PALMD mRNA CTD PMID:20660070 NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:207,574,249...207,626,239 		JBrowse link
G Pappa pappalysin multiple interactions
increases expression
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of PAPPA mRNA; PAPPA protein affects the reaction [CGB3 protein results in increased abundance of Progesterone]
Progesterone results in increased expression of PAPPA mRNA
Progesterone results in decreased expression of PAPPA mRNA 		CTD PMID:18497975 PMID:20130263 PMID:20660070 PMID:21273126 PMID:21795739 NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361 		JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PAPSS2 mRNA CTD PMID:20660070 NCBI chr 1:239,867,597...239,952,614
Ensembl chr 1:239,867,574...239,952,616 		JBrowse link
G Parm1 prostate androgen-regulated mucin-like protein 1 increases expression EXP Progesterone results in increased expression of PARM1 mRNA CTD PMID:20726854 NCBI chr14:16,752,541...16,861,570
Ensembl chr14:16,752,541...16,881,138 		JBrowse link
G Patz1 POZ (BTB) and AT hook containing zinc finger 1 decreases expression ISO Progesterone results in decreased expression of PATZ1 mRNA CTD PMID:18037150 NCBI chr14:82,378,226...82,396,679
Ensembl chr14:82,377,697...82,396,686 		JBrowse link
G Pax5 paired box 5 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of PAX5 mRNA CTD PMID:17404688 NCBI chr 5:63,554,784...63,741,380
Ensembl chr 5:63,560,722...63,739,987 		JBrowse link
G Pbk PDZ binding kinase increases expression
decreases expression 		ISO Progesterone results in increased expression of PBK mRNA
Progesterone results in decreased expression of PBK mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570 		JBrowse link
G Pbx1 PBX homeobox 1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of PBX1 mRNA CTD PMID:17404688 NCBI chr13:80,278,766...80,588,563
Ensembl chr13:82,812,131...83,121,066 		JBrowse link
G Pcbp3 poly(rC) binding protein 3 increases expression ISO Progesterone results in increased expression of PCBP3 mRNA CTD PMID:20864642 NCBI chr20:11,635,579...11,877,721
Ensembl chr20:11,677,751...11,877,722 		JBrowse link
G Pcca propionyl-CoA carboxylase subunit alpha decreases expression
increases expression 		ISO
EXP 		Progesterone results in decreased expression of PCCA mRNA
Progesterone results in increased expression of PCCA mRNA 		CTD PMID:20726854 PMID:21540246 NCBI chr15:106,034,586...106,374,908
Ensembl chr15:106,034,610...106,374,908 		JBrowse link
G Pcdh18 protocadherin 18 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PCDH18 mRNA CTD PMID:20660070 NCBI chr 2:135,982,929...135,996,917
Ensembl chr 2:135,983,144...135,996,826 		JBrowse link
G Pcdh7 protocadherin 7 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PCDH7 mRNA CTD PMID:20660070 NCBI chr14:56,684,817...57,114,976
Ensembl chr14:56,687,725...57,112,665 		JBrowse link
G Pcdh9 protocadherin 9 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PCDH9 mRNA CTD PMID:20660070 NCBI chr15:69,340,108...70,237,531
Ensembl chr15:75,749,278...76,645,302 		JBrowse link
G Pcdhga1 protocadherin gamma subfamily A, 1 decreases expression ISO Progesterone results in decreased expression of PCDHGA1 mRNA CTD PMID:18070364 NCBI chr18:29,487,404...29,667,865 JBrowse link
G Pcdhga11 protocadherin gamma subfamily A, 11 decreases expression ISO Progesterone results in decreased expression of PCDHGA11 mRNA CTD PMID:18070364 NCBI chr18:29,583,373...29,667,865 JBrowse link
G Pcdhga3 protocadherin gamma subfamily A, 3 decreases expression ISO Progesterone results in decreased expression of PCDHGA3 mRNA CTD PMID:18070364 NCBI chr18:29,499,148...29,667,865 JBrowse link
G Pcdhgc3 protocadherin gamma subfamily C, 3 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of PCDHGC3 mRNA CTD PMID:17404688 NCBI chr18:29,633,016...29,667,865 JBrowse link
G Pcgf2 polycomb group ring finger 2 affects expression ISO Progesterone affects the expression of PCGF2 mRNA CTD PMID:17251523 NCBI chr10:82,682,563...82,694,563
Ensembl chr10:83,179,916...83,183,999 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions ISO [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in decreased expression of PCK1 mRNA]; [Progesterone co-treated with Estradiol] inhibits the reaction [Phenobarbital results in decreased expression of PCK1 mRNA]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [HNF4A protein binds to PCK1 promoter]]; Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in decreased expression of PCK1 mRNA]; Progesterone inhibits the reaction [Phenobarbital results in decreased expression of PCK1 mRNA]; Progesterone promotes the reaction [Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [HNF4A protein binds to PCK1 promoter]]]
1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [[Progesterone co-treated with Estradiol] results in increased expression of PCK1 mRNA]; [Progesterone co-treated with Estradiol] results in increased expression of PCK1 mRNA 		CTD PMID:21768169 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561 		JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) increases expression ISO Progesterone results in increased expression of PCK2 mRNA CTD PMID:21795739 NCBI chr15:32,997,853...33,006,691
Ensembl chr15:32,997,834...33,016,864 		JBrowse link
G Pclaf PCNA clamp associated factor increases expression
decreases expression 		ISO Progesterone results in increased expression of PCLAF mRNA
Progesterone results in decreased expression of PCLAF mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:75,315,707...75,328,106 		JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
decreases expression
increases expression 		ISO
EXP 		Estradiol promotes the reaction [Progesterone inhibits the reaction [perfluorooctanoic acid results in decreased expression of PCNA protein]]; Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of PCNA protein]]; Progesterone inhibits the reaction [Estradiol results in increased expression of PCNA protein]; Progesterone inhibits the reaction [perfluorooctanoic acid results in decreased expression of PCNA protein]; Progesterone promotes the reaction [Estradiol inhibits the reaction [perfluorooctanoic acid results in decreased expression of PCNA protein]]
[Progesterone co-treated with Estrogens] results in increased expression of PCNA protein
Progesterone results in decreased expression of PCNA mRNA
Progesterone results in increased expression of PCNA mRNA 		CTD PMID:15845746 PMID:16966611 PMID:19847363 PMID:20726854 PMID:21258428 More... NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pcsk5 proprotein convertase subtilisin/kexin type 5 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PCSK5 mRNA CTD PMID:20660070 NCBI chr 1:224,263,823...224,694,350
Ensembl chr 1:224,264,678...224,694,347 		JBrowse link
G Pcsk6 proprotein convertase subtilisin/kexin type 6 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of PCSK6 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of PCSK6 mRNA
Progesterone results in increased expression of PCSK6 mRNA 		CTD PMID:17404688 PMID:18070364 PMID:20660070 NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:128,839,232...129,052,128 		JBrowse link
G Pdap1 PDGFA associated protein 1 increases expression ISO Progesterone results in increased expression of PDAP1 mRNA CTD PMID:16888808 NCBI chr12:14,584,414...14,594,641
Ensembl chr12:14,584,398...14,594,641 		JBrowse link
G Pdcd4 programmed cell death 4 increases expression ISO Progesterone results in increased expression of PDCD4 mRNA CTD PMID:18497975 NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189 		JBrowse link
G Pdcl3 phosducin-like 3 decreases expression ISO Progesterone results in decreased expression of PDCL3 mRNA CTD PMID:18037150 NCBI chr 9:48,730,083...48,738,554
Ensembl chr 9:48,723,767...48,739,529 		JBrowse link
G Pde1c phosphodiesterase 1C decreases expression ISO Progesterone results in decreased expression of PDE1C mRNA CTD PMID:21795739 NCBI chr 4:85,300,858...85,777,948
Ensembl chr 4:86,626,282...87,193,259 		JBrowse link
G Pde4b phosphodiesterase 4B decreases expression
increases expression 		ISO Progesterone results in decreased expression of PDE4B mRNA
Progesterone results in increased expression of PDE4B mRNA 		CTD PMID:18497975 PMID:21795739 NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267 		JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein increases expression EXP Progesterone results in increased expression of PDE4DIP mRNA CTD PMID:20726854 NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:187,981,878...188,178,869 		JBrowse link
G Pde9a phosphodiesterase 9A decreases expression ISO Progesterone results in decreased expression of PDE9A mRNA CTD PMID:21540246 NCBI chr20:9,471,136...9,564,286
Ensembl chr20:9,471,167...9,564,286 		JBrowse link
G Pdgfa platelet derived growth factor subunit A multiple interactions
increases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of PDGFA mRNA
Progesterone results in increased expression of PDGFA mRNA 		CTD PMID:16888808 PMID:17404688 NCBI chr12:15,645,549...15,667,056
Ensembl chr12:20,754,208...20,780,322 		JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of PDGFB mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of PDGFB mRNA
Progesterone results in decreased expression of PDGFB mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343 		JBrowse link
G Pdgfra platelet derived growth factor receptor alpha multiple interactions
increases expression 		ISO [Progesterone results in increased secretion of [VEGFA protein binds to VEGFA protein]] which results in increased phosphorylation of PDGFRA protein; Progesterone promotes the reaction [Imatinib Mesylate results in decreased expression of PDGFRA protein modified form]; Progesterone promotes the reaction [Imatinib Mesylate results in decreased expression of PDGFRA protein]
Progesterone results in increased expression of PDGFRA mRNA
[Estradiol co-treated with Progesterone co-treated with Cuprizone] results in increased expression of PDGFRA mRNA 		CTD PMID:16888808 PMID:17614352 PMID:19031445 PMID:22238285 NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516 		JBrowse link
G Pdgfrb platelet derived growth factor receptor beta multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of PDGFRB mRNA CTD PMID:18692832 NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233 		JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 affects expression ISO Progesterone affects the expression of PDIA3 mRNA CTD PMID:17251523 NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327 		JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 affects expression ISO Progesterone affects the expression of PDIA4 mRNA CTD PMID:17251523 NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:78,134,144...78,153,191 		JBrowse link
G Pdia6 protein disulfide isomerase family A, member 6 affects expression ISO Progesterone affects the expression of PDIA6 mRNA CTD PMID:17251523 NCBI chr 6:45,791,704...45,808,947
Ensembl chr 6:45,791,678...45,810,091 		JBrowse link
G Pdk2 pyruvate dehydrogenase kinase 2 increases expression EXP Progesterone results in increased expression of PDK2 mRNA CTD PMID:20726854 NCBI chr10:80,469,388...80,483,988
Ensembl chr10:80,469,389...80,484,355 		JBrowse link
G Pdlim1 PDZ and LIM domain 1 decreases expression
increases expression 		ISO Progesterone results in decreased expression of PDLIM1 mRNA
Progesterone results in increased expression of PDLIM1 mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379 		JBrowse link
G Pdlim3 PDZ and LIM domain 3 increases expression ISO Progesterone results in increased expression of PDLIM3 mRNA CTD PMID:22238285 NCBI chr16:46,352,460...46,383,680
Ensembl chr16:53,085,020...53,116,217 		JBrowse link
G Pdlim7 PDZ and LIM domain 7 decreases expression ISO Progesterone results in decreased expression of PDLIM7 mRNA CTD PMID:18070364 NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,129,525...9,144,956 		JBrowse link
G Pdp1 pyruvate dehydrogenase phosphatase catalytic subunit 1 decreases expression ISO Progesterone results in decreased expression of PDP1 mRNA CTD PMID:18037150 NCBI chr 5:30,245,699...30,252,494
Ensembl chr 5:30,242,704...30,253,960 		JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase-1 multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of PDPK1 mRNA CTD PMID:17404688 NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,610,063...13,679,181 		JBrowse link
G Pdpn podoplanin multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PDPN mRNA CTD PMID:20660070 NCBI chr 5:160,884,995...160,919,112
Ensembl chr 5:160,884,993...160,925,637 		JBrowse link
G Pds5a PDS5 cohesin associated factor A increases expression ISO Progesterone results in increased expression of PDS5A mRNA CTD PMID:18070364 NCBI chr14:42,551,653...42,651,074
Ensembl chr14:42,905,328...43,004,740 		JBrowse link
G Pdzd2 PDZ domain containing 2 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of PDZD2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of PDZD2 mRNA
Progesterone results in increased expression of PDZD2 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 2:61,384,614...61,770,516
Ensembl chr 2:63,111,650...63,497,478 		JBrowse link
G Pecam1 platelet and endothelial cell adhesion molecule 1 decreases expression ISO Progesterone results in decreased expression of PECAM1 mRNA CTD PMID:18070364 NCBI chr10:91,590,521...91,652,279
Ensembl chr10:92,090,235...92,151,839 		JBrowse link
G Peg10 paternally expressed 10 decreases expression
increases expression 		ISO Progesterone results in decreased expression of PEG10 mRNA
Progesterone results in increased expression of PEG10 mRNA 		CTD PMID:18070364 PMID:21795739 NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:33,817,190...33,819,166
Ensembl chr 4:33,817,190...33,819,166 		JBrowse link
G Pelo pelota mRNA surveillance and ribosome rescue factor multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PELO mRNA CTD PMID:20660070 NCBI chr 2:46,797,853...46,799,621
Ensembl chr 2:48,530,907...48,532,761 		JBrowse link
G Pemt phosphatidylethanolamine N-methyltransferase multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of PEMT mRNA
Progesterone results in increased expression of PEMT mRNA 		CTD PMID:20660070 PMID:20864642 NCBI chr10:45,275,434...45,349,651
Ensembl chr10:45,275,412...45,420,037 		JBrowse link
G Penk proenkephalin affects expression
multiple interactions 		ISO Progesterone affects the expression of PENK mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of PENK mRNA 		CTD PMID:17251523 PMID:19693291 NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705 		JBrowse link
G Per1 period circadian regulator 1 increases expression
multiple interactions 		EXP
ISO 		Progesterone results in increased expression of PER1 mRNA; Progesterone results in increased expression of PER1 protein
Mifepristone inhibits the reaction [Progesterone results in increased expression of PER1 mRNA] 		CTD PMID:17761890 PMID:18037150 PMID:20096720 PMID:21795739 NCBI chr10:54,299,002...54,313,804
Ensembl chr10:54,302,641...54,314,211 		JBrowse link
G Per2 period circadian regulator 2 decreases expression
multiple interactions
increases expression 		EXP
ISO 		Progesterone results in decreased expression of PER2 mRNA
[Progesterone co-treated with Estradiol] results in increased expression of PER2 mRNA
Progesterone results in increased expression of PER2 mRNA 		CTD PMID:20096720 PMID:20726854 NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993 		JBrowse link
G Per3 period circadian regulator 3 decreases expression ISO Progesterone results in decreased expression of PER3 mRNA CTD PMID:21795739 NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999 		JBrowse link
G Pfas phosphoribosylformylglycinamidine synthase multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of PFAS mRNA CTD PMID:17404688 NCBI chr10:54,189,157...54,210,685
Ensembl chr10:54,189,157...54,207,272 		JBrowse link
G Pfkm phosphofructokinase, muscle increases expression EXP Progesterone results in increased expression of PFKM mRNA CTD PMID:20726854 NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:131,100,753...131,138,248 		JBrowse link
G Pfn2 profilin 2 decreases expression EXP Progesterone results in decreased expression of PFN2 mRNA CTD PMID:20726854 NCBI chr 2:142,067,102...142,072,938
Ensembl chr 2:144,205,636...144,222,936 		JBrowse link
G Pgap1 post-GPI attachment to proteins inositol deacylase 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PGAP1 mRNA CTD PMID:20660070 NCBI chr 9:55,975,574...56,044,325
Ensembl chr 9:63,470,024...63,538,772 		JBrowse link
G Pgbd5 piggyBac transposable element derived 5 multiple interactions ISO [Progesterone co-treated with Estradiol] results in increased expression of PGBD5 mRNA CTD PMID:17404688 NCBI chr19:69,234,171...69,299,315
Ensembl chr19:69,234,171...69,299,560 		JBrowse link
G Pglyrp1 peptidoglycan recognition protein 1 affects expression
increases expression 		ISO Progesterone affects the expression of PGLYRP1 mRNA
Progesterone results in increased expression of PGLYRP1 mRNA 		CTD PMID:17251523 PMID:21549006 NCBI chr 1:78,531,815...78,537,001
Ensembl chr 1:87,651,271...87,665,048 		JBrowse link
G Pgm2l1 phosphoglucomutase 2-like 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PGM2L1 mRNA CTD PMID:20660070 NCBI chr 1:154,571,410...154,620,901
Ensembl chr 1:163,983,917...164,033,027 		JBrowse link
G Pgm3 phosphoglucomutase 3 increases expression ISO Progesterone results in increased expression of PGM3 mRNA CTD PMID:18037150 NCBI chr 8:96,398,331...96,416,045
Ensembl chr 8:96,398,269...96,416,021 		JBrowse link
G Pgr progesterone receptor multiple interactions
increases activity
increases expression
affects expression
affects localization
decreases expression
affects binding 		ISO
EXP 		1-hydroxypyrene inhibits the reaction [Progesterone binds to PGR protein]; 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene inhibits the reaction [Progesterone binds to PGR protein]; 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene inhibits the reaction [Progesterone results in increased expression of PGR protein]; 4-hydroxy-2',3',4'-5'-tetrachlorobiphenyl inhibits the reaction [Progesterone binds to PGR protein]; 4-hydroxy-2',4',6'-trichlorobiphenyl inhibits the reaction [Progesterone binds to PGR protein]; 6-hydroxychrysene inhibits the reaction [Progesterone binds to PGR protein]; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Progesterone co-treated with Estradiol] affects the expression of and affects the phosphorylation of PGR protein; [Progesterone affects the activity of PGR protein alternative form] which affects the expression of AREG mRNA; [Progesterone affects the activity of PGR protein alternative form] which affects the expression of IGFBP3 mRNA; [Progesterone affects the activity of PGR protein alternative form] which affects the expression of ITGB4 mRNA; [Progesterone affects the activity of PGR protein alternative form] which affects the expression of MT1L mRNA; [Progesterone co-treated with 1-hydroxypyrene] results in decreased expression of PGR mRNA; [Progesterone co-treated with 4-hydroxy-2',3',4'-5'-tetrachlorobiphenyl] results in decreased expression of PGR mRNA; [Progesterone co-treated with 4-hydroxy-2',4',6'-trichlorobiphenyl] results in decreased expression of PGR mRNA; [Progesterone co-treated with 6-hydroxychrysene] results in decreased expression of PGR mRNA; [Progesterone co-treated with Endosulfan] results in decreased expression of PGR mRNA; [Progesterone co-treated with Hexachlorocyclohexane] results in decreased expression of PGR mRNA; alachlor inhibits the reaction [Progesterone binds to PGR protein]; Aldicarb inhibits the reaction [Progesterone results in increased activity of PGR protein]; Aldrin inhibits the reaction [Progesterone binds to PGR protein]; Apigenin inhibits the reaction [Progesterone binds to PGR protein]; bendiocarb inhibits the reaction [Progesterone results in increased activity of PGR protein]; biochanin A inhibits the reaction [Progesterone binds to PGR protein]; bisphenol A inhibits the reaction [Progesterone binds to PGR protein]; bisphenol AF inhibits the reaction [Progesterone binds to PGR protein]; bisphenol B inhibits the reaction [Progesterone binds to PGR protein]; bisphenol Z inhibits the reaction [Progesterone binds to PGR protein]; Butylated Hydroxyanisole inhibits the reaction [Progesterone binds to PGR protein]; Carbaryl inhibits the reaction [Progesterone results in increased activity of PGR protein]; Chlordecone inhibits the reaction [Progesterone binds to PGR protein]; Chlorpyrifos inhibits the reaction [Progesterone binds to PGR protein]; Chlorpyrifos metabolite inhibits the reaction [Progesterone binds to PGR protein]; Coal Ash inhibits the reaction [Progesterone results in increased activity of PGR protein]; DDT inhibits the reaction [Progesterone binds to PGR protein]; DDT inhibits the reaction [Progesterone results in increased expression of PGR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Progesterone binds to PGR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Progesterone results in increased expression of PGR protein]; Endosulfan inhibits the reaction [Progesterone binds to PGR protein]; Endosulfan inhibits the reaction [Progesterone results in increased expression of PGR protein]; Estradiol promotes the reaction [Progesterone binds to PGR protein]; fenvalerate inhibits the reaction [Progesterone results in increased expression of PGR protein]; Hexachlorocyclohexane inhibits the reaction [Progesterone binds to PGR protein]; Industrial Waste inhibits the reaction [Progesterone results in increased expression of PGR protein]; kaempferol inhibits the reaction [Progesterone binds to PGR protein]; Methomyl inhibits the reaction [Progesterone results in increased activity of PGR protein]; Methoxychlor inhibits the reaction [Progesterone binds to PGR protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of PGR protein]; Mifepristone promotes the reaction [Progesterone affects the expression of PGR mRNA]; Mitotane inhibits the reaction [Progesterone binds to PGR protein]; nonachlor inhibits the reaction [Progesterone binds to PGR protein]; nonylphenol inhibits the reaction [Progesterone binds to PGR protein]; nonylphenol inhibits the reaction [Progesterone results in increased expression of PGR protein]; O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate inhibits the reaction [Progesterone binds to PGR protein]; o,p'-DDT inhibits the reaction [Progesterone binds to PGR protein]; o,p'-DDT inhibits the reaction [Progesterone results in increased expression of PGR protein]; oxamyl inhibits the reaction [Progesterone results in increased activity of PGR protein]; Particulate Matter inhibits the reaction [Progesterone results in increased activity of PGR protein]; Permethrin inhibits the reaction [Progesterone results in increased expression of PGR protein]; Pesticides inhibits the reaction [Progesterone results in increased expression of PGR mRNA]; PGR protein affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ITGA1]; PGR protein affects the reaction [Progesterone results in increased expression of TRIM22 mRNA]; phthalic acid analog inhibits the reaction [Progesterone binds to PGR protein]; Progesterone binds to and results in increased activity of PGR protein; Progesterone inhibits the reaction [Estradiol results in increased expression of PGR mRNA]; Progesterone promotes the reaction [PGR protein results in increased expression of CXCL14 mRNA]; Propoxur inhibits the reaction [Progesterone results in increased activity of PGR protein]; Resveratrol inhibits the reaction [PGR protein affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ITGA1]]; Soil Pollutants inhibits the reaction [Progesterone results in increased expression of PGR mRNA]; Soot inhibits the reaction [Progesterone results in increased activity of PGR protein]; Toxaphene inhibits the reaction [Progesterone binds to PGR protein]; Vehicle Emissions inhibits the reaction [Progesterone results in increased activity of PGR protein]; vinclozolin inhibits the reaction [Progesterone binds to PGR protein]; vinclozolin inhibits the reaction [Progesterone results in increased expression of PGR protein]; zearalenol promotes the reaction [Progesterone binds to and results in increased activity of PGR protein]; Zearalenone inhibits the reaction [Progesterone binds to and results in increased activity of PGR protein]; ZNF366 protein inhibits the reaction [Progesterone results in increased activity of PGR protein]
Progesterone results in increased expression of PGR mRNA; Progesterone results in increased expression of PGR protein; Progesterone results in increased expression of PGR protein alternative form
[Estradiol co-treated with Progesterone] affects the expression of PGR protein; [lipopolysaccharide, E coli O55-B5 co-treated with Progesterone] results in decreased expression of PGR protein alternative form; [Progesterone results in increased activity of PGR protein] which results in decreased expression of RBP4 mRNA; [Progesterone results in increased activity of PGR protein] which results in increased expression of ADH5 mRNA; [Progesterone results in increased activity of PGR protein] which results in increased expression of ALDH1A1 mRNA; [Progesterone results in increased activity of PGR protein] which results in increased expression of CITED2 mRNA; [Progesterone results in increased activity of PGR protein] which results in increased expression of CYP26A1 mRNA; [Progesterone results in increased activity of PGR protein] which results in increased expression of GATA2 mRNA; [Progesterone results in increased activity of PGR protein] which results in increased expression of KLK5 mRNA; [Progesterone results in increased activity of PGR protein] which results in increased expression of KLK6 mRNA; [Progesterone results in increased activity of PGR protein] which results in increased expression of RBP1 mRNA; bisphenol A inhibits the reaction [Progesterone results in increased expression of PGR mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of PGR mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of PGR protein]; octylphenol inhibits the reaction [Progesterone results in increased expression of PGR mRNA]; PGR gene mutant form inhibits the reaction [Progesterone results in increased expression of CCNG1 mRNA]; PGR protein affects the reaction [Progesterone results in decreased expression of BMP2 mRNA]; PGR protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA]; PGR protein affects the reaction [Progesterone results in decreased expression of WIF1 mRNA]
Progesterone affects the localization of PGR protein
Progesterone results in decreased expression of PGR mRNA; Progesterone results in decreased expression of PGR protein alternative form
Progesterone binds to PGR protein; Progesterone binds to PGR protein alternative form
[Estradiol co-treated with Progesterone] results in increased expression of PGR mRNA; [Estrogens co-treated with Progesterone] results in increased phosphorylation of PGR protein; [Ethinyl Estradiol co-treated with Progesterone] results in increased expression of PGR protein; [Mifepristone binds to and results in decreased activity of PGR protein] which results in decreased susceptibility to Progesterone; [Progesterone co-treated with Estradiol] affects the expression of PGR mRNA; Atrazine inhibits the reaction [Progesterone binds to PGR protein]; Diethylstilbestrol inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of PGR protein]; Estradiol promotes the reaction [Progesterone binds to PGR protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of PGR mRNA]; o,p'-DDT promotes the reaction [Progesterone binds to PGR protein]; RNF4 protein promotes the reaction [Progesterone results in increased activity of PGR protein]; Simazine inhibits the reaction [Progesterone binds to PGR protein]; Ursodeoxycholic Acid inhibits the reaction [[Ethinyl Estradiol co-treated with Progesterone] results in increased expression of PGR protein] 		CTD PMID:1544902 PMID:4375319 PMID:7414049 PMID:8812239 PMID:9126867 More... NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pgrmc1 progesterone receptor membrane component 1 affects binding EXP Progesterone binds to PGRMC1 protein CTD PMID:15934950 NCBI chr  X:120,698,610...120,706,805
Ensembl chr  X:120,698,610...120,706,805 		JBrowse link
G Phactr3 phosphatase and actin regulator 3 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PHACTR3 mRNA CTD PMID:20660070 NCBI chr 3:165,205,247...165,423,692
Ensembl chr 3:185,582,796...185,801,822 		JBrowse link
G Phb1 prohibitin 1 multiple interactions ISO PHB1 protein inhibits the reaction [FSHB protein results in increased secretion of Progesterone] CTD PMID:23254195 NCBI chr10:80,605,268...80,618,043
Ensembl chr10:81,102,028...81,116,233 		JBrowse link
G Phf7 PHD finger protein 7 affects expression ISO Progesterone affects the expression of PHF7 mRNA CTD PMID:17251523 NCBI chr16:6,439,968...6,452,671
Ensembl chr16:6,439,970...6,452,671 		JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression
multiple interactions 		ISO Progesterone results in increased expression of PHLDA1 mRNA
[Estradiol co-treated with Progesterone] results in increased expression of PHLDA1 mRNA
[Estradiol co-treated with Progesterone] results in decreased expression of PHLDA1 mRNA 		CTD PMID:18556351 PMID:20660070 PMID:21795739 NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542 		JBrowse link
G Phlda2 pleckstrin homology-like domain, family A, member 2 increases expression ISO Progesterone results in increased expression of PHLDA2 mRNA CTD PMID:18037150 NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:208,126,302...208,127,920 		JBrowse link
G Phox2a paired-like homeobox 2a increases expression EXP Progesterone results in increased expression of PHOX2A mRNA CTD PMID:20726854 NCBI chr 1:156,178,754...156,183,118
Ensembl chr 1:165,590,757...165,595,122 		JBrowse link
G Phyh phytanoyl-CoA 2-hydroxylase increases expression EXP Progesterone results in increased expression of PHYH mRNA CTD PMID:20726854 NCBI chr17:78,238,747...78,255,645
Ensembl chr17:78,238,747...78,255,645 		JBrowse link
G Pi15 peptidase inhibitor 15 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PI15 mRNA CTD PMID:20660070 NCBI chr 5:6,178,427...6,206,548
Ensembl chr 5:6,174,963...6,247,841 		JBrowse link
G Pibf1 progesterone immunomodulatory binding factor 1 increases expression ISO Progesterone results in increased expression of PIBF1 mRNA; Progesterone results in increased expression of PIBF1 protein CTD PMID:17701593 NCBI chr15:82,258,243...82,427,546
Ensembl chr15:82,258,468...82,427,548 		JBrowse link
G Pid1 phosphotyrosine interaction domain containing 1 multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of PID1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of PID1 mRNA
Progesterone results in increased expression of PID1 mRNA 		CTD PMID:17404688 PMID:20660070 NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:92,734,214...92,750,070 		JBrowse link
G Piezo2 piezo-type mechanosensitive ion channel component 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PIEZO2 mRNA CTD PMID:20660070 NCBI chr18:58,738,734...59,115,252
Ensembl chr18:58,738,740...59,115,215 		JBrowse link
G Pik3r3 phosphoinositide-3-kinase regulatory subunit 3 decreases expression ISO Progesterone results in decreased expression of PIK3R3 mRNA CTD PMID:21795739 NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762 		JBrowse link
G Pim1 Pim-1 proto-oncogene, serine/threonine kinase multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PIM1 mRNA; Mifepristone promotes the reaction [Progesterone affects the expression of PIM1 mRNA] CTD PMID:20660070 PMID:22414680 NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,556,113...7,561,764 		JBrowse link
G Pim3 Pim-3 proto-oncogene, serine/threonine kinase increases expression EXP Progesterone results in increased expression of PIM3 mRNA CTD PMID:20726854 NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:121,832,742...121,836,259 		JBrowse link
G Pip5k1b phosphatidylinositol-4-phosphate 5-kinase type 1 beta multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PIP5K1B mRNA CTD PMID:20660070 NCBI chr 1:231,331,836...231,610,092
Ensembl chr 1:231,340,606...231,496,812 		JBrowse link
G Pitpnb phosphatidylinositol transfer protein, beta affects expression ISO Progesterone affects the expression of PITPNB mRNA CTD PMID:17251523 NCBI chr12:45,249,308...45,298,388
Ensembl chr12:50,909,143...50,958,140 		JBrowse link
G Pkd1 polycystin 1, transient receptor potential channel interacting multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PKD1 mRNA CTD PMID:19693291 NCBI chr10:14,077,733...14,125,682
Ensembl chr10:14,078,679...14,125,681 		JBrowse link
G Pkhd1l1 PKHD1 like 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PKHD1L1 mRNA CTD PMID:20660070 NCBI chr 7:77,505,063...77,679,994
Ensembl chr 7:77,505,152...77,679,994 		JBrowse link
G Pkia cAMP-dependent protein kinase inhibitor alpha multiple interactions ISO [Progesterone co-treated with Estradiol] results in decreased expression of PKIA mRNA CTD PMID:17404688 NCBI chr 2:94,398,869...94,473,638
Ensembl chr 2:96,306,184...96,321,262 		JBrowse link
G Pkm pyruvate kinase M1/2 affects expression ISO Progesterone affects the expression of PKM mRNA CTD PMID:17251523 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396 		JBrowse link
G Pla2g10 phospholipase A2, group X affects expression ISO Progesterone affects the expression of PLA2G10 mRNA CTD PMID:17251523 NCBI chr10:2,104,927...2,117,998
Ensembl chr10:2,104,927...2,116,172 		JBrowse link
G Pla2g4a phospholipase A2 group 4A increases expression ISO Progesterone results in increased expression of PLA2G4A mRNA CTD PMID:18070364 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Pla2g5 phospholipase A2, group V increases expression
decreases expression 		EXP
ISO 		Progesterone results in increased expression of PLA2G5 mRNA
Progesterone results in decreased expression of PLA2G5 mRNA 		CTD PMID:20726854 PMID:22238285 NCBI chr 5:156,324,628...156,393,065
Ensembl chr 5:156,324,629...156,381,926 		JBrowse link
G Pla2g7 phospholipase A2 group VII decreases expression ISO Progesterone results in decreased expression of PLA2G7 mRNA CTD PMID:22238285 NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747 		JBrowse link
G Plaat3 phospholipase A and acyltransferase 3 increases expression EXP Progesterone results in increased expression of PLAAT3 mRNA CTD PMID:20726854 NCBI chr 1:204,782,608...204,816,397
Ensembl chr 1:214,211,791...214,246,763 		JBrowse link
G Plac8 placenta associated 8 increases expression ISO Progesterone results in increased expression of PLAC8 mRNA CTD PMID:22238285 NCBI chr14:9,356,950...9,378,586
Ensembl chr14:9,356,972...9,378,572 		JBrowse link
G Plat plasminogen activator, tissue type increases expression
decreases expression 		ISO Progesterone results in increased expression of PLAT mRNA
Progesterone results in decreased expression of PLAT mRNA 		CTD PMID:21795739 PMID:22238285 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plau plasminogen activator, urokinase multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of PLAU mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of PLAU mRNA
Progesterone results in decreased expression of PLAU mRNA 		CTD PMID:17404688 PMID:18070364 PMID:20660070 NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030 		JBrowse link
G Plaur plasminogen activator, urokinase receptor increases expression
multiple interactions 		EXP
ISO 		Progesterone results in increased expression of PLAUR mRNA; Progesterone results in increased expression of PLAUR protein
[Estradiol co-treated with Progesterone] results in decreased expression of PLAUR mRNA 		CTD PMID:17170212 PMID:20660070 NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130 		JBrowse link
G Plcb1 phospholipase C beta 1 decreases expression ISO Progesterone results in decreased expression of PLCB1 mRNA CTD PMID:20864642 NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646 		JBrowse link
G Plcb4 phospholipase C, beta 4 increases expression ISO Progesterone results in increased expression of PLCB4 mRNA CTD PMID:22238285 NCBI chr 3:143,405,721...143,775,129
Ensembl chr 3:143,405,950...143,775,113 		JBrowse link
G Plce1 phospholipase C, epsilon 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PLCE1 mRNA CTD PMID:20660070 NCBI chr 1:245,655,855...245,964,966
Ensembl chr 1:245,657,080...245,963,828 		JBrowse link
G Plch1 phospholipase C, eta 1 decreases expression ISO Progesterone results in decreased expression of PLCH1 mRNA CTD PMID:21795739 NCBI chr 2:150,298,547...150,514,120
Ensembl chr 2:150,299,075...150,464,019 		JBrowse link
G Pld1 phospholipase D1 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of PLD1 mRNA
Progesterone results in decreased expression of PLD1 mRNA 		CTD PMID:19693291 NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:112,777,951...112,976,245 		JBrowse link
G Plec plectin decreases expression ISO Progesterone results in decreased expression of PLEC mRNA CTD PMID:18037150 PMID:18070364 NCBI chr 7:109,768,447...109,829,798
Ensembl chr 7:109,768,447...109,828,089 		JBrowse link
G Plek2 pleckstrin 2 multiple interactions
decreases expression 		ISO [Progesterone co-treated with Estradiol] results in decreased expression of PLEK2 mRNA
Progesterone results in decreased expression of PLEK2 mRNA 		CTD PMID:17404688 NCBI chr 6:103,434,156...103,452,457
Ensembl chr 6:103,434,156...103,452,371 		JBrowse link
G Plekha7 pleckstrin homology domain containing A7 increases expression ISO Progesterone results in increased expression of PLEKHA7 mRNA CTD PMID:21795739 NCBI chr 1:170,364,524...170,547,843
Ensembl chr 1:179,799,040...179,982,281 		JBrowse link
G Plekho1 pleckstrin homology domain containing O1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PLEKHO1 mRNA CTD PMID:20660070 NCBI chr 2:186,233,435...186,242,114
Ensembl chr 2:186,233,452...186,241,354 		JBrowse link
G Plk2 polo-like kinase 2 multiple interactions
decreases expression 		ISO
EXP 		[Estradiol co-treated with Progesterone] results in decreased expression of PLK2 mRNA
Progesterone results in decreased expression of PLK2 mRNA 		CTD PMID:20660070 PMID:20726854 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Plk4 polo-like kinase 4 affects expression ISO Progesterone affects the expression of PLK4 mRNA CTD PMID:17251523 NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892 		JBrowse link
G Pllp plasmolipin multiple interactions
increases expression 		ISO [Estradiol co-treated with Progesterone] results in increased expression of PLLP mRNA
Progesterone results in increased expression of PLLP mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr19:10,321,080...10,341,869
Ensembl chr19:10,321,080...10,342,226 		JBrowse link
G Pln phospholamban increases expression
multiple interactions 		EXP Progesterone results in increased expression of PLN mRNA
Mifepristone inhibits the reaction [Progesterone inhibits the reaction [bisphenol A results in increased phosphorylation of PLN protein]]; Pertussis Toxin inhibits the reaction [Progesterone inhibits the reaction [bisphenol A results in increased phosphorylation of PLN protein]]; Progesterone inhibits the reaction [bisphenol A results in increased phosphorylation of PLN protein]; wortmannin inhibits the reaction [Progesterone inhibits the reaction [bisphenol A results in increased phosphorylation of PLN protein]] 		CTD PMID:16376865 PMID:28324061 NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241 		JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 increases expression EXP Progesterone results in increased expression of PLOD2 mRNA CTD PMID:21770760 NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022 		JBrowse link
G Plp1 proteolipid protein 1 multiple interactions ISO [Progesterone co-treated with Estradiol] inhibits the reaction [Cuprizone results in decreased expression of PLP1 mRNA] CTD PMID:19031445 NCBI chr  X:104,933,921...104,993,317
Ensembl chr  X:104,975,780...104,993,314 		JBrowse link
G Plpp3 phospholipid phosphatase 3 increases expression ISO Progesterone results in increased expression of PLPP3 mRNA CTD PMID:20864642 NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667 		JBrowse link
G Plscr4 phospholipid scramblase 4 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PLSCR4 mRNA CTD PMID:20660070 NCBI chr 8:92,987,290...93,026,056
Ensembl chr 8:101,866,888...101,905,831 		JBrowse link
G Plxdc1 plexin domain containing 1 decreases expression ISO Progesterone results in decreased expression of PLXDC1 mRNA CTD PMID:21795739 NCBI chr10:83,418,837...83,478,451
Ensembl chr10:83,418,837...83,478,755 		JBrowse link
G Plxnc1 plexin C1 increases expression ISO Progesterone results in increased expression of PLXNC1 mRNA CTD PMID:20864642 NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:31,276,978...31,431,092 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 multiple interactions
decreases expression 		ISO [Estradiol co-treated with Progesterone] results in decreased expression of PMAIP1 mRNA
Progesterone results in decreased expression of PMAIP1 mRNA 		CTD PMID:20660070 PMID:22238285 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382 		JBrowse link
G Pmepa1 prostate transmembrane protein, androgen induced 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PMEPA1 mRNA CTD PMID:20660070 NCBI chr 3:182,430,193...182,478,649
Ensembl chr 3:182,430,193...182,478,649 		JBrowse link
G Pmp22 peripheral myelin protein 22 multiple interactions
increases expression 		EXP Progesterone inhibits the reaction [Streptozocin results in decreased expression of PMP22 mRNA]
Progesterone results in increased expression of PMP22 mRNA 		CTD PMID:16787508 PMID:17187935 NCBI chr10:48,294,932...48,324,941
Ensembl chr10:48,297,437...48,324,940 		JBrowse link
G Pnliprp1 pancreatic lipase-related protein 1 multiple interactions ISO [Estradiol co-treated with Progesterone] results in increased expression of PNLIPRP1 mRNA CTD PMID:19693291 NCBI chr 1:267,854,027...267,869,654
Ensembl chr 1:267,854,027...267,869,654 		JBrowse link
G Pnma8a PNMA family member 8A multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PNMA8A mRNA CTD PMID:20660070 NCBI chr 1:77,629,272...77,643,156
Ensembl chr 1:86,756,168...86,815,182 		JBrowse link
G Pnoc prepronociceptin multiple interactions EXP nociceptin (1-13) amide inhibits the reaction [PNOC protein inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of LHB protein]]; PNOC protein inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of LHB protein] CTD PMID:17640482 NCBI chr15:43,800,240...43,827,841
Ensembl chr15:43,800,246...43,827,470 		JBrowse link
G Pnrc2 proline-rich nuclear receptor coactivator 2 multiple interactions ISO [Estradiol co-treated with Progesterone] results in decreased expression of PNRC2 mRNA CTD PMID:21453500 NCBI chr 5:148,103,966...148,106,950
Ensembl chr 5:153,378,863...153,390,748 		JBrowse link
G Podxl podocalyxin-like increases expression EXP Progesterone results in increased expression of PODXL mRNA CTD PMID:20726854 NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789 		JBrowse link
G Pof1b POF1B, actin binding protein multiple interactions
decreases expression 		ISO NCOA2 protein affects the reaction [Progesterone results in decreased expression of POF1B mRNA] CTD PMID:17556502 NCBI chr  X:81,875,348...81,942,046
Ensembl chr  X:81,875,348...81,941,906 		JBrowse link
G Pofut1 protein O-fucosyltransferase 1 decreases expression ISO Progesterone results in decreased expression of POFUT1 mRNA CTD PMID:18037150 NCBI chr 3:162,168,855...162,195,798
Ensembl chr 3:162,168,606...162,195,018 		JBrowse link
G Pold1 DNA polymerase delta 1, catalytic subunit decreases expression EXP Progesterone results in decreased expression of POLD1 mRNA CTD PMID:20726854 NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:104,162,016...104,172,982 		JBrowse link
G Pole4 DNA pol